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1.1 Imaging	  life	  at	  the	  molecular	  level	  The	   average	   human	   body	   is	   composed	   of	   ~3.7	   x	   1013	   cells	   (Bianconi	   et	   al.,	   2013).	  Mammalian	  cells	  range	  from	  100-­‐10,000	  μm3	  in	  volume	  (Andersen	  et	  al.,	  2003;	  Frank	  et	  al.,	  1997),	   and	   in	   each	   cubic	   micron	   of	   the	   cell,	   there	   are	   2-­‐4	   million	   individual	   protein	  molecules	   (Milo,	   2013).	   This	  means	   even	   in	   the	   smallest	   cell,	   there	   are	   over	   200	  million	  proteins.	   The	   cellular	   environment	   is	   thus	   immensely	   crowded,	   and	   in	   this	   environment,	  proteins,	   lipids,	   nucleic	   acids	   and	   other	   constituents	   assemble	   into	   complex	   molecular	  machines	   that	   carry	   out	   all	   the	   biological	   processes	   necessary	   for	   life	   (Figure	   1-­‐1).	  Understanding	  the	  three-­‐dimensional	  (3D)	  spatial	  arrangement	  of	  these	  components	  helps	  to	  explain	  how	  they	  interact	  and	  function.	  	   	  
Figure	  1-­‐1	  The	  crowded	  




Figure	   1-­‐2	   Techniques	   to	   study	   cellular	   and	   macromolecular	   complexes.	   These	  include	  transmission	  electron	  microscopy	  (TEM)	  and	  nuclear	  magnetic	  resonance	  (NMR).	  
1.1.1 Light	  and	  fluorescence	  microscopy	  	  Simple	  light	  microscopes	  were	  the	  first	  devices	  used	  to	  significantly	  extend	  our	  capacity	  to	   visualise	   small	   objects	   beyond	   the	   resolving	   power	   of	   the	   human	   eye.	   In	   the	   17th	  century,	  Hooke	  and	  van	  Leeuwenhoek	  used	  glass	  lenses	  and	  basic	  microscopes	  to	  observe	  a	  previously	  unseen	  world,	  uncovering	  the	  existence	  of	  cells	  and	  single-­‐celled	  organisms	  (Amos,	   2000;	   Gest,	   2004).	   Since	   then,	   light	   microscopy	   has	   revolutionised	   our	  understanding	   of	   the	   microscopic	   world,	   and	   advances	   in	   technology	   have	   greatly	  increased	  the	  resolution	  at	  which	  specimens	  can	  be	  imaged.	  A	  significant	  innovation	  that	  has	   made	   optical	   microscopy	   one	   of	   the	   most	   widely	   used,	   and	   powerful	   tools	   in	   cell	  biology	   were	   the	   advent	   of	   fluorescence	   microscopy	   (FM),	   and	   the	   accompanying	  development	  of	  a	  wide	  range	  of	  staining	  and	  tagging	  methods.	  These	  allow	  specific	  cellular	  
3	  
	  
constituents	   to	   be	   localized	   in	   both	   chemically	   fixed	   and	   live	   cells.	   For	   example,	  fluorescence	   in	  situ	   hybridisation	   (FISH)	  allows	  specific	   sequences	  of	  nucleic	  acids	   to	  be	  detected,	   while	   cloneable	   fluorescence	   tags	   such	   as	   Green	   Fluorescent	   Protein	   (GFP)	  enable	  visualisation	  of	  fusion	  proteins	  in	  live	  cells.	  Other	  useful	  variants	  of	  GFP,	  including	  yellow	  fluorescent	  protein	  and	  calcium	  sensitive	  GFP,	  have	  been	  developed,	  facilitating	  the	  study	  of	  secondary-­‐messenger	  cascades	  and	  other	  forms	  of	  intracellular	  signalling,	  as	  well	  as	  intracellular	  localization	  (Pedelacq	  et	  al.,	  2006;	  Miyawaki	  et	  al.,	  1997).	  A	  whole	  host	  of	  fluorescent	   proteins	   and	   tags	   that	   can	   be	   expressed	   recombinantly	   are	   now	   available.	  Additionally,	   fluorescent	   tags	  with	  a	  broad	   range	  of	   chemistries	  have	  been	  developed	   to	  allow	  multiple	  protein	  labelling	  strategies	  to	  be	  applied.	  FM	  is	  thus	  a	  flexible	  tool	  to	  study	  a	  broad	  range	  of	  cellular	  processes	  (van	  Roessel	  &	  Brand,	  2002;	  Correa,	  2014).	  	  While	   traditional	   light	   microscopy	   has	   revolutionised	   our	   understanding	   of	   the	   cell,	  structures	  on	  the	  molecular	  scale,	  such	  as	  viruses,	  molecular	  chaperones	   like	  GroEL,	  and	  molecular	  motors	  like	  dynein,	  cannot	  be	  visualised	  using	  traditional	  light	  microscopy.	  The	  resolution	   of	   light	   microscopy	   is	   fundamentally	   limited	   by	   the	   wavelength	   of	   light	   to	  around	  200-­‐300	  nm	  laterally	  (x	  and	  y	  axes,	  perpendicular	  to	  the	  beam)	  and	  500-­‐700	  nm	  axially	   (z	   axis,	   parallel	   to	   the	   beam)(Huang	   et	   al.,	   2009).	   When	   light	   is	   focused	   by	   the	  microscope’s	  objective	  lens,	  it	  does	  not	  converge	  to	  an	  infinitely	  sharp	  focal	  point,	  but	  to	  a	  blurred	   point	   of	   a	   finite	   size	   defined	   by	   the	   numerical	   aperture	   of	   the	   lens	   and	   the	  wavelength	  of	  light,	  the	  size	  of	  which	  limits	  the	  resolution	  that	  can	  be	  achieved.	  This	  was	  first	  described	  by	  Ernst	  Abbe	  and	   is	  known	  as	   the	  Abbe	   limit	   (Schermelleh	  et	  al.,	  2010).	  Other	  methods	  are	  therefore	  needed	  if	  we	  are	  to	  examine	  the	  architecture	  of	  subcellular	  structures	  and	  molecular	  machines.	  
1.1.2 Super	  resolution	  light	  microscopy	  Several	   super	  resolution	  methods	  have	  been	  developed	   that	   improve	   the	  resolution	   that	  can	   be	   obtained	   using	   light	  microscopy.	   There	   are	   two	  main	   approaches.	   The	   first	   uses	  patterned	   illumination	   to	   spatially	   modulate	   fluorophores	   within	   a	   diffraction	   limited	  region,	   so	   that	   the	   fluorophores	   do	   not	   emit	   simultaneously	   (Schermelleh	   et	   al.,	   2010).	  Examples	  of	  this	  include	  simulated	  emission	  depletion	  (STED)	  microscopy	  and	  structured	  illumination	  microscopy	   (SIM).	   Instant	   SIM	   is	   well	   suited	   for	   live	   cell	   imaging	   as	   it	   can	  acquire	   images	  at	  >100	   frames	  per	   second,	   and	  offers	  a	   resolution	  of	  ~145	  nm	   laterally	  and	   320	   nm	   axially	   at	   488	   nm	   excitation	   wavelength	   and	   a	   1.49	   NA	   objective	   lens,	   in	  addition	  to	  real-­‐time	  display	  of	  super	  resolution	  images	  (Curd	  et	  al.,	  2015).	  	  	  Stochastic	   optical	   reconstruction	   microscopy	   (STORM)(Rust	   et	   al.,	   2006)	   and	  photoactivated	  localisation	  microscopy	  (PALM)(Betzig	  et	  al.,	  2006)	  use	  fluorophores	  that	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stochastically	  activate	  or	  photo-­‐switch	  at	  different	  times.	  Within	  single	  images	  of	  sparsely	  emitting	  fluorophores,	  the	  positions	  of	  individual	  fluorphores	  can	  be	  calculated	  with	  very	  high	   accuracy,	   and	   are	   then	   combined	   to	   yield	   a	   sub	  diffraction	   limit	   image.	   In	   order	   to	  perform	  STORM/PALM,	  fluorescent	  probes	  need	  to	  have	  emission/excitation	  spectra	  that	  do	  not	  overlap	  with	  the	  dark	  state,	  and	  that	  are	  bright	  (i.e.	  emit	  a	  high	  number	  of	  photons	  in	  one	  duty	  cycle	  and	  a	  low	  spontaneous	  fluorophore	  activation	  rate)(Huang	  et	  al.,	  2010).	  Many	   such	   probes	   are	   now	   available,	   including	   fluorescent	   proteins	   and	   organic	   dyes.	  Resolutions	   better	   than	   10	   nm	   can	   now	   be	   achieved	   through	   these	   techniques,	   but	   as	  image	  acquisition	  can	  take	  minutes,	  samples	  are	  usually	  fixed	  before	  imaging	  (Huang	  et	  al.,	  2010).	  
1.1.3 X-­‐	  ray	  crystallography	  and	  small	  angle	  X	  ray	  scattering	  	  Compared	  with	  visible	  light	  which	  has	  a	  wavelength	  of	  400-­‐700	  nm,	  a	  typical	  X-­‐ray	  source	  has	  a	  wavelength	  of	  ~	  0.01	  nm,	  allowing	  a	  theoretical	  maximum	  resolution	  of	  ~0.5	  Å	  to	  be	  obtained,	  which	  is	  approximately	  half	  the	  length	  of	  a	  carbon	  bond.	  X-­‐ray	  crystallography	  is	  a	  powerful	  technique	  for	  studying	  the	  atomic	  structure	  of	  proteins.	  In	  pioneering	  work	  in	  the	   field,	  X-­‐rays	  were	  used	  to	  examine	  the	  structural	  properties	  of	  biological	  samples	  by	  William	  Astbury	   at	   the	  University	   of	   Leeds,	  who	  used	   fibre	  diffraction	   to	   study	  proteins	  including	   keratin	   (Astbury	   &	   Sisson	   1935;	   Astbury	   &	   Marwick,	   1931).	   Fibres	   such	   as	  keratin	   and	   deoxyribonucleic	   acid	   (DNA)	   produce	   diffraction	   patterns	   with	   layer	   line	  reflections,	   however	  X-­‐rays	   can	   also	  be,	   and	  are	  now	  most	   commonly	  used,	   to	   study	  3D	  crystals.	   Proteins	   in	   a	   crystal	   are	   arranged	   in	   a	   lattice,	  with	   the	   smallest	   repeating	   unit	  known	   as	   a	   unit	   cell.	   The	   points	   recorded	   from	   X-­‐ray	   diffraction	   through	   the	   crystal	  correspond	   to	   points	   on	   a	   reciprocal	   lattice.	   This	   pattern	   of	   diffraction	   spots,	   or	   Bragg	  peaks,	  are	  predicted	  by	  Bragg’s	  Law,	  which	  describes	  how	  constructive	  interference	  gives	  rise	   to	   the	   diffraction	   pattern	   (Drenth,	   2007;	   Bragg	   1913).	   Each	   spot	   of	   the	   diffraction	  pattern	  represents	  a	  sampling	  of	  the	  unit	  cell	  of	  the	  crystal.	  Typically,	  large,	  well-­‐ordered	  crystals	   consist	   of	  more	   unit	   cells,	   and	   so	   can	   amplify	   the	   diffraction	   signal	   better	   than	  disordered	   or	   smaller	   crystals.	   For	  most	   crystals,	   in	   order	   to	   adequately	   sample	   the	   3D	  reciprocal	   lattice	   of	   the	   crystal,	   several	   diffraction	   patterns	   must	   be	   recorded	   with	   the	  crystal	  rotated	  at	  different	  angles.	  The	  intensity	  of	  the	  diffraction	  spots	  are	  recorded	  and	  converted	  to	  wave	  amplitudes	  that,	  along	  with	  phase	  information,	  can	  be	  used	  to	  calculate	  the	  electron	  density	  of	   the	  unit	   cell.	  Phase	   information	   is	  not	   recorded	   in	   the	  diffraction	  pattern,	   and	   so	   must	   be	   determined	   using	   other	   approaches,	   such	   as	   multiple	  isomorphous	  replacement,	  molecular	   replacement,	  or	  anomalous	  dispersion	  (Ladd	  et	  al.,	  2013).	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As	  of	  November	  2015,	  over	  113,000	  X-­‐ray	  crystallography	  structures	  have	  been	  deposited	  in	   the	   Research	   Collaboratory	   for	   Structural	   Bioinformatics	   (RCSB)	   Protein	   Data	   Bank	  (PDB).	  Many	  proteins	  and	  complexes	  of	  interest	  form	  well-­‐ordered	  3D	  crystals,	  making	  X-­‐ray	  crystallography	  a	  viable	  technique	  to	  study	  their	  structure.	  However,	  some	  specimens	  have	  eluded	  crystallisation,	  such	  as	  many	  virus	  capsids	  and	  membrane	  proteins.	  Here	  we	  will	   consider	   the	   reasons	  virus	   capsids	  may	  not	   crystallise.	   Firstly,	   the	   capsid	   itself	  may	  disassemble,	   creating	   heterogeneity	   in	   the	   sample,	   become	   insoluble	   at	   concentrations	  required	   for	   crystallisation,	   or	   be	   intrinsically	   heterogeneous,	   all	   factors	   preventing	   the	  formation	  of	  well-­‐ordered	  3D	  crystals.	  Other	  challenges	  present	  themselves	  because	  of	  the	  size	   of	   capsids;	   the	   asymmetric	   unit	   of	   a	   capsid	   crystal	   is	   very	   large	   compared	   with	   a	  typical	   protein,	   meaning	   many	   more	   X-­‐ray	   reflections	   are	   present	   in	   the	   diffraction	  pattern,	  which	  are	  typically	  weak,	  complicating	  structure	  determination	  (Fry	  et	  al.,	  1999).	  Even	  where	  crystallisation	  is	  possible,	  elements	  of	  the	  structure	  may	  not	  be	  visible	  in	  an	  X-­‐ray	  crystallography	  experiment	  for	  example,	  flexible	  N-­‐terminal	  or	  C-­‐terminal	  extensions	  and	  the	  genome	  are	  typically	  disordered	  and	  so	  invisible	  during	  crystallographic	  analysis,	  although	  there	  are	  some	  interesting	  exceptions	  such	  as	  bean	  pod	  mottle	  virus	  where	  the	  symmetry	   of	   the	   capsid	   is	   reflected	   in	   part	   by	   the	   structure	   of	   the	   genome	   (Fry	   et	   al.,	  1999).	  	  
1.1.4 Soft	  X-­‐ray	  cryo-­‐microscopy	  Transmission	   soft	   X-­‐ray	   cryo	   microscopy/tomography	   (cryoXM/T)	   is	   a	   technique	   that	  uses	   photons	   with	   wavelengths	   of	   4.37-­‐2.29	   nm	   to	   image	   cryo-­‐immobilised	   (Section	  1.2.1.3)	  biological	  specimens	  such	  as	  whole	  eukaryotic	  cells	  (Dent	  et	  al.,	  2014).	  Photons	  at	  these	   energies	   are	   in	   the	   ‘water	   window’,	   where	   contrast	   arises	   from	   the	   differential	  absorption	  of	  X-­‐rays.	  A	  biological	  specimen,	  such	  as	  a	  cell,	  primarily	  comprises	  of	  carbon,	  nitrogen,	   oxygen	   and	   phosphate.	   These	   atoms	   will	   strongly	   absorb	   X-­‐rays	   at	   these	  energies,	   so	   the	   resulting	   image	   reflects	   the	   specimen’s	   elemental	   makeup.	   Prominent	  features	   include	   lipid	  bodies,	   the	  nuclear	  envelope	  and	  vesicles.	  As	  cryoXM	  is	  dependent	  on	   the	   absorption	   contrast	   of	   the	   sample,	   it	   is	   possible	   that	   the	   linear	   absorption	  coefficient	  of	  different	  parts	  of	   the	  specimen	  could	  be	  used	   for	  sample	   identification,	   for	  example	   characterizing	   different	   compartments	   in	   a	   cell.	   Photons	   at	   510-­‐520	   eV	   are	  routinely	  used,	  allowing	  samples	  ~20	  μM	  thick	  to	  be	  imaged.	  Resolutions	  of	  36-­‐70	  nm	  can	  be	  achieved	  for	  biological	  specimens	  (Müller	  et	  al.,	  2012).	  	  The	   cryoXM	   is	   maintained	   under	   a	   high	   vacuum,	   typically	   <	   10-­‐7	   torr,	   with	   the	   sample	  mounted	  in	  a	  frozen	  hydrated	  state	  on	  an	  electron	  microscopy	  (EM)	  grid,	  or	  in	  a	  capillary	  tube	   (depending	   on	   the	   microscope)(Dent	   et	   al.,	   2014).	   The	   cryoXM	   has	   two	   primary	  optical	  components,	  a	  condenser	  and	  objective	  Fresnel	  zone	  plate,	  used	  to	  illuminate	  the	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specimen	  and	  form	  the	  magnified	  image	  onto	  the	  detector,	  respectively.	  Zone	  plates	  are	  a	  circular	   diffraction	   grating	   with	   a	   series	   of	   concentric,	   strongly	   X-­‐ray	   absorbing	   metal	  rings	   overlaid	   with	   a	   ~	   100	   nm	   silicone	   nitride	   membrane,	   and	   function	   by	   using	  diffraction	  to	  focus	  X-­‐rays.	  The	  maximum	  possible	  resolution	  is	  dependent	  on	  the	  smallest	  zone	  width	  and	  so	  zone	  plate	  technology	  is	  currently	  a	  major	  limiting	  factor	  to	  improving	  resolution.	   Work	   is	   being	   undertaken	   to	   produce	   superior	   zone	   plates	   which	   may	  (theoretically)	  enable	  resolutions	  of	  better	  than	  12	  nm	  to	  be	  achieved	  (Chao	  et	  al.,	  2009).	  	  	  As	   cryoXM	   is	   usually	   applied	   to	   relatively	   thick	   samples	   such	   as	   cells,	   two-­‐dimensional	  (2D)	   images,	  which	   represent	   a	  projection	  view	  of	   the	   sample,	   can	  be	  hard	   to	   interpret.	  Consequently,	   the	   most	   useful	   data	   is	   obtained	   when	   a	   tomographic	   approach	   is	   used	  (Section	   1.4.3).	   Such	   experiments	   involve	   the	   collection	   of	   many	   images	   of	   the	   sample,	  each	   tilted	   at	   a	   different	   angle.	   The	   back-­‐projection	   of	   these	   images	   is	   then	   used	   to	  calculate	  a	  3D	  reconstruction	  of	  the	  sample.	  Using	  these	  data,	  the	  3D	  relationship	  between	  cellular	   components	   can	   be	   determined.	   The	   technique	   has	   achieved	   resolutions	  approaching	  30	  nm	  and	  better	  for	  test	  objects	  (Müller	  et	  al.,	  2012).	  CryoXM	  is	  increasingly	  being	  used	  as	  a	   complementary	   technique	   in	  conjunction	  with	  both	  cryo-­‐EM	  and	  optical	  techniques,	  and	  correlative	  approaches	  are	  being	  developed	  (Section	  1.5.1)(Carlson	  et	  al.,	  2013).	  	  




Figure	   1-­‐3	   An	   early	   example	   of	  
biological	   TEM.	   Fibroblast	   like	  cell	   fixed	   with	   osmium	   tetroxide	  on	   formvar	   plastic.	   Adapted	   from	  	  Porter	  et	  al.,	  1945.	  	  	  
1.2.1 Sample	  preparation	  To	   image	   with	   electrons,	   a	   microscope	   must	   be	   maintained	   under	   a	   high	   vacuum,	  excluding	   air	   molecules	   that	   will	   scatter	   the	   beam.	   However,	   hydrated	   biological	  specimens	  would	  dehydrate	  rapidly	  into	  a	  non-­‐native	  state	  under	  a	  high	  vacuum.	  To	  image	  a	  biological	  specimen,	  it	  must	  therefore	  first	  be	  preserved	  in	  a	  native	  (or	  native-­‐like)	  state.	  Another	  consideration	  is	  sample	  thickness.	  In	  some	  cases,	  the	  sample	  may	  be	  too	  thick	  for	  electrons	  to	  be	  ‘transmitted’,	  a	  prerequisite	  for	  TEM,	  and	  so	  the	  specimen	  may	  need	  to	  be	  processed	   to	   make	   it	   thinner.	   The	   choice	   of	   preparation	   technique	   is	   ultimately	  determined	  by	  the	  nature	  of	  the	  sample	  and	  the	  resolution	  needed	  to	  achieve	  the	  intended	  biological	  insight.	  	  




staining	  can	  be	  used	  to	  elucidate	  the	  binding	  of	  small	  molecule	  inhibitors	  in	  a	  timeframe	  of	  weeks,	   (Muench	   et	  al.,	   2014),	   assess	   conformational	   changes	   (Hesketh	   et	  al.,	   2015a;	   A.J.	  Roberts	   et	   al.,	   2009),	   complex	   stability	   (Wu	   et	   al.,	   2012)	   and	   subunit	  stoichiometry/position	  (Rasmussen	  et	  al.,	  2011;	  Low	  et	  al.,	  2014).	  The	  process	  of	  negative	  staining	  has	  been	  reviewed	  in	  (Ohi	  et	  al.,	  2004).	  	  
	  
	  
1.2.1.2 Plastic	  embedding	  and	  thin	  sectioning	  of	  cells	  When	  imaging	  cells	  or	   tissues	   in	   the	  TEM,	  specimen	  thickness	  becomes	  a	   limiting	   factor.	  To	   overcome	   this,	   samples	   can	   be	   chemically	   fixed,	   embedded	   in	   plastic	   and	   sectioned.	  This	   involves	   fixation	   (e.g.	   with	   gluteraldehyde),	   staining	   with	   osmium	   tetroxide	   and	  dehydration	   in	   alcohol	   or	   acetone.	   The	   specimen	   is	   then	   embedded	   in	   a	   resin	   and	  sectioned	   using	   a	   microtome.	   Sections	   are	   mounted	   onto	   a	   support	   grid	   and	   further	  stained	   with	   heavy	  metal	   such	   as	   uranyl	   acetate.	   Each	   step	   is	   harsh	   and	   can	   introduce	  artefacts,	   making	   image	   interpretation	   difficult.	   However,	   despite	   these	   problems	   this	  technique	   has	   revolutionised	   our	   understanding	   of	   cell	   ultrastructure	   (Knott	   &	   Genoud,	  2013).	  	  
1.2.1.3 Cryogenic	  preparation	  Staining,	   plastic	   embedding	   and	   sectioning	   dehydrate	   the	   biological	   specimen,	  fundamentally	  removing	  it	  from	  its	  native,	  aqueous	  environment.	  To	  better	  preserve	  such	  specimens	  in	  their	  native	  state	  in	  the	  high	  vacuum	  of	  the	  EM,	  cryogenic	  immobilisation	  can	  be	   used.	   Cryo-­‐immobilisation	   has	   the	   dual	   benefits	   of	   preserving	   the	   specimen	   in	   an	  aqueous	   environment	   inside	   the	   EM,	   and	   also	   the	   low	   temperature	   ameliorates	   the	  damaging	  effect	  of	  the	  electron	  beam.	  The	  sample	  must	  be	  frozen	  extremely	  rapidly,	  at	  a	  rate	  of	  ~106	  °C/s,	  so	  that	  the	  water	  in,	  and	  surrounding,	  the	  specimen	  is	  fixed	  in	  a	  vitreous	  state	   (Dubochet	   et	  al.,	   1988).	   If	   freezing	   occurs	  more	   slowly,	   ice	   crystals	   form	   from	   the	  hydration	   shell	   of	   the	   complexes,	   or	   even	   within	   the	   sample,	   disrupting	   the	   atomic	  
Figure	   1-­‐4	   Positive	   and	   negative	  
staining	   using	   heavy	   metal	   salts.	  Negative	   staining	   (A),	   the	   stain	   fully	  envelops	   the	   macromolecular	  complex;	  the	  complex	  appears	  light	  on	  a	   dark	   background.	   Positive	   staining	  (B)	   results	   in	   a	   small	   amount	   of	   stain	  forming	   a	   thin	   shell	   around	   the	  molecule,	  meaning	  the	  sample	  appears	  dark	  on	  a	  light	  background.	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structure	  of	   the	  specimen.	   Image	  quality	   is	  also	  reduced	  owing	  to	  electron	  diffraction	  by	  ice	   crystals	   (Figure	   1-­‐5).	   Hexagonal	   ice	   can	   form	   during	   freezing,	  while	   cubic	   ice	   forms	  when	  vitreous	  ice	  layers	  warm	  (Dubochet	  &	  Lepault,	  1984).	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  





larger	   number	   of	   variables	   during	   the	   blotting	   and	   plunging	   process	   to	   achieve	   more	  reproducible	  results,	  including	  models	  by	  FEI,	  Leica	  and	  Gatan.	  	  	  A	  key	  consideration	  in	  cryogenic	  specimen	  preparation	  is	  the	  support	  film	  to	  be	  used.	  EM	  grids	   are	   traditionally	  3.05	  mm	  across,	   and	  made	   from	  a	  mesh	  of	  metal	   such	   as	   copper,	  gold,	   nickel,	  molybdenum	   or	   rhodium.	   The	  mesh	   size,	   or	   number	   of	   squares	   across	   the	  grid,	  is	  defined	  as	  the	  number	  of	  squares	  in	  one	  inch.	  For	  example,	  a	  200-­‐mesh	  grid	  has	  20	  squares	  across	  in	  one	  direction,	  and	  a	  300	  mesh	  30	  squares.	  200-­‐400	  mesh	  grids	  are	  most	  commonly	  used	  in	  cryo-­‐EM.	  The	  next	  consideration	  is	  support	  film.	  Generally,	  perforated	  carbon	  films	  are	  used	  so	  the	  specimen	  is	   imaged	  in	   ice	  suspended	  in	  holes	   in	  such	  films.	  However,	   samples	   have	   differing	   affinities	   for	   the	   carbon	   film,	   with	   some	   almost	  exclusively	  depositing	  on	  the	  carbon.	  The	  surface	  properties	  of	  the	  carbon	  can	  be	  altered	  by	  a	  variety	  of	  processes,	   including	  exposure	   to	  UV	  radiation	  and	  glow	  discharge,	  which	  render	  the	  carbon	  film	  hydrophilic	  (Grassucci	  et	  al.,	  2007).	  Altering	  the	  charge	  properties	  of	  the	  carbon	  film	  can	  aid	  the	  partition	  of	  the	  sample	  into	  the	  holes,	  but	  this	  needs	  to	  be	  optimised	   for	  each	   sample.	   Some	  samples	  have	  very	  high	  affinities	   for	   the	   carbon,	   these	  samples	  sometimes	  benefit	   from	  a	  thin	  (~10	  nm	  or	  thinner,	  although	  there	  is	  a	  trade	  off	  between	   carbon	   stability	   and	   thickness)	   continuous	   carbon	   film	   over	   the	   surface	   of	   the	  grid	  to	  improve	  particle	  distribution.	  Perforated	  films	  are	  available	  commercially,	  and	  can	  consist	   of	   regular	   arrays	   of	   equal	   sized	   holes,	   as	   with	   Quantifoil	   and	   C-­‐flat	   grids,	   or	  irregular	  as	  in	  lacy	  carbon	  (Figure	  2-­‐1).	  Carbon	  support	  films	  are	  widely	  used,	  but	  are	  not	  without	  their	  problems.	  Instability	  of	  the	  carbon	  film	  contributes	  to	  beam	  induced	  particle	  motion,	   blurring	   the	   image	   of	   the	   specimen	   (Russo	   &	   Passmore,	   2014).	   Novel	   support	  films	   have	   been	   recently	   developed	   to	   tackle	   this	   problem,	   including	   gold	   supports	   and	  doped	   silicone	   carbide	   films.	   Both	   appear	   to	   reduce	   beam	   induced	   particle	   movement	  (Russo	  &	  Passmore,	  2014;	  Yoshioka	  et	  al.,	  2010).	  	  	  While	   thin	   samples,	   such	   as	  macromolecular	   assemblies,	   or	   the	   thin	   edge	   of	   larger	   cells	  may	   be	   cryogenically	   fixed	   by	   plunge	   freezing,	   thicker	   samples	   (<	   1	   μm)	   such	   as	   the	  nuclear	   and	   perinuclear	   regions	   of	   eukaryotic	   cells,	   or	   tissue	   sections	   are	   likely	   to	  experience	   some	   crystalline	   ice	   formation.	   For	   these	   specimens,	   high-­‐pressure	   freezing	  (HPF)	  is	  an	  effective	  alternative.	  HPF	  involves	  raising	  the	  pressure	  of	  the	  sample	  to	  ~2000	  bar	   while	   dropping	   the	   temperature	   using	   liquid	   nitrogen	   (McDonald	   &	   Auer,	   2006).	  Samples	   over	   100	   μm	   thick	   can	   be	   vitrified	   using	   HPF.	   Vitrified	   samples	   must	   then	  sectioned	   to	   be	   thin	   enough	   for	   TEM.	   Sectioning	   can	   be	   performed	   under	   cryogenic	  conditions,	  which	  gives	  the	  best	  preservation	  of	  the	  sample.	  The	  technique	  known	  as	  cryo-­‐EM	  of	  vitreous	  sections	  (CEMOVIS)	  uses	  cryo-­‐ultramicrotomy	  with	  a	  diamond	  knife	  under	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cryogenic	   conditions	   to	   produce	   sections	   40-­‐100	   nm	   thick	   (Al-­‐Amoudi	   et	   al.,	   2004;	  Chlanda	  &	  Sachse,	  2014).	  It	  is	  a	  useful	  technique	  to	  image	  thick	  specimens	  in	  a	  native-­‐like	  state,	  but	  it	  is	  technically	  challenging.	  A	  common	  alternative	  approach	  is	  to	  perform	  freeze	  substitution,	   which	   enables	   sectioning	   and	   imaging	   at	   room	   temperature	   (Walther	   &	  Ziegler,	   2002;	  Matsko	  &	  Mueller,	   2005).	   Freeze	   substitution	   involves	  gradually	  warming	  the	   specimen	   and	   replacing	   the	   water	   with	   acetone.	   The	   sample	   can	   then	   be	   stained,	  embedded	  in	  resin	  and	  sectioned.	  This	  technique	  introduces	  fewer	  artefacts	  compared	  to	  traditional	   plastic	   embedding.	   However,	   some	   small	   ice	   crystals	   do	   form	   causing	  rearrangement	  of	  cell	  structures,	  and	  staining	  is	  not	  uniform	  so	  interpreting	  images	  can	  be	  challenging.	  	  	  Frozen-­‐hydrated	   samples	  must	  be	  visualised	  at	   cryogenic	   temperatures,	   known	  as	   cryo-­‐EM.	  A	  major	  technical	  challenge	  in	  cryo-­‐EM	  is	  transferring	  the	  specimen	  at	  -­‐180	  °C	  to	  the	  microscope	  without	   warming	   it	   above	   -­‐137	  °C,	   the	   temperature	   of	   water	   devitrification	  (Dubochet	   et	   al.,	   1988),	   while	   also	  maintaining	   the	   thermal	   and	  mechanical	   stability	   of	  microscope	  components	  to	  allow	  imaging.	  	  
1.2.1.4 Focus	  Ion	  Beam	  Milling	  For	  thicker	  samples,	  such	  as	  whole	  eukaryotic	  cells	  or	  networks	  of	  cells,	  focused	  ion	  beam	  (FIB)	  milling	   can	   be	   used	   to	   reduce	   specimen	   thickness	   or	   to	   perform	   serial	   block-­‐face	  imaging	   (Schertel	  et	  al.,	   2013;	  K.	  Wang	  et	  al.,	   2012).	  FIB	  milling	   is	   carried	  out	  on	   frozen	  hydrated	  specimens	  in	  a	  dual	  beam	  scanning	  EM/FIB.	  In	  this	  approach,	  a	  focused	  beam	  of	  ions	   blasts	   material	   from	   the	   surface	   of	   the	   sample	   in	   a	   defined	   manner,	   while	   the	  scanning	   electron	  microscope	   (SEM)	  allows	   simultaneous	  non-­‐destructive	  monitoring	  of	  the	  milling	   process	   (Rigort	  &	  Plitzko,	   2015).	   In	   FIB	  milling,	   incoming	   ions	   expel	   surface	  atoms	  in	  a	  process	  known	  as	  sputtering,	  and	  the	  beam	  is	  rastered	  across	  the	  surface	  of	  the	  specimen	   removing	   material	   in	   a	   layer-­‐by-­‐layer	   manner.	   Gallium	   ions	   are	   the	   most	  popular	   due	   to	   their	   volatility	   (Rigort	  &	   Plitzko,	   2015).	   The	   ion	   beam	   is	   generated	   by	   a	  liquid	  metal	   ion	   source	  and	   liberated	  by	  an	  extraction	  electrode.	  Electromagnetic	   lenses	  and	   apertures	   are	   used	   to	   focus	   the	   ion	   beam,	   and	   deflectors	   to	   control	   the	   pattern	   of	  milling.	  	  	  FIB	  milling	  can	  introduce	  artefacts.	  Sputtered	  material	  can	  redeposit	  on	  the	  surface	  of	  the	  specimen,	   although	   an	   anti-­‐contaminator	   device	   close	   to	   the	   specimen	   can	   reduce	   this.	  Milling	   can	   also	   produce	   streaking	   or	   curtaining	   across	   the	   surface	   when	   differential	  milling	  occurs.	  Another	  concern	  is	  the	  transfer	  of	  thermal	  energy	  to	  the	  specimen,	  causing	  local	  heating	  and	  devitrification.	  However	  it	  has	  been	  shown	  that	  under	  set	  conditions	  FIB	  milling	  does	  not	  raise	  temperatures	  sufficiently	  for	  this	  to	  be	  a	  routine	  problem	  (Marko	  et	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al.,	  2006).	  It	  would	  be	  very	  interesting	  to	  perform	  FIB	  milling	  on	  a	  crystal	  and	  assess	  how	  it	  affects	  diffraction,	  as	  this	  may	  reveal	  how	  the	  process	  degrades	  high-­‐resolution	  features	  of	  the	  specimen.	  	  	  Since	   the	   first	   successful	   cryo-­‐FIB	  experiment	   in	  2003	   (Mulders,	   2003),	  workflows	  have	  been	   developed	   to	   improve	   and	   optimise	   the	   technique	   including	   in	   situ	   cryo-­‐lamella	  preparation	   of	   cells	   grown	   on	   EM	   grids	   (Figure	   1-­‐6).	   Cryo-­‐FIB	   technology	   is	   still	   being	  developed,	   one	   particularly	   exciting	   development	   is	   the	   implementation	   of	   correlative	  light	  microscopy	  in	  combination	  with	  FIB	  milling,	  as	  discussed	  in	  Section	  1.5.1.2	  (Rigort	  et	  
al.,	  2012).	   	  	  	  	  	  
Figure	   1-­‐6	   Preparation	   of	   in	   situ	  
cryo-­‐lamellar	   using	   focused	   ion	  
beam	  milling.	  Milling	  patterns	  can	  be	  adapted	  to	  produce	  lamellar	  (A,	  green	  lamellar)	   in	   perinuclear	   regions	   of	   a	  cell.	  The	  lamellar	  can	  be	  viewed	  in	  the	  SEM	   (B-­‐	   top	   down	   view	   of	   lamellar,	  scale	   bar	   2	   μm),	   and	   transferred	   into	  the	  TEM	  for	  cryo-­‐electron	  tomography	  (discussed	   in	   Section	   1.4.3),	   a	   slice	  through	   a	   tomogram	   of	   a	   perinuclear	  region	  of	  the	  cell	  (C-­‐	  scale	  bar	  200	  nm)	  revealing	   the	  nuclear	   envelope	   (black	  arrow)	   and	   nuclear	   pore	   complexes	  (white	  arrow).	  Adapted	  from	  Rigort	  &	  Plitzko,	  2015.	  






	  One	   of	   the	  most	   common	   approaches	   to	   achieving	   time	   resolution	   utilises	  microfluidics	  where	   one	   reactant	   is	   sprayed	   onto	   the	   grid	   and	   a	   second	   reactant	   sprayed	   on	   before	  freezing	  (White	  et	  al.,	  2003).	  In	  an	  alternative	  approach,	  rapid	  mixing	  of	  the	  two	  reagents	  is	  performed,	  which	  are	  then	  sprayed	  onto	  a	  thin	  film	  that	  is	  rapidly	  vitrified.	  The	  fastest	  reported	   time	   resolution	   has	   been	   achieved	   using	   a	  monolithic	  micro-­‐fabricated	   silicon	  device	  that	  incorporates	  a	  mixing	  mechanism,	  incubation	  channel	  and	  pneumatic	  sprayer	  in	  a	  single	  chip	  (Shaikh	  et	  al.,	  2014).	  It	  is	  capable	  of	  achieving	  mixing	  within	  0.4	  ms	  and	  a	  minimum	   reaction	   time	   of	   9.4	   ms	   (Shaikh	   et	   al.,	   2014).	   Using	   this	   methodology,	   the	  dynamics	   of	   bridges	   associating	   the	   30S	   and	   50S	   bacterial	   ribosomal	   subunits	   was	  examined	   (Shaikh	   et	   al.,	   2014).	   While	   improvements	   in	   microfluidic	   devices	   may	   yield	  improvements	  in	  time	  resolution,	   it	  has	  been	  suggested	  that	  the	  use	  of	  photo-­‐activatable	  complexes	  may	  enable	  even	  faster	  time	  resolution	  to	  be	  achieved.	  For	  example,	  by	  fitting	  a	  fibre	  optic	  cable	  or	  another	  bright	  light	  source	  very	  close	  to	  the	  cryogen	  before	  the	  sample	  is	  plunged,	   a	   conformational	   change	  may	  be	   induced	  and	   fixed	  by	  vitrification	  on	   the	  ns	  time	   scale.	   Depending	   on	   the	   temporal	   resolution	   of	   the	   approach	   and	   the	   timescales	  under	  which	   the	   reaction	  or	   conformational	   change	   is	  occurring,	   often	   the	   cryogenically	  fixed	   sample	   will	   represent	   a	   range	   of	   conformations	   or	   reaction	   states.	   New	  developments	   enable	   in	   silico	   purification	   of	   heterogeneous	   mixes	   of	   conformations	  (Voorhees	  et	  al.,	  2014),	  as	  discussed	  in	  Section	  1.4.2.2.	  
1.3 Design	  of	  the	  EM	  In	   its	   most	   basic	   form,	   the	   TEM	   consists	   of	   an	   electron	   source/gun,	   a	   series	   of	  electromagnetic	   lenses	   to	   focus	   the	   electron	   beam,	   and	   a	   mechanism	   for	   viewing	   or	  recording	  an	  image	  of	  the	  specimen,	  all	  maintained	  under	  high	  vacuum	  (Figure	  1-­‐7).	  Many	  different	  EM’s	  are	  available	  commercially	  from	  companies	  including	  FEI	  and	  JEOL,	  which	  share	  similar	  main	  components	  and	  designs.	  Here	  the	  principal	  components	  of	  the	  EM	  and	  process	  of	  image	  formation	  are	  discussed.	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1.3.1 Image	  formation	  in	  the	  TEM	  In	   the	   TEM,	   electrons	   are	   transmitted	   through	   the	   specimen,	   and	   the	   projected	   image	  consists	  of	  areas	  of	  light	  and	  dark,	  which	  provide	  information	  about	  the	  electron	  density	  of	  the	  specimen.	  Electrons	  can	  be	  scattered	  by	  the	  specimen	  in	  two	  main	  ways	  (Figure	  1-­‐8).	  Elastic	  scattering	  causes	  the	  path	  of	  the	  electron	  to	  be	  altered	  with	  no	  energy	  loss,	  while	  inelastic	  scattering	   transfers	  energy	   to	   the	  specimen.	  For	  biological	  specimens,	   for	  every	  elastic	   scattering	   event	   that	   contributes	   positively	   to	   image	   formation,	   3-­‐4	   inelastic	  scattering	  events	  also	  occur	  (Henderson,	  1995).	  Energy	  transfer	  from	  incoming	  electrons	  to	   the	   specimen	   can	   cause	   ionisation,	   induce	   free	   radical	   formation,	   X-­‐ray	   emission	   and	  chemical	   bond	   rearrangement,	   as	  well	   as	   induce	   secondary	   electron	   scattering,	   limiting	  the	   resolution	   of	   the	   image	   both	   by	   damaging	   the	   specimen	   and	   introducing	   noise.	  Multiple	   electron	   scattering	   events	   can	   also	   occur;	   sample	   thickness	   is	   minimised	   to	  reduce	  this.	  
Figure	   1-­‐7	   Schematic	   of	   a	  
typical	  TEM.	  The	  electron	  beam	  (light	  grey)	   is	  directed	  down	  the	  central	   axis	   (dashed	   black	   line)	  of	   the	   column,	   directed	   by	  electromagnetic	   lenses	   (black)	  and	   through	   apertures,	  producing	   a	   magnified	   image,	  which	   can	   be	   viewed	   on	   the	  fluorescent	  screen	  or	  detector.	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Figure	  1-­‐8	  Interactions	  of	  the	  electron	  beam	  with	  the	  sample.	  As	  incident	  electrons	  hit	  the	  electron	  cloud	  of	   a	   specimen,	  no	  energy	   is	   lost	  but	   the	   incident	  electron	   is	  deflected	  (elastic	   scattering).	   If	   incoming	  electrons	   collide	  with	  electrons	  of	   the	  nucleus,	   energy	   is	  lost	   (inelastic	   scattering)	   and	   secondary	   electrons	   may	   be	   produced	   or	   X-­‐rays	   emitted.	  Adapted	  from	  Orlova	  &	  Saibil,	  2011.	  	  The	   generation	   of	   contrast	   in	   the	   images,	   can	   be	   split	   into	   two	   primary	   categories,	  amplitude	  and	  phase	  contrast.	  Phase	  contrast	  arises	   from	   interference	  between	  electron	  waves,	  while	  amplitude	  contrast	  arises	  from	  the	  absorption	  of	  electrons	  by	  the	  specimen,	  or	   exclusion	   of	   widely	   scattered	   electrons	   from	   the	   image.	   The	   method	   of	   specimen	  preparation	  defines	  which	  process	  contributes	  most	  to	  contrast.	  Biological	  specimens	  are	  primarily	   made	   of	   light	   atoms	   such	   as	   carbon,	   nitrogen,	   oxygen	   and	   hydrogen.	   These	  atoms	  do	  not	  absorb	  electrons	  strongly	  from	  the	  incident	  beam	  and	  so	  amplitude	  contrast	  is	   low	   when	   performing	   cryo-­‐EM	   of	   thin	   aqueous	   films.	   However,	   if	   the	   biological	  specimen	  is	  encapsulated	  in	  a	  heavy	  metal	  stain,	  as	   in	  negative	  staining,	  the	  heavy	  metal	  atoms	  absorb	  electrons	  introducing	  amplitude	  contrast.	  	  	  Frozen-­‐hydrated	  biological	  specimens	  in	  thin	  films	  are	  classified	  as	  weak	  phase	  objects	  as	  they	  cause	  a	  weak	  phase	  shift	  of	  the	  incident	  electron	  beam	  and	  extremely	  low	  amplitude	  contrast.	   As	   this	   is	   so	   small,	   it	   must	   be	   converted	   into	   an	   amplitude-­‐varying	   signal.	   In	  practice	  this	  is	  achieved	  by	  defocusing	  the	  microscope.	  Which	  in	  combined	  with	  spherical	  aberrations,	  induces	  a	  phase	  shift	  between	  scattered	  and	  unscattered	  electrons,	  producing	  stronger	  image	  contrast.	  	  







or	  Schottky	  emission	  guns,	  known	  as	  a	  field	  emission	  gun	  (FEG)(Williams	  &	  Carter,	  2009).	  Common	   thermionic	   sources	   include	   tungsten	   filaments	   or	   lanthanum	   hexaboride	  crystals,	  which	  are	  heated	  so	  the	  voltage	  potential	  exceeds	  the	  work	  function	  required	  to	  free	  electrons	  from	  the	  source.	  Most	  thermionic	  sources	  operate	  at	  an	  extraction	  voltage	  of	  80-­‐200	   kV	   (Williams	   &	   Carter,	   2009).	   The	   Schottky	   emission	   gun	   is	   an	   extremely	   fine	  tungsten	  filament	  coated	  with	  zirconium	  oxide,	  typically	  operated	  at	  an	  extraction	  voltage	  of	  200-­‐300	  kV	  and	  a	  temperature	  of	  1800	  K	  (1526	  °C)	  (Williams	  &	  Carter,	  2009).	   In	  true	  field	  emission,	  the	  cathode	  electron	  source	  is	  held	  at	  a	  negative	  potential	  compared	  with	  the	  anode,	   so	   the	  electric	   field	  at	   the	   tip	   is	   strong	  enough	   that	   the	  electrons	  can	   ‘tunnel’	  and	  leave	  the	  cathode	  without	  the	  thermal	  energy	  input	  needed	  in	  thermionic	  sources	  (Joy	  
et	   al.,	   1986).	   In	   Schottky	   emission	   electron	   sources	   the	   field	   strength	   is	   not	   sufficiently	  strong	   for	   quantum	   mechanical	   tunnelling,	   and	   so	   thermal	   energy	   input	   is	   required	   to	  overcome	   the	  potential	  barrier	   (Williams	  &	  Carter,	  2009).	  As	  a	   result	   Schottky	  emission	  guns	  are	  ‘field	  assisted	  thermionic	  emitters’	  rather	  than	  true	  FEGs.	  Schottky	  emission	  guns	  result	  in	  a	  much	  brighter	  and	  coherent	  electron	  beam	  compared	  with	  thermionic	  sources.	  	  
1.3.3 Electromagnetic	  lenses	  Electrons	   are	   negatively	   charged	   and	   so	   can	   be	   focused	   using	   electromagnetic	   lenses.	  These	   lenses	   function	  by	  passing	  an	  electric	   current	   through	  a	   coil	  of	  wire,	   generating	  a	  magnetic	   field,	   which	   deflects	   electrons.	   The	   first	   set	   of	   lenses	   the	   electron	   beam	  encounters	  upon	  leaving	  the	  source	  is	  the	  condenser	  lens	  system,	  or	  illumination	  system,	  which	   comprises	   the	   condenser	   lens	   and	   condenser	   aperture.	   Most	   commonly	   the	  illumination	  system	  has	  two	  or	  three	  lenses,	  with	  the	  three-­‐lens	  system	  enabling	  parallel	  illumination	   to	   be	   more	   easily	   achieved.	   Further	   down	   the	   column,	   the	   electron	   beam	  meets	  the	  objective	  lens,	  the	  most	  important	  lens	  for	  image	  formation.	  It	  provides	  the	  first	  magnification	   and	   focuses	   the	   beam	   onto	   the	   image	   plane	   after	   electrons	   have	   been	  scattered	  by	  the	  sample.	  In	  most	  EMs	  the	  specimen	  sits	  within	  the	  objective	  lens,	  meaning	  it	  is	  immersed	  in	  the	  magnetic	  field.	  The	  objective	  aperture	  sits	  in	  the	  back	  focal	  plane	  of	  the	  lens,	  removing	  electrons	  scattered	  at	  high	  angles	  and	  so	  improving	  contrast.	  The	  image	  is	  then	  magnified	  by	  intermediate	  and	  projector	  lenses	  onto	  the	  detector.	  The	  lens	  system	  allows	  a	  wide	  range	  of	  magnifications	  to	  be	  achieved,	  typically	  from	  20	  to	  200,000	  times.	  	  
1.3.4 Electron	  detectors	  Once	  the	  different	  lenses	  of	  the	  TEM	  form	  the	  image,	  it	  must	  be	  visualised	  or	  recorded.	  The	  high-­‐energy	  electrons	  used	  in	  TEM	  are	  invisible	  (and	  damaging)	  to	  the	  human	  eye,	  and	  so	  they	   are	   viewed	   indirectly	   using	   a	   phosphorescent	   screen	   or	   detector.	   The	   images	  recorded,	   known	   as	   electron	   micrographs,	   can	   be	   captured	   on	   film,	   charged	   coupled	  device	  (CCD)	  cameras	  or	  direct	  electron	  detectors	  (DED).	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  Cryo-­‐EM	   images	   of	   biological	   specimens	   are	   intrinsically	   noisy	   due	   to	   the	   low	   electron	  doses	   used.	   A	   perfect	   detector	  would	   add	   no	   additional	   noise.	   However,	   in	   practice,	   all	  detectors	   introduce	   additional	   noise.	   This	   can	   be	   expressed	   as	   the	   detective	   quantum	  efficiency	  (DQE)	  of	  the	  detector	  at	  a	  given	  spatial	  frequency,	  the	  square	  ratio	  of	  the	  output	  SNR	  (SNRo)	  over	   the	   input	  SNR	  (SNRi)(McMullan	  et	  al.,	  2014).	  A	  perfect	  detector	  would	  have	  a	  DQE	  of	  1.	  	  	   𝐷𝑄𝐸 = 𝑆𝑁𝑅𝑜!/𝑆𝑁𝑅𝑖!	  	  Historically,	  film	  was	  the	  most	  common	  detector.	  It	  has	  a	  large	  field	  of	  view,	  an	  extremely	  small	   ‘pixel’	   (the	  grain	  size	  of	  silver	  halide	  crystals	   in	   the	  emulsion),	  and	  relatively	  good	  DQE.	  However,	   recording	   large	   data	   sets	   using	   film	   is	   inconvenient,	   expensive	   and	   time	  consuming.	  Film	  emulsion	  contains	  water	  and	  introduces	  contamination	  into	  the	  column	  of	   the	   EM.	   It	   also	   needs	   developing,	   and	   digitisation	   using	   extremely	   expensive	   and	  delicate	   densitometry.	   As	   a	   result,	   CCD	   cameras	   are	   currently	   the	  most	   commonly	   used	  detectors.	   CCDs	   utilise	   a	   phosphor	   scintillator,	   which	   induces	   the	   emission	   of	   photons	  when	   electrons	   strike	   it.	   The	   CCD	   camera	   then	   transforms	   these	   photons	   into	   electrical	  signals.	  The	  DQE	  of	  a	  CCD	  camera	  is	  inferior	  to	  film	  at	  the	  electron	  energies	  typically	  used	  for	   imaging.	   The	   scintillator	   layer	   results	   in	   electron	   and	   so	   photon	   scattering,	   causes	   a	  loss	   in	   sensitivity	  as	  well	  as	   introducing	  an	  accelerating	  voltage	  dependent	  point	   spread	  function	  (PSF).	  Despite	  these	  problems,	  data	  collected	  on	  a	  CCD	  camera	  under	  appropriate	  imaging	   conditions	   can	   be	   processed	   to	   sub-­‐nanometre	   resolution	   (Cheng	   et	   al.,	   2010).	  CCD	  cameras	  are	  also	  much	  more	  convenient	  than	  film,	  and	  allow	  images	  to	  be	  inspected	  immediately	  after	  collection.	  	  In	   the	   last	   few	  years,	   the	  use	  of	  DEDs	  has	   revolutionised	  biological	  TEM.	  Combining	   the	  benefits	  of	  a	  high	  DQE	  detector	  with	  the	  convenience	  of	  an	  electronic	  read	  out,	  DED’s	  are	  now	  the	  recording	  medium	  of	  choice.	  Several	  detector	  designs	  were	  developed,	  including	  monolithic	   active	   pixel	   sensors	   (MAPS)	   and	   hybrid	   pixel	   detectors	   (Faruqi	   &	  McMullan,	  2011),	  but	  MAPS	  based	  DED’s	  are	  becoming	  prevalent	  (Bai,	  McMullan,	  et	  al.,	  2015).	  	  	  MAPS	  detectors	  detect	   incident	   electrons	  directly	   as	   they	  pass	   through	  a	   semiconductor	  membrane	   ~10	   μm	   in	   depth	   where	   they	   deposit	   energy.	   Some	   electrons	   are	   back	  scattered	   from	   the	   support	   matrix	   and	   pass	   through	   the	   membrane	   again,	   generating	  noise.	  As	  a	  result,	  high	  DQE	  DEDs	  are	  ‘back	  thinned’,	  which	  involves	  removing	  as	  much	  of	  the	   support	  matrix	   as	   possible	   (to	   less	   than	   50	   μm),	  meaning	  most	   electrons	   pass	   right	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through	   the	   detector.	   Monte	   Carlo	   simulations	   show	   the	   thinner	   the	   substrate	   the	   less	  scattering	   is	   observed	   (McMullan	   et	   al.,	   2009).	   DEDs	   are	   available	   commercially	   from	  three	  manufacturers,	  FEI,	  Direct	  Electron	  and	  Gatan,	  all	  of	  which	  have	  a	  DQE	  better	  than	  film	   (McMullan	   et	   al.,	   2014).	   Currently,	   the	   FEI	   Falcon	   II	   and	   some	   Direct	   Electron	  solutions	  work	  by	  integrating	  signal	  from	  electrons	  hitting	  the	  detector.	  The	  limitation	  of	  this	   approach	   is	   that	   incoming	   electrons	  may	  have	  different	   energies,	   and	   so	   contribute	  differently	   to	   the	   output	   signal	   (McMullan	   et	   al.,	   2014).	   By	   contrast,	   counting	   detectors	  such	   as	   the	   Gatan	   K2,	   FEI	   Falcon	   III	   and	   Direct	   Electron	   DE-­‐20	   can	   count	   individual	  electrons	  as	  they	  hit	  the	  detector.	  This	  enables	  some	  counting	  detectors	  to	  image	  in	  ‘super	  resolution	  mode’,	  providing	  information	  beyond	  the	  Nyquist	  limit,	  by	  analysing	  the	  point	  spread	  function	  (PSF)	  of	  the	  incoming	  electron	  and	  localising	  its	  location	  within	  the	  pixel.	  Low	   spatial	   frequencies	   are	   better	   preserved	   on	   detectors	   which	   operate	   in	   counting	  mode,	  however	  longer	  exposure	  times	  are	  used	  as	  a	  low	  electron	  dose	  rate	  is	  required	  in	  order	   for	  counting	  (and	  super	  resolution)	  mode	  to	   function.	  Other	   limitations	  arise	   from	  errors	   in	  counting.	  For	  example,	  single	  events	  may	  be	  split	  over	  several	  pixels,	  and	  even	  with	  careful	  dark	  and	  gain	  references	  some	  pixels	  will	  be	  hit	  by	  multiple	  electrons	  which	  will	  produce	  noise	  (Ruskin	  et	  al.,	  2013).	  The	  counting	  algorithm	  may	  also	  misinterpret	  the	  path	  of	  an	  electron	  (McMullan	  et	  al.,	  2014).	  A	  major	  benefit	  of	  DED’s	  is	  the	  ability	  to	  spread	  the	  dose	  across	  several	  frames,	  creating	  a	  movie	  of	  the	  exposure.	  This	  is	  useful	  as	  it	  allows	  correction	   for	   specimen	  movement	   during	   the	   exposure	   (Section	   1.4.2.5).	   Structures	   at	  near-­‐atomic	  resolution	  have	  been	  determined	  using	  all	  three	  manufacturers’	  DEDs	  (Parent	  
et	  al.,	  2014;	  Voorhees	  et	  al.,	  2014;	  Lu	  et	  al.,	  2014).	  
1.3.5 Phase	  plates	  and	  energy	  filters	  As	  discussed	  fully	  in	  Section	  1.3.1,	  cryo-­‐EM	  produces	  images	  with	  poor	  SNR,	  and	  in	  order	  to	  retain	  high-­‐resolution	  information	  in	  our	  images,	  they	  must	  be	  taken	  close	  to	  true	  focus,	  again	   reducing	  overall	   image	   contrast.	  To	   combat	   this,	   two	  complementary	   technologies	  have	  been	  developed	  to	  increase	  SNR	  in	  images:	  phase	  plates	  and	  energy	  filters.	  	  	  When	  imaging,	  a	  proportion	  of	  electrons	  that	  interact	  with	  the	  specimen	  are	  inelastically	  scattered,	  i.e.	  they	  deposit	  energy	  in	  the	  specimen.	  Their	  resulting	  lower	  energy,	  and	  thus	  longer	   wavelength	   causes	   these	   inelastically	   scattered	   electrons	   to	   be	   focused	   in	   a	  different	  plane	   to	   the	  elastically	   scattered	  electrons	   (Orlova	  &	  Saibil,	  2011).	   Inelastically	  scattered	  electrons	  can	  be	  considered	  a	   form	  of	  chromatic	  aberration,	   introducing	  noise.	  Energy	   filtering	   can	   prevent	   inelastically	   scattered	   electrons	   from	   contributing	   to	   the	  recorded	   image.	  There	  are	   two	  commercialised	  energy	   filters	  currently	  available,	   the	   in-­‐column	   Omega	   (Ω)	   filter	   and	   post-­‐column	   Gatan	   Energy	   Filter	   (GIF)(Williams	   &	   Carter,	  2009).	  Both	  work	  on	  the	  principle	  that	  electrons	  of	  different	  energies/wavelengths	  can	  be	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Figure	  1-­‐9	  Zernike	  phase	  plates.	  An	  unused	  Zernike	  phase	  plate	  with	  1	  μm	  aperture	  (A)	  and	  a	  phase	  plate	  used	  for	  several	  experiments	  (B),	  the	  wide	  dark	  grey	  circle	  around	  the	  central	  aperture	  is	  where	  beam	  induced	  damage	  of	  the	  carbon	  has	  occurred.	  Adapted	  from	  Danev	  &	  Nagayama,	  2001.	  Volta	  potential	  phase	  plates	  (VPPP)	  uses	  an	  ~12	  nm	  film	  of	  amorphous	  carbon	  heated	  to	  200	   °C	   to	   introduce	   a	   phase	   shift	   (Danev	   et	   al.,	   2014).	   The	   physics	   underlying	   this	  phenomenon	  remains	  unclear,	  but	  it	  is	  hypothesized	  to	  function	  by	  a	  beam-­‐induced	  Volta	  potential	   (Danev	   et	   al.,	   2014).	   This	   potential	   is	   thought	   to	   arise	   from	   beam-­‐induced	  surface	   modification	   of	   the	   carbon	   combined	   with	   a	   chemical	   equilibrium	   between	   the	  carbon	   surface	   and	   residual	   gases	   in	   the	   EM	   column.	   VPPPs	   do	   not	   introduce	   fringing	  artefacts,	   and	   they	   are	   reported	   to	   be	   stable	   for	  months	   (Danev	   et	  al.,	   2014).	   As	   VPPPs	  have	  been	  developed	  recently,	  they	  have	  not	  been	  extensively	  tested.	  	  As	   both	   phase	   plate	   designs	   boost	   SNR	   at	   low	   spatial	   frequencies,	   they	   are	   particularly	  useful	   when	   performing	   ET.	   For	   single	   particle	   work	   it	   remains	   to	   be	   seen	   how	   much	  benefit	   phase	   plates	   will	   yield,	   as	   CTF	   correction	   compensates	   (Section	   1.3.8.1)	   for	   the	  information	   lost	  by	   introducing	   a	  phase	   shift	   by	  defocusing	   the	  microscope.	   In	  principle	  however,	  they	  may	  reduce	  the	  amount	  of	  data	  needed	  to	  generate	  a	  structure	  to	  the	  same	  resolution	   compared	  with	   a	   dataset	   collected	  with	   no	   phase	   plate	   (Murata	   et	  al.,	   2010),	  and	  may	  be	  beneficial	  for	  samples	  that	  are	  particularly	  small	  or	  hard	  to	  align.	  




migrate	  and	  cause	  further	  reactions.	  Tertiary	  damage	  occurs	  as	  hydrogen	  gas	  is	  produced	  within	  the	  sample,	  causing	  gross	  damage.	  	  Radiation	  damage	  thus	  dictates	  that	  total	  electron	  dose	  should	  be	  minimised,	  but	  without	  sufficient	   dose	   the	   specimen	   cannot	   be	   visualised.	   Dose	   is	   thus	   a	   compromise	   between	  contrast	  and	  damage.	  During	  data	  collection,	  areas	  suitable	  for	  imaging	  must	  be	  identified,	  and	   the	   appropriate	   focus	   chosen.	   These	   processes	   expose	   the	   sample	   to	   the	   electron	  beam	   contributing	   to	   the	   total	   dose	   the	   specimen	   receives.	   Low	  dose	   imaging	   protocols	  have	   been	   developed	   to	   minimise	   this	   exposure	   prior	   to	   imaging,	   thereby	   allowing	  maximal	  dose	   to	  be	   applied	  during	   the	   acquisition	  of	   the	   final	   image.	   Low	  dose	   imaging	  occurs	  in	  three	  modes.	  Firstly,	  a	  low	  magnification	  ‘Search’	  mode,	  with	  a	  very	  low	  electron	  dosage	  per	  Å2,	   is	  used	   to	   identify	   the	   field	  of	   interest.	  Then,	   the	  microscope	   is	   focused	  a	  short	  distance	  away	  from	  the	  area	  of	  interest.	  Finally,	  the	  image	  is	  acquired,	  with	  a	  typical	  total	  electron	  dose	  of	  15-­‐100	  e-­‐/Å2.	  	  
1.3.7 Automated	  data	  collection	  software	  Alongside	   recent	   advances	   in	   EM	   hardware,	   software	   has	   been	   developed	   to	   aid	   data	  collection.	  The	  SNR	  of	  cryo-­‐EM	  images	  is	  very	  low	  and	  so	  many	  images	  are	  usually	  needed	  to	   generate	   a	   structure.	   As	   a	   result,	   several	   software	   packages	   have	   been	   developed	   to	  automate	   data	   collection,	  making	   efficient	   use	   of	  microscope	   time.	   One	   commonly	   used	  commercial	  package	   is	  FEI’s	  E	  Pluribus	  Unum	  (EPU).	  EPU	  generates	  an	  atlas	  of	   the	  grid,	  identifying	  suitable	  grid	  squares.	  Suitable	  holes	  within	  the	  square	  can	  then	  be	   identified,	  and	  a	  recording	  template	  defined.	  Depending	  on	  the	  magnification	  used,	  multiple	  images	  can	   be	   taken	   in	   one	   hole.	   EPU	   will	   collect	   images	   independent	   of	   human	   intervention,	  according	   to	   this	   template,	   until	   stopped	  or	   there	   are	  no	  more	   selected	   areas.	  However,	  EPU	   only	   functions	   on	   FEI	   microscopes.	   Open-­‐source	   programmes	   with	   similar	  functionality	   have	   been	   developed,	   such	   as	   Leginon	   (Carragher	   et	  al.,	   2000;	   Stagg	   et	  al.,	  2006)	   and	  TOM2	   (Unverdorben	  et	  al.,	   2014;	  Korinek	  et	  al.,	   2011).	   Software	   to	   allow	   the	  automated	   collection	   of	   tilt	   series	   has	   also	   been	   developed,	   including	   SerialEM	  (Mastronarde,	   2005),	   UCSF	   Tomo	   (Zheng	   et	   al.,	   2010),	   Xplore3D	   (FEI)	   and	   Leginon	  (Suloway	  et	  al.,	  2009).	  
1.3.8 Microscope	  aberrations	  The	   lens	   system	   of	   the	   EM	   gives	   rise	   to	   aberrations,	   the	   most	   significant	   of	   which	   are	  chromatic,	   astigmatic	   and	   spherical.	   Chromatic	   aberration	   arises	   from	   the	   lens	   focusing	  long	  wavelengths	  more	  strongly	  than	  shorter	  wavelengths	  so	  that	  the	  image	  is	  formed	  in	  different	  planes.	  In	  the	  EM,	  this	  can	  be	  caused	  by	  energy	  (‘colour’)	  spread	  in	  the	  electron	  beam,	  as	  well	  as	   inelastic	  scattering.	  Astigmatic	  aberrations	  are	  caused	  by	  asymmetry	   in	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the	  electromagnetic	  lenses	  used	  to	  focus	  the	  beam,	  and	  causes	  an	  imaged	  point	  to	  become	  elliptical.	   It	  can	  be	  corrected	  to	  a	  large	  extent	  by	  adjusting	  stigmator	  coils	  to	  symmetrise	  the	  magnetic	   field	  strength	  with	   the	   lens.	  Spherical	  aberration	  (Cs)	   is	  caused	  by	  electron	  waves	  being	  refracted	  differentially	  by	  different	  parts	  of	  the	  lens;	  waves	  passing	  through	  the	   lens	  periphery	   are	   refracted	  more	   strongly	   compared	  with	  paraxial	  waves.	  Methods	  have	   been	   developed	   to	   correct	   for	   Cs	   during	   imaging,	   by	   the	   use	   of	   a	   second	   set	   of	  electromagnetic	   lenses	   and	   apertures,	   but	   while	   they	   have	   been	   used	   to	   generate	  structures	   to	   high	   resolutions,	   such	   as	   of	   the	   E.	   coli	   ribosome–EF-­‐Tu	   complex	   to	   2.9	   Å	  (Fischer	   et	   al.,	   2015).	   Cs	   correctors	   are	   complex	   to	   align	   and	   expensive,	   so	   their	   use	   is	  currently	  limited	  in	  biological	  TEM.	  
1.3.8.1 Contrast	  transfer	  function	  Cumulatively,	  imperfections	  in	  the	  lens	  system	  of	  a	  microscope	  lead	  to	  the	  recorded	  image	  being	   distorted	   by	   a	   contrast	   transfer	   function	   (CTF),	   which	   describes	   the	   transfer	   of	  information	  as	  a	  function	  of	  spatial	  frequency	  (or	  resolution).	  The	  effect	  of	  the	  CTF	  on	  the	  observed	   image	   can	   be	   described	   by	   a	   Fourier	   Transform	   (FT,)	   that	   produces	   a	   power	  spectrum	  which	  relates	  a	  signal	  (the	  image)	  to	  the	  frequencies	  of	  which	  it	  is	  composed.	  In	  real	  space,	  the	  effect	  of	  the	  CTF	  is	  as	  a	  PSF,	  where	  information	  from	  one	  part	  of	  the	  image	  is	   spread	   into	   adjacent	   areas.	   The	   CTF	   is	   thus	   the	   Fourier	   space	   representation	   of	   the	  microscope’s	  PSF.	  	  	  The	   recorded	   image	   of	   the	   object	   is	   the	   convolution	   of	   the	   real	   image	   with	   the	  microscope’s	  point	  spread	  function	  (PSF).	  The	  CTF	  serves	  as	  a	  mathematical	  description	  of	  the	  relationship	  between	  the	  recorded	  image	  and	  the	  weak	  phase	  object	  that	  generated	  it.	  Thus	   the	   FT	   of	   the	   recorded	   image	   (I)	   is	   the	  multiplication	   of	   the	  microscopes	   CTF	   (M)	  with	  the	  weak	  phase	  object’s	  FT	  (O),	  plus	  noise	  (N);	  	   𝐼 = 𝑀 ∗ 𝑂 + 𝑁	  	  In	  Fourier	  space,	  the	  CTF	  appears	  as	  a	  sinusoidal	  function	  with	  increasing	  frequency	  and	  decreasing	   amplitude.	   The	   function	   γ(s)	   describes	   the	   wave	   aberration	   function	   of	   the	  microscope.	   The	   microscope’s	   CTF	   is	   influenced	   by	   spherical	   aberration	   (Cs),	   electron	  wavelength	  (λ)	  and	  defocus	  (ΔZ).	  The	  CTF	  can	  be	  described	  as;	  	   CTF=	  sin ϒ(s)	  With	  Υ(!) = 2𝜋 𝐶𝑠4 𝜆!𝑠! − Δ𝑍2 𝜆𝑠!	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  While	   an	   ideal	   CTF	   would	   possess	   a	   uniform	   value	   for	   information	   transfer	   across	   all	  spatial	  frequencies,	  the	  oscillations	  of	  the	  real	  CTF	  results	  in	  zero	  contrast	  at	  some	  spatial	  frequencies	  for	  any	  given	  defocus.	  The	  greater	  the	  defocus,	  the	  higher	  the	  frequency	  of	  the	  oscillations	  and	  so	  the	  lower	  amount	  of	  high-­‐resolution	  information	  collected.	  	  	  The	  overall	  CTF	  also	  suffers	  from	  attenuation	  of	  high	  spatial	  frequency	  information	  due	  to	  other	  imperfections	  in	  imaging,	  including	  imperfect	  coherency	  of	  the	  electron	  source,	  lens	  and	   mechanical	   instability,	   and	   detectors	   imperfections.	   Computational	   methods	   to	  correct	  the	  CTF	  have	  been	  developed	  and	  are	  described	  in	  1.4.2.1.	  	  
1.4 Image	  processing	  Each	   recorded	   EM	   image	   (micrograph)	   represents	   all	   the	   information	   of	   a	   3D	   sample	  projected	   onto	   a	   single	   2D	   plane.	   However,	   computational	   processing	   of	   2D	   images	   can	  reconstruct	  3D	  information	  about	  the	  specimen.	  There	  are	  two	  primary	  ways	  this	  is	  done.	  Firstly,	   single	   particle	   analysis	   (SPA).	   By	   recording	   many	   images	   of	   an	   identical	  macromolecular	   complex	   randomly	   orientated	   within	   a	   vitreous	   ice	   layer,	   different	  ‘views’,	   or	   orientations	   can	   be	   classified	   and	   averaged	   to	   obtain	   a	   2D	   projection	   with	  improved	   SNR.	   If	   the	   angular	   relationships	   between	   these	   2D	   projections	   can	   be	  determined	   a	   3D	   object	   can	   be	   reconstructed.	   Secondly,	   a	   tilt	   series	   can	   be	   collected,	  where	  many	  images	  are	  taken	  across	  range	  of	  tilt	  angles	  (typically	  +/-­‐	  60°	  for	  tomographic	  reconstruction),	   back	   projecting	   such	   a	   series	   generates	   a	   ‘tomogram’,	   or	   3D	   volume	  representing	   the	   specimen.	   Tilting	   the	   specimen	   can	   also	   be	   applied	   to	   2D	   crystals	   as	  discussed	  in	  Section	  1.4.1.	  	  
1.4.1 Electron	  crystallography	  Electron	  crystallography	  applies	  many	  of	  the	  principles	  discussed	  in	  X-­‐ray	  crystallography	  (Section	  1.1.3)	  to	  ‘2D	  crystals’.	  2D	  crystals	  are	  one	  unit	  cell	  thick,	  compared	  with	  crystals	  used	   for	  X-­‐ray	  crystallography	  which	  are	   typically	  many	  unit	   cells	  wide	   in	  X,	  Y	  and	  Z.	   In	  order	   to	   record	   sufficient	   information	   to	  extrapolate	  a	  3D	  structure,	   the	   crystal	  must	  be	  tilted	  and	  imaged	  at	  many	  tilt	  angles.	  This	  approach	  has	  been	  applied	  successfully	  to	  many	  proteins,	  one	  of	   the	  first	  structures	  obtained	  by	  this	  technique	  was	  bacteriorhodopsin	  to	  3.5	   Å	   resolution	   (Henderson	   et	   al.,	   1990). Other	   proteins	   studied	   using	   this	   technique	  include	  aquaporins,	  in	  one	  study	  1.9	  Å	  resolution	  was	  achieved,	  sufficient	  to	  visualise	  and	  build	   a	  model	   of	   protein-­‐lipid	   interactions	   (Gonen	   et	  al.,	   2005).	   Electron	   diffraction	   can	  also	  be	  performed	  using	  very	  small	  3D	  crystals,	  a	  method	  known	  as	  MicroED	  (Iadanza	  &	  Gonen,	  2014;	  Rodriguez	  et	  al.,	  2015;	  Shi	  et	  al.,	  2013).	  Electron	  crystallography	  can	  provide	  high-­‐resolution	   information,	  but	  ultimately	   requires	   the	   specimen	   to	  be	   crystallised.	  For	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many	  proteins,	  especially	  membrane	  proteins,	  this	  can	  be	  challenging	  and	  thus	  limits	  the	  applications	  of	  this	  technique.	  	  
1.4.2 Single	  particle	  analysis	  	  As	  of	  December	  2015,	  the	  Electron	  Microscopy	  Data	  Bank	  (EMDB)	  had	  over	  2600	  electron	  density	  maps	  generated	  by	  SPA,	  with	  resolutions	  below	  10	  Å	  becoming	  routine,	  and	  many	  at	  near	  atomic	  resolution.	  Below	  4.5	  Å,	  the	  Cα	  backbone	  can	  be	  resolved,	  separating	  beta	  strands	  in	  the	  density	  map,	  and	  some	  side	  chains	  are	  visible.	  Between	  4.5-­‐9	  Å	  α	  helices	  are	  resolved.	   Information	  above	  10	  Å	  can	  still	  be	   invaluable,	  especially	  when	  combined	  with	  other	  structural	   techniques.	  For	  example,	  homology	  models	  of	  protein	  subunits	  of	   the	  V-­‐ATPase	   have	   been	   fitted	   into	   an	   EM	   density	   map	   (Rawson	   et	   al.,	   2015).	   Single	   particle	  reconstruction	  has	  many	  advantages	  over	   crystal-­‐based	   techniques.	  Besides	   the	  obvious	  advantage	  of	  not	  needing	  to	  grow	  crystals,	  outside	  the	  confines	  of	  a	  lattice	  the	  specimen	  is	  able	  to	  sample	  a	  range	  of	  native	  conformations	  in	  solution	  before	  being	  trapped	  by	  cryo-­‐fixation.	   This	   allows	   information	   about	   conformational	   changes,	   and	   to	   some	   extent	  flexibility,	  to	  be	  elucidated.	  	  	  SPA	  traditionally	  assumes	  a	  homogenous	  population	  of	  macromolecular	  complexes,	  which	  are	  orientated	  randomly	  over	  a	  full	  range	  of	  orientations.	  A	  data	  set	  may	  contain	  hundreds	  or	   thousands	  of	  micrographs,	   containing	  potentially	  millions	  of	  particles,	   although	  many	  data-­‐sets	  are	  much	  smaller.	  Particles	  can	  then	  be	  ‘boxed’	  out	  of	  their	  micrographs,	  aligned,	  classified	  into	  orientations	  and	  averaged	  to	  produce	  2D	  ‘class	  averages’.	  Each	  particle	  in	  a	  micrograph	  corresponds	  to	  a	  2D	  projection	  of	  the	  3D	  structure.	  SPA	  relies	  upon	  Projection	  Theorem,	  which	   shows	   that	   Fourier	   transforms	   of	   the	   2D	   projections	   represent	   central	  slices	   through	   the	  3D	  Fourier	   transform	  of	  object	   (Figure	  1-­‐10).	   In	  SPA,	   the	  angular	  and	  translational	   relationships	   between	   each	   2D	   projection	   are	   calculated,	   allowing	   the	  generation	  of	  a	  3D	  structure.	  The	  accuracy	  of	  particle	  alignment	  is	  dependent	  on	  SNR	  the	  of	   the	   particle,	   and	   the	   presence	   of	   features	   that	   can	   guide	   alignment.	   Larger,	   more	  ‘featured’	   objects	   tend	   to	   align	   better,	   and	   so	   SPA	  has	   historically	  most	   commonly	   been	  applied	   to	  samples	   larger	   than	  ~1	  MDa.	  However,	   improved	  EM	  and	  detector	  hardware,	  alongside	  improved	  imaging	  processing	  algorithms	  mean	  that	  ever-­‐smaller	  complexes	  are	  being	  studied	  with	  great	  success.	  For	  example,	   the	  structure	  of	  beta	  galactosidase,	  0.465	  MDa,	   has	  been	   solved	   to	  4.2	  Å	   resolution	   (Scheres,	   2015)	   and	   the	  0.17MDa	  γ	   -­‐secretase	  complex	  to	  3.4	  Å	  resolution	  (Bai,	  Yan,	  et	  al.,	  2015).	  	  There	   are	   many	   software	   packages	   available	   for	   SPA,	   including	   SPIDER	   (Shaikh	   et	   al.,	  2008),	  IMAGIC	  (van	  Heel	  et	  al.,	  2000),	  EMAN2	  (Tang	  et	  al.,	  2007),	  RELION	  (Scheres,	  2012),	  Xmipp	  (la	  Rosa-­‐Trevin	  et	  al.,	  2013)	  and	  SIMPLE	  (Elmlund	  &	  Elmlund,	  2012).	  Many	  of	  the	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steps	  taken	  in	  generating	  a	  model	  in	  SPA	  are	  common	  to	  all	  programs,	  and	  so	  an	  overview	  of	  the	  general	  process	  is	  now	  given.	  	  




Figure	   1-­‐10	   Schematic	   of	  












Figure	   1-­‐11	   CTF	   correction.	  Micrographs	   in	   a	   data	   series	  are	  collected	  at	  different	  defoci	  such	   as	   A	   (1	   μm	  defocus)	   and	  B	   (4	   μm	   defocus);	   the	   more	  defocused	   the	  micrograph,	   the	  greater	   the	   contrast.	   The	  power	  spectrum	  of	  the	  images	  (C	   and	   D)	   shows	   the	   Thon	  rings,	   whose	   position	   relative	  to	   the	   origin	   and	   oscillations	  can	   be	   used	   to	   calculate	  defocus	   and	   CTF	   curves	   such	  as	   shown	   in	   E.	   The	   CTF	   is	  defocus	  dependent	  (F-­‐	  red	  CTF	  curve	  of	   image	  closer	  to	   focus,	  purple	   line	   further	   from	  focus),	   and	   so	   when	   multiple	  CTFs	   are	   summed	   (G)	   and	  phase	   flipped	   (H),	   the	   sum	  total	  of	   the	  spatial	   frequencies	  represented	  in	  the	  data	  can	  be	  seen.	  E-­‐H	  adapted	  from	  Orlova	  &	  Saibil,	  2011.	  
1.4.2.2 Classification	  and	  alignment	  Particle	   classification	   and	   alignment	   aims	   to	   take	   a	   series	   of	   unaligned,	   noisy	   images,	  calculate	   their	  angular	   relationships	  and	  separate	  a	  homogenous	  subset	  of	  particles	   that	  can	   be	   used	   to	   generate	   a	   3D	   structure	   (Section	   1.4.2).	   Programs	   such	   as	   RELION	   and	  XMIPP	   implement	   maximum	   likelihood	   (ML)	   algorithms	   for	   classification,	   in	   order	   to	  account	  for	  the	  low	  SNR	  of	  cryo-­‐EM	  data.	  In	  ML	  classification,	  probabilities	  are	  assigned	  to	  class	   assignments,	   to	   account	   for	   the	   fact	   that	   there	   is	   uncertainty	   in	   the	   assignment.	   If	  data	  were	  perfect,	  there	  would	  be	  no	  difference	  in	  the	  output	  of	  ML	  approaches	  compared	  with	  ‘standard’	  cross	  correlation	  approaches.	  	  	  2D	   classification	   can	   be	   used	   to	   assess	   the	   data	   and	   remove	   poor	   quality	   particles,	  although	   2D	   classes	   are	   often	   informative	   in	   their	   own	   right	   (Imai	   et	   al.,	   2015).	   Many	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programs	  use	   referenced	  based	  2D	  alignment,	  which	   involves	  using	  aligning	  particles	   to	  references	   and	   calculating	   the	   cross	   correlation	   in	   an	   iterative	   manner.	   RELION	  implements	   a	  multi-­‐reference	  maximum	   likelihood	   alignment	   scheme	   to	   simultaneously	  align	   and	   classify	   particle	   images.	   These	   reference	   free	   averages	   are	   generated	   in	   an	  unsupervised	   manner,	   with	   the	   user	   simply	   defining	   the	   number	   of	   classes.	   The	   ML	  approach	  means	  all	  images	  are	  compared	  with	  all	  references,	  in	  all	  possible	  orientations.	  Probability	  weights	  are	  calculated	  for	  each	  possibility.	  The	  classes	  produced	  are	  weighted	  averages,	  so	  every	  particle	  contributes	  to	  every	  class.	  In	  reality,	  particles	  often	  contribute	  strongly	   to	   one	   class	   or	   a	   set	   of	   similar	   classes,	   and	   weakly	   to	   every	   other	   class.	   This	  process	  is	  iterated,	  typically	  25	  times.	  Particles	  from	  ‘good’	  classes	  can	  then	  be	  analysed	  or	  taken	  forward	  for	  3D	  classification	  (Scheres,	  2010).	  	  A	   key	   challenge	   in	   3D	   reconstruction	   is	   the	   introduction	   of	   bias	   from	   false	   assumptions	  about	   the	   spatial	   relationship	   between	   classes.	   Complexity	   is	   also	   introduced	   when	  heterogeneity	   is	   present	   in	   the	   dataset,	   e.g.	   different	   conformations	   of	   a	   complex,	   or	  different	   complexes	   are	   present	   (Fernández	   et	   al.,	   2013).	   This	   can	   result	   in	   a	   low	  resolution,	   or	   even	   a	   completely	   artefactual	   map	   being	   generated.	   These	   issues	   can	   be	  tackled	   by	   the	   use	   of	   multi-­‐reference	   ML	   refinement,	   such	   as	   implemented	   in	   RELION,	  which	   can	   be	   used	   to	   perform	  unsupervised	   classification	   of	   structurally	   heterogeneous	  datasets	   (Scheres	  et	  al.,	  2007).	  A	   low-­‐resolution	   (~60	  Å)	  starting	  model	   is	  used,	  and	   the	  user	  defines	  an	  arbitrary	  number	  of	  3D	  models	  to	  be	  simultaneously	  refined,	  which	  should	  ideally	  reflect	  the	  number	  of	  conformations	  present	  in	  the	  dataset.	  The	  process	  is	  iterated	  until	   the	   number	   of	   particles	   that	   change	   their	   optimal	   orientation/class	   has	   stabilised,	  and	  the	   log-­‐likelihood	   increase	  has	   levelled	  off,	   indicating	  the	  refinement	  has	  converged.	  3D	  classification	  can	  be	  performed	  in	  a	  hierarchical	  manner,	  enabling	  structures	  of	  lowly	  populated	   conformations	   to	  be	  generated	   (Fernández	  et	  al.,	   2013).	  One	  drawback	  of	   the	  3D	   ML	   classification	   is	   that	   it	   is	   computationally	   expensive,	   and	   so	   down-­‐sampling	   or	  binning	   the	  particles	   and/or	   limiting	   the	   angular	   sampling	   rate	   is	   sometimes	  necessary,	  depending	  on	  the	  computational	  resources	  available	  and	  the	  size	  of	  the	  particle.	  	  	  Once	  a	  subset	  of	  sufficiently	  homogenous	  particles	  has	  been	  generated,	  the	  structure	  can	  be	  refined	  to	  high	  resolution.	  The	  ‘gold	  standard’	  Fourier	  Shell	  Correlation	  (FSC)	  is	  used	  to	  calculate	   the	   agreement	   between	   two	   independently	   refined	   halves	   of	   the	   dataset,	   and	  provide	  a	  measure	  of	  the	  resolution.	  In	  RELION,	  the	  procedure	  estimates	  the	  accuracy	  of	  angular	   assignments	   and	   automatically	   determines	  when	   the	   refinement	   has	   converged	  (Scheres,	  2012).	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1.4.2.3 B-­‐factor	  correction	  and	  map	  sharpening	  Sub-­‐nanometer	  resolution	  SPA	  structures	  are	  now	  routine	  (Bai	  et	  al.,	  2013).	  At	  these	  high	  resolutions,	   information	   is	   lost	   both	   because	   of	   experimental	   factors,	   including	   beam	  induced	  movement	   and	   radiation	  damage,	   and	   computational	   factors	   such	   as	   inaccurate	  determination	  of	  angular	  orientations.	  Traditionally,	  this	  loss	  was	  modelled	  by	  a	  Gaussian	  decay	   of	   structure	   factors	   with	   a	   temperature	   factor,	   or	   B-­‐factor,	   but	   this	   approach	  significantly	   affects	   high-­‐resolution	   features	   and	   makes	   identification	   of	   secondary	  structure	   elements	   challenging	   (Fernandez	   et	   al.,	   2008).	   These	   high-­‐resolution	   features	  must	   be	   restored,	   or	   ‘sharpened’	   to	   bring	   out	   features	   in	   the	   map.	   A	   method	   was	  developed	  to	  estimate	  the	  amplitude	  decay	  of	  the	  structure	  factors	  by	  comparison	  with	  a	  theoretical	  scattering	  curve,	  along	  with	  a	  weighting	  function	  to	  account	  for	  the	  noise	  in	  the	  map	   (Rosenthal	   &	   Henderson,	   2003).	   The	   weighting	   function	   is	   needed	   to	   avoid	   the	  amplification	  of	  noise	  and	  increase	  robustness	  against	  over-­‐fitting.	  This	  method	  removes	  the	  need	  for	  ad	  hoc	  B-­‐factor	  assignment.	  Programs	  are	  available	  to	  implement	  this	  B-­‐factor	  correction	  method,	  such	  as	  EM-­‐BFACTOR	  (Fernandez	  et	  al.,	  2008),	  and	  sharpening	  by	  this	  method	  is	  implemented	  in	  RELION	  (Chen	  et	  al.,	  2013).	  	  	  The	   assessment	   of	   resolution	   and	   model	   validation	   is	   the	   subject	   of	   (heated)	   on-­‐going	  discussion	  in	  the	  EM	  community.	  Over	  fitting	  of	  data	  can	  lead	  to	  inflated	  resolution	  claims	  and	  erroneous	   interpretation	  of	   the	  resulting	  density.	  Tilt	  pair	  validation	  can	  be	  used	   to	  validate	  3D	  structures,	  which	  involves	  taking	  a	  micrograph	  of	  the	  sample	  at	  00	  and	  at	  a	  tilt,	  typically	  ~300.	  These	  images	  are	  then	  compared	  with	  their	  predicted	  projections	  of	  the	  3D	  map.	  The	  output	  from	  this	  process	  is	  a	  tilt	  pair	  parameter	  plot,	  clustering	  patterns	  of	  can	  provide	  a	  confident	  validation	  of	  the	  structure	  (Henderson	  et	  al.,	  2011).	  An	  online	  server	  is	  available	  to	  enable	  tilt	  pair	  validation	  to	  be	  achieved	  (Wasilewski	  &	  Rosenthal,	  2014).	  	  	  The	  use	  of	  a	  ‘gold	  standard	  FSC’	  procedure	  is	  currently	  generally	  accepted	  as	  the	  optimal	  method	  for	  assessing	  the	  resolution	  of	  cryo-­‐EM	  density,	  which	  measures	  self-­‐consistency	  within	   the	   dataset.	   A	   correlation	   threshold	   is	   used	   to	   assign	   the	   resolution	   to	   the	   final	  reconstruction.	  0.143	  has	  been	  suggested	  as	  the	  most	  appropriate	  threshold	  to	  use	  as	  an	  indication	  of	  the	  true	  resolution	  of	  the	  map	  (Scheres	  &	  Chen,	  2012).	  	  	  The	  gold	  standard	  FSC	  calculates	   the	  global	  resolution	   for	  a	  density	  map,	  but	  algorithms	  have	   been	   developed	   to	   assess	   local	   resolution.	   This	   can	   be	   extremely	   informative,	   as	  resolution	   can	   vary	   considerably	   across	   the	   structure.	   One	   such	   tool	   is	   ResMap,	   which	  functions	  by	  testing	  each	  voxel	  3D	  pixel	  (Kucukelbir	  et	  al.,	  2014).	  The	  theory	  is	  based	  on	  the	   idea	   that	   if	   a	   λ-­‐	   Å	   feature	   exists	   at	   a	   voxel,	   a	   3D	   local	   sinusoid	   of	   λ	   is	   statistically	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detectable	   above	   the	   noise	   (calculated	   from	   the	   surrounding	   voxels).	   At	   a	   given	   λ,	   a	  likelihood	  ratio	  test	  is	  used	  to	  evaluate	  the	  λ-­‐	  Å	  sinusoid	  model,	  and	  a	  false	  discovery	  rate	  control	  is	  applied.	  The	  local	  resolution	  at	  a	  voxel	  is	  defined	  as	  the	  smallest	  λ	  at	  which	  the	  local	   sinusoid	   is	  detectable.	  Using	   this	  method	   there	  are	  no	  parameters	   to	   tune,	   and	   the	  local	   resolution	   is	   defined	   unambiguously	   at	   a	   given	   P	   value	   (Kucukelbir	   et	   al.,	   2014).	  Local	  resolution	  analysis	  is	  most	  commonly	  applied	  to	  sub-­‐nanometer	  structures,	  but	  can	  also	  be	  performed	  on	   tomographic	  data	  and	  other	   imaging	  modalities,	  whose	   resolution	  may	  be	  much	  lower	  (Kucukelbir	  et	  al.,	  2014).	  	  To	  assess	   the	  quality	  and	   features	  of	  density	  maps,	   it	   is	  often	  useful	   to	  visualise	   the	   full	  map	   rather	   than	   simply	   2D	   figures	   in	   a	   paper.	   As	   a	   prequisite	   for	   publication,	   many	  journals	  now	  require	  the	  deposition	  of	  EM	  derived	  density	  maps	  into	  public	  archives	  such	  as	   the	   EMDB,	  which	   is	   the	   single	   biggest	   global	   archive	   for	   EM	  derived	   structures,	  with	  over	  3400	  entries	   to	  date	   from	  single	  particle	  experiments,	  2D	  electron	  crystallography,	  helical	   reconstruction,	   tomography	   and	   sub-­‐tomographic	   averaging	   (Patwardhan	   et	   al.,	  2014).	  
1.4.2.4 Applying	  symmetry	  Many	  biological	  specimens	  possess	  symmetry;	  there	  is	  a	  strong	  tendency	  for	  symmetry	  in	  complexes,	   even	   for	   heteromeric	   complexes,	   and	   many	   viruses	   possess	   icosahedral	  symmetry	   (Chapter	   5)(Levy	   et	  al.,	   2006;	  Bhella	  &	  Bakker,	   2013).	   This	   symmetry	   can	   be	  exploited	  when	  generating	  3D	  reconstructions.	  For	  example,	   icosahedrons	  are	  built	   from	  60	  asymmetric	  units.	  In	  the	  projection	  of	  an	  icosahedral	  structure,	  the	  asymmetric	  unit	  is	  visualised	  in	  60	  orientations.	  The	  redundancy	  of	  information	  can	  be	  utilised	  by	  averaging	  when	   the	  orientation	  of	   the	   view	   is	   known.	  While	  utilising	   a	   sample’s	   symmetry	   greatly	  improves	   reconstructions,	   any	   asymmetric	   features,	   which	   do	   not	   conform	   to	   that	  symmetry,	   will	   be	   lost.	   For	   example,	   the	   genomes	   of	   icosahedral	   viruses	   will	   be	  inappropriately	   symmetrised	   when	   icosahedral	   symmetry	   is	   applied.	   Computational	  methods	   are	   now	   being	   developed	   to	   aid	   structure	   determination	   of	   complexes	   with	  symmetry	  mis-­‐matches	  (Liu	  &	  Cheng,	  2015).	  
1.4.2.5 Movie	  processing	  Under	   cryo-­‐EM	   imaging	   conditions,	   biological	   samples	   undergo	   radiation	   damage	   and	  beam	   induced	   movement,	   and	   charging	   of	   the	   specimen	   is	   sometimes	   observed.	   These	  factors	   contribute	   to	   typical	   images	   being	   poorer	   than	   they	   might	   be	   in	   theory	  (Henderson,	  1992).	  Recent	  advances	  in	  detector	  technology,	  specifically	  the	  development	  of	   DEDs	   (Section	   1.3.4),	   help	   to	   ameliorate	   some	   of	   these	   effects.	   Along	  with	   their	   high	  DQE,	   DEDs	   record	   images	   at	   a	   high	   rate	   (16-­‐44	   images/s),	  meaning	   that	   ‘movies’	   of	   an	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exposure	   can	   be	   taken	   (Bai	   et	   al.,	   2013).	   In	   RELION,	   a	   trajectory	   for	   particles	   can	   be	  calculated	   through	   the	   exposure,	   and	   has	   subsequently	   corrected.	   There	   are	   several	  algorithms	  available	   for	   this	   calculation/correction	   (	  Li	  et	  al.,	  2013;	  Scheres,	  2014).	  This	  methodology	  was	  initially	  developed	  on	  large	  (>1	  MDa)	  complexes	  such	  as	  the	  ribosome	  and	  icosahedral	  viruses	  (Bai	  et	  al.,	  2013),	  and	  subsequently	  been	  used	  to	  correct	  smaller	  specimens	  (X.	  Li	  et	  al.,	  2013;	  Scheres,	  2014;	  Rubinstein	  &	  Brubaker,	  2015).	  	  
1.4.3 Electron	  tomography	  The	  word	   tomography	   originates	   from	   two	   Greek	  words;	   Tomos	  meaning	   ‘to	   slice’	   and	  graph	  meaning	  ‘image’	  (Luci	  c	  et	  al.,	  2005).	  Whereas	  SPA	  allows	  (relatively)	  homogenous	  specimens	   to	   be	   examined,	   ET	   can	   be	   used	   to	   generate	   3D	   information	   of	   ‘unique’	  structures,	   including	   areas	   of	   the	   cell,	   organelles	   and	   pleomorphic	   viruses	   such	   as	   HIV,	  herpes	   and	  measles	   (Liljeroos	   et	  al.,	   2011;	   Ibiricu	   et	  al.,	   2011;	   Carlson	   et	  al.,	   2010;	   Van	  Driel,	   et	   al,.	   2009).	   ET	   provides	   molecular	   resolution,	   typically	   between	   4-­‐10	   nm.	  Tomography	   involves	   taking	   a	   tilt	   series	   of	   images,	   each	   representing	   a	   slice	   of	  information	  related	  by	  the	  known	  angular	  relationship	  between	  each	  tilt.	  The	  tilt	  series	  is	  aligned	  and	  back	  projected,	  creating	  a	  3D	  volume	  known	  as	  a	  tomogram.	  	  	  Single	   axis	   tilt	   series	   are	   routinely	   collected	   from	   +/-­‐	   60°,	   with	   a	   tilt	   increment	   of	   1-­‐3°	  (Figure	   1-­‐12),	   although	   dual	   axis	   data	   collection	   is	   possible	   The	   tilt	   range	   that	   can	   be	  achieved	   is	   limited	   by	   the	   thickness	   of	   the	   sample	   and	   hardware	   constraints	   of	   the	   EM,	  which	  requires	  the	  grid	  to	  be	  secured	  by	  a	  specimen	  arm,	  which	  is	  much	  thicker	  than	  the	  grid	   itself.	  As	   the	   tilt	   series	  collected	  does	  not	  represent	   the	   full	  angular	  sampling	  of	   the	  specimen,	   some	   information	   is	   missing.	   In	   a	   single	   axis	   tilt	   series	   this	   is	   known	   as	   the	  ‘missing	   wedge’,	   and	   in	   a	   dual	   axis	   tomogram	   a	   ‘missing	   pyramid’.	   This	   missing	  information	   leads	   to	   distortion	   and	   elongation	   along	   the	   Z-­‐axis,	   but	   sub-­‐tomographic	  averaging	  of	  repeating	  features	  within	  tomograms	  can	  be	  used	  to	  correct	  for	  this	  (Section	  1.4.3.2).	  	  	  ET	  is	  typically	  carried	  out	  using	  200-­‐300	  keV	  microscopes,	  whose	  electrons	  can	  penetrate	  the	  specimen	  better	  and	  are	  less	  likely	  to	  be	  inelastically	  scattered	  compared	  with	  lower	  energy	  electrons.	  Electron	  dose	  is	  a	  key	  consideration	  when	  collecting	  tilt	  series.	  As	  many	  images	  are	  collected	  in	  one	  area,	  very	  low	  electron	  doses	  must	  be	  used	  for	  each	  image	  to	  prevent	   radiation	   damage.	   For	   specimens	   under	   cryogenic	   conditions,	   typical	   doses	   are	  below	   120	   e-­‐/Å	   2.	   However,	   for	   some	   specimens,	   total	   dose	   must	   be	   kept	   even	   lower.	  Weibel-­‐Palade	  bodies	  exposed	  to	  a	  total	  dose	  of	  >	  50	  e-­‐/Å	  2	  ‘bubble’	  and	  become	  damaged,	  compared	   with	   surrounding	   organelles	   which	   are	   unaffected,	   possibly	   because	   of	   their	  extensive	  glycosylation	  (Berriman	  et	  al.,	  2009).	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1.4.3.1 Construction	  of	  the	  tomogram	  There	  are	   two	  main	  methods	  used	   to	  reconstruct	  an	  aligned	   tilt	   series	   into	  a	   tomogram;	  back-­‐projection	   and	   simultaneous	   iterative	   reconstruction	   technique	   (SIRT).	   Back-­‐projection	  reconstructions	  can	  be	  carried	  out	  in	  real	  or	  reciprocal	  space.	  In	  real	  space,	  2D	  density	   is	   ‘smeared’	   along	   lines	   into	   a	   3D	   volume	   at	   angles	   predefined	   by	   the	   relative	  orientations	  of	  each	  2D	  projection.	  This	  is	  an	  ‘unweighted’	  back-­‐projection,	  and	  results	  in	  blurry	  reconstructions.	  Many	  programs	  to	  reconstruct	  tilt	  series	  use	  weighted	  algorithms,	  such	  as	  IMOD	  which	  has	  the	  option	  of	  R-­‐weighted	  back	  projection	  (Gilbert,	  1972;	  Kremer	  
et	  al.,	   1996).	   SIRT	   initially	  generates	  a	   trial	   tomogram,	   reprojecting	   images	  at	   the	   stated	  tilt	   angles,	   and	   then	   adjusts	   the	   tomogram	   for	   the	   differences	   between	   the	   original	  projections	   and	   the	   new	   reprojections.	   This	   process	   is	   iterated	   to	   achieve	   a	   balance	  between	   noise	   and	   signal.	   In	   the	   first	   iterations,	   the	   tomogram	   is	   dominated	   by	   low	  frequencies,	   leading	   to	   blurry	   features.	   As	   iterations	   progress,	   higher	   frequency	  information	   is	   added,	   but	   so	   is	   some	   noise.	   SIRT	   will	   not	   intrinsically	   produce	   a	  reconstruction	   where	   different	   spatial	   frequencies	   possess	   the	   correct	   relative	  magnitudes,	  as	  back-­‐projection	  does.	  	  For	  images	  collected	  with	  the	  sample	  tilted,	  CTF	  correction	  is	  challenging.	  Not	  only	  do	  the	  images	  possess	  poor	  signal	  to	  noise	  ratio	  due	  to	  the	  low	  doses	  used,	  but	  the	  defocus	  also	  varies	   across	   the	   image	   due	   to	   the	   tilt.	   Programs	   have	   been	   developed	   to	   enable	   CTF	  correction	  of	   this	   type	  of	  data,	   such	  as	  CTFPLOTTER	   (Xiong	  et	  al.,	   2009).	   It	   functions	  by	  taking	  a	  1D	  power	  spectrum	  by	  periodogram	  and	  rotational	  averaging,	  then	  estimates	  the	  noise	  background	  by	  comparing	  with	  micrographs	  of	  no	  specimen.	  The	  background	  is	  then	  subtracted	  from	  the	  power	  spectrum.	  Regions	  of	  the	  image	  at	  different	  defocus	  values	  are	  then	  shifted	  to	  align	  their	  first	  zeros,	  and	  averaged	  together.	  This	  averaging	  improves	  the	  SNR	   so	   that	   it	   becomes	   possible	   to	   determine	   the	   defocus	   for	   subsets	   of	   the	   tilt	   series.	  Once	  the	  defocus	  is	  known,	  phase	  flipping	  can	  then	  be	  applied	  as	  in	  Section	  1.3.8.1.	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Figure	   1-­‐12	   Electron	   tomography.	   A)	   The	   specimen	   holder	   is	   tilted	   incrementally	  around	  an	  axis	  perpendicular	  to	  the	  electron	  beam.	  Projection	  images	  of	  the	  same	  object	  of	  interest	  are	  recorded	  at	  each	  tilt	  angle.	  Tilt	   increments	  are	  typically	  0.5◦	  to	  5◦	  and	  the	  tilt	  range	   is	   about	   ±70◦.	   B)	   The	   2D	   projection	   images	   of	   specimen	   at	   successive	   tilt	   angles.	  These	   are	   translationally	   and	   rotationally	   aligned.	   C)	   Aligned	   2D	   projection	   images	   are	  reconstructed	  into	  a	  3D	  density	  map	  or	  tomogram	  by	  a	  weighted-­‐back	  projection	  or	  SIRT.	  Adapted	  from	  Steven	  &	  Belnap,	  2005	  









wedge/pyramid	  of	  information.	  Commonly,	  classification	  is	  carried	  out	  prior	  to	  averaging,	  as	  all	  features	  may	  not	  be	  identical.	  	  	  Sub-­‐tomographic	  alignment	  of	  randomly	  orientated	  objects	  is	  complicated	  by	  the	  presence	  of	  the	  missing	  wedge/pyramid	  of	  information.	  As	  a	  result,	  weighted	  averaging	  algorithms	  must	  be	  used	  to	  compensate.	  These	  function	  by	  locating	  the	  missing	  wedge	  and	  mapping	  each	  non-­‐zero	  Fourier	  component	  into	  the	  aligned	  volume	  (Nicastro	  et	  al.,	  2006).	  Methods	  have	  also	  been	  developed	  to	  enable	  the	  classification	  of	   features	  with	  missing	  wedges	  of	  information.	   These	   algorithms	   constrain	   similarity	   comparisons	   to	   regions	   of	   Fourier	  space	  outside	  of	  the	  missing	  wedge,	  but	  which	  are	  shared	  between	  features	  (Förster	  et	  al.,	  2008).	  This	  constrained	  approach	  is	  known	  as	  constrained	  cross-­‐correlation,	  and	  enables	  classification	   of	   sub-­‐tomograms	   on	   structural	   features	   rather	   than	   missing	   wedge	  artefacts.	   Sub-­‐tomographic	   averaging	   has	   been	   used	   to	   study	   the	   structure	   of	   many	  complexes	  to	  sub	  nanometer	  resolution	  for	  example	  the	  features	  of	  the	  HIV-­‐1	  capsid	  at	  8.8	  Å	  resolution	  (Schur	  et	  al.,	  2015).	  
1.5 Finding	  the	  needle	  in	  the	  haystack	  Cryo-­‐electron	   tomograms	   have	   poor	   SNR,	   so	   how	   can	   features	   by	   unambiguously	  identified?	   Objects	   such	   as	   mitochondria	   and	   cytoskeleton	   can	   be	   confidently	   assigned	  based	  on	  morphology,	  but	  this	  is	  not	  the	  case	  for	  many	  structures.	  In	  addition,	  increasingly	  EM	   is	  being	  used	   to	  study	  spatially	  and	   temporally	   rare	  events,	   such	  as	  endocytosis	  and	  virus	  entry	  into	  cells	  (Ibiricu	  et	  al.,	  2011;	  Gan	  &	  Jensen,	  2012).	  As	  a	  result,	  methods	  have	  been	  developed	  to	  enable	  researchers	  to	  find	  the	  ‘needle	  in	  the	  haystack’	  in	  a	  sample,	  and	  to	  aid	  functional	  interpretation.	  	  	  Fluorescence	   microscopy	   in	   combination	   with	   fluorescent	   markers	   and	   cloneable	  fluorescent	  tags	  have	  lead	  to	  huge	  advances	  in	  cell	  biology	  (Tsien,	  1998;	  Chang	  et	  al.,	  2014;	  Paez-­‐Segala	  et	  al.,	   2015).	  Through	   the	  use	  of	  different	   fluorescent	   labels,	   the	   spatial	   and	  temporal	  location	  of	  many	  proteins	  or	  cellular	  components	  can	  be	  simultaneously	  tracked.	  There	   have	   been	   two	  main	   approaches	   to	   replicate	   this	   kind	   of	   functionality	   in	   EM,	   the	  generation	  of	  tags/markers	  of	  points	  of	  interest,	  and	  correlative	  light	  electron	  microscopy	  (CLEM).	  
1.5.1 Correlated	  light-­‐electron	  microscopy	  Correlative	  methods	  have	  been	  developed	  to	  combine	  information	  from	  two	  or	  more	  types	  of	  microscope	  that	  offer	  complementary	   information,	  overcoming	  the	   limitations	  of	  each	  individual	  technique	  and	  allowing	  more	  complex	  biological	  questions	  to	  be	  addressed.	  The	  two	  key	  questions	  when	  designing	  a	  CLEM	  experiment	  are	  which	  microscopy	  techniques	  
35	  
	  
to	  combine,	  and	  how	  to	  perform	  the	  correlations.	  Many	  different	  microscopy	   techniques	  have	  been	  combined	  and	  solutions	  for	  correlation	  determination	  developed.	  
1.5.1.1 Performing	  correlations	  Methods	   for	   correlating	   information	   from	   two	   or	  more	  microscopy	   techniques	   fall	   into	  two	   categories.	  The	   first	   are	   integrated	  microscopes,	   capable	  of	   two	   imaging	  modalities.	  Often,	  software	  is	  available	  with	  these	  set-­‐ups	  to	  aid	  correlations,	  which	  usually	  relies	  on	  a	  fiducial	   marker	   system	   to	   ensure	   accuracy.	   As	   the	   sample	   does	   not	   move	   between	  instruments,	  the	  risk	  of	  damage	  and	  contamination	  is	  reduced,	  and	  an	  area	  of	  interest	  can	  be	   located	   in	  one	   imaging	  mode	   then	   imaged	  directly	  using	  another.	  Dual	  mode	   imaging	  instruments	  are	  very	  convenient.	  The	  second	  category	  involves	  performing	  the	  imaging	  on	  two	   separate	   instruments,	   and	   a	   fiducial	   marker	   system	   to	   navigate	   to	   the	   region	   of	  interest	  in	  the	  second	  imaging	  mode.	  While	  correlations	  of	  this	  kind	  can	  be	  more	  difficult	  to	  implement,	  they	  are	  often	  cheaper	  and	  more	  flexible	  than	  integrated	  systems.	  	  	  Two	   of	   the	  most	   commonly	   combined	   imaging	   techniques	   are	   fluorescence	  microscopy	  with	  TEM.	  One	  commercially	  available	  option	   is	   the	  FEI	   iCorr	  system,	  which	   integrates	  a	  fluorescence	  microscope	  (FM)	  into	  a	  Tecnai	  G2	  microscope	  (Agronskaia	  et	  al.,	  2008).	  A	  15	  x	   0.5	   NA	   lens	   is	   integrated;	   one	   laser	   line	   is	   fitted	   allowing	   the	   imaging	   of	   GFP,	  AlexaFluor488	  or	  other	  spectrally	  similar	  fluorophores.	  The	  FM	  sits	  within	  the	  vacuum	  of	  the	  EM	  and	  is	  mounted	  perpendicular	  to	  the	  electron	  beam	  of	  the	  TEM,	  meaning	  the	  grid	  is	  rotated	  by	  90°	  to	  switch	  between	  imaging	  modes.	  In-­‐column	  fluorescent	  microscopes	  have	  also	   been	   implemented	   for	   cryo-­‐XM.	   For	   example,	   a	   system	   is	   available	   at	   the	   BESSY	   II	  U41-­‐XM	   beamline	   with	   an	   integrated	   100	   x	   objective	   with	   a	   0.75	   NA	   (Schneider	   et	   al.,	  2012).	   Bright	   field,	   fluorescence	   and	   DIC	   images	   can	   be	   collected,	   with	   a	   retractable	  objective	   lens	   (Schneider	   et	   al.,	   2012).	   A	   similar	   system	   has	   been	   implemented	   at	   the	  Diamond	   Light	   Source,	   a	   Carl	   Zeiss	   cryo-­‐XM,	   which	   has	   an	   integrated	   epi-­‐fluorescence	  microscope	   with	   a	   20	   x	   0.42	   NA	   lens	   (Dent	   et	   al.,	   2014).	   In	   this	   set	   up,	   the	   sample	   is	  rotated	  to	  enable	  imaging	   in	  bright	  field,	  epi-­‐fluoresence	  or	  reflective	  modes	  (Dent	  et	  al.,	  2014).	  	  	  While	   integrated	   dual	   mode	   microscopes	   are	   convenient,	   commercially	   available	  equipment	  can	  be	  prohibitively	  expensive.	  The	  technical	  complications	  of	  combining	  two	  microscopes	  into	  one	  often	  mean	  that	  compromises	  are	  made,	  for	  example	  in	  the	  FEI	  iCorr	  system	  a	  poor	  magnification	  and	  NA	  of	  the	  lens.	  Integrated	  systems	  are	  also	  inflexible	  and	  have	  a	  fixed	  configuration.	  An	  alternative	  to	  integrated	  dual	  mode	  microscopes	  is	  to	  image	  on	   two	   separate	   instruments	   and	   perform	   correlations	   to	   allow	   navigation	   back	   to	   the	  point	  of	  interest.	  Cryo-­‐FM	  is	  now	  increasingly	  being	  used	  in	  conjunction	  with	  TEM.	  It	  has	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been	   demonstrated	   that	   fluorophores	   still	   fluoresce	   under	   cryo-­‐conditions,	   and	   in	   fact	  photobleaching	  is	  slowed	  (Schwartz	  et	  al.,	  2007).	  	  	  Several	   stages	   have	   been	   designed	   to	   perform	   cryo-­‐FM	   on	   both	   upright	   and	   inverted	  optical	   systems,	   and	   a	   wide	   range	   of	   microscopy	   techniques	   can	   be	   performed	   under	  cryogenic	   conditions	   including	   confocal	   microscopy	   and	   z	   stack	   imaging	   (Sartori	   et	   al.,	  2007;	   Schwartz	  et	  al.,	   2007;	  Van	  Driel	  et	  al.,	   2009).	  Very	   low	  cost	   cryo-­‐light	  microscopy	  stages	   (<	   $40	   USD)	   have	   been	   developed	   from	  materials	   commonly	   found	   in	   hardware	  stores,	   although	   their	   functionality	   and	   stability	   is	   limited	   compared	   with	   commercial	  models	  (Carlson	  &	  Evans,	  2011).	  The	  most	  commonly	  used	  commercial	  cryo-­‐FM	  stages	  are	  the	  cryostage2	  by	  FEI,	  developed	  with	  Baumeister	  and	  colleagues	  (Rigort	  et	  al.,	  2010),	  and	  the	   Linkam	   cryostage	   (Linkam	   Scientific	   Instruments)	   in	   collaboration	   with	   Koster	   and	  colleagues.	  The	  Linkam	  stage	  can	  be	  fitted	  to	  a	  variety	  of	  commercially	  available	  upright	  confocal	  microscopes,	  and	  can	  function	  with	  a	  0.75	  NA	  100	  x	  lens,	  which	  sits	  in	  the	  lid	  of	  the	  holder.	  The	  resolution	  of	  cryo-­‐FM	  is	  limited	  by	  the	  NA	  of	  the	  lens	  used,	  for	  the	  Linkam	  system	  ~	  400	  nm.	  The	  lens	  has	  a	  relatively	  long	  working	  distance	  (4	  mm),	  which	  allows	  it	  to	  sit	  in	  the	  heated	  lid	  close	  to	  the	  specimen	  without	  freezing.	  The	  stage	  has	  been	  designed	  to	   minimise	   contamination	   in	   both	   sample	   transfer	   and	   during	   imaging,	   although	  contamination	   is	   still	   a	   significant	   problem	  when	   performing	   grid	   transfer	   and	   imaging.	  Stages	  of	  this	  design	  have	  been	  widely	  used	  to	  perform	  cryo-­‐FM	  and	  correlate	  with	  TEM	  and	  cryo-­‐XM	  (Section	  1.5.1.2).	  	  	  With	  cryo-­‐FM	  stages,	  markers	  across	  several	  orders	  of	  magnitude	  in	  scale	  must	  be	  used	  to	  navigate	   to	   the	   region	   of	   interest	   between	   the	   FM	   and	   TEM.	   Grids	   with	   large	   visual	  markers	  such	  as	  numbers,	   letters	  or	  symbols	  can	  be	  used	   for	  crude	  navigation.	  Features	  within	  a	  grid	   square,	   such	  as	   regular	  Quantifoil	   carbon	  holes	   can	  also	  be	  used	   for	   crude	  correlations.	   For	   greater	   accuracy,	   different	   systems	   and	   software	   programs	   have	   been	  developed.	  In	  many	  approaches,	  a	  low	  magnification	  ‘map’	  of	  the	  grid	  is	  generated.	  These	  maps	  are	   likely	  to	  be	  different	  scales,	  magnifications,	  rotations	  and	  even	  mirrors	  of	  each	  other	   and	   so	   several	   transformations	   may	   be	   needed	   to	   bring	   the	   maps	   into	   register.	  Different	   features	   in	   the	   maps	   may	   have	   very	   different	   contrast	   levels	   in	   the	   different	  imaging	  techniques,	  for	  example	  cells	  in	  the	  light	  microscope	  appear	  light/translucent	  but	  in	   the	   TEM	   are	   dark,	   and	   as	   a	   result	   simple	   cross	   correlation	   approaches	   are	   often	   not	  effective.	  Algorithms	  have	  been	  developed	   to	  enable	   featured	  based	   transformations,	   for	  example	   scale	   invariant	   feature	   transformation,	   which	   is	   implemented	   in	   the	   TOM2	  software	   program	   (Korinek	   et	   al.,	   2011).	   Accuracy	   of	   correlations	   in	   each	   of	   these	  approaches	  is	  limited	  to	  1-­‐2	  μm.	  Methods	  have	  been	  developed	  to	  perform	  more	  accurate	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correlations.	   For	   example,	  when	   imaging	   resin	   embedded	   sections,	   correlations	  with	   an	  accuracy	  of	  ~100	  nm	  can	  be	  performed	  by	  using	  fluorescent,	  electron	  dense	  microspheres	  as	  fiducial	  markers	  (Kukulski	  et	  al.,	  2011;	  Kukulski	  et	  al.,	  2012).	  A	  similar	  system	  has	  now	  been	   developed	   for	   cryo-­‐FM/EM,	   using	   a	   combination	   of	   TetraSpek	   fluorescent	  microspheres	   and	   fluorescent	   electron	   dense	   microspheres	   to	   perform	   accurate	  correlations	  to	  ~	  60	  nm	  (Schellenberger	  et	  al.,	  2014).	  	  	  Fluorescent,	  electron	  dense	  markers	  such	  as	  quantum	  dots	  (QD)	  are	  ideal	  for	  correlations.	  QDs	  are	  typically	  made	  of	  cadmium	  selenide	  or	  similar,	  with	  a	  shell	  such	  as	  zinc	  sulphide	  (Giepmans	  et	  al.,	  2005).	  They	  can	  be	  covered	  with	  a	  polymer	  which	  allows	  a	  wide	  range	  of	  functionalisation,	   for	   example	   with	   streptavidin	   or	   F(ab)2	   fragments	   (Giepmans	   et	   al.,	  2005).	  The	   fluorescence	  properties	  of	  QDs	  are	   ‘tuneable’	  by	   their	   size,	  with	   smaller	  QDs	  typically	   fluorescing	  at	   shorter	  wavelengths	   (E.	  Brown	  &	  Verkade,	  2010).	   In	   theory,	   this	  enables	   different	  QDs	   to	   be	   distinguishable	   in	   the	  TEM,	   however	   in	   practice	   this	   can	   be	  challenging,	  as	  their	  core	  is	  not	  very	  electron	  dense	  (Brown	  &	  Verkade,	  2010).	  It	  has	  been	  shown	  in	  plastic	  embedded	  sections	  up	  to	  three	  QD	  sizes	  can	  be	  distinguished	  (Giepmans	  
et	  al.,	  2005)	  QDs	  are	  photostable	  and	  bright,	  making	  them	  ideal	  for	  fluorescence	  imaging	  (Medintz	  et	  al.,	  2005).	  	  
1.5.1.2 Complementary	  imaging	  techniques	  Many	  microscopy	  techniques	  have	  now	  been	  combined	  to	  answer	  different	  questions.	  As	  shown	   in	  Table	   1.1,	   combining	  different	   types	   or	   resolutions	   of	   information	  has	   yielded	  insights	  into	  a	  wide	  range	  of	  biological	  questions.	  	  	  In	  many	  cases,	  live	  cell	  FM	  is	  used	  to	  identify	  the	  region	  of	  interest	  and	  the	  sample	  is	  then	  quickly	  immobilised	  (time	  scale	  of	  minutes,	  typically).	  Using	  this	  method,	  at	  the	  very	  least,	  there	  is	  a	  ~30	  second	  gap	  between	  the	  FM	  image	  and	  the	  EM	  image,	  and	  as	  a	  result	   it	   is	  not	  suitable	  for	  studying	  rapid	  processes.	  The	  alternative	  approach	  is	  to	  prepare	  samples	  for	   EM	  prior	   to	   imaging	  with	   FM.	  Recently,	   protocols	   for	   preserving	   the	   fluorescence	   of	  GFP	  and	  other	  fluorophores	  when	  processing	  samples	  by	  high	  pressure	  freezing	  followed	  by	  freeze	  substitution	  and	  resin	  embedding/sectioning	  have	  been	  developed	  (Kukulski	  et	  
al.,	  2011).	  This	  has	  resulted	  in	  a	  large	  number	  of	  CLEM	  studies,	  which	  perform	  FM	  and	  EM	  on	  resin	  embedded	  sections.	  This	  combination	  of	   imaging	   techniques	  has	  been	  powerful	  for	   studying	   rare	   temporal	   events	   such	   as	   endocytosis	   (Kukulski	   et	   al.,	   2012),	   and	   is	  technically	  less	  challenging	  than	  other	  forms	  of	  CLEM	  as	  all	  imaging	  can	  be	  performed	  at	  room	   temperature.	   However,	   freeze	   substitution,	   resin	   embedding	   and	   sectioning	   can	  introduce	   artefacts	   as	   discussed	   in	   section	   1.2.1.2.	   Vitrification	   of	   samples	   is	   widely	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regarded	  as	  the	  best	  way	  to	  retain	  native-­‐like	  samples	  for	  visualisation	  in	  the	  EM,	  and	  so	  cryo-­‐FM	  can	  be	  used.	  	  	  CLEM	  is	  a	  developing	  field,	  and	  in	  coming	  years	  many	  more	  imaging	  techniques	  are	  likely	  to	   be	   combined.	   For	   example,	   stages	   are	   under	   development	   to	   allow	   super	   resolution	  imaging	   (e.g.	   PALM/STORM)	   of	   frozen-­‐hydrated	   specimens	   (Kaufmann	   et	   al.,	   2014).	  Another	  interesting	  area	  that	  is	  likely	  to	  expand	  is	  using	  cryo-­‐FM	  to	  guide	  cryo-­‐FIB	  milling	  and	  cryo-­‐ET,	  which	  has	  already	  been	  shown	  to	  be	  technically	  feasible	  (Rigort	  et	  al.,	  2010).	  By	   using	   this	   combination	   of	   techniques,	   a	  molecular	   resolution	   view	   of	   rare	   spatial	   or	  temporal	  events	  in	  thick	  regions	  of	  the	  cell	  such	  as	  the	  nucleus	  or	  perinuclear	  region	  can	  be	  generated	  (Rigort	  &	  Plitzko,	  2015).	  
Study	   Imaging	  
technique	  1	   Imaging	  technique	  2	   Reference	  
	  Intracellular	  dynamics 	  Live	  cell	  FM Immunogold	  labelling	  resin	  embedded	  cell	  	  sections Polishchuk	  et	  al.,	  2000	  
	  GFP	  labeled	  proteins	   	  Live	  cell	  FM ET	  of	  resin	  embedded	  sections	  (di-­‐aminobenzidine	  photo	  conversion	  using	  GFP	  	  bleaching) Grabenbauer	  et	  al.,	  2005	  
	  Endosome	  dynamics 	  Live	  cell	  FM Ultrathin	  cryo-­‐sections	  with	  immunogold	  	  labelling van	  Rijnsoever	  et	  al.,	  2008	  	  Endocytosis	  in	  yeast FM	  on	  resin	   	  embedded	  sections ET	  on	  resin	  embedded	  	  sections Kukulski	  et	  al.,	  2012	  	  HIV-­‐1	  infection Time	  lapse	  live	  cell	  	  FM/cryo-­‐FM Cryo-­‐ET	  at	  thin	  edge	  of	  	  whole	  HeLa	  cells Jun	  et	  al.,	  2011	  
	  Mitochondria 	  Cryo-­‐FM Cryo-­‐ET	  at	  the	  thin	  edge	  	  of	  HUVEC	  cells Van	  Driel	  et	  al.,	  2009	  
	  Herpesviridae	  proteins Cryo-­‐FM	  (in	  	  column) 	  Cryo-­‐XM Hagen	  et	  al.,	  2012	  Endosomes	   Cryo-­‐FM	  (Linkam	  cryo	  stage)	   Cryo-­‐XM	   Duke	  et	  al.,	  2014	  
Adenovirus	  particles	   Cryo-­‐FM	  (FEI	  Cryostage2)	   Cryo-­‐EM	   Schellenberger	  et	  al.,	  2014	  
Table	  1.1	  Topics	  of	  study	  and	  microscopy	  techniques	  combined	  in	  CLEM.	  
1.5.2 EM	  tags	  Recombinantly	  expressed	  tags	  such	  as	  GFP	  have	  revolutionised	  optical	  microscopy,	  and	  so	  researchers	   have	   sought	   to	   develop	   similar	   systems	   for	   EM.	  One	   of	   the	  most	   developed	  systems	   is	   based	   on	   the	   protein	   metallothionein	   (MT).	   When	   fused	   with	   a	   protein	   of	  interest	  and	  treated	  with	  gold	  salts,	  a	  single	  tag	  will	  build	  an	  electron	  dense	  cluster	  of	  ~	  1	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nm	   in	   diameter.	   This	   technique	   has	   been	   used	   to	   detect	   intracellular	   proteins	   in	   both	  eukaryotic	   and	   prokaryotic	   cells	   (Risco	   et	   al.,	   2012;	   Diestra	   et	   al.,	   2009).	   It	   can	   offer	  improved	  resolutions	  compared	  with	  immunogold-­‐based	  techniques,	  where	  there	  can	  be	  15-­‐20	   nm	   between	   the	   protein	   of	   interest	   and	   the	   marker.	   MT	   tags	   can	   be	   used	   when	  imaging	  whole	   cells,	   but	   are	   also	  maintained	  when	   cells	   are	  processed	  by	  embedding	   in	  acrylic	  resin	  and	  sectioned.	  While	  MT	  tags	  can	  replace	  the	  need	  for	  CLEM	  in	  some	  systems	  where	  only	  one	  protein	  must	  be	  unambiguously	  identified,	  it	  is	  possible	  for	  the	  MT	  tag	  to	  be	  combined	  with	  fluorescence	  tags	  such	  as	  GFP,	  or	  smaller	  cloneable	  fluorophores	  such	  as	   mini-­‐singlet	   Oxygen	   generator	   (mini-­‐SOG)	   to	   ensure	   the	   identification	   of	   the	   same	  macromolecular	  complexes	  at	  different	  spatial	  resolutions	  (Risco	  et	  al.,	  2012).	  	  	  MT	   tags	   still	   have	   significant	   barriers	   to	   overcome	   for	   their	   use	   to	   be	   as	   ubiquitous	   as	  optical	  cloneable	  tags.	  Complications	  of	  this	  technique	  include	  the	  presence	  of	  endogenous	  MT	   in	  many	   cell	   types,	  whose	   expression	   is	   often	   up	   regulated	   upon	   exposure	   to	  metal	  salts,	   although	   studies	   have	   shown	   background	   from	   endogenous	   MT	   to	   be	   negligible	  (Risco	   et	   al.,	   2012).	   Eukaryotic	   cells	   are	   also	   particularly	   sensitive	   to	   gold	   salts	   and	   so	  protocols	  must	  be	  optimised	  to	  reduce	  cytotoxicity.	  Currently,	  only	  one	  type	  of	  tag	  can	  be	  employed,	   a	   limitation	   of	   the	   technique.	   Methods	   are	   currently	   being	   investigated	   to	  enable	  the	  labelling	  of	  multiple	  proteins,	  for	  example	  through	  different	  sized	  MT	  peptides	  yielding	  different	  sized	  nanoclusters	  of	  metal	  (Fernández	  de	  Castro	  et	  al.,	  2014).	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1.6 Perspectives	  For	   many	   years,	   structure	   determination	   by	   electron	   microscopy	   was	   limited	   to	   large	  macromolecular	   complexes	   to	  molecular	   resolutions,	   structures	  much	   below	   10	   Å	  were	  the	   exception	   (Bai,	   McMullan,	   et	   al.,	   2015).	   Over	   the	   last	   ~	   four	   years,	   cryo-­‐EM	   has	  undergone	  a	   ‘resolution	   revolution’	   as	  a	   result	  of	   improved	  hardware	   such	  as	  DEDs	  and	  improved	   image	   processing	   techniques	   (Kuehlbrandt,	   2014).	   For	  many	  macromolecular	  complexes	   such	   as	   the	   ribosome	   and	   proteasome,	   achieving	   sub	   5	   Å	   resolution	   is	   now	  routine,	   a	   feat	   almost	   unthinkable	   a	   decade	   ago.	   Many	   other	   samples	   that	   historically	  would	  have	  been	  too	  small	  (typically	  <	  500	  kDa),	  or	  too	  heterogeneous	  for	  high-­‐resolution	  structure	  determination	  by	  cryo-­‐EM	  are	  now	  within	  reach,	   for	  example	   the	  sub	  0.5	  MDa	  beta-­‐galactosidase	   and	   γ-­‐secretase,	   and	   heterogeneous	   ribosome	   populations	   (Scheres,	  2014;	   Bai,	   Yan,	   et	   al.,	   2015;	   Scheres,	   2010).	   As	   cryo-­‐EM	   produces	   maps	   of	   improving	  resolution,	   new	  opportunities	   are	   opening	   to	   solve	   structures	  de	  novo	   or	   refine	   existing	  crystal	  structures,	  using	   tools	  originally	  designed	   for	  X-­‐ray	  crystallography	  data	  (Emsley	  
et	   al.,	   2010;	   Murshudov	   et	   al.,	   1997).	   Another	   opportunity	   for	   the	   field	   is	   investigating	  small	  molecule	  binding,	  potentially	  opening	  up	  cryo-­‐EM	  as	  a	  tool	  for	  structure	  based	  drug	  design	  and	  validation	  (Bartesaghi	  et	  al.,	  2015).	  Aside	  from	  SPA,	  the	  new	  DEDs	  and	  phase	  plate	   technologies	   have	   the	   potential	   to	   revolutionise	   electron	   tomography,	   and	  correlative	  microscopy	  along	  with	  FIB	  milling	  may	  revolutionise	  cryo-­‐EM’s	  contribution	  to	  cell	  biology.	  	  Despite	  recent	  advances,	  many	  challenges	  remain.	  It	  is	  still	  challenging	  to	  generate	  high	  (<	  5	   Å)	   resolution	   structures	   for	   many	   macromolecular	   complexes	   that	   may	   be	   unstable,	  highly	   flexible,	   small	   (less	   than	   200	   kDa),	   or	   highly	   heterogeneous;	   in	   reality	   these	  challenges	  may	  have	   to	  be	   tackled	   in	   the	   laboratory	  with	   improved	   sample	  preparation.	  Even	   the	   generation	   of	   near	   atomic	   resolution	   maps	   is	   creating	   new	   challenges,	   for	  example	   in	   model	   validation.	   The	   field	   has	   moved	   rapidly	   in	   the	   last	   few	   years,	   but	  progress	  can	  still	  be	  made.	  Better	  electron	  detectors	  with	  improved	  DQEs,	  implementation	  of	  more	   automation	   in	   both	   data	   collection	   and	   processing,	   improved	   understanding	   of	  mechanisms	  of	  beam	  induced	  particle	  movement	  and	   finally	   improved	   image	  processing	  algorithms	   are	   all	   areas	   likely	   to	   progress	   the	   fields	   ability	   to	   generate	   high	   resolution	  structures	  of	  a	  range	  of	  macromolecular	  complexes.	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2 Experimental	  procedures	  
2.1 Materials	  All	  reagents	  were	  supplied	  by	  Sigma-­‐Aldrich	  unless	  stated	  in	  Table	  2.1.	  Buffer	  and	  media	  compositions	   are	   shown	   in	   Table	   2.2.	   Source	   of	   materials	   is	   shown	   in	   Table	   2.3.	   Pure	  deionised	  water	  (dH2O)	  was	  obtained	  from	  a	  purite	  water	  system	  (Purite	  ltd).	  	  
Reagent	   Supplier	  1-­‐palmitoyl-­‐2-­‐oleoyl-­‐sn-­‐glycero-­‐3-­‐phospho-­‐(1'-­‐rac-­‐glycerol	  (POPG-­‐	  840457)	   Avanti	  Polar	  Lipids	  1-­‐palmitoyl-­‐2-­‐oleoyl-­‐sn-­‐glycero-­‐3-­‐phospho-­‐L-­‐serine	  (POPS)	   Avanti	  Polar	  Lipids	  1-­‐palmitoyl-­‐2-­‐oleoyl-­‐sn-­‐glycero-­‐3-­‐phosphocholine	  (POPC)	   Avanti	  Polar	  Lipids	  1-­‐palmitoyl-­‐2-­‐oleoyl-­‐sn-­‐glycero-­‐3-­‐phosphoethanolamine	  (POPE)	   Avanti	  Polar	  Lipids	  1,2-­‐dimyristoyl-­‐sn-­‐glycero-­‐3-­‐phospho-­‐L-­‐serine	  (DMPS)	   Avanti	  Polar	  Lipids	  2-­‐[[5-­‐[5-­‐(4-­‐hydroxyphenyl)thiophen-­‐2-­‐yl]thiophen-­‐2-­‐yl]methylidene]propanedinitrile	  (NIAD-­‐4)	   ChemShuttle	  bis(monoaclglycero)phosphate	  (BMP)	   Avanti	  Polar	  Lipids	  Complete	  protease	  inhibitor	  mix,	  ETDA	  free	   Roache	  Applied	  Science	  Foetal	  bovine	  serum	  (FBS)	   Biosera	  Isopropyl	  β-­‐D-­‐1-­‐thiogalactopyranoside	  (IPTG)	   Melford	  Luria	   Bertani	   (LB)	   containing	   per	   L,	   10	   g	   bacto-­‐tryptone,	   5	   g	  yeast	  extract	  and	  10	  g	  NaCl.	   Melford	  Lysotracker	  deep	  red	   Molecular	  Probes	  sphingomyelin	  purified	  from	  porcine	  brain	   Avanti	  Polar	  Lipids	  Supersignal	  West	  Pico	  chemiluminescent	  substrate	   Perbio	  
Table	  2.1	  Suppliers	  of	  reagents.	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Buffer	   Components	  2	  x	  Laemmli	  buffer	   100	  mM	  Tris-­‐HCl	  pH	  6.8,	   20	  %	   (v/v)	   glycerol,	   4	  %	   (w/v)	  SDS,	   0.2	   %	   (w/v)	   bromophenol	   blue,	   100	   mM	  dithiothreitol	  (DTT)	  Acid	  phosphatase	  substrate	   5	  mM	  4-­‐nitrophenyl	  phosphate	  in	  0.09	  M	  citric	  acid,	  pH	  4.5	  Alkaline	  phosphatase	  substrate	   5	   mM	   4-­‐nitrophenyl	   phosphate	   in	   5	   mM	   magnesium	  acetate,	   70	   mM	   KCl,	   5	   mM	   glycine,	   0.2%	   (v/v)	   Triton	   X-­‐100,	  pH	  9	  Alpha-­‐N-­‐acetylgalactosaminidase	  (NAGA)	  substrate	   2	   mM	   4-­‐nitrophenyl	   N-­‐acetyl-­‐	   β-­‐D-­‐glucosaminide	   in	   100	  mM	  citric	  acid,	  0.2%	  (v/v)	  Triton	  X-­‐100	  pH	  4.5	  Anode	  buffer	   400	  mM	  Tris-­‐HCl	  pH	  8.8	  Bacterial	  lysis	  buffer	   25	   mM	   Tris-­‐HCl	   pH	   8.0,	   lysozyme	   100	   μg/ml,	   PMSF	   50	  μg/ml,	  DNase	  20	  μg/ml,	  1mM	  EDTA	  	  Blocking	  buffer	   Phosphate	  buffered	  saline	  (PBS),	  0.2	  %	  (v/v)	  Tween-­‐20,	  5	  %	  skimmed	  milk	  power	  Carboxyfluorescein	  buffer	   50	  mM	  sodium	  phosphate	  buffer,	  pH	  7.4	  containing	  50	  mM	  carboxyfluorescein,	  10	  mM	  NaCl	  and	  1	  mM	  EDTA	  Cathode	  buffer	   200	   mM	   Tris-­‐HCl,	   200	   mM	   Tricine,	   0.2%	   (w/v)	   Sodium	  dodecyl	  sulfate,pH	  8.25	  Cell	  culture	  medium	   Dulbecco’s	  modified	  eagle’s	  medium	  (DMEM),	  10	  %	  (v/v)	  foetal	   bovine	   serum,	   2	   mM	   L-­‐	   glutamine,	   100	   IU/ml	  penicillin,	  100	  μg/ml	  streptomycin	  	  Coomassie	  brilliant	  blue	  stain	   50%	   methanol	   (v/v),	   10%	   acetic	   acid	   (v/v)	   and	   0.25%	  (w/v)	  Coomassie	  Brilliant	  Blue	  Coomassie	  destain	   50	  %	  (v/v)	  methanol,	  10	  %	  (v/v)	  acetic	  acid	  Dye	  release	  buffer	  pH	  4.5	   50	   mM	   citric	   acid/sodium	   phosphate	   buffer,	   pH	   4.5,	   107	  mM	  NaCl	  and	  1	  mM	  EDTA	  Dye	  release	  buffer	  pH	  6.5	   50	   mM	   citric	   acid/sodium	   phosphate	   buffer,	   pH	   6.5,	   107	  mM	  NaCl	  and	  1	  mM	  EDTA	  Dye	  release	  buffer	  pH	  7.4	   50	   mM	   citric	   acid/sodium	   phosphate	   buffer,	   pH	   7.4,	   107	  mM	  NaCl	  and	  1	  mM	  EDTA	  Optiprep	   60	  %	  w/v	  iodixanol	  in	  water	  Percoll	  homogenisation	  buffer	   10	  mM	  acetic	  acid,	  1	  mM	  EDTA,	  190	  mM	  sucrose,	  10	  mM	  triethanolamine,	  pH	  7.4	  pH	  2.0	  β2m	  fibril	  buffer	   10	  mM	  sodium	  phosphate	  buffer,	  50	  mM	  NaCl,	  pH	  2.0	  SDS-­‐PAGE	  running	  buffer	   25	  mM	  Tris-­‐HCl,	  pH	  8.0,	  192	  mM	  glycine,	  0.1	  %	  (w/v)	  SDS	  Transfer	  buffer	   15	  mM	  Tris-­‐HCl,	  150	  mM	  glycine,	  0.02	  %	  (w/v)	  SDS,	  20	  %	  (v/v)	  methanol	  
Table	  2.2	  Buffer	  and	  media	  compositions	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Material	   Supplier	  0.2	  µm	  syringe	  filter	   Millipore	  0.4	  µm	  polycarbonate	  pore	   Whatmann	  1.5	  ml	  glass	  vial	   Chromacol	  3	  cm	  glass	  bottomed	  imaging	  dish-­‐	  FluoroDish	   World	  Precision	  Instruments	  6	  well	  dish	   Corning	  Costar	  96	  well	  plate	   Corning	  Costar	  Cell	  scraper	   Grenier	  Bio-­‐one	  Continuous	  carbon	  EM	  grids	   Agar	  Scientific	  Lacey	  EM	  grids	   Agar	  Scientific	  Polyvinylidene	  fluoride	  membranes	   GE	  healthcare	  Quantifoil	  EM	  grids	   Quantifoil	  Zeba™	  spin	  desalting	  column	   Thermo	  Fisher	  SnakeSkin™	   Dialysis	   Tubing,	   3.5K	   Molecular	   weight	   cut	   off	  (MWCO)	   Thermo	  Fisher	  Tissue	  culture	  flasks	  (75	  cm3	  or	  175	  cm3)	   Corning	  Costar	  Whatman	  No.1	  filter	  paper	   Agar	  Scientific	  
Table	  2.3	  Suppliers	  of	  materials.	  





Anti-­‐	  β2m	   Rabbit	   Polyclonal	   11	  μg/ml	   DakoCytomation	  (A0072)	  Anti-­‐Calreticulin	   Rabbit	   Polyclonal	   1/2000	   Calbiochem	  (208910)	  Anti-­‐Cathepsin	  D	   Goat	   Polyclonal	   0.4	  μg/ml	   R&D	  systems	  (AF1029)	  Anti-­‐Complex	  I	   Mouse	   Monoclonal	   0.5	  μg/ml	   Molecular	  Probes	  (A21344)	  
Table	  2.4	  Primary	  antibodies	  used	  in	  western	  blotting.	  
Antibody	   Host	   Clone	   Working	  
concentration	  
Buffer	   Supplier	  
A11	  Anti-­‐Oligomer	   Rabbit	   Polyclonal	   0.5	  ng/ml	   PBS,	   0.05	   %	  (v/v)	  Tween-­‐20	  	   Charles	  Glabe,	  University	   of	  California,	  Irvine	  	  Anti-­‐	  β2m	   Rabbit	   Polyclonal	   11	  μg/ml	   PBS,	  0.2	  %	  (v/v)	  Tween-­‐20	   Dako	  WO1	  	  Anti-­‐Fibrillar	   Mouse	   Monoclonal	  (WO1)	  	   1	  μg/ml	   PBS,	  0.2	  %	  (v/v)	  Tween-­‐20	   Ronald	  Wetzel,	  University	   of	  Pittsburgh	  	  




Antibody	   Host	   Clone	   Concentration	  	   Supplier	  (Catalogue	  number)	  HRP-­‐conjugated	  anti-­‐mouse	  IgG	   Rabbit	   Polyclonal	   0.1	  μg/ml	   GeneTex	  (GTX213112-­‐01)	  HRP-­‐conjugated	  anti-­‐goat	  IgG	   Rabbit	   Polyclonal	   50	  μg/ml	   Dako	  (Po449)	  HRP-­‐conjugated	  anti-­‐rabbit	   Goat	   Polyclonal	   1/5000	   BD	  Biosciences	  (554021)	  
Table	  2.6	  Horseradish	  peroxidase	   (HRP)	   conjugated	   secondary	  antibodies	  used	   in	  
immnoblotting	  and	  western	  blotting.	  	  
2.2 Gel-­‐based	  techniques	  
2.2.1 Sodium	  dodecyl	  sulphate	  polyacrylamide	  gel	  electrophoresis	  Tris-­‐tricine	   or	   tris-­‐glycine	   buffered	   sodium	   dodecyl	   sulphate	   polyacrylamide	   gel	  electrophoresis	   (SDS-­‐PAGE)	  was	   used	   to	   separate	   proteins	   according	   to	   their	  molecular	  weight.	   Components	   of	   the	   layered	   gels,	   consisting	   of	   stacking	   and	   resolving	   gels,	   are	  shown	   in	   Table	   2.7	   and	   Table	   2.8.	   Gel	   plates	   were	   assembled	   according	   to	   the	  manufacturer’s	   instructions	   (Hoefer).	   The	   resolving	   gel	  mixture	  was	   used	   to	   fill	   the	   gel	  plates	  leaving	  ~	  2	  cm	  air	  at	  the	  top.	  ~1	  ml	  water-­‐saturated	  butanol	  was	  added	  to	  exclude	  air	   and	   ensure	   a	   smooth	   gel.	  Once	   set,	  water-­‐saturated	  butanol	  was	  poured	  off,	   and	   the	  stacking	  gel	  poured.	  A	  comb	  was	  immediately	  inserted	  to	  create	  wells	  for	  sample	  loading.	  	  	  Samples	  were	  diluted	   two	   fold	   in	  2x	  Laemmli	  buffer	   (Table	  2.2)	  and	  heated	   to	  95	   °C	   for	  five	  minutes	  before	  loading	  onto	  the	  gel.	  Gel	  samples	  were	  subsequently	  stored	  at	  –	  20	  °C.	  15	   μl	   protein	  marker	   (Bio-­‐Rad	   precision	   plus	   dual	   colour	   protein)	  was	   also	   loaded.	   For	  tris-­‐tricine	  gels,	  cathode	  and	  anode	  buffers	  (Table	  2.2)	  were	  used	  in	  appropriate	  chambers	  during	   electrophoresis	   of	   the	   proteins	   through	   the	   gel.	   A	   current	   of	   30	  mA	  was	   applied	  until	  the	  samples	  entered	  the	  resolving	  gel,	  at	  which	  point	  the	  current	  was	  increased	  to	  60	  mA	  until	  the	  dye	  front	  reached	  the	  bottom	  of	  the	  gel.	  For	  tris-­‐glycine	  gels,	  running	  buffer	  was	  used	  during	  electrophoresis,	  and	  a	  current	  of	  15	  mA	  applied	  until	  the	  sample	  entered	  the	  resolving	  gel,	  when	  it	  was	  increased	  to	  25	  mA.	  	  Gels	  were	  then	  stained	  with	  Coomassie	  or	  probed	  by	  western	  blotting	  (Section	  2.2.2).	  For	  Coomassie	   blue	   staining,	   gels	  were	   incubated	  with	   Coomassie	   brilliant	   blue	   stain	   for	   30	  minutes,	   rocking	   at	   room	   temperature.	   Gels	   were	   then	   washed	   in	   Coomassie	   destain	  (Table	  2.2)	  until	  bands	  were	  clearly	  visible	  and	  background	  staining	  minimised.	  Gels	  were	  photographed	  in	  the	  InGenius	  gel	  documentation	  system	  (Syngene).	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Gel	  component	   Resolving	  Gel	  (ml)	   Stacking	  gel	  (ml)	  30%	  (w/v)	  Acrylamide:	  0.8%	  (w/v)	  bis-­‐acrylamide	  	   7.5	   0.83	  3	  M	  Tris.HCl,	  0.3%	  (w/v)	  SDS	  pH	  8.45	  	   5	   1.55	  dH2O	   0.44	   3.72	  Glycerol	   2.0	   -­‐	  10	  %	  (w/v)	  ammonium	  persulphate	   0.05	   0.1	  Tetramethylethylenediamine	  (TEMED)	  	   0.005	   0.005	  
Table	  2.7	  Tris-­‐tricine	  buffered	  gel	  components.	  
Gel	  component	   Resolving	  Gel	  (ml)	   Stacking	  gel	  (ml)	  30%	  (w/v)	  Acrylamide:	  0.8%	  (w/v)	  bis-­‐acrylamide	  	   3.33	   0.83	  3	  M	  Tris.HCl,	  0.8%	  (w/v)	  SDS	  pH	  8.8	  	   1.35	  	   -­‐	  1	  M	  Tris.HCl,	  0.8%	  (w/v)	  SDS	  pH	  6.8	   -­‐	   0.63	  dH2O	   5.31	   3.4	  10	  %	  (w/v)	  ammonium	  persulphate	   0.05	   0.1	  Tetramethylethylenediamine	  (TEMED)	  	   0.005	   0.005	  
Table	  2.8	  Tris-­‐glycine	  buffered	  gel	  components	  
2.2.2 Western	  Blotting	  Tris-­‐glycine	   SDS-­‐PAGE	   was	   carried	   out	   as	   described	   above.	   Gels	   were	   transferred	   onto	  polyvinylidene	   fluoride	   membranes	   using	   a	   semi-­‐dry	   electrophoretic	   transfer	   cell	   (Bio-­‐rad)	  according	  to	  the	  manufacturers	  instructions,	  using	  transfer	  buffer,	  at	  12-­‐20	  V	  for	  1-­‐2	  hours.	   Membranes	   were	   blocked	   with	   blocking	   buffer	   for	   1	   hour	   (h)	   rocking	   at	   room	  temperature,	  then	  incubated	  with	  primary	  (1°)	  antibodies	  as	  specified	  in	  Table	  2.4	  for	  16	  h	   at	   4	   °C.	  Membranes	  were	   then	  washed	   at	   least	   three	   times	   for	   5	  minutes	   in	   blocking	  buffer	   (Table	   2.2)	   before	  being	   incubated	  with	   secondary	   (2°)	   antibody	   for	   1	   h	   at	   room	  temperature.	  Membranes	  were	  washed	  a	   further	   two	   times	   in	  blocking	  buffer.	  Antibody	  binding	   to	   the	   membrane	   was	   detected	   using	   chemiluminescene	   detection	   with	  Supersignal	  West	   Pico	   chemiluminescent	   substrate	   and	  medical	   imaging	   film	   (Fujifilm).	  Film	  was	  developed	  on	  a	  Kornica	  SRX-­‐101A	  developer.	  	  
2.2.3 Immunoblotting	  (dot	  blotting)	  Fibril	  samples	  or	  controls	  (2.8	  μg	  protein,	  monomer	  equivalent,	  per	  dot)	  were	  applied	  to	  nitrocellulose	   membrane	   (Hybond-­‐Enhanced	   Chemiluminescence,	   GE	   Healthcare)	   and	  dried	  at	  room	  temperature.	  Negative	  controls	  were	  used	  for	  all	  blots.	  The	  buffer	  for	  each	  antibody	  varies	   in	  concentration	  of	  Tween-­‐20,	  appropriate	  buffers	   for	  each	  antibody	  are	  shown	   in	   Table	   2.5.	   For	   β2m	   and	  A11	   blots	  membranes	  were	   blocked	  with	   10	  %	   (w/v)	  skimmed	  milk	  powder	  (Marvel)	  in	  appropriate	  buffer	  (Table	  2.5)	  for	  16	  h	  at	  4	  °C.	  For	  WO1	  blots,	   blocking	   was	   performed	   by	   incubation	   with	   appropriate	   buffer	   containing	   3	   %	  (w/v)	  bovine	  serum	  albumin	  (BSA)	  for	  16	  h	  at	  4	  °C.	  	  	  During	   1°antibody	   incubation,	   for	   A11	   and	   anti-­‐β2m	   dot	   blots,	   samples	   were	   incubated	  with	  1°	  antibody	  in	  appropriate	  buffer	  containing	  5	  %	  (w/v)	  skimmed	  milk	  powder	  for	  1	  h	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at	   25	   °C	   (Table	   2.5).	   For	   WO1	   blots,	   samples	   were	   incubated	   with	   1o	   antibody	   in	  appropriate	   buffer	   containing	   3	   %	   (w/v)	   BSA	   for	   16	   h	   at	   4	   °C.	   For	   all	   antibodies,	  membranes	   were	   washed	   three	   times	   in	   appropriate	   buffer	   before	   incubation	   with	  horseradish	   peroxidase	   (HRP)	   conjugated	   2°	  antibody	   (Table	   2.6),	   in	   appropriate	   buffer	  (Table	  2.5).	  The	  membranes	  were	  washed	  three	  times	  with	  appropriate	  blot	  buffer,	  before	  visualisation	  of	  antibody	  binding	  using	  Supersignal	  West	  Pico	  chemiluminescent	  substrate	  and	  medical	  imaging	  film	  (Fujifilm),	  developed	  on	  the	  Konica	  SRX-­‐101A	  developer.	  
2.3 Expression	  and	  purification	  of	  recombinant	  β2m	  
2.3.1 Expression	  of	  β2m	  in	  E.coli	  BL21	  DE3	  cells	  transformed	  with	  pINK	  plasmid	  containing	  the	  human	  gene	  for	  β2m	  (Kad	  
et	  al	   2003)	  were	   streaked	  out	   onto	   an	   Lysogeny	  broth	   (LB)	   agar	   plate.	   Throughout	   this	  expression	  LB	  supplemented	  with	  100	  mg/ml	  carbenicillin	  was	  used.	  A	  single	  colony	  was	  used	   to	   inoculate	   two	   flasks	   of	   100	   ml	   LB	   broth.	   Flasks	   were	   incubated	   at	   37	   °C	   in	   a	  shaking	  incubator	  (200	  rpm)	  for	  16	  hours.	  These	  cultures	  were	  then	  used	  to	  inoculate	  10	  x	  1	  L	  LB	  broth	   in	  2.5	  L	   flasks.	  10	  ml	  of	   culture	  per	   flask	  was	  used	   to	   inoculate	  each	   flask,	  which	   was	   incubated	   at	   37	   °C,	   200	   rpm	   and	   OD600	   monitored	   periodically	   in	   a	  spectrophometer	  (Amersham	  Biosciences)	  until	   it	  reached	  0.6.	  IPTG	  was	  then	  added	  to	  a	  final	  concentration	  of	  1	  mM	  to	  each	  flask	  and	  the	  cultures	  further	  incubated	  for	  16	  h.	  Cells	  were	  harvested	  using	  a	  continual	  action	  centrifuge	  (Heraeus	  centrifuge	  stratus	  3049	  with	  a	  continuous	  flow	  rotor,	  15,000	  rpm).	  	  
2.3.2 Inclusion	  body	  isolation	  The	   cell	   pellet	   was	   resuspended	   in	   100	   ml	   bacterial	   lysis	   buffer	   and	   agitated	   at	   room	  temperature	  for	  30	  minutes.	  Cells	  were	  further	  lysed	  using	  a	  cell	  disruptor	  operating	  at	  20	  kPSi	   (Constantsytem).	  Lysed	  cells	  were	  centrifuged	  at	  15,000	  rpm	  (Beckman	   JLA	  16.250	  rotor)	  for	  30	  minutes,	  4	  °C.	  The	  supernatant	  was	  discarded	  and	  a	  lipid	  film	  on	  top	  of	  the	  pellet	   removed	   by	   gently	   scraping	   with	   a	   spatula,	   before	   re-­‐suspending	   the	   pellet	  containing	  inclusion	  bodies	  in	  25mM	  Tris-­‐HCL,	  pH	  8.0.	  This	  process	  was	  repeated	  until	  the	  pellet	  appeared	  a	  pale	  cream	  colour	  devoid	  of	   cellular	  debris	   (typically	  3-­‐5	   times).	  After	  the	  final	  wash	  step	  the	  pellet	  was	  resuspended	  in	  25	  mM	  Tris-­‐HCL	  pH	  8.0,	  8	  M	  urea,	  and	  agitated	   at	   room	   temperature	   for	   16	   h	   to	   resolubilise	   β2m.	   The	   solution	   was	   then	  centrifuged	  at	  15,000	  rpm	  at	  4	  °C,	  30	  minutes,	  to	  remove	  precipitate	  and	  the	  supernatant	  taken	  forward	  for	  dialysis.	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2.3.3 Refolding	  by	  dialysis	  Protein	  from	  inclusion	  body	  isolation	  was	  dialysed	  against	  5	  L	  of	  25	  mM	  Tris-­‐HCL	  pH	  8.0	  in	   3500	  MWCO	  dialysis	   tubing	   at	   4	   °C,	  with	   the	   buffer	   changed	  6	   x	   over	   48	   hours.	   Post	  dialysis,	  precipitate	  was	  removed	  by	  centrifugation	  at	  15,000	  rpm	  at	  4	  °C	  for	  30	  minutes.	  
2.3.4 Anion	  exchange	  Refolded	  protein	  was	  separated	  from	  contaminants	  using	  a	  XK50	  column	  (GE	  healthcare)	  containing	   ~200	   ml	   fast	   flow	   Q-­‐Sepharose.	   The	   column	   was	   washed	   with	   5	   x	   column	  volume	  of	   dH2O	  before	   being	   equilibrated	  with	  25	  mM	  Tris-­‐HCL	  pH	  8.0	   until	   steady	  UV	  conductivity	   baselines	   were	   achieved.	   The	   protein	   was	   applied	   to	   the	   column	   and	   the	  column	  further	  washed	  with	  2	  X	  column	  volume	  of	  equilibration	  buffer.	  Protein	  was	  eluted	  from	  the	  column	  using	  0.5	  M	  NaCl.	  Fractions	  containing	  recombinant	  protein	  were	  pooled	  and	  freeze-­‐dried	  before	  storage	  at	  -­‐20	  °C.	  
2.3.5 Gel	  filtration	  Monomeric	   β2m	  was	   further	   separated	   from	   contaminants	   and	   higher	   order	   aggregates	  using	   a	   Superdex	   75	   gel	   filtration	   column	   attached	   to	   an	   AKTA	   prime-­‐GE	   Healthcare	  Chromatography	  System.	  The	  column	  was	  washed	  with	  dH2O	  until	  absorbance	  at	  280	  nm	  (A280)	  and	  conductivity	   traces	  stabilised,	  and	   then	  washed	  with	  25	  mM	  Tris-­‐HCL	  pH	  8.0.	  Protein	   was	   resuspended	   to	   20	   mg/ml	   in	   25	   mM	   Tris-­‐HCL	   pH	   8.0,	   filtered,	   and	   5	   ml	  injected	  onto	  the	  column.	  Protein	  was	  eluted	  using	  the	  programme	  illustrated	  in	  Table	  2.9.	  Fractions	   containing	   β2m	   were	   pooled	   and	   dialysed	   against	   5	   L	   dH2O	   in	   3500	   MWCO	  dialysis	  tubing	  at	  4	  °C,	  with	  the	  buffer	  changed	  3	  x	  over	  24	  hours	  before	  freeze	  drying	  and	  storage	   at	   -­‐20	   °C.	   Protein	   molecular	   weight	   was	   determined	   by	   electrospray	   ionisation	  mass	  spectrometry	  (ESI-­‐MS)	  by	  James	  Ault,	  University	  of	  Leeds.	  	  Parameters	   for	  Superdex	   75	  gel	   filtration	  column	  programme	  Breakpoint	  (ml)	  
Flow	  Rate	  (ml/min)	   Fraction	  Size	   Buffer	  Valve	  position	   Inject	  Valve	  position	   Set	  	  Peak	  collect	   Auto	  zero	   Event	  mark	   Time	  after	  run	  start	  
0	   2	   0ml	   1	   Load	   No	   No	   No	   -­‐	  10	   2	  	   0ml	   1	   Inject	   No	   Yes	   Yes	   5	  min	  20	   2	  	   0ml	   1	   Load	   No	   No	   Yes	   10	  min	  110	   2	  	   3ml	   1	   Load	   No	   No	   Yes	   60	  min	  360	   2	  	   0ml	   1	   Load	   No	   No	   No	   180	  min	  
Table	   2.9	   Programme	   for	   the	   collection	   of	   protein	   using	   the	   AKTA	   prime	   GE	  
Healthcare	  Chromatography	  System	  with	  Superdex	  75	  gel	  filtration	  column.	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2.3.6 Quantifying	  protein	  concentration	  Protein	   samples	  were	  diluted	   to	  obtain	  UV	  absorption	  values	   at	   280	  nm	  of	  between	  0.1	  and	  1.0.	  Protein	  solutions	  were	  diluted	  into	  6	  M	  Guanidine-­‐HCL,	  20	  mM	  NaPi,	  pH	  6.5	  to	  a	  final	  volume	  of	  200	  µl.	  All	  absorption	  values	  were	  acquired	  using	  a	  reference	  standard	  of	  buffer-­‐only	  solutions.	  Protein	  concentrations	  were	  determined	  using	  Beer-­‐Lambert’s	  law.	  Wild-­‐type	  β2m	  has	  an	  extinction	  coefficient	  of	  20065	  M-­‐1.cm-­‐1	  (Gill	  &	  Hippel,	  1989).	  
2.3.7 Labelling	  of	  β2m	  with	  a	  fluorescent	  dye	  Alexa	   Fluor	   ®	   647	   succinimidyl	   ester	   (10	   mg/ml	   in	   DMSO)	   was	   added	   dropwise	   to	  monomeric	  β2m	  (10	  mg/ml	  0.1	  M	  sodium	  bicarbonate	  pH	  8.3)	  at	  a	  volumetric	  ratio	  of	  1:20	  dye:protein	  and	   incubated	  at	  room	  temperature	   for	  1	  hour.	  A	  2	  ml	  Zeba™	  spin	  desalting	  column	  with	  a	  7	  K	  MWCO,	  was	  used	  according	  to	  manufacturers	  instructions.	  The	  column	  was	  equilibrated	  with	  dH2O	  and	   the	   sample	  was	   loaded	  and	  eluted	   in	  dH2O.	  Monomeric	  β2m-­‐Alexa	   Fluor	   conjugate	   was	   lyophilised	   and	   stored	   at	   -­‐20	   °C.	   ~	   33	  %	   labelling	   was	  confirmed	  using	  ESI-­‐MS,	  performed	  by	  James	  Ault,	  University	  of	  Leeds.	  
2.3.8 Formation	  of	  β2m	  fibrils	  Seeds	   for	   β2m	   fibrillation	   were	   generated	   by	   agitating	   a	   500	   μl	   aliquot	   of	   120	   μM	   β2m	  monomer	   in	   pH	   2.0	   β2m	   fibril	   buffer	   (Table	   2.2)	   for	   three	   days	   in	   a	   glass	   vial	   with	   a	  polytetrafluoroethylene	   (PTFE)	   coated	   magnetic	   stirring	   bar,	   stirred	   in	   a	   custom	   built	  precision	  stirrer	  (Workshop	  of	  the	  School	  of	  Physics	  and	  Astronomy,	  University	  of	  Leeds)	  at	  1000	  rpm,	  room	  temperature.	  Two	  batches	  of	  seeds	  were	  used	  to	  generate	  all	  fibrils	  for	  this	  project.	  Morphological	  consistency	  between	  seeds	  was	  confirmed	  using	  negative	  stain	  EM.	  	  For	   the	   formation	   of	   amyloid	   fibrils,	   lyophilised	   β2m	   monomeric	   protein	   was	   passed	  through	   a	   0.2	   μM	   syringe	   filter	   and	   dissolved	   in	   pH	   2.0	   β2m	   fibril	   buffer.	   Protein	  concentration	   was	   adjusted	   to	   120	   μM	   and	   seeded	   with	   0.1	  %	   (v/v)	   seed.	   Sample	   was	  incubated	   quiescently	   at	   room	   temperature	   for	   24	   h	   to	   generate	   long,	   straight	   (Ls)	   β2m	  fibrils.	  Fragmented	  long,	  straight	  fibrils	  (Ls-­‐f)	  were	  generated	  by	  agitating	  a	  500	  μl	  aliquot	  of	  Ls	  fibrils	  (120	  μM	  β2m	  monomer	  equivalent,	  in	  pH	  2.0	  β2m	  fibril	  buffer)	  in	  a	  1.5	  ml	  glass	  vial	  with	  a	  PTFE	  coated	  magnetic	  stirring	  bar,	  stirred	  in	  a	  custom	  built	  precision	  stirrer	  at	  1000	  rpm	  at	  room	  temperature	  for	  48	  h.	  	  	  Fluorescently	  labelled	  fibrils	  were	  generated	  by	  mixing	  unlabelled	  monomer	  with	  labelled	  monomer	  at	  a	  ratio	  of	  1:9,	  resulting	  in	  an	  approximate	  overall	  labelling	  density	  of	  ~3/100	  monomers	  labelled	  with	  Alexa	  Fluor®	  647.	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Amorphous	   β2m	   aggregates	  were	   generated	   as	   previously	   described	   (Jahn	   et	  al.,	   2008).	  120	  μM	  monomer	  equivalent	  β2m	  in	  10	  mM	  sodium	  phosphate,	  pH	  5.0	  was	  heated	  to	  60	  °C	  for	  1	  h.	  
2.3.9 Small	  molecule	  binding	  to	  amyloid	  fibrils	  
2.3.9.1 Thioflavin-­‐T	  Samples	  containing	  6	  μM	  protein	  and	  10	  μM	  thioflavin-­‐T	  (ThT),	  pH	  2.0	  fibril	  buffer	  were	  incubated	  for	  10	  minutes	  at	  25	  °C.	  Fluorescence	  intensity	  at	  440	  nm	  excitation	  and	  480	  nm	  emission	   was	   measured	   using	   a	   Photon	   Technology	   International	   (PTI)	   Quantmaster	  fluorescence	  spectrometer,	  with	  a	  slit	  width	  of	  3	  nm.	  
2.3.9.2 NIAD-­‐4	  Samples	  containing	  12	  μM	  β2m	  monomer/Ls-­‐f	  (monomer	  equivalent)	  and	  7.5	  μM	  NIAD-­‐4	  were	  diluted	  into	  pH	  2.0	  β2m	  fibril	  buffer,	  dye	  release	  buffer	  pH	  4.4	  or	  dye	  release	  buffer	  pH	   7.4	   (Table	   2.2).	   Samples	   were	   incubated	   at	   25	   °C	   for	   10	   minutes.	   Fluorescence	  emission	   spectra	  were	  measured	  using	  a	  PTI	  Quantmaster	   fluorescence	   spectrometer	   at	  an	   excitation	  wavelength	   of	   500	  nm	  with	   a	   slit	  width	   of	   6	   nm,	  with	   emission	  measured	  between	  520-­‐740	  nm	  with	  a	  slit	  width	  of	  8	  nm.	  Emission	  spectra	  were	  normalised	  against	  7.5	  μM	  NIAD-­‐4	  in	  respective	  buffer.	  	  
2.4 Atomic	  force	  microscopy	  AFM	  was	  performed	  and	  analysed	  by	  Kevin	  Tipping.	  Samples	  were	  prepared	  for	  tapping-­‐mode	  AFM	  by	  diluting	  samples	  to	  0.4	  μM	  monomer	  equivalent	  concentrations	  in	  dH2O.	  20	  μl	  of	  sample	  was	  deposited	  onto	  freshly	  cleaved	  mica	  and	  incubated	  at	  room	  temperature	  for	   5	   min.	   Surfaces	   were	   then	   washed	   with	   1	   ml	   of	   dH2O	   before	   gently	   aspirating	   the	  surface	   with	   a	   stream	   of	   N2	   gas	   to	   complete	   dryness.	   Samples	   were	   imaged	   using	   a	  Dimension	  3100	   scanning	  probe	  microscope	   (Veeco	   Instruments)	   and	  PPP-­‐NCLR	   silicon	  cantilever	  probes	  (Nanosensors,	  Neuchatel,	  Switzerland)	  with	  a	  nominal	  force	  constant	  of	  48	   N/m.	   Typically,	   10	   μm2	   images	   at	   a	   pixel	   ratio	   of	   1024	   x	   1024	   were	   collected	   for	  analysis.	   To	   generate	   fibril	   length	   distributions,	   images	   were	   analysed	   using	   scripts	  generated	  in	  Matlab	  (Mathworks)	  by	  Dr	  Wei-­‐Feng	  Xue	  (Xue	  et	  al.,	  2009).	  
2.5 Cell	  culture	  RAW	  264.7,	  HeLa	  and	  SH-­‐SY5Y	  cells	  were	  cultured	  in	  cell	  culture	  media	  (Table	  2.2)	  at	  37	  °C,	  5	  %	  CO2,	  in	  75	  cm3	  or	  175	  cm3	  tissue	  culture	  flasks	  and	  passaged	  when	  they	  reached	  ~	  80	  %	  confluency.	  RAW	  264.7	  cells	  were	  passaged	  using	  a	  cell	  scraper.	  HeLa	  and,	  SH-­‐SY5Y	  cells	  with	  1	  %	  Trypsin-­‐EDTA	  solution.	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For	   imaging	   in	   the	  electron	  microscope,	   cells	  were	  grown	  on	  EM	  grids	   (Section	  2.11)	  by	  seeding	  at	  250,000	  cells/ml	  into	  a	  6	  well	  dish,	  with	  EM	  grids	  pre-­‐irradiated	  with	  UV	  for	  30	  minutes	  placed	  into	  the	  bottom	  of	  the	  dish.	  Cells	  were	  incubated	  at	  37	  °C,	  5	  %	  CO2	  for	  16	  h	  before	  vitrification	  (Section	  2.11.3).	  
2.5.1 	  MTT	  cell	  viability	  assay	  RAW	  264.7	  cells	  were	  plated	  into	  96	  well	  dishes,	  500,000	  cells/well	  and	  cultured	  for	  16	  h.	  1.2	  μM	  monomer	  or	  monomer	  equivalent	  fibril	  sample,	  buffer,	  or	  0.1	  %	  w/v	  sodium	  azide	  were	  added	  to	  wells,	  and	  cells	   further	   incubated	  for	  24	  hours.	  Cells	  were	  then	  incubated	  with	   3-­‐(4,5-­‐Dimethylthiazol-­‐2yl)-­‐2,5-­‐diphenyltetrazolium	   bromide	   (MTT)	   at	   a	   final	  concentration	   of	   0.5	   mg/ml	   for	   1	   hour.	   Cell	   medium	   was	   then	   removed	   and	   formazan	  crystals	   resuspended	   in	   DMSO.	   Absorbance	   at	   570	   nm	   was	   measured	   using	   a	  spectrophometer	  (Powerwave	  XS2,	  Biotek).	  Absorbance	  at	  650	  nm	  was	  taken	  and	  used	  to	  correct	   for	   background	   cell	   debris.	   Results	  were	   normalised	   to	   sodium	   azide	   treatment	  (0%	  MTT	  reduction)	  and	  untreated	  sample	  (100	  %	  MTT	  reduction).	  	  
2.6 Liposome	  dye	  release	  
2.6.1 Preparation	  of	  lipid	  film	  from	  purchased	  lipid	  	  The	   desired	   mass	   of	   lipid	   (typically	   20	   mg)	   required	   to	   form	   LUVs	   (e.g.	   25	   mol	   %	  cholesterol	   and	   75	   %	   mol	   1-­‐palmitoyl-­‐2-­‐oleoyl-­‐sn-­‐glycero-­‐3-­‐phospho-­‐(1'-­‐rac-­‐glycerol)	  (PG),	  100	  mol	  %	  1,2-­‐dimyristoyl-­‐sn-­‐glycero-­‐3-­‐phospho-­‐L-­‐serine	  (DMPS)	  or	  100	  mol	  %	  L-­‐α-­‐Lecithin	   (Sigma	   P	   5394))	   was	   suspended	   in	   chloroform	   which	   was	   then	   evaporated	  under	  a	  stream	  of	  N2	  gas	  to	  form	  a	  thin	  lipid	  film	  over	  the	  bottom	  of	  a	  glass	  tube.	  The	  film	  was	   further	  dried	  under	  vacuum	  for	  approximately	  3	  h.	  The	   film	  was	  stored	  at	  4	   °C	  and	  used	  within	  one	  week.	  	  
2.6.2 Preparation	  of	  RAW	  264.7	  lipid	  film	  Lipids	   were	   extracted	   from	   cells	   using	   a	   lipid	   extraction	   kit	   (Cell	   Biolabs	   STA-­‐612)	  according	   to	   the	   manufacturer’s	   instructions.	   The	   kit	   extracts	   total	   lipids	   by	   organic	  extraction,	  using	  a	  proprietary	  alcohol.	  Lipid	  in	  the	  upper	  organic	  phase	  was	  dried	  under	  a	  stream	  of	  N2	   gas	   to	   form	  a	   thin	   lipid	   film	  over	   the	  bottom	  of	   a	   glass	   tube.	   The	   film	  was	  further	  dried	  under	  vacuum	  for	  approximately	  3	  h.	  The	  film	  was	  stored	  at	  4	  °C	  and	  used	  within	  one	  week.	  
2.6.3 Large	  unilamellar	  vesicles	  preparation	  The	  lipid	  film	  (Section	  2.6.1,	  2.6.2)	  was	  resuspended	  in	  carboxyfluorescin	  buffer	  to	  give	  a	  final	   lipid	   concentration	   of	   25	   mM.	   At	   least	   four	   freeze-­‐thaw	   cycles	   were	   performed	  between	  LN2	   and	  90	  °C	  water	  bath,	   vortexing	  between	  each	   cycle.	   Free	   lipids	  were	   then	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extruded	   using	   the	   mini-­‐Extruder	   apparatus	   (Avanti)	   by	   passing	   through	   a	   0.4	   µm	  polycarbonate	  pore	  up	  to	  35	  times	  to	  generate	  400	  nm	  extruded	  large	  unilamellar	  vesicles	  (LUVs).	  For	  DMPS	  and	  RAW	  264.7	   lipid	  where	  stated,	  extrusion	  was	  performed	  at	  50	  °C.	  LUVs	  were	  washed	  by	  successive	  rounds	  (up	  to	  5)	  of	  centrifugation	  at	  16,000	  x	  g	   for	  25	  min	  and	  re-­‐suspension	  of	  the	  lipid	  pellet	  in	  dye	  release	  buffer	  pH	  7.4.	  LUVs	  were	  stored	  on	  ice	  and	  used	  within	  48	  h	  of	  extrusion.	  
2.6.4 Dye	  release	  assay	  For	  the	  dye	  release	  assay,	  LUVs	  were	  adjusted	  to	  5	  μM	  lipid	  monomer	  in	  dye	  release	  buffer	  of	  appropriate	  pH.	  Each	  dye	  release	  reaction	  was	  carried	  out	  at	   least	   in	  triplicate	  in	  a	  96	  well	  plate.	  In	  all	  LUV	  lipid	  types,	  190	  μl	  of	  LUV	  was	  incubated	  with	  10	  μl	  buffer	  control	  or	  protein	  condition	  (final	  working	  concentration	  6	  μM	  monomer	  equivalent).	  For	  reactions	  carried	  out	  at	  pH	  4.5	  and	  6.4,	  after	  the	  experimental	  duration,	  samples	  were	  diluted	  1:2	  in	  dye	   release	   buffer	   pH	   7.4	   (Table	   2.2)	   before	   fluorescence	   intensity	   was	   quantified.	   For	  reactions	  carried	  out	  at	  pH	  7.4,	  fluorescence	  was	  measured	  every	  minute	  for	  the	  duration	  of	  the	  experiment.	  For	  DMPS	  LUVs,	  reactions	  were	  carried	  out	  at	  45	  °C.	  For	  biological	  and	  PG	  based	  LUVs,	  reactions	  were	  carried	  out	  at	  37	  °C.	  Fluorescence	  spectra	  were	  measured	  using	   the	   CLARIOstar	   plate	   reader	   (BMG	   Labtech)	   with	   a	   monochromator,	   using	   an	  excitation	  wavelength	  of	  490	  +/-­‐	  4	  nm.	  Emission	  spectra	  were	  recorded	  between	  510	  +/-­‐	  4	   nm	   and	   600	   +/-­‐	   4	   nm	   for	   reactions	   at	   acidic	   pH,	   and	   between	   510-­‐520	   +/-­‐	   4	   nm	   for	  reactions	   at	   pH	   7.5.	   Data	   were	   initially	   analysed	   using	   CLARIOstar	   analysis	   software.	  100%	  dye	  release	  values	  were	  obtained	  for	  each	  sample	  by	  the	  addition	  of	  Triton	  X-­‐100	  to	  a	   final	  concentration	  of	  0.2%	  (v/v).	  Normalised	  dye	  release	  values	   for	  each	  sample	  were	  calculated	  using	  the	  following	  equation;	  	   %  𝐷𝑦𝑒  𝑅𝑒𝑙𝑒𝑎𝑠𝑒 =    𝐹 − 𝐹!𝐹𝑇 − 𝐹! 	  	  Where	   F	   is	   the	   fluorescence	   intensity	   of	   the	   sample,	   Fb	   is	   the	   background	   dye	   release	  (carboxyfluorescein	  fluorescence	  from	  LUVs	  in	  the	  presence	  of	  appropriate	  buffer)	  and	  FT	  is	  the	  fluorescence	  intensity	  after	  the	  addition	  of	  Triton	  X-­‐100.	  
2.6.5 Dynamic	  light	  scattering	  To	   characterise	   LUVs	   dynamic	   light	   scattering	   (DLS)	   was	   performed	   by	   Dr	   Sophia	  Goodchild	   on	   a	   miniDAWN	   TREOS	   system,	   equipped	   with	   a	   Wyatt	   quasi-­‐elastic	   light	  scattering	  (QELS)	  detector	  (Wyatt	  Technology),	  run	  in	  batch	  mode	  at	  room	  temperature.	  LUVs	  were	  measured	  at	  ~	  50	  μM	  lipid	  molecule	  concentration	  in	  dye	  release	  buffer	  pH	  7.4.	  For	   each	   sample,	   three	  measurements	  were	   performed.	   QELS	   data	  was	   collected	   at	   five	  seconds	  intervals	  for	  three	  minutes.	  Data	  were	  processed	  by	  regularisation	  analysis	  using	  
52	  
	  
Wyatt	  ASTRA	  6.0	  software.	  Hydrodynamic	  radii	  are	  reported	  as	   the	  weighted	  average	  of	  three	  experiments	  for	  each	  sample	  with	  an	  error	  of	  1	  standard	  deviation	  (SD).	  
2.7 Enrichment	  of	  lysosomes	  
2.7.1 Homogenisation	  using	  a	  ball	  bearing	  homogeniser	  Desired	   numbers	   of	   cells	   were	   harvested	   by	   centrifugation	   at	   500	   x	   g	   for	   5	   minutes	  (Eppendorph	   5804	   centrifuge)	   and	   washed	   three	   times	   with	   PBS.	   The	   cell	   pellet	   was	  resuspended	  in	  an	  appropriate	  homogenisation	  buffer	  and	  passed	  through	  a	  ball	  bearing	  homogeniser	   (10	   μm	   clearance,	   Isobiotec)	   until	   >90	   %	   breakage	   was	   achieved.	   Cell	  homogenisation	  was	  carried	  out	  on	   ice,	  with	  homogeniser	  and	  buffers	  pre-­‐cooled	  on	   ice.	  Homogenisation	  in	  this	  manner	  maintains	  the	  integrity	  of	  subcellular	  organelles	  (Balch	  &	  Rothman,	  1985).	  	  
2.7.2 Generation	  of	  post	  nuclear	  supernatant	  	  Whole	  cell	   lysate	  was	  centrifuged	  at	  1000	  x	  g	   for	  10	  minutes	  at	  4	  °C	  (Eppendorf	  5415	  R	  microfuge)	  to	  pellet	   the	  nucleus	  and	  large	  mitochondria.	  Post	  nuclear	  supernatant	  (PNS)	  was	  moved	  to	  a	  clean	  eppendorf	  tube	  and	  the	  pellet	  discarded.	  	  
2.7.3 Generation	  of	  crude	  lysosomal	  pellet	  The	  PNS	  was	  centrifuged	  at	  20,000	  x	  g	  (Sorvall	  discovery	  M150	  SE	  micro-­‐ultracentrifuge,	  S55-­‐S	   rotor,	   Sorvall)	   to	   generate	   crude	   lysosomal	   pellet	   (CLP)	   enriched	   in	   lysosomes,	  endoplasmic	   reticulum	   and	   micochondria.	   CLP	   was	   resuspended	   in	   an	   appropriate	  homogenisation	   buffer	   for	   imaging	   or	   taken	   forward	   for	   subcellular	   fractionation	   on	   an	  iodixanol	  gradient.	  
2.7.4 Subcellular	  fractionation	  using	  a	  percoll	  gradient	  Subcellular	  fractionation	  using	  percoll	  was	  performed	  using	  an	  adaptation	  of	  a	  published	  protocol	   (Casey	   et	  al.,	   2007).	   Briefly,	   5	   x	   107	   cells	  were	   homogenised	   (Section	   2.7.1)	   in	  percoll	  homogenisation	  buffer	  (Table	  2.2)	  supplemented	  with	  protease	  inhibitor	  mixture.	  The	  PNS	  was	  generated	  (Section	  2.7.2)	  and	  loaded	  onto	  the	  top	  of	  9	  ml	  27	  %	  (v/v)	  percoll,	  in	  percoll	  homogenisation	  buffer.	  To	  separate	  organelles	  by	  their	  density,	  the	  gradient	  was	  centrifuged	  at	  48,500	  x	  g	  for	  1	  hour	  at	  4	  °C	  (T1270	  rotor	  Sorvall	  Discovery	  90SE).	  Ten	  1	  ml	  fractions	  were	   collected	   from	   the	   top	  of	   the	   gradient	   and	   enzyme	  assays	   (Section	  2.7.6)	  were	   performed	   to	   identify	   fractions	   enriched	   in	   lysosomes.	   An	   aliquot	   of	   each	   fraction	  was	   analysed	   by	   SDS-­‐PAGE	   and	   immunoblotting	   to	   identify	   the	   location	   of	   organelles	  across	  the	  gradient.	  The	  enriched	  lysosomal	  fraction(s)	  were	  centrifuged	  241,000	  x	  g	  for	  1	  h	   at	   4	   °C	   (TLS-­‐55	   rotor,	   Beckman	   Coulter	   TLX	   ultracentrifuge).	   The	   layer	   of	   lipid	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(lysosomes)	  on	  top	  of	  percoll	  pellet	  was	  pipetted	  off	  to	  yield	  the	  lysosomal	  fraction,	  which	  was	  taken	  forward	  for	  imaging	  by	  cryo-­‐EM.	  
2.7.5 Subcellular	  fractionation	  on	  an	  Optiprep™	  gradient	  CLP	  was	  resuspended	  to	  19	  %	  (v/v)	  Optiprep™	  and	  loaded	  between	  22.5	  and	  16%	  (v/v)	  layers	   into	   a	   discontinuous	   gradient	   of	   27,	   22.5,	   16,	   12,	   6	   %	   (v/v)	   Optiprep,	   with	   the	  densest	  fractions	  at	  the	  bottom	  of	  the	  ultracentrifuge	  tube.	  The	  gradient	  was	  centrifuged	  at	   150,000	   x	   g	   4	   hours	   at	   4	   °C	   (Sorvall	   discovery	   90	   SE	   ultracentrifuge,	   Sorvall	   AH650	  swing	   out	   rotor).	   200	   μl	   was	   removed	   at	   the	   interface	   between	   layers	   that	   were	   taken	  forward	  for	  further	  analysis.	  	  
2.7.6 Enzyme	  assays	  
2.7.6.1 N-­‐acetylglucosaminidase	  assay	  To	   assess	   the	   levels	   of	   N-­‐acetyl	   glucosaminidase	   (NAGA),	   a	   marker	   for	   lysosomes	  (Sellinger	  et	  al.,	  1960),	  the	  NAGA	  activity	  of	  each	  subcellular	  fraction	  was	  determined.	  100	  μl	  NAGA	  substrate	  (Table	  2.2)	  was	  incubated	  with	  10	  μl	  of	  sample	  in	  a	  96	  well	  plate	  and	  incubated	   at	   37	   °C	   for	   30	   minutes	   (whole	   cell	   homogenate	   and	   homogenisation	   buffer	  acted	  as	  positive	  and	  negative	  controls	  respectively).	  	  The	  reaction	  was	  stopped	  using	  200	  μl	   200	  mM	  glycine,	   pH	  10.3.	   Absorbance	  was	   then	   read	   at	   405	   nm	  using	   a	   plate	   reader	  (Powerwave	  XS2,	  Biotek).	  
2.7.6.2 NAGA	  release	  from	  CLP	  fraction	  2	   x	   107	   RAW	   264.7	   cells	   were	   used	   to	   a	   generate	   CLP	   (Section	   2.7.3),	   which	   was	  resuspended	  to	  1	  ml	  in	  Optiprep™	  homogenisation	  buffer.	  100	  μl	  CLP	  was	  incubated	  with	  a	   final	  concentration	  of	  6	  μM	  monomer	  equivalent	  β2m	  monomer,	  Ls	  or	  Ls-­‐f,	  0.5%	  (v/v)	  Triton	  X-­‐100	  detergent	  or	   fibril	  buffer	   for	  1	  hour,	  37	  °C	  under	  gentle	  agitation	  to	  ensure	  mixing.	   The	   sample	   was	   then	   centrifuged	   at	   100,000	   x	   g	   for	   30	   mins	   at	   4	   °C	   (Sorvall	  discovery	   M150SE	   micro-­‐ultracentrifuge,	   Sorvall	   S100	   AT3	   rotor).	   The	   soluble	   fraction	  was	   removed	   and	   retained	   on	   ice.	   The	   pellet	   was	   surface	   washed	   with	   1	   ml	  homogenisation	   buffer,	   and	   ultra-­‐centrifuged	   100,000	   x	   g	   30	  mins,	   4	   °C.	   The	   pellet	  was	  resuspended	  into	  the	  same	  volume	  as	  the	  soluble	  fraction	  with	  Optiprep™	  homogenisation	  buffer.	  NAGA	  assays	  were	  then	  performed	  on	  the	  soluble	  and	  pellet	  fractions.	  	  
2.7.6.3 Acid	  phosphatase	  assay	  The	  activity	  of	  acid	  phosphatase.,	   a	   lysosomal	  marker	   (Bull	  et	  al.,	  2002)	  was	  assessed	   in	  each	   subcellular	   fraction.	   100	   μl	   acid	   phosphatase	   substrate	   (Table	   2.2)	   was	   incubated	  with	  5	  μl	  of	  sample	  in	  a	  96	  well	  plate	  and	  incubated	  at	  37	  °C	  for	  30	  minutes.	  The	  reaction	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was	  stopped	  using	  100	  μl	  0.5	  M	  NaOH.	  Absorbance	  was	  then	  read	  at	  405	  nm	  using	  a	  plate	  reader	  (Powerwave	  XS2,	  Biotek).	  
2.7.6.4 Alkaline	  phosphatase	  assay	  To	  quantify	   the	   levels	  of	  alkaline	  phosphatase,	  a	  plasma	  membrane	  marker	   (Emmelot	  et	  
al.,	   1964),	   the	   activity	   in	   each	   subcellular	  was	   determined.	   100	   μl	   alkaline	   phosphatase	  substrate	  was	  incubated	  with	  10	  μl	  of	  sample	  in	  a	  96	  well	  plate	  and	  incubated	  at	  37	  °C	  for	  30	  mins.	  Absorbance	  was	  then	  read	  at	  405	  nm	  (Powerwave	  XS2,	  Biotek).	  
2.8 Live	  cell	  confocal	  microscopy	  RAW	  264.7	  cells	  were	  seeded	  at	  25,000	  cells/ml	   in	  3	  cm	  glass	  bottomed	   imaging	  dishes	  and	  cultured	   for	  16	  h.	  Cells	  were	   then	   incubated	  with	   treatment	   for	   the	  designated	   time	  frame,	  such	  as	  120	  μM	  monomer	  equivalent	  amyloid	  fibrils	  or	  monomeric	  protein	  labelled	  with	  Alexa	  Fluor®	  647	  (Absorbance	  647	  nm,	  emission	  671	  nm).	  Cells	  were	  incubated	  with	  50	   nm	   LysoTracker	   deep	   red	   (Absorbance	   647	   nm,	   emission	   688	   nm)	   or	   50	   nM	  Lysotracker	   green	   (Absorbance	   504	   nm,	   emission	   516	   nm)	   and/or	   100	   nm	   NIAD-­‐4	  (Absorbance	  487	  nm	  emission	  625	  nm)	  30	  minutes	  before	  imaging.	  Cells	  were	  washed	  3	  times	   in	  preheated	  phenol	   red-­‐free	  medium	  before	   imaging.	   Images	  were	   acquired	  on	   a	  Zeiss	  LSM700	  meta	   laser	  scanning	   inverted	  confocal	  microscope	  with	  a	  heated	  stage	  (37	  °C)	  and	  63X	  objective	  lens.	  Montages	  were	  generated	  using	  FIJI	  (Schindelin	  et	  al.,	  2012).	  
2.9 Cryo-­‐fluorescence	  microscopy	  Cryo-­‐fluorescence	   microscopy	   was	   performed	   on	   cryogenically	   frozen	   samples	   (Section	  2.11.3)	  using	  a	  Linkam	  cryo-­‐stage	  on	  a	  Zeiss	  LSM510	  META	  Upright	  confocal,	  on	  a	  Zeiss	  LD	  EC	  Epiplan-­‐Neofluar	  100X/.75HDDICd=4	  objective.	  
2.10 Leviviridae	  expression	  and	  purification	  Recombinantley	  expressed	  MS2	  (rMS2)	  and	  wtMS2	  and	  F-­‐pili	  were	  expressed	  and	  purified	  by	  Amy	  Barker,	  as	  described	  previously	  (Dent	  et	  al.,	  2013;	  Toropova	  et	  al.,	  2011;	  Mastico	  
et	  al.,	   1993;	   Lima	   et	  al.,	   2006).	   For	  MS2	   binding	   to	   F-­‐pilus	   studies,	  wtMS2	   or	   rMS2	  was	  added	  to	  F-­‐pilus	  (~2	  mg/ml:	  ~0.2	  mg/ml	  final	  concentrations,	  respectively)	  (50	  mM	  Tris-­‐HCl	   (pH	   7.8)	   in	   75	  mM	  NaCl,	   2	  mM	   EDTA.)	   and	   incubated	   at	   room	   temperature	   for	   30	  minutes	  before	  preparation	  for	  cryo-­‐EM	  (Section	  2.11.3).	  	  Bacteriophage	  Qβ	  was	  gifted	  from	  Dr.	  D.	  S.	  Peabody	  and	  purified	  by	  Amy	  Barker.	  Qβ	  was	  dialysed	  into	  10	  mM	  HEPES,	  10	  mM	  NaCl,	  pH	  7.5	  (Pierce	  Slide-­‐A-­‐Lyzer®	  MWCO	  20	  kDa).	  CsCl	   was	   added	   to	   the	   Qβ	   (final	   density,	   ρ=1.38±0.01)	   and	   mixed	   overnight	   at	   4	   °C.	  Samples	   centrifuged	   at	   20,000	   rpm,	   4	   °C	   for	   20	   hours	   (SW40Ti	   Beckman	   rotor,	   12	  mL	  tubes).	  Tubes	  were	  fractionated	  (BioComp	  Gradient	  Fractionator),	  dialysed	  overnight	  at	  4	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°C	   into	   10	   mM	   HEPES,	   10	   mM	   NaCl,	   pH	   7.5,	   quantified	   by	   UV	   Spectrophotometer	   and	  verified	   using	   SDS-­‐Page.	   The	   fraction	   containing	   bacteriophage	   Qβ	   was	   concentrated	  (Vivaspin	  500	  MWCO	  100	  kDa)	   to	  ~7	  mg/ml	   in	  10	  mM	  HEPES	  10	  mM	  NaCl	  pH	  7.5	   and	  stored	  at	  4	  °C.	  
2.11 Specimen	  preparation	  for	  transmission	  electron	  microscopy	  
2.11.1 Glow	  discharge	  of	  EM	  grids	  Carbon-­‐coated	   EM	   grids	   were	   rendered	   hydrophilic	   by	   glow	   discharge	   in	   air.	   EM	   grids	  were	   placed	   onto	   a	   parafilm	   coated	   glass	   slide,	   carbon	   side	   up,	   and	   subjected	   to	   glow	  discharge	   at	   a	   High	   Tension	   (HT)	   setting	   of	   10	   for	   20	   seconds	   using	   a	   Cressington	   208	  Carbon	  Coating	  Unit.	  	  
2.11.2 Negative	  staining	  3	  μl	  of	   sample	  was	  applied	   to	  a	  glow	  discharge	   treated	  EM	  grid	  with	   continuous	  carbon	  film	   for	  30	   seconds.	  Excess	   sample	  was	  blotted	  away	  using	  Whatman	  No.	  1	   filter	  paper.	  The	  grid	  was	  washed	  twice	  using	  10	  μl	  droplets	  of	  dH2O	  on	  parafilm.	  The	  grid	  was	   then	  washed	  in	  a	  droplet	  of	  stain	  (1	  %	  w/v	  uranyl	  acetate).	  A	  final	  droplet	  of	  10	  μl	  of	  stain	  was	  applied	  to	  the	  grid	  and	  left	  for	  20	  seconds.	  Excess	  stain	  was	  blotted	  away	  leaving	  a	  small	  meniscus	  by	  which	  approximate	  stain	  depth	  could	  be	  judged.	  	  
2.11.3 Cryo	  immobilisation	  The	  principle	  of	  cryo-­‐immobilisation	  is	  to	  fix	  the	  structure	  of	  interest	  in	  a	  frozen,	  hydrated,	  native-­‐like	  state	  in	  a	  thin	  layer	  of	  vitreous	  ice.	  This	  is	  achieved	  by	  applying	  an	  aliquot	  of	  an	  aqueous	  solution	  onto	  an	  EM	  grid	  covered	  by	  a	  carbon	  support	  film	  (Figure	  2-­‐1).	  Blotting	  away	  the	  excess	  fluid	  leaves	  a	  thin	  layer	  containing	  the	  specimen	  suspended	  in	  the	  holes	  of	  the	  carbon	  support	  by	  surface	  tension.	  This	  is	  then	  vitrified	  by	  plunging	  into	  liquid	  ethane	  cooled	  by	  LN2.	  Plunge	  freezing	  was	  performed	  using	  automated	  freezing	  devices,	  the	  Leica	  EM	  GP	  or	  FEI	  Vitrobot	  mark	  IV.	  	  	  For	  the	  Vitrobot	  Mark	  IV,	  briefly,	  LN2	  was	  added	  to	  the	  dewar	  designed	  to	  cool	  the	  ethane	  bucket	   through	   the	   cooling	   legs.	  Once	   ethane	   bucket	  was	   sufficiently	   cooled,	   ethane	   gas	  was	   passed	   into	   the	   bucket	   and	   allowed	   to	   liquefy	   until	   the	   bucket	   was	   4/5th	   full.	   The	  chamber	  of	  the	  Vitrobot	  was	  adjusted	  to	  the	  appropriate	  temperature	  and	  humidity.	  The	  EM	  grid	  was	  loaded	  into	  the	  chamber	  and	  the	  specimen	  applied	  to	  the	  grid	  through	  ports	  in	   the	   side.	   The	   liquid	   ethane	   bucket	   was	   then	   raised	   up	   to	  meet	   the	   chamber	   area	   so	  during	  plunge	  freezing	  the	  grid	  remains	  within	  the	  temperature	  and	  humidity	  controlled	  chamber	  for	  as	  long	  as	  possible.	  The	  grid	  was	  blotted	  with	  fresh	  blotting	  paper	  according	  to	  parameters	  that	  were	  optimised	  according	  to	  the	  sample/grids	  used.	  After	  blotting	  the	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EM	  grid	  was	  plunged	  into	  the	  bucket	  of	  liquid	  ethane.	  The	  grid	  was	  then	  transferred	  from	  the	   liquid	   ethane	   into	   liquid	  nitrogen	   through	   liquid	  nitrogen	  vapour.	  After	   vitrification,	  grids	   were	   stored	   in	   plastic	   pucs	   under	   liquid	   nitrogen	   in	   storage	   dewars	   (Wessington	  Cryogenics).	  	  
	  	  
Figure	   2-­‐1	   Example	   carbon	  




Figure	  2-­‐2	  The	  Vitrobot	  mark	  
IV	  (FEI)	  (A).	  System	  is	  controlled	  through	  touch	  screen	  panels	  (B,C).	  Dewar	  for	  LN2	  is	  designed	  to	  maintain	  the	  ethane	  bucket	  at	  optimal	  temperature	  (D).	  	  	  	  	  	  	  	  	  	  
Figure	  2-­‐3	  The	  Leica	  EM	  GP	  (A).	  System	   is	   controlled	   through	  touch	  screen	  panels	  (B,C).	  Dewar	  for	   LN2	   is	   designed	   to	   maintain	  the	   ethane	   bucket	   at	   desired	  temperature,	   typically	   -­‐175	   °C	  (D).	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Eukaryotic	  cells	   Quantifoil	  R2/2	   Au	  200	  mesh	   1.5	   0	   1,1	   10	   100	  %	  Organelles	  from	  percoll	  gradient	  
Lacy	  carbon	  grid	   6	   6	   1,1	   4	   100	  %	  Qβ	   Quantifoil	  R2/2	   Cu	  200	  mesh	   4	   4	   1,1	   4	   100	  %	  
Table	  2.10	  Example	  Vitrobot	  mark	  IV	  blotting	  conditions.	  











Arm	   position,	  
grid	   height,	  
ethane	  height	  Organelles	  from	  gradient	   Quantifoil	  R2/1	   Cu	  200	  mesh	   1.5	   1,0	   8	  	   95	  %	   225,	  5,	  2	  
Table	  2.11	  Example	  Leica	  EM	  GP	  blotting	  conditions.	  
2.12 Electron	  microscopy	  
2.12.1 Microscopes	  used	  	  Microscopes	  used	  in	  this	  project	  can	  be	  found	  in	  Table	  2.12.	  Unless	  otherwise	  stated,	  cryo-­‐EM	  data	  was	  collected	  on	  an	  F20	  microscope,	  University	  of	  Leeds.	  	  










FEI	  Tecnai	  F20	   University	  of	  Leeds	   FEG	   200	  	   Gatan	  US4000/SP	  CCD	  camera	   15	  	   	  FEI	  Tecnai	  T12	   University	  of	  Leeds	   LaB6	   120	   Gatan	  US1000XP	  CCD	  camera	   14	   	  FEI	  Titan	  Krios	   MRC	  LMB,	  Cambridge	   FEG	   300	   FEI	  Back-­‐thinned	  Falcon	  II	  Direct	  detector	   14	   	  FEI	  Polara	   Birkbeck	  College,	  London	   FEG	   300	   Gatan	  K2	  bioquantum	  967	  direct	  electron	  detector	  
5	   Quantum	  energy	  filter	  	  
Table	  2.12	  Electron	  microscopes	  used.	  Tilt	   series	  were	   collected	   on	   FEI	   Polara	  microscope	  with	   a	   sampling	   of	   of	   5.38	   Å/pixel,	  using	  a	  6	  second	  exposure,	  with	  an	  electron	  dose	  of	  0.177	  e-­‐/Å2/second,	  leading	  to	  a	  total	  dose	   of	   ~	   1	   e-­‐/	   Å	   per	   exposure.	   Dose	   was	   fractionated	   at	   0.25	   s	   intervals,	   with	   drift	  correction	  carried	  out	  by	  Gatan	  software.	  Tilt	  series	  were	  collected	  +/-­‐	  	  65°,	  with	  a	  2°	  tilt	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increment	   and	   a	   target	   defocus	   of	   -­‐8	   μm.	   Tilt	   series	   were	   collected	   using	   SerialEM.	  Microscope	  alignments	  were	  performed	  by	  Dan	  Clare.	  	  Data	  collected	  on	  the	  FEI	  Titan	  Krios	  magnification	  of	  103,704	  x,	  resulting	  in	  a	  sampling	  of	  1.35	  Å	  per	   pixel	   and	   a	   total	   dose	   of	  ~50	   e-­‐/Å2.	  Dose	  was	   fractionated	   across	   34	   frames	  during	  a	  2	  s	  exposure.	  Target	  defocus	  range	  was	  from	  -­‐1	  to	  -­‐3	  μm.	  Microscope	  alignments	  were	  performed	  by	   Shaoxia	  Chen	   and	  Christos	   Savva.	  Data	  was	   collected	  using	   FEI	  EPU	  software.	  
2.12.2 Microscope	  alignments	  at	  University	  of	  Leeds	  EM	  alignments	  were	  carried	  out	  to	  ensure	  the	  electron	  beam	  passes	  down	  the	  microscope	  column	   through	   the	   centre	  of	   the	   apertures	   and	   lenses,	   keeping	  optical	   aberrations	   to	   a	  minimum.	  Microscope	   alignments	  were	   performed	   starting	   from	   the	   top	   of	   the	   column.	  Gun	  and	  C2	  aperture	  alignments	  were	  performed	  by	  Dr	  Peiyi	  Wang	  (EM	  facility,	  University	  of	  Leeds).	  The	  objective	  aperture	  was	  centred	  in	  diffraction	  mode.	  The	  grid	  was	  bought	  to	  eucentric	  height	  and	  focus	  (contrast	  minima).	  Beam	  tilt	  pivot	  points	  were	  then	  corrected	  to	  make	   the	   electron	  beam	  parallel	   to	   the	   axis	   of	   the	  objective	   lens.	  The	   rotation	   centre	  alignment	  was	  performed	   to	   ensure	   the	   electron	  beam	  passes	   through	   the	   centre	  of	   the	  objective	   lens.	  To	  minimise	  beam	  shifts	  during	  magnification	  changes	   in	   low	  dose	  mode,	  beam	  shift	  alignments	  were	  performed.	  	  
2.12.3 Electron	  microscopy	  at	  University	  of	  Leeds	  At	   the	  beginning	  of	  each	  session,	   the	  anti-­‐contaminator	  was	  cooled	  using	  LN2,	  and	   left	   to	  equilibrate	   for	   20	   minutes	   before	   specimen	   loading.	   Imaging	   was	   performed	   using	  standard	  low-­‐dose	  imaging	  as	  described	  in	  Section	  2.12.3.3.	  	  
2.12.3.1 	  Negative	  stain	  electron	  microscopy	  Negatively	   stained	   grids	   were	   placed	   into	   a	   single	   tilt	   holder	   and	   inserted	   into	   the	  microscope.	  	  
2.12.3.2 	  Cryo	  electron	  microscopy	  Every	  tool/surface	   that	  comes	   into	  contact	  with	   the	  cryo-­‐grid	   is	  dried	  thoroughly	  before	  use	  and	  then	  pre-­‐cooled	  using	  LN2.	  The	  cryo-­‐holder	  was	  inserted	  into	  the	  EM	  and	  cooled	  to	   ~-­‐180	   °C.	   using	   LN2.	   Several	   designs	   of	   cryo-­‐holder	   for	   side	   entry	   microscopes	   are	  available,	   here	   Gatan	   626b	   and	   Oxford	   instruments	   3500	   holders	   were	   used.	   Once	   the	  holder	  reached	  a	  stable	   temperature,	   the	  cryo-­‐transfer	  station	  was	  cooled	  with	  LN2.	  The	  cooled	   cryo-­‐holder	  was	   then	   transferred	  quickly	  out	   from	   the	  microscope	   into	   the	   cryo-­‐station.	  The	  clip	  ring,	  which	  holds	  the	  grid	  in	  place,	  was	  removed	  using	  the	  clip	  ring	  tool.	  A	  grid	  was	  transferred	  through	  LN2	  or	  LN2	  into	  the	  grid	  slot	  of	   the	  cryo	  holder	  and	  the	  clip	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ring	   replaced.	   In	  order	   to	  keep	   the	  grid	  cool	  during	   transfer	   to	   the	  microscope,	   the	  cryo	  shield	  was	  closed.	  	  	  During	  transfer	  from	  the	  cryo-­‐station	  to	  the	  microscope,	  the	  goniometer	  was	  set	  to	  -­‐60°	  so	  some	   nitrogen	   is	   retained	   in	   the	   dewar	   whilst	   the	   cryo-­‐holder	   was	   loaded	   into	   the	  microscope.	  The	  air	  lock	  of	  the	  microscope	  was	  pre-­‐pumped	  before	  cryo-­‐holder	  loading	  to	  ensure	  the	  high	  vacuum	  of	  the	  column	  was	  maintained,	  and	  transfer	  of	  the	  holder	  into	  the	  column	   occurred	   in	   ~one	   minute.	   The	   temperature	   of	   the	   cryo-­‐holder	   was	   monitored	  during	  transfer	  and	  typically	  stayed	  cooler	  than	  -­‐165	  °C.	  The	  goniometer	  was	  reset	  to	  0°	  and	  the	  dewar	  topped	  up	  with	  LN2.	  At	  the	  end	  of	  the	  session	  the	  cryo	  holder	  was	  inserted	  into	  a	  pumping	  station	  (Gatan	  655	  pumping	  station,	  Gatan	  Pleasanton	  CA)	  and	  the	  zeolite	  cycle	  was	  initiated.	  This	  heats	  the	  dewar	  so	  an	  improved	  vacuum	  can	  be	  generated	  in	  the	  vacuum	  chamber	  of	  the	  holder.	  Finally,	  the	  LN2	  was	  removed	  from	  the	  microscope’s	  anti-­‐contaminator	   and	   the	   cryo-­‐cycle	   initiated	   for	   4-­‐8	   hours.	   This	   removes	   contaminants	  adsorbed	  to	  the	  anti-­‐contaminator.	  
2.12.3.3 	  Low-­‐dose	  imaging	  As	  biological	  specimens	  are	  highly	  susceptible	  to	  radiation	  damage,	  low	  dose	  imaging	  was	  performed	   to	   minimise	   sample	   exposure	   to	   the	   electron	   beam	   and	   so	   minimise	   total	  electron	  dose.	  Three	  imaging	  modes	  are	  operated	  in	  low-­‐dose,	  search,	  focus	  and	  exposure.	  Search	  mode	  allows	  the	  user	  to	  examine	  a	  relatively	  large	  grid	  area	  and	  identify	  regions	  of	  interest	  while	  exposing	  the	  sample	  to	  very	  little	  electron	  dose.	  Using	  search	  mode,	  areas	  of	  good	   quality	   ice	   can	   be	   identified.	   Once	   an	   area	   has	   been	   identified	   for	   imaging,	   focus	  mode	   was	   used	   to	   find	   focus	   (contrast	   minima).	   Focusing	   is	   performed	   at	   high	  magnification,	   typically	  over	  100,000	  X	  magnification	  at	   the	  specimen	   level,	   and	  ~	  2	  μm	  from	  the	  area	  to	  be	   imaged.	  Exposure	  mode	   is	  set	   to	  magnification	  and	  dose	  required	   in	  the	  final	  image,	  and	  a	  micrograph	  is	  taken.	  Calibrations	  were	  performed	  to	  minimise	  beam	  shift	  when	  switching	  between	  modes.	  
2.12.3.4 	  Liposome	  diameter	  measurements	  Liposome	  diameters	  were	  assessed	  using	  cryo-­‐EM.	  For	  each	  lipid	  condition,	  200	  liposome	  diameters	  were	  calculated	  in	  FIJI	  (Schindelin	  et	  al.,	  2012).	  	  
2.12.3.5 	  Cryo-­‐electron	  tomography	  SerialEM	  version	  3.1.1	  (Kremer	  et	  al.,	  1996)	  was	  used	  to	  collect	   tilt	  series.	   In	  addition	  of	  basic	   microscope	   alignments	   described	   above,	   SerialEM	   calibrations	   were	   performed	  including	  stage	  shift,	  image	  shift	  and	  electron	  calibrations.	  Tilt	  series	  were	  collected	  up	  to	  a	  maximum	  tilt	  range	  of	  +/-­‐55°,	  with	  a	  step	  size	  of	  2°	  or	  3°.	  Tilt	  series	  were	  collected	  using	  low	  dose	  imaging	  (Table	  2.13).	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   View	   Focus	   Record	  Magnification	   2900	   23,000	   13,000	  	  Spot	  size	   8	   8	   8	  Dose	  (e-­‐/Å2)	   	   	   1	  Exposure	  (seconds)	   0.3	   0.5	   1	  Binning	   4	   1	   1	  
Table	  2.13	  Low-­‐dose	  imaging	  settings	  used	  in	  SerialEM	  during	  tilt	  series	  collection	  
at	  University	  of	  Leeds.	  
2.13 Soft	  X-­‐ray	  microscopy	  Soft	   X-­‐ray	   microscopy	   was	   performed	   at	   Diamond	   Light	   Source	   (Beamline	   B24	   cryo-­‐transmission	   X-­‐ray	   microscopy)	   using	   an	   Xradia	   UltraXRM-­‐S/L220c	   microscope	   and	  PIXIS-­‐XO	  1024B	  (Princeton	  Instruments)	  detector,	  using	  a	  laboratory	  X-­‐ray	  source	  and	  40	  nm	  zone	  plate.	  Tilt	  series	  were	  processed	  using	  IMOD	  as	  in	  Section	  2.14.2.	  
2.14 Image	  processing	  
2.14.1 Single	  particle	  processing	  Micrograph	   defocus	   and	   astigmatism	   was	   determined	   using	   CTFFIND4	   (Rohou	   &	  Grigorieff,	   2015).	   Micrographs	   with	   unacceptable	   astigmatism,	   drift	   or	   defocus	   were	  discarded.	   Single	   particle	   processing	   was	   performed	   in	   RELION	   version	   1.3	   (Scheres,	  2012).	  Approximatley	  2000	  particles	  were	  manually	  picked	  and	  classified	  using	  reference	  free	   2D	   classification.	   These	   2D	   classes	   were	   used	   as	   templates	   for	   automated	   particle	  picking	   (Scheres,	   2015).	   Particles	   were	   extracted	   with	   ‘dust	   correction’	   applied,	   where	  pixels	   with	   values	   higher	   and	   lower	   than	   five	   times	   the	   image	   standard	   deviation	   are	  replaced	  with	  values	  from	  a	  Gaussian	  distribution.	  	  	  Reference	  free	  2D	  classification	  and	  particle	  sorting	  were	  performed	  iteratively	  to	  obtain	  a	  ‘homogenous’	   particle	   stack	   (Scheres,	   2015).	   2D	   classification	   was	   performed	   into	   50	  classes	   for	   25	   iterations	  with	   a	   regularisation	   parameter	   T	   value	   of	   2.	   Image	   alignment	  was	  performed	  with	  an	  in-­‐plane	  angular	  sampling	  (psi)	  of	  5°,	  an	  offset	  search	  range	  of	  five	  pixels	   and	   offset	   search	   step	   of	   one	   pixel.	   CTF	   correction	   was	   performed	   in	   RELION	  according	  to	  parameters	  calculated	  by	  CTFFIND4;	  Wiener	  filtering	  was	  applied.	  	  3D	   classification	   was	   performed	   over	   25	   iterations	   with	   a	   regularisation	   parameter	   T	  value	  of	  2.	  A	  sphere	  generated	  in	  Spider,	  or	  a	  previous	  map	  filtered	  to	  50	  Å	  was	  used	  as	  a	  starting	   model.	   Classification	   was	   performed	   into	   two	   classes,	   with	   I3	   symmetry	   was	  imposed.	   RELION	   uses	   XMIPP's	   libraries	   for	   symmetry	   operations.	   CTF	   correction	   was	  performed.	   In	   3D	   classification,	   image	   alignment	   was	   performed	   with	   auto-­‐sampling,	  where	  the	  angular	  sampling	  interval	  decreases	  automatically	  through	  the	  refinement.	  An	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offset	   search	   range	   of	   5	   pixels	   and	   offset	   search	   step	   of	   1	   pixel	  was	   used,	  with	   no	   local	  angular	  searches.	  	  	  For	  3D	  autorefine,	  the	  output	  from	  3D	  classification	  filtered	  to	  50	  Å	  was	  used	  as	  a	  starting	  model.	   CTF	   correction	   was	   performed	   (Scheres,	   2012).	   Auto-­‐sampling	   was	   performed	  with	  an	  initial	  angular	  sampling	  of	  7.5°,	  an	  initial	  offset	  range	  of	  5	  pixels	  and	  initial	  offset	  step	   of	   1	   pixel.	   Local	   searches	   were	   performed	  when	   angular	   sampling	   dropped	   below	  0.9°.	  	  	  To	   correct	   for	   drift	   and	   beam-­‐induced	   movement	   of	   particles,	   movie	   processing	   and	  particle	   polishing	   was	   performed	   (Bai	   et	   al.,	   2013).	   For	   movie	   processing	   a	   running	  average	   of	   3	   frames	   and	   a	   standard	   deviation	   on	   the	   translations	   of	   2	   pixels,	   with	   no	  rotational	   searches	   was	   used.	   For	   particle	   ‘polishing’,	   linear	   particle	   movements	   were	  fitted.	  Polishing	  was	  performed	  using	  a	  running	  average	  of	  3	  movie	  frames.	  Each	  particle	  was	   fitted	   individually.	   B-­‐factor	   weighting	   was	   performed.	   The	   B-­‐factors	   across	   movie	  frames	  were	  plotted,	  and	  as	  a	  result	  of	  this	  particle	   ‘polishing’	  was	  performed	  again	  only	  using	  frames	  5-­‐25	  of	  the	  movie.	  The	  resulting	  ‘shiny’	  particle	  stack	  was	  reprocessed	  using	  the	   3D	   autorefine	   procedure	  with	   either	   I3	   (icosahedral)	   or	   C1	   (asymmetric)	   symmetry	  applied.	  	  	  The	   final	  3D	  structures	  were	   subjected	   to	  post-­‐processing	   that	   included	  masking	  and	  B-­‐factor	   correction.	   Resolution	   was	   calculated	   using	   the	   gold	   standard	   Fourier	   shell	  correlation	   (FSC=0.143)	   criterion	   (Scheres	   &	   S.	   Chen,	   2012).	   Local	   resolution	   was	  calculated	  using	  ResMap,	  with	  a	  P-­‐value	  of	  0.05	   (Kucukelbir	  et	  al.,	   2014).	  UCSF	  Chimera	  was	  used	  for	  map	  visualisation,	  generation	  of	  figures	  and	  as	  a	  fitting	  tool	  to	  fit	  	  (Pettersen	  
et	  al.,	  2004).	  
2.14.1.1 Refinement	  of	  X-­‐ray	  crystal	  structure	  Refinement	  of	  X-­‐ray	  crystal	  structures	  was	  performed	  in	  Rosetta	  using	  RosettaScripts	  the	  ‘relax’	  protocol,	  with	  an	  additional	  tool	  to	  assess	  agreement	  with	  the	  density	  (DiMaio	  et	  al.,	  2015).	  Agreement	  to	  density	   is	   implemented	  as	  an	  additional	  energy	  term,	  calculated	  by	  computing	   the	   expected	   density	   for	   a	   given	  model	   and	  measuring	   the	   agreement	   of	   the	  expected	  and	  experimental	  density.	  Rosetta	   scoring	  was	  performed	   to	  assess	  agreement	  between	  existing	  PDB	  structures	  and	  electron	  density.	  The	  MolProbity	  server	  was	  used	  to	  assess	  structures	  generated	  in	  Rosetta	  (Chen	  et	  al.,	  2010).	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2.14.2 	  Tilt	  series	  processing	  Tilt	   series	   were	   reconstructed	   into	   tomograms	   using	   the	   ETOMO	   program	   within	   the	  IMOD	  package	  (Kremer	  et	  al.,	  1996).	  Initially,	  CCD	  Eraser	  was	  used	  to	  remove	  strong	  pixel	  intensities	   which	   may	   be	   attributed	   to	   X-­‐rays,	   and	   which	   may	   interfere	   with	   cross-­‐correlation	   calculations	   later	   in	   processing.	   Tiltxcorr	   was	   then	   used	   to	   perform	   cross-­‐correlation	  calculations	  and	  align	   the	   images.	  Tilt	   series	  were	  either	  aligned	  using	  patch	  tracking	  or	  gold	  fiducial	  markers	  to	  make	  a	  fiducial	  model.	  A	  sample	  tomogram	  was	  then	  created	   and	   the	   boundaries	   of	   the	   specimen	  marked	   using	   6	   contours	   (2	   for	   each	   axis).	  Aligned	  tilt	   series	  were	  binned	  by	  2	  and	  a	  3D	  tomogram	  calculated	  using	  weighted	  back	  projection	  or	  SIRT.	  Tomograms	  were	  then	  inspected	  and	  trimmed	  in	  3DMOD.	  	  
2.14.3 Tomogram	  segmentation	  Tomogram	  segmentation	  was	  performed	  using	  Amira	  (FEI).	  Amira	  uses	  a	  modular	  system,	  where	  each	  process	  applied	  to	  the	  tomogram	  can	  be	  tracked.	  The	  filter	  sandbox	  tool	  was	  used	   to	  select	   the	  most	  appropriate	   filter	   to	  maximise	  signal	   to	  noise	   in	   the	   tomograms;	  commonly	   Gaussian,	   median,	   anisotropic	   diffusion	   and	   non-­‐local	   means	   filters	   were	  useful.	   The	   interactive	   thresholding	   tool	   was	   used	   to	   select	   density	   automatically.	   This	  typically	   yielded	   a	   very	   noisy	   segmentation	   that	   was	   cleaned	   using	   the	   ‘remove	   small	  spots’	  tool	  was	  used.	  This	  was	  used	  iteratively	  in	  both	  2D	  and	  3D	  planes,	  where	  segmented	  density	   smaller	   than	   the	   defined	   pixel	   volume/dimensions	   was	   removed.	   The	   resulting	  segmented	  density	  can	  be	  visualised	  as	  a	  surface.	  Typically,	  no	  smoothing	  or	  constrained	  smoothing	  was	   applied	   during	   surface	   generation;	   this	  was	   assessed	   on	   a	   tomogram	  by	  tomogram	   basis,	   depending	   on	   the	   features	   the	   segmentation	   sought	   to	   reveal.	   Where	  needed,	   the	   segmentation	   editor	   tool	   was	   used	   to	   assign	   voxels	   from	   each	   frame	   to	   a	  material,	  such	  as	  membrane	  or	  material.	  These	  selected	  voxels	  can	  then	  be	  independently	  manipulated.	  All	  figures	  of	  tomogram	  segmentation	  were	  generated	  in	  Amira.	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3 Preparation	  and	  characterisation	  of	  β2m	  amyloid	   fibrils,	  and	  their	  
propensity	  to	  perturb	  membranes	  
3.1 Introduction	  Amyloid	  is	  the	  name	  given	  to	  a	  protein	  conformation	  defined	  by	  a	  highly	  ordered,	  β-­‐sheet-­‐rich	   structure	   that	   has	   a	   cross-­‐β	   motif.	   The	   term	   ‘amyloid’	   was	   first	   used	   in	   a	   disease	  context	   by	   Virchow	   in	   1854	   (Sipe	   &	   Cohen,	   2000).	   The	   name	   was	   given	   originally	   as	  amyloid	   was	   thought	   to	   be	   starch,	   and	   although	   the	   fibrils	   are	   now	   known	   to	   be	  proteinaceous,	   the	   name	   has	   persisted	   (Toyama	   &	   Weissman,	   2011;	   Dobson,	   2001).	  Proteins	   and	   polypeptides	   possessing	   a	   diverse	   range	   of	   native	   structures	   have	   been	  shown	   to	   form	   amyloid,	   including	   proteins	   rich	   in α-­‐helices,	   β-­‐sheet,	   and	   intrinsically	  disordered	  proteins	  (Chiti	  &	  Dobson,	  2006)(Table	  3.1).	  Although	  the	  propensity	  to	  do	  so	  varies	   with	   sequence;	   it	   has	   been	   suggested	   that	   the	   ability	   to	   adopt	   the	   amyloid	  conformation	  is	  an	  inherent	  property	  of	  polypeptide	  chains	  (Stefani	  &	  Dobson,	  2003).	  	  	  Despite	   the	   heterogeneity	   of	   amyloid	   precursor	   proteins,	   all	   amyloid	   assemblies	   share	  common	  characteristics.	  Fibrils	  are	  long,	  unbranched	  filaments	  of	  variable	  length,	  typically	  7-­‐20	  nm	   in	  width,	   that	  are	   readily	  observed	  by	  atomic	   force	  microscopy	   (AFM)	  and	  EM.	  The	  core	  of	  the	  amyloid	  fibril	  is	  β-­‐sheet	  rich,	  where	  the	  β-­‐strands	  are	  highly	  ordered	  and	  perpendicular	   to	   the	   fibril	   length.	  The	  repeat	  produced	  by	   the	  cross-­‐β	  architecture	  gives	  rise	   to	   a	   characteristic	   X-­‐ray	   fibre	   diffraction	   pattern	   (Astbury	   et	   al.,	   1935;	   Jahn	   et	   al.,	  2010).	   Other	   characteristic	   properties	   of	   amyloid	   include	   its	   apple	   green	   birefringence	  under	  polarised	   light	  upon	  binding	  with	  Congo	  Red	  dye	   (Puchtler	  et	  al.,	   1962).	  Amyloid	  also	   increases	   the	   fluorescence	  of	   some	  dyes	  such	  as	  ThT	  and	  NIAD-­‐4	  (Bae	  et	  al.,	  2015).	  Amyloid	   fibrils	   also	   share	   conformational	   epitopes	   recognised	   by	   specific	   antibodies	  (O'Nuallain	  &	  Wetzel,	  2002).	  These	  generic	  properties	  are	   shared	  by	  ex	  vivo	  and	   in	  vitro	  formed	  amyloid	  fibrils	  (Jahn	  et	  al.,	  2008).	  Fourier	  transform	  infrared	  spectroscopy	  (FTIR)	  has	  been	  used	   to	   compare	   the	   structural	   properties	   of	  β-­‐2-­‐microglobulin	   (β2m)	   amyloid	  fibrils	   formed	   at	   pH	   2.5,	   7.0	   or	   ex	   vivo	   fibrils,	   and	   all	   share	   the	   same	   structural	  characteristics	  (Jahn	  et	  al.,	  2008;	  Kawai-­‐Noma	  et	  al.,	  2010).	  	  
3.1.1 Amyloidosis	  Protein	  misfolding	  and	  aggregation	  is	  the	  basis	  for	  much	  human	  disease	  (Reynaud,	  2010;	  Dobson,	  2003).	  Although	  eukaryotic	  cells	  have	  extensive	  quality	  control	  mechanisms	   for	  proteostasis	   which	   prevent	   aberrant	   protein	   misfolding	   and	   aggregation,	   these	   can	   be	  ineffective	  (Baumeister	  &	  Walz,	  1998;	  Trombetta	  &	  Parodi,	  2003).	  The	  amyloidoses	  are	  a	  group	   of	   diseases	   associated	   with	   the	   conversion	   of	   proteins	   and	   peptides	   from	   their	  functional	   (normally	   soluble)	   forms	   into	   amyloid,	   which	   deposit	   as	   extracellular	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aggregates	  or	  intracellular	  inclusions.	  To	  date,	  31	  proteins	  are	  known	  to	  form	  extracellular	  amyloid	   fibrils,	   and	   several	   more	   form	   intracellular	   inclusions	   (Table	   3.1)	   (Sipe	   et	   al.,	  2014),	  but	  they	  share	  no	  apparent	  similarity	  in	  amino	  acid	  sequence,	  tertiary	  structure	  or	  biological	   function	   in	   their	   soluble	   forms	   (Knowles	  et	  al.,	   2014).	   These	   amyloid-­‐forming	  proteins	   are	   associated	   with	   ~	   50	   diverse	   disorders,	   including	   the	   debilitating	  neurodegenerative	   conditions	   Alzheimer’s	   and	   Parkinson’s	   Diseases	   (AD	   and	   PD,	  respectively),	   organ-­‐specific	   disorders	   such	   as	   diabetes	   mellitus	   type	   2	   and	   systemic	  disorders	  such	  as	  dialysis	  related	  amyloidosis	  (Selkoe,	  2003;	  Knowles	  et	  al.,	  2014).	  	  With	   increased	   life	   expectancy	   globally,	   the	   prevalence	   of	   these	   diseases	   will	   increase.	  Although	   the	   relationship	   between	   ageing	   and	   amyloid	   formation	   is	   poorly	   understood,	  proteostasis	   is	   thought	   to	  become	   less	  effective	  with	  age,	   increasing	   the	  susceptibility	   to	  misfolding	   diseases	   (Labbadia	   &	   Morimoto,	   2015).	   Here	   some	   of	   the	   most	   prevalent	  amyloidoses	  are	  discussed.	  
Disease	   Extracellular	  deposits/	  
Intracellular	  inclusions	  
Target	  site	   Precursor	   protein	  
(fold)	  Dialysis	   related	  amyloidosis	   Extracellular	  deposits	   Musculoskeletal	  system	   β2m	   (predominantly	   β	  sheet)	  Amyloid	   light	   chain	  amyloidosis	   Extracellular	  deposits	   Systemic	   Immunoglobulin	   Light	  Chain	   (predominantly	   β	  sheet)	  AA	  amyloidosis	   Extracellular	  deposits	   Systemic	   Serum	  amyloid	  A	  protein	  (predominantly	   α	  helical)	  Alzheimer’s	  Disease	   Extracellular	  deposits	   CNS	   Amyloid	   β	   (intrinsically	  disordered)	  Transthyretin	  amyloidosis	  	  	   Extracellular	  deposits	   Systemic	   Transthyretin	  (predominantly	  β	  sheet)	  Spongiform	  encephalopathies	  including	   Creutzfeldt-­‐Jakob	   Disease	   and	  Fatal	   Familial	  insomnia	  
Extracellular	  deposits	   CNS	   Prion	   protein	   (PrP)	  (intrinsically	  disordered)	  
Diabetes	  mellitus	  type	  2	   Extracellular	  deposits	   Islets	   of	  Langerhans,	  Insulinomas	  	   Islet	   Amyloid	  Polypeptide	  (intrinsically	  disordered)	  Parkinson’s	  Disease	   Intracellular	  inclusions	  ‘Lewy	  bodies’	   Neurons,	  intracytoplasmic	  	   α-­‐synuclein	  (intrinsically	  disordered)	  
Huntington’s	  Disease	   Intracellular	  inclusions	  ‘Huntington	  bodies’	   Neurons,	  intranuclear	  	  	   PolyQ	   expanded	  Huntingtin	   (intrinsically	  disordered)	  Alzheimer’s	  Disease	   Intracellular	   inclusions	  ‘Neurofibrillary	  tangles’	   Neurons	  intracytoplasmic	   Tau	   (intrinsically	  disordered)	  Lysozyme	  amyloidosis	   	   	   Lysozyme	   (α	   and	   β	  content,	  lysozyme	  fold)	  
Table	  3.1	  Selection	  of	  amyloidosis.	  Adapted	  from	  Sipe	  et	  al.,	  2014,	  Chiit	  et	  al,.	  2006.	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3.1.1.1 Alzheimer’s	  disease	  AD	  is	  a	  neurodegenerative	  disease	  first	  described	  in	  1906,	  and	  is	  the	  most	  common	  cause	  of	   dementia	   (Haass,	   2004).	   The	   hallmarks	   of	   AD	   are	   extracellular	   amyloid	   plaques	   and	  neurofibrillary	  tangles	   formed	  from	  amyloid	  β	  (Aβ)	  peptides	  and	  tau	  respectively	  (Table	  3.1)(Hardy	  &	  Higgins,	   1992).	   Aβ	   is	   a	   proteolytic	   cleavage	   product	   of	   amyloid	   precursor	  protein	  (APP),	  which	  is	  processed	  by	  β-­‐secretases	  and	  ϒ-­‐secretases	  to	  a	  peptide	  of	  39-­‐43	  residues	   (Zhang	   et	   al.,	   2011).	   Longer	   Aβ	   peptides	   are	   more	   amyloidogenic	   than	   their	  shorter	  counterparts	  (Haass	  et	  al.,	  2012).	  Aβ1-­‐40	  and	  Aβ1-­‐42	  are	  the	  most	  common	  forms	  in	  amyloid	  plaques,	  with	  Aβ1-­‐42	  being	  less	  prevalent,	  but	  more	  toxic	  (Kayed	  et	  al.,	  2003).	  The	  normal	  physiological	   role	   of	  APP	   is	   unclear,	   although	   roles	   in	   inter-­‐cell	   interactions	   and	  cell	   adhesion,	   cell	   migration,	   calcium	   homeostasis,	   and	   neuroprotection	   have	   been	  proposed	   (Young-­‐Pearse	   et	   al.,	   2007;	   Nalivaeva	   &	   Turner,	   2013;	   Corrigan	   et	   al.,	   2014).	  Mutations	   in	   APP	   are	   linked	   with	   familial	   and	   early-­‐onset	   AD,	   implicating	   Aβ	   in	   the	  pathogenesis	  of	  AD	  (Karch	  &	  Goate,	  2015).	  Other	  genes	  identified	  as	  risk	  factors,	   include	  apolipoprotein	   E	   (APOE)	   gene	   polymorphs	   (Van	   Cauwenberghe	   et	   al.,	   2015;	  Medway	   &	  Morgan,	  2014).	  	  	  In	   addition	   to	   Aβ,	   hyperphosphorylation	   of	   Tau	   has	   been	   long	   been	   implicated	   in	   AD,	  through	   loss	   of	   normal	   physiological	   function	   and	   aggregation	   into	   intracellular	  aggregates	  known	  as	  neurofibrillary	  tangles	  (Medeiros	  et	  al.,	  2011).	  Tau	  is	  a	  microtubule-­‐associated	   protein	   found	   primarily	   in	   axonal	   cells,	   where	   it	   modulates	   microtubule-­‐dependent	  transport	  of	  organelles	  and	  biomolecules	  (Ballatore	  et	  al.,	  2007).	  	  	  People	   with	   AD	   are	   typically	   >	   65	   years	   old	   and	   have	   symptoms	   including	   progressive	  memory	  loss,	  especially	  short-­‐term	  memory,	  hallucinations,	  personality	  change,	  agitation	  and	  anxiety.	  It	  is	  projected	  that	  by	  2050	  there	  will	  be	  1	  million	  new	  cases	  per	  year	  in	  the	  USA	   alone,	   with	   a	   total	   of	   11-­‐16	   million	   people	   living	   with	   the	   disease	   (Alzheimer’s	  Association,	  2015).	  AD	  is	  set	  to	  become	  a	  global	  epidemic	  in	  the	  coming	  decades.	  By	  2040	  there	  will	  be	  an	  estimated	  81.1	  million	  people	  living	  with	  AD	  (Prince	  et	  al.,	  2013).	  People	  with	  dementia	  often	  require	  round	  the	  clock	  care,	  especially	  in	  the	  advanced	  stages	  of	  the	  disease.	  Globally	   in	  2010	  healthcare	  expenditure	  on	  dementia	  was	  estimated	   to	  be	  $604	  billion,	  with	  these	  costs	  expected	  to	  rise	   in	   line	  with	   increased	  prevalence	  of	   the	  disease	  (Schaller	  et	  al.,	  2015).	  	  	  There	   is	   currently	   no	   cure	   for	   AD,	   and	   no	   treatments	   that	   significantly	   slow	   disease	  progression.	  Given	  the	  global	  economic	  burden,	  intensive	  research	  is	  underway	  to	  develop	  therapeutics.	   One	   drug	   under	   investigation,	   is	   a	   humanized	   monoclonal	   IgG1	   antibody	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directed	  against	  Aβ	  peptide,	  known	  as	  solanezumab	  (Siemers	  et	  al.,	  2015).	  Initial	  research	  indicates	  that	  this	  antibody	  may	  slow	  cognitive	  decline	  in	  patients	  with	  mild	  dementia	  by	  34	   %	   (Siemers	   et	   al.,	   2015),	   although	   further	   research	   is	   required	   to	   validate	   these	  findings.	  Other	  approaches	  include	  vaccination;	  a	  phase	  III	  trial	  of	  a	  vaccine	  called	  CAD106	  is	  due	  to	  start	  late	  2015	  (Underwood,	  2015).	  The	  vaccine	  is	  composed	  of	  a	  fragment	  of	  Aβ	  linked	  to	  a	  virus-­‐like	  particle,	  which	  will,	  in	  theory,	  prompt	  the	  immune	  system	  to	  clear	  Aβ	  peptide.	  Another	  approach	  by	  Novartis	  is	  treating	  carriers	  of	  the	  APOE4	  gene	  variant	  early	  in	   their	   life	   with	   inhibitors	   of	   BACE,	   an	   enzyme	   involved	   in	   the	   proessing	   of	   APP	  (Underwood,	  2015).	  All	   these	  approaches	   target	  patients	  before	  symptoms	  emerge	  or	  at	  the	   very	   earliest	   stages,	   before	   extensive	   neurodegeneration	   has	   occurred.	   This	   further	  increases	   the	  need	   for	   biomarkers	   to	   enable	   early	  diagnosis,	  which	   is	   itself	   a	   significant	  challenge	  (Sancesario	  &	  Bernardini,	  2015).	  	  
3.1.1.2 	  Parkinson’s	  disease	  PD	   is	   the	   second	  most	   common	  neurodegenerative	  condition	   that	   specifically	  affects	   the	  dopaminergic	  neurons	  of	   the	  substantia	  nigra	  (Herva	  &	  Spillantini,	  2015).	   It	   is	  a	  chronic	  and	   progressive	   disease,	   with	   an	   average	   life	   expectancy	   of	   15	   years	   after	   diagnosis	  (Shulman	  et	  al.,	  2011).	  Those	  living	  with	  PD	  exhibit	  a	  broad	  range	  of	  motor	  and	  non-­‐motor	  symptoms	   including	   resting	   tremor,	   bradykinesia	   and	   loss	   of	   postural	   reflexes;	   cardinal	  symptoms	  of	  PD	  (Jankovic,	  2008).	  Non-­‐motor	  symptoms	  include	  dementia,	  hallucinations	  and	  sleep	  disorders	  (Jankovic,	  2008).	  On	  a	  cellular	  level,	  intracellular	  aggregates	  known	  as	  Lewy	  bodies,	  are	  observed,	  which	  contain	  many	  proteins	  including	  primarily	  α-­‐synuclein	  (Dickson	  et	  al.,	  2009).	  A	  range	  of	  other	  disorders,	  together	  termed	  the	  α-­‐synucleinopathies	  are	  associated	  with	  the	  aggregation	  of	  α-­‐synuclein,	  including	  dementia	  with	  Lewy	  bodies	  and	  multiple	  system	  atrophy.	  	  	  
α-­‐synuclein	  is	  an	  intrinsically	  disordered	  protein	  that	  is	  widely	  expressed	  throughout	  the	  nervous	  system,	  and	  is	  enriched	  in	  presynaptic	  terminals,	  where	  it	  is	  thought	  to	  play	  a	  role	  in	  synaptic	  vesicle	  trafficking	  and	  the	  fast	  kinetics	  of	  synaptic	  vesicle	  endocytosis	  (Vargas	  
et	  al.,	   2014).	   Its	   expression	  has	  also	  been	   reported	   in	  kidney,	   liver	  and	  heart	   (Ltic	  et	  al.,	  2004).	  Mutations	  in	  the	  SNCA	  gene	  encoding	  α-­‐synuclein	  are	  found	  in	  familial	  cases	  of	  PD,	  and	  single	  nucleotide	  polymorphisms	  at	  the	  SNCA	   locus	  have	  been	  linked	  to	   incidence	  of	  sporadic	  forms	  of	  the	  disease	  (Shulman	  et	  al.,	  2011).	  α-­‐synuclein	  undergoes	  several	  post-­‐translational	   modifications	   which	   affect	   pathology,	   including	   N-­‐terminal	   acetylation,	  ubiquitination	   and	   phosphorylation,	   and	   may	   be	   present	   in	   a	   tetrameric	   form	   in	   vivo	  (Trexler	  &	  Rhoades,	  2012;	  Bartels	  et	  al.,	  2011).	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Currently,	   the	   motor	   symptoms	   of	   PD	   are	   managed	   through	   dopamine	   replacement	  therapy,	   such	   as	   Levodopa	   (Chase,	   1998).	  While	   this	   partially	   relieves	  motor	   symptoms	  and	  extends	  life	  expectancy,	  it	  does	  not	  address	  neurological	  symptoms	  or	  the	  underlying	  neurodegeneration,	   and	   may	   in	   fact	   accelerate	   the	   loss	   of	   nigrostriatal	   cells.	   Currently,	  there	  is	  only	  one	  approved	  treatment	  of	  dementia	  associated	  with	  PD,	  rivastigmin,	  which	  temporarily	   slows	   progression	   of	   symptoms,	   but	   does	   not	   modify	   underlying	   disease	  progression	  (Ding	  et	  al.,	  2015;	  Shulman	  et	  al.,	  2011).	  
3.1.1.3 Diabetes	  mellitus	  type	  II	  Diabetes	   mellitus	   type	   II	   is	   a	   common	   metabolic	   disease,	   with	   more	   than	   300	   million	  people	   currently	   living	  with	   the	  disease	   (Knowles	  et	  al.,	   2014).	  Diabetes	  mellitus	   type	   II	  occurs	  when	  cells	  become	   insulin	  resistant,	   leading	   to	  hyperglycemia.	  Patients	  also	  have	  lower	   insulin	   levels	  compared	  with	  healthy	   individuals.	  Secondary	  complications	   include	  blindness,	   stroke,	   heart	   attack	   and	   loss	   of	   blood	   flow	   to	   extremities	   leading	   to	  amputations,	  leading	  to	  life	  expectancy	  of	  patients	  decreasing	  by	  10	  years,	  compared	  with	  healthy	  individuals	  (Patel	  et	  al.,	  2008).	  	  	  Islet	  amyloid	  polypeptide	  (IAPP)	  is	  strongly	  associated	  with	  diabetes	  mellitus	  type	  II.	  IAPP	  and	  insulin	  are	  under	  the	  control	  of	  the	  same	  regulatory	  elements;	  they	  are	  co-­‐expressed	  and	   co-­‐secreted	   (20:1	   molar	   ratio	   insulin:IAPP)	   in	   pancreatic	   islet	   β	   cells	   (Cluck	   et	   al.,	  2005;	  Martin,	  2006).	  As	  an	  individual	  becomes	  insulin	  resistant,	  expression	  of	  both	  insulin	  and	   IAPP	   is	   increased.	   It	   may	   be	   that	   these	   increased	   concentrations	   promote	   the	  formation	   of	   amyloid	   fibrils	   from	   IAPP.	   It	   is	   currently	   unclear	   whether	   islet	   amyloid	  deposition,	   or	   intermediate	   oligomers,	   are	   the	   causative	   agents	   of	   pathogenesis,	   but	  evidence	   from	   in	   vivo	  mouse	   models	   suggests	   that	   both	   may	   be	   toxic	   and	   pathogenic	  factors	  (Höppener	  et	  al.,	  1993;	  Höppener	  &	  Lips,	  2006;	  Lin	  et	  al.,	  2007).	  	  	  The	  incidence	  of	  diabetes	  mellitus	  type	  II	  is	  predicted	  to	  rise	  over	  the	  coming	  decades,	  and	  while	   the	   disease	   can	   be	   controlled,	   current	   therapies	   have	   limited	   efficacy,	   side-­‐effects	  and	  high	  cost	   (Rochester,	  2014).	  Targeting	  amyloid	   formation,	  preventing	  or	  delaying	  β-­‐cell	  loss,	  is	  an	  attractive	  avenue	  for	  the	  development	  of	  new	  therapeutics.	  	  
3.1.1.4 	  Dialysis	  related	  amyloidoisis	  The	   formation	   of	   β2m	   fibrils	   is	   associated	   with	   the	   systemic	   disorder	   dialysis	   related	  amyloidosis	  (DRA).	  In	  vivo,	  β2m	  is	  a	  component	  of	  the	  major	  histocompatibility	  complex	  I	  (MHC	  I)	  that	  presents	  8-­‐10	  residue	  long	  peptides	  on	  the	  surface	  of	  nucleated	  cells,	  which	  are	   then	   recognized	   by	   T-­‐lymphocytes	   as	   part	   of	   self-­‐recognition	   and	   the	   immune	  response	  (Williams	  et	  al.,	  2002).	  In	  healthy	  individuals	  β2m	  is	  constitutively	  expressed	  and	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transported	   to	   the	  cell	   surface	  as	  part	  of	   the	  MHC	   I	   complex,	  where	   it	  dissociates	  and	   is	  transported	  to	  the	  kidney	  for	  degradation	  (Williams	  et	  al.,	  2002).	  β2m	  is	  removed	  from	  the	  blood	   by	   glomerular	   filtration	   followed	   by	   proximal	   tubular	   reabsorption	   and	   finally	  proteolytic	  cleavage.	  Significant	  quantities	  of	  β2m	  are	  synthesised	   in	  healthy	   individuals;	  2.4	   ±	   0.7	  mg	   per	   kg	   of	   body	  mass	   per	   day	   (Floege	   et	  al.,	   1991).	  When	   renal	   function	   is	  compromised,	  β2m	  is	  no	  longer	  efficiently	  removed	  from	  the	  blood	  and	  degraded,	  leading	  to	  a	  25-­‐60	  fold	  increase	  in	  serum	  β2m.	  Current	  dialysis	  treatments	  are	  unable	  to	  efficiently	  remove	  all	  β2m	  (Rabindranath	  et	  al.,	  2006;	  Floege	  &	  Ehlerding,	  1996).	  	  	  Over	  many	   years	   of	   compromised	   renal	   function,	   elevated	   levels	   of	   β2m	   are	   thought	   to	  promote	  its	  aggregation	  into	  amyloid	  fibrils	  (Figure	  3-­‐1)	  throughout	  the	  musculoskeletal	  system,	  possibly	  due	  to	  the	  presence	  of	  collagen	  and	  glycosaminoglycans	  (GAGs)	  in	  these	  locations	   (Otsubo	   et	   al.,	   2009;	   Linke	   et	   al.,	   2000).	   This	   leads	   to	   painful	   joints.	   Such	  extracellular	   aggregates	   are	   primarily	   formed	   from	   full	   length	   β2m,	   although	   the	   highly	  amyloidogenic	   truncated	   form	   of	   β2m,	   ΔN6,	   can	   form	   up	   to	   30	  %	   total	   β2m	   within	   the	  extracellular	  deposits	  (Linke	  et	  al.,	  1989;	  Esposito	  et	  al.,	  2000).	  Other	  modified	  versions	  of	  β2m	   are	   also	   found	   in	   ex	   vivo	   deposits,	   and	   contain	   other	   components	   such	   as	  glycosaminoglycans,	  proteoglycans,	  collagen,	  apolipoprotein	  E	  and	  serum	  amyloid	  protein	  (Hodkinson	  et	  al.,	  2012).	  These	  additional	  factors	  are	  thought	  to	  stabilise	  fibrils	  and	  play	  a	  role	  in	  pathogenesis	  and	  disease	  progression.	  	  	  Patients	   undergoing	   long-­‐term	  dialysis	   for	   renal	   insufficiency	   experience	   symptoms	  ~	  5	  years	   after	   treatment	   starts.	   Carpal	   tunnel	   syndrome,	   chronic	   arthropathy,	   destructive	  spondyloarthropathy,	   and	   cystic	   bone	   lesions	   which	   can	   result	   in	   bone	   lesions	   and	  fractures	   can	   all	   occur	   as	   the	   disease	   progresses	   (Yamamoto	   et	   al.,	   2013).	   Current	  treatments	  relieve	  chronic	  pain	  and	  inflammation	  (Floege	  &	  Ketteler,	  2001).	  However,	  the	  only	   curative	   treatment	   is	   renal	   transplantation,	   which	   rapidly	   and	   drastically	   reduces	  symptoms	   (Floege	   &	   Ehlerding,	   1996),	   although	   it	   has	   yet	   to	   be	   shown	   whether	   β2m	  amyloid	  deposits	  diminish	  after	  transplantation	  (Campistol,	  2001).	  Transplantation	  is	  not	  always	   possible	   due	   to	   the	   age	   of	   the	   patient,	   availability	   of	   organs	   or	   cultural	   reasons.	  Future	  treatment	  options	  may	  include	  improved	  dialysis	  membranes,	  but	  their	  long	  term	  effects	  remain	  unclear	  (Yamamoto	  et	  al.,	  2009).	  Some	  studies	  suggest	  haemodiafiltration,	  which	  more	   effectively	   removes	   β2m,	   does	   not	   offer	   any	   improvement	   to	   quality	   of	   life	  over	  haemodialysis	  treatments	  (Mazairac	  et	  al.,	  2013).	  It	  may	  be	  that	  levels	  of	  β2m	  are	  not	  reduced	  enough	  to	  prevent	  the	  onset	  of	  pathogenesis.	  In	  one	  study,	  the	  mean	  predialysis	  serum	  β2m	   concentrations	  were	   33.5	  mg/L	   in	   the	   high-­‐flux	   haemodialysis	   group	   versus	  26.4	  mg/L	   in	   the	  haemodiafiltration	   (Leypoldt	  et	  al.,	   2012).	  Although	  haemodiafiltration	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may	  offer	  an	  improvement	  over	  conventional	  dialysis,	  these	  serum	  concentrations	  of	  β2m	  are	  still	  over	  10-­‐fold	  higher	  than	  in	  individuals	  with	  normal	  renal	  function.	  	  More	  recently,	  a	  variant	  of	  β2m	  was	  described,	  D76N,	  which	  is	  associated	  with	  autosomal	  dominant	   hereditary	   systemic	   amyloidosis;	   patients	   experience	   progressive	   bowel	  dysfunction	  and	  extensive	  visceral	  amyloid	  deposits,	  while	  their	  renal	  function	  and	  serum	  concentrations	  of	  β2m	  remain	  normal	   (Valleix	  et	  al.,	  2012).	   Interestingly,	   compared	  with	  dialysis	   related	   amyloidosis,	   no	   ΔN6	   β2m	   was	   detected	   in	   plaques.	   Under	   physiological	  conditions	   in	   vitro	   the	   D76N	   variant	   was	   fully	   converted	   into	   amyloid	   fibrils	   within	   48	  hours,	  compared	  with	  wt	  β2m	  which	  does	  not	  aggregate	  under	  these	  conditions	  (Valleix	  et	  
al.,	  2012).	  	  
	  
Figure	  3-­‐1	  Disease	  progression	  of	  dialysis	  related	  amyloidosis.	  β2m	  (pink)	  dissociates	  from	  the	  MHC	  I	  complex,	  on	  the	  surface	  of	  all	  nucleated	  cells	  (1).	  β2m	  is	  transported	  in	  the	  blood	   to	   the	   kidneys	   (2)	   where	   in	   healthy	   individuals	   it	   is	   removed	   by	   glomerular	  filtration	   and	   proteolytic	   cleavage	   (3).	   In	   patients	   undergoing	   dialysis	   treatment,	   β2m	   is	  not	  removed	  from	  the	  blood	  and	  so	  serum	  concentrations	  increase	  (4)	  and	  aggregates	  into	  amyloid	   fibrils	   (5)	   in	   the	   joint	   environment	   as	   shown	   by	   the	   scintigram	   of	   a	   dialysis	  related	  amyloidosis	  patient	  (6,	  from	  Linke	  et	  al.,	  2000).	  
3.1.2 Amyloid	  as	  a	  prion-­‐like	  transmissible	  agent	  	  Proteinaceous	   infectious	   particles,	   or	   prions,	   are	   now	   generally	   accepted	   as	   the	   causal	  agents	   of	   Transmissible	   Spongiform	   Encephalopathies	   (TSEs),	   which	   include	   Scrapie	   in	  sheep,	   bovine	   spongiform	   encephalopathy	   in	   cattle	   and	   Creutzfeldt–Jakob	   disease,	  Gerstmann–Sträussler–Scheinker	  syndrome	  and	  fatal	  familial	  insomnia	  in	  humans	  (Collins	  
et	  al.,	  2004).	  In	  all	  TSE’s,	  the	  ubiquitously	  expressed	  cellular	  prion	  protein	  (PrPc)	  misfolds	  into	  Scrapie	  prion	  protein	  (PrPSc),	  which	  then	  acts	  as	  a	  high	  fidelity	  seed,	  propagating	  the	  prion	  through	  the	  cell,	  and	  ultimately	  the	  organism,	  via	  a	  range	  of	  mechanisms	  including	  exosomes	  and	  tunnelling	  nanotubes	  between	  cells	  (Prusiner,	  1998;	  Gerdes,	  2009).	  Prions	  occur	   as	   distinct	   strains;	   all	   share	   the	   underlying	   PrPc	  protein,	   but	   differ	   in	   their	   PrPSc	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conformation,	   and	   exhibit	   diverse	   phenotypes	   and	   disease	   progression	   (Soto,	   2012).	  Prions	   can	   also	   be	   transmitted	   between	   individuals,	   with	   high	   fidelity	   of	   strain	  preservation	   (Prusiner,	   2012).	   The	  precise	  mechanisms	  of	   PrPSc	  toxicity	   are	   still	   unclear	  despite	  intensive	  research	  (Aguzzi	  &	  Falsig,	  2012).	  Biochemically,	  PrPSc	  has	  a	  high	  β-­‐sheet	  content	   and	  high	   levels	  of	   resistance	   to	  proteinase	  K	  digestion	   compared	  with	  PrPc.	   and	  can	  form	  oligomeric	  and	  fibrillar	  amyloid	  species	  (Riesner,	  2003).	  	  	  Interestingly,	  recent	  studies	  have	  suggested	  that	  other	  protein	  misfolding	  diseases	  share	  striking	   similarities	   to	   TSE’s,	   and	   may	   exhibit	   prion-­‐like	   mechanisms	   of	   propagation.	  Shared	   features	   such	   as	   the	   ability	   to	   seed	   or	   template	   proteins	   into	   the	   amyloid	  conformation,	   as	   well	   as	   the	   mechanisms	   of	   cell-­‐cell	   transmission,	   have	   lead	   many	  researchers	   to	   term	   a	   subset	   of	   protein	   misfolding	   disorders	   ‘prion-­‐like’	   (Fernández-­‐Borges	  et	  al.,	  2015).	  Some	  of	   the	  strongest	  evidence	   for	  prion-­‐like	  properties	   is	   found	   in	  AD	  and	  PD.	  The	  remaining	  feature	  which	  appears	  to	  still	  separate	  TSE’s	  from	  other	  protein	  misfolding	  disorders	  is	  that	  true	  prions	  spread	  not	  only	  within	  the	  affected	  organism	  but	  also	   between	   individuals	   (Angot	  et	  al.,	   2010).	  An	   interesting	   recent	   study	  demonstrated	  that	   Aβ	   pathology	  may	   have	   been	   transmitted	   through	   iatrogenic	  mechanisms;	   patients	  injected	   with	   human	   cadaveric	   pituitary-­‐derived	   growth	   hormone	   showed	   signs	   of	  significant	   Aβ	   deposition,	   despite	   their	   young	   (36-­‐51)	   age	   and	   lack	   of	   gene	   mutations	  associated	  with	  AD	  (Jaunmuktane	  et	  al.,	  2015).	  This	  is	  the	  first	  evidence	  of	  transmission	  of	  AD	  pathology	   between	   humans,	   and	   raises	   concerns	   that	   pathology	  may	   be	   transmitted	  through	   previously	   unsuspected	   routes	   such	   as	   contaminated	   surgical	   instruments	   or	  blood	   transfusions.	   Several	   groups	   have	   reported	   that	   Aβ	   and	   tau	   display	   prion-­‐like	  transmission	  between	   cells	   (Frost	  et	  al.,	   2009;	  Eisele	  et	  al.,	   2009).	  Brain	   extracts	   from	  a	  human	   patient	   with	   AD	   can	   be	   injected	   into	   the	   brains	   of	   transgenic	   mice	   expressing	  amyloid	   precursor	   protein	   (APP)	   and	   induce	   aggregation	   and	   deposition	   of	   Aβ	  extracellular	   aggregates	   (Meyer-­‐Luehmann	   et	  al.,	   2006).	  However,	   in	   contrast	   to	   prions,	  administration	   of	   brain	   extract	   through	   oral,	   intravenous,	   intraocular	   or	   intranasal	  mechanisms	   does	   not	   lead	   to	   Aβ	   aggregation	   (Eisele	   et	   al.,	   2009).	   Other	   studies	   have	  suggested	   the	   existence	   of	   polymorphic	   strains	   of	   Aβ,	   further	   indicating	   prion	   like	  behaviour	   (Petkova	   et	   al.,	   2005).	   These	   studies	   suggest	   that	   introducing	   exogenous	  aggregates	   of	   Aβ	   or	   tau	   can	   induce	   aggregation	   or	   formation	   of	   inclusions	   from	  endogenously	  expressed	  Aβ	  or	  tau,	  which	  may	  spread	  to	  neighbouring	  cells	  (Angot	  et	  al.,	  2010).	  	  	  For	   α-­‐synuclein,	   cell-­‐to-­‐cell	   transfer	   of	   inclusions	   has	   been	   demonstrated	   in	   both	   cell	  culture	   and	   transgenic	   mice	   (Desplats	   et	   al.,	   2009),	   although	   not	   all	   studies	   have	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corroborated	   cell-­‐cell	   transfer	   (Luk	   et	   al.,	   2009).	   Distinct,	   self	   propagating	   strains	   have	  also	  been	   reported	   (Yonetani	  et	  al.,	   2009).	  Recent	   studies	  even	   suggest	   that	   a	  particular	  prion	  like	  stain	  of	  α-­‐synuclein	  may	  be	  responsible	  for	  causing	  the	  disease	  multiple	  system	  atrophy	  (Prusiner	  et	  al.,	  2015).	  	  Crucial	   distinctions	   remain	   between	   prions	   and	   other	   protein	   misfolding	   disorders.	  Despite	  decades	  of	  study,	  no	  evidence	  has	  been	  found	  for	  the	  spontaneous	  transmission	  of	  AD	   or	   PD	   between	   individuals	   (Frost	   &	   Diamond,	   2010).	   Serum	   amyloidosis	   A	   is	   being	  studied	  as	  a	  potentially	   infectious	  amyloid	  disease	  which	  may	  spread	  via	  oral	   infectivity	  (Lundmark	   et	   al.,	   2003).	   There	   are	   also	   differences	   in	   the	   progression	   rates	   of	   disease;	  most	   prionopathies	   exhibit	   relatively	   rapid	   disease	   progression,	   patients	   with	   CJD	  typically	   surviving	   4-­‐6	   months	   from	   the	   onset	   of	   symptoms,	   compared	   with	   AD	   or	   PD	  where	   patients	   can	   survive	   for	   decades	   (Frost	   &	   Diamond,	   2010).	   Despite	   these	  differences,	   increasing	   our	   understanding	   of	   the	   potential	   prion-­‐like	   nature	   of	   amyloid	  species	  may	  reveal	  novel	  targets	  for	  therapeutic	  intervention	  (Brundin	  et	  al.,	  2010).	  	  
3.1.3 Functional	  amyloid	  	  Although	   amyloid	   is	   primarily	   studied	   as	   a	   disease-­‐associated	   agent,	   its	   stability,	  mechanical	  strength,	  proteolytic	  resistance	  and	  prion-­‐like	  properties	  have	  been	  exploited	  by	   evolution	   to	   play	   functional	   roles	   in	   organisms	   from	   E.	   coli	   to	   humans	   (Table	   3-­‐2)(Shewmaker	   et	   al.,	   2011;	   Fowler	   et	   al.,	   2007).	   The	   prevalence	   of	   functional	   amyloid	  across	   different	   domains	   of	   life	   suggests	   its	   quaternary	   structure	   may	   be	   an	  evolutionarily-­‐conserved	  structure	  underpinning	  processes	  vital	  for	  normal	  cell	  and	  tissue	  physiology	   (Fowler	   et	   al.,	   2006).	   Functional	   amyloid	   fibrils	   share	   the	   generic	  characteristics	   of	   their	   disease-­‐causing	   relatives,	   and	   it	   has	   been	   suggested	   that	   the	  difference	   lies	   in	   their	   tight	   regulation	   and	   coordination	   by	   other	   cellular	   processes	   to	  prevent	   cytotoxicity	   (Badtke	   et	   al.,	   2009).	   The	   study	   of	   functional	   amyloid	   may	   help	  rationalise	  the	  cytotoxicity	  of	  amyloid	  species	  in	  various	  disease	  states.	  The	  amyloid	  fold	  may	   also	   be	   exploited	   for	   biotechnological	   applications,	   for	   example	   fibrils	   can	   form	  monodisperse	  microgels	  and	  gel	  shells	  which	  may	  have	  applications	  as	  drug	  carrier	  agents	  (Shimanovich	  et	  al.,	  2015).	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Protein	   Organisms(s)	   Function	   Reference	  Peptide	  hormones	   Mammals	   High	  Storage	  Density	   (Maji	  et	  al.,	  2009).	  Melanin	   formation-­‐	  Pmel17	  proteolytically	  cleaved	  into	  Mα.	  
Mammals	   Melanin	  formation	  	   (Hearing,	   2000;	   Berson	   et	   al.,	  2003;	  Fowler	  et	  al.,	  2006)	  
Transmissible	  element-­‐	  Sup35	   Yeast	   Modulation	  of	  normal	  translation	  termination.	   (Uptain	  &	  Lindquist,	  2002;	  Saibil	  et	  al.,	  2012).	  Transmissible	  element-­‐	  Ure2p	   Yeast	   Regulation	   of	  nitrogen	  catabolism	   (Peter	  Chien	  et	  al.,	  2004).	  Curli	  fimbraie	   Bacteria	   such	  as	  E.coli	   Biofim	  formation	  	   	  (Hammer	  et	  al.,	  2007;	  Dueholm	  et	  al.,	  2011;	  Evans	  et	  al.,	  2015;	  Evans	  &	  Chapman,	  2014)	  
Table	  3.2	  Examples	  of	  functional	  amyloid	  in	  nature.	  	  
1.1.1 Formation	  of	  amyloid	  The	   formation	   of	   amyloid	   fibrils	   from	   soluble	   protein	   is	   a	   complex	   process,	   with	   the	  formation	  of	  multiple	  heterogeneous	  species	  en	  route	  to	  the	  final,	  mature	  fibril	  (Knowles	  
et	   al.,	   2014).	   The	   majority	   of	   amyloid	   species	   display	   nucleation-­‐dependent	   growth	  kinetics	  in	  vitro	  (Collins	  et	  al.,	  2004;	  Xue	  et	  al.,	  2008;	  Ferrone,	  1999;	  Knowles	  et	  al.,	  2009).	  In	   an	   in	   vitro	   setting,	   using	   a	   defined	   concentration	   of	   monomer,	   a	   lag	   phase	   occurs	  followed	  by	  exponential	  growth,	  and	  finally	  a	  plateau	  as	  monomer	  becomes	  sequestered	  in	  aggregates	  (Figure	  3-­‐2).	  In	  the	  lag	  phase,	  a	  dynamic	  equilibrium	  exists	  between	  different	  soluble	  oligomers	  formed	  from	  fully	  or	  partially	  unfolded	  monomer.	  In	  some	  cases,	  these	  associate	  into	  higher	  order	  assemblies	  known	  as	  protofilaments.	  These	  protofilaments	  and	  other	   oligomeric	   species,	   may	   be	   on	   or	   off	   pathway	   intermediates	   of	   mature	   fibril	  assembly	   (Caughey	  &	  Lansbury,	  2003).	  For	  most	  proteins,	   the	   rate	   limiting	   step	  of	   fibril	  formation	   is	   the	   generation	   of	   a	   nucleus	   which	   acts	   as	   a	   template	   onto	   which	   soluble	  species	   can	   bind	   and	   change	   conformation	   to	   elongate	   the	   fibril	   (primary	   nucleation),	  however	  the	  rate	  limiting	  step	  can	  be	  the	  conformational	  conversion	  of	  the	  soluble	  species	  or	   even	   the	   dissociation	   of	   stable,	   native	   complexes	   to	   release	   an	   aggregation-­‐prone	  precursor	  (Lee	  et	  al.,	  2011;	  Hurshman	  et	  al.,	  2004;	  Xue	  et	  al.,	  2008).	  The	  lag	  phase	  can	  be	  reduced	  or	  eliminated	  by	  the	  addition	  of	  pre-­‐formed	  seeds	  (Wood	  et	  al.,	  1996;	  O'Nuallain	  
et	  al.,	  2004).	  Secondary	  processes,	  for	  example	  upon	  fibril	  fragmentation,	  can	  increase	  the	  rate	   of	   soluble	   species	   sequestering	   into	  mature	   fibrils	   and	   reduce	   or	   eliminate	   the	   lag	  phase.	  In	  the	  exponential	  growth	  phase,	  soluble	  species	  are	  rapidly	  added	  to	  a	  nucleating	  particle	  which	  acts	  as	  a	  template	  or	  seed,	  enabling	  the	  soluble	  species	  to	  adopt	  the	  cross-­‐β	  architecture	  (Knowles	  et	  al.,	  2014).	  	  	  The	  process	   of	  mature	   fibril	   formation	   can	  be	  monitored	  by	   the	  use	   of	   fluorescent	   dyes	  such	   as	   Thioflavin-­‐T	   or	   Congo	   red	   (Nilsson,	   2004;	  Westermark	   et	  al.,	   1999),	   along	  with	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other	  techniques	  such	  as	  circular	  dichroism	  and	  mass	  spectrometry	  (Knowles	  et	  al.,	  2014).	  Different	   species	   formed	   en	   route	   to	   fibrils	   can	   also	   be	   recognised	   by	   various	  conformation-­‐specific	  antibodies	  such	  as	  A11	  (pre	  fibrillar	  soluble	  oligomers),	  OC	  (fibillar	  oligomers)	  and	  WO1	  (mature	  fibrils)	  (O'Nuallain	  &	  Wetzel,	  2002;	  Glabe,	  2004;	  Kayed	  et	  al.,	  2007;	   Kayed	   et	   al.,	   2003).	   Aggregation	   kinetics	   are	   highly	   variable,	   depending	   on	   the	  precursor	  species	  and	  solution	  conditions	  (Kad	  et	  al	  2003;	  Buell	  et	  al.,	  2011;	  Buell	  et	  al.,	  2014).	   There	   is	   also	   a	   potential	   discrepancy	   between	   amyloid	   fibril	   formation	   in	   vitro,	  which	  often	  occurs	  on	  the	  timescale	  of	  days,	  and	  in	  vivo	  which	  occurs	  over	  decades.	  	  	  	  
Figure	   3-­‐2	   Typical	   amyloid	  
aggregation	   as	   measured	  
by	   ThT	   fluorescence.	   A)	  Typical	   ThT	   fluorescence	  kinetics	   observed	   during	   de	  
novo	   (green)	   and	   seeded	  (blue)	  amyloid	  aggregation.	  	  	  
3.1.4 Structure	  of	  amyloid	  The	  cross-­‐β	  motif	  characteristic	  of	  amyloid	  is	  formed	  from	  the	  lamination	  of	  successive	  β-­‐sheets	   (Biancalana	   et	   al.,	   2010).	   Despite	   the	   sequence	   diversity	   between	   proteins	   that	  form	  amyloid,	   fibrils	  have	  structural	   similarities.	  The	   fact	   that	  many	  structurally	  diverse	  proteins	   can	   form	   amyloid	   fibrils	   suggests	   that	   the	   amyloid	   fold	   is	   governed	   by	   protein	  backbone	   interactions,	   while	   the	   kinetics	   and	   thermodynamics	   of	   fibrillation	   may	   be	  modulated	   by	   side	   chain	   interactions.	   Amyloid	   fibrils	   are	   commonly	   identified	   by	   their	  propensity	   to	   bind	   dyes	   (Bertoncini	   &	   Celej,	   2011).	   However,	   the	   gold	   standard	   for	  identification	   remains	   the	   characteristic	   X-­‐ray	   fibre	   diffraction	   pattern	   (Figure	   3-­‐3,	   A-­‐C)	  (Sunde	  et	  al.,	  1997;	  Eanes	  &	  Glenner,	  1968;	  Astbury	  et	  al.,	  1935;	  Jahn	  et	  al.,	  2010),	  which	  demonstrates	  that	  the	  strongest	  repeating	  feature	  shared	  by	  amyloid	  fibrils	   is	  a	  set	  of	  β-­‐sheets	  parallel	  to	  the	  fibril	  axis	  (Nelson	  et	  al.,	  2005;	  Jahn	  et	  al.,	  2010).	  
	  X-­‐ray	   crystallography	   studies	   of	   peptides	   which	   form	   amyloid-­‐like	   fibrils,	   such	   as	  GNNQQNY	  from	  the	  yeast	  prion	  Sup35,	  suggest	  the	  fibril	  core	  is	  comprised	  from	  β-­‐strands	  spaced	  ~	  4.8	  Å	  apart	  that	  run	  perpendicular	  to	  the	  fibril	  axis,	  and	  that	  these	  form	  β-­‐sheets	  with	  hydrogen	  bonding	  parallel	   to	   the	  axis	   (Nelson	  et	  al.,	   2005)(Figure	  3-­‐3	  D,	  E).	   It	   also	  reveals	   that	   side	   chains	   from	   adjacent	   chains	   form	   a	   steric	   zipper	   between	   pairs	   of	   β-­‐




























Figure	   3-­‐3	   Structure	   of	   amyloid	   fibrils.	   X-­‐ray	   fibre	   diffraction	   patterns	   from	   a	   wide	  range	   of	   fibrils	   formed	   from	   different	   precursor	   proteins	   show	   characteristic	   cross-­‐β	  pattern	   including	  Aβ1-­‐42	  (A)	   IAPP1-­‐37	  (B)	  Aβ11-­‐25	  (C)	  (adapted	  from	  Jahn	  et	  al.,	  2010).	  X-­‐ray	  crystallography	  has	  been	  used	  to	  solve	  the	  structure	  of	  GNNQQNY	  peptide	  (D,E).	  Carbon	  atoms	   are	   coloured	   in	   purple	   or	   grey/white,	   oxygen	   in	   red,	   nitrogen	   in	   blue.	   Arrows	  represent	  backbone	  of	  each	  β-­‐strand,	  with	  side	  chains	  protruding.	  Β-­‐strands	  are	  spaced	  by	  4.8	   Å.	   The	   steric	   zipper	   viewed	   edge	   on	   shows	   interdigitation	   of	   side	   chains;	   Grey	   line	  shows	   dry	   interface,	   red	   lines	   show	   wet	   interface	   (E)	   (D,E	   Adapted	   from	   Nelson	   et	   al.,	  2005).	   Structure	   of	   α-­‐synuclein	   peptides	   have	   been	   solved	   by	   electron	   diffraction	   of	  microcrystals	   (F,G	   adapted	   from	   Rodriguez	   et	   al.,	   2015).	   Speculative	   model	   of	   an	   α-­‐synuclein	  protofibril	  with	  the	  A53T	  mutation	  shown	  in	  black,	  where	  the	  strong	  interface	  of	  NACore	  (residues	  68–78,	  orange)	  forms	  the	  core	  of	  the	  fibril	  (F).	  Crystal	  structure	  of	  the	  NACore	  (G)	  shows	  4.8	  Å	  spacing.	  Information	  from	  a	  range	  of	  structural	  techniques	  can	  be	  combined	   to	   yield	   a	  model	   of	   an	   amyloid	   fibril,	   such	   as	   the	  magic	   angle	   spinning	   NMR	  structure	   of	   an	   11	   residue	   peptide	   fitted	   into	   a	   cryo-­‐EM	   density,	   scale	   bar	   50	   nm	   (H,	  adapted	  from	  (Fitzpatrick	  et	  al.,	  2013).	  A	  range	  of	  fibril	  morphologies	  can	  be	  formed	  from	  the	  same	  precursor	  protein,	  as	  negative	  stain	  electron	  microscopy	  images	  show	  for	  IAPP	  fibrils	  (adapted	  from	  Serpell,	  2014)	  
3.1.5 β2m	  as	  a	  model	  system	  As	  many	  amyloid	  fibrils	  share	  similar	  structural	   features,	  common	  properties	  of	  amyloid	  fibrils	  can	  be	  investigated	  using	  a	  single	  amyloidogenic	  protein.	  In	  this	  thesis,	  β2m	  is	  used	  as	  a	  model	  system.	  In	  vivo,	  β2m	  is	  the	  non-­‐covalent	  component	  of	  the	  MHC	  I	  complex.	  It	  is	  a	  99-­‐residue	   protein	   consisting	   of	   seven	   antiparallel	   β-­‐strands,	   which	   form	   an	  immunoglobulin,	  β-­‐sandwich	  fold	  consisting	  of	  seven	  β-­‐strands	  stabilised	  by	  a	  disulphide	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bond	  between	  β-­‐strands	  B	  and	  F.	  The	  structure	  of	  β2m	  as	  part	  of	  the	  MHC	  I	  molecule	  and	  in	  its	  monomeric	  form	  has	  been	  solved	  by	  X-­‐ray	  crystallography	  (Borbulevych	  et	  al.,	  2010;	  Trinh	  et	  al.,	  2002)	  and	  by	  solution	  NMR	  (Verdone	  et	  al.,	  2002;	  Eichner	  et	  al.,	  2011).	  There	  are	  5	  proline	  residues	  in	  β2m,	  4	  in	  the	  trans-­‐conformation,	  with	  only	  proline	  32	  in	  the	  cis	  conformation;	  this	   isomerisation	  is	  thought	  to	  play	  a	  role	  in	  β2m	  aggregation	  (Jahn	  et	  al.,	  2006).	  	   	  	  	  	  
Figure	  3-­‐4	  Structure	  of	  human	  monomeric	  β2m	  	  Sheets	  A,	  B	  and	  E	  are	  labelled.	  	  	  (PDB	  1LDS)	  (Trinh	  et	  al.,	  2002).	  	  	  	  	  
3.1.5.1 β2m	  amyloid	  formation	  Interestingly,	  wt	  β2m	  does	  not	  form	  fibrils	  at	  physiological	  pH	  and	  temperature,	  unless	  in	  the	   presence	   of	   additional	   factors	   such	   as	   trifluoroethanol,	   SDS,	   glycosaminoglycans	  (GAGs),	  proteoglycans,	  collagen	  or	  Cu2+	  (Eakin	  &	  Miranker,	  2005;	  Myers	  et	  al.,	  2006;	  Relini	  
et	  al.,	  2006;	  McParland	  et	  al.,	  2000).	  Fibril	  formation	  in	  vitro	  can	  occur	  at	  low	  pH,	  with	  the	  pathway	  influenced	  by	  salt	  concentration,	  agitation,	  buffer	  and	  pH	  (Kad	  et	  al.,	  2001;	  Smith	  
et	  al.,	  2003;	  Gosal	  et	  al.,	  2005).	  At	  low	  pH	  and	  low	  ionic	  strength	  (pH	  2.0,	  50	  mM	  NaCl)	  β2m	  amyloid	   fibril	   formation	   proceeds	   via	   a	   nucleation-­‐dependent	   mechanism	   (Gosal	   et	   al.,	  2005).	   Fibrils	   formed	   in	   non-­‐physiological	   conditions	   exhibit	   the	   classical	   cross-­‐β	   fibre	  diffraction	  pattern	  (Platt	  &	  Radford,	  2009),	   thioflavin	  T	  binding	  (Xue	  et	  al.,	  2008),	  Congo	  red	  birefringence	  and	  WO1	   immunoreactivity,	   (Myers	  et	  al.,	  2006).	  Vigorous	  agitation	  of	  these	  β2m	   fibrils	   results	   in	   fibrils	  with	   the	   same	   long	   straight	   (Ls)	  morphology	  but	  with	  shorter	   lengths	   due	   to	   fragmentation	   (Ls-­‐f)	   (Xue	  et	  al.,	   2009).	   The	  β2m	  variant	  ΔN6	  has	  been	   shown	   to	   form	   fibrils	   under	  physiological	   conditions,	   and	   therefore	   is	  proposed	   to	  play	   a	   role	   in	   initiating	   amyloid	   formation	   (Jones	   et	   al.,	   2003).	   Further	   supporting	   this,	  truncated	   β2m	   ΔN6	   and	   full	   length	   β2m	   have	   been	   shown	   to	   co-­‐polymerise	   to	   form	  heteropolymers,	  which	  have	  distinct	  biophysical	  properties	  compared	  with	  fibrils	  formed	  from	  a	  single	  monomeric	  species	  (Sarell	  et	  al.,	  2013).	  Using	  NMR,	  it	  has	  been	  shown	  that	  the	  truncated	  β2m	  variant	  ΔN6	  promotes	  conformational	  changes	  of	  full	  length	  β2m	  at	  pH	  6.2	   into	   an	   amyloid-­‐competent	   state	   (Karamanos	   et	  al.,	   2014).	   The	   interaction	   between	  β2m	   ΔN6	   and	   full	   length	   β2m	   involves	   transient,	   weakly	   associated,	   head-­‐to-­‐head	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interactions,	  which	  destabilises	  the	  native	  state	  sufficiently	  to	  allow	  fibril	  formation	  of	  wt	  β2m	  (Karamanos	  et	  al.,	  2014).	  
3.1.6 Morphology	  of	  β2m	  β2m	  fibrils	  have	  been	  extensively	  studied	  using	  biophysical	  techniques	  (Katou	  et	  al.,	  2002;	  Ladner	   et	   al.,	   2010;	   Monti	   et	   al.,	   2005;	   White	   et	   al.,	   2009).	   The	   quaternary	   packing	   of	  protofilaments	   within	   the	  mature	   fibril,	   and	   the	   subunit	   packing	  within	   protofilaments,	  has	  been	  examined	  using	   cryo-­‐EM	   (White	  et	  al.,	   2009).	   β2m	   fibrils	   formed	  at	  pH	  2.0	   are	  heterogeneous	   in	   their	   repeat	   length	   (120-­‐185	  nm),	   but	   can	  be	   subcategorised	   into	   two	  major	   types	   (A	   and	   B)(White	   et	   al.,	   2009).	   The	   3D	   reconstructions	   show	   β2m	   amyloid	  fibrils	  are	  built	  from	  a	  dimer-­‐of-­‐dimers	  building	  block	  which	  assemble	  into	  protofilaments	  that	   associate	   in	   an	   asymmetric	   fashion	   into	   crescent	   shaped	   units,	   which	   then	   in	   turn	  associate	   back	   to	   back	   to	   form	   the	   full	   amyloid	   fibril.	   In	   each	   crescent,	   three	  protofilaments	  form	  at	   least	  three	  non-­‐equivalent	  subunit	  contacts	  (Figure	  3-­‐5)(White	  et	  
al.,	   2009).	   Scanning	   transmission	   electron	   microscopy	   (STEM)	   analysis	   of	   mature	   β2m	  fibrils	   showed	  a	  packing	  density	  of	  52	  kDa/nm,	   indicating	   that	   each	   repeat	   length	   (5.25	  nm)	  must	   be	   composed	   of	   ~24	   β2m	  monomers	   (White	   et	   al.,	   2009).	   NMR	   and	   electron	  paramagnetic	  resonance	  demonstrate	  that	  β-­‐strands	  within	  the	  mature	  wt	  β2m	  fibril	  core	  are	   arranged	   in	   a	   parallel,	   in	   register	   order,	   an	   architecture	   found	   in	   amyloid	   fibrils	  formed	  from	  other	  precursor	  proteins	  (Debelouchina	  et	  al.,	  2010).	  	  
	  













	  In	  this	  thesis,	  β2m	  fibrils	  have	  been	  assembled	  at	  pH	  2.0.	  FTIR	  spectroscopy	  has	  been	  used	  to	  compare	   the	  structural	  properties	  of	  β2m	  amyloid	   fibrils	   formed	  at	  pH	  2.5,	  7.0	  and	  ex	  
vivo	   fibrils,	   with	   all	   sharing	   the	   same	   structural	   characteristics	   (Jahn	   et	   al.,	   2008).	   This	  suggests	   it	   is	   valid	   to	   draw	   biologically	   relevant	   conclusions	   from	   the	   experimental	   use	  fibrils	  formed	  at	  non-­‐physiological	  pH.	  
3.1.6.1 Oligomers	  vs	  fibrils:	  two	  sides	  of	  a	  toxic	  coin	  An	  on-­‐going	  debate	  in	  the	  field	  is	  the	  relative	  cytotoxicities	  of	  the	  diverse	  range	  of	  amyloid	  species	  that	  can	  form	  (Verma	  et	  al.,	  2015).	  When	  fibrillar	  deposits	  were	  initially	  found	  in	  patients,	  they	  were	  proposed	  as	  the	  causative	  agents	  of	  disease	  (Hardy	  &	  Higgins,	  1992).	  These	  deposits	  are	  now	  known	  to	  consist	  primarily	  of	  amyloid	  fibrils.	  Such	  fibrils,	  formed	  from	   a	   wide	   range	   of	   precursor	   proteins,	   are	   associated	   with	   disease,	   including	   Aβ,	  lysozyme,	  IAPP,	  as	  well	  as	  non-­‐disease	  associated	  proteins	  such	  as	  Sup35	  and	  Ure2p,	  have	  been	  shown	  to	  exert	  cytotoxic	  effects	  (Gharibyan	  et	  al.,	  2007;	  Petkova	  et	  al.,	  2005;	  Pieri	  et	  
al.,	  2012;	  Engel	  et	  al.,	  2008;	  Novitskaya	  et	  al.,	  2006;	  Mossuto	  et	  al.,	  2011;	  Mossuto	  et	  al.,	  2010;	  Picone	  et	  al.,	  2009;	  Qiang	  et	  al.,	  2012).	  However,	  the	  observation	  that	  the	  presence	  of	  soluble	  Aβ	  amyloid	  species	  correlated	  better	  with	  AD	  progression	  than	  the	  deposition	  of	  extracellular,	  fibrillar	  aggregates,	  drew	  attention	  to	  these	  soluble	  species	  and	  their	  role	  in	  cytotoxicity	  (Fox	  et	  al.,	  1999;	  Naslund	  et	  al.,	  2000;	  McLean	  et	  al.,	  1999).	  It	  was	  noted	  that	  extensive	  amyloid	  plaques	  have	  been	   found	   in	   the	  brain	  of	  patients	  who	  appear	   to	  have	  normal	  cognition,	  while	  mouse	  models	  of	  Alzhiemer’s	  disease	  show	  cell	  dysfunction	  and	  reductions	   in	   synaptic	   plasticity	   long	   before	   extracellular	   aggregates	   are	   detectable	  (Zhang	  et	  al.,	  2011;	  Moechars	  et	  al.,	  1999).	  This	  further	  supports	  a	  role	  for	  soluble	  amyloid	  species	  in	  disease.	  	  	  It	   has	   proved	   difficult	   to	   extract	   oligomers	   from	   an	   in	   vivo	   setting,	   but	   they	   have	   been	  extracted	  from	  cell	  culture	  and	  brain	  tissues.	  It	  is	  noteworthy	  that	  the	  extraction	  methods	  often	   involve	   harsh	   steps	   such	   as	   boiling,	   homogenisation,	   urea	   or	   β-­‐mercaptoethanol	  treatment,	   which	   may	   destabilise	   any	   fibrillar	   species	   present,	   or	   alter	   the	   oligomeric	  species	  present	  in	  the	  original	  sample.	  With	  this	  caveat	  in	  mind,	  both	  ex	  vivo	  and	   in	  vitro	  oligomeric	   species	   have	   cytotoxic	   potential	   (Pountney	   et	   al.,	   2004;	   Lesne	   et	   al.,	   2006;	  Walsh	  et	  al.,	  2002;	  Cleary	  et	  al.,	  2005;	  Townsend	  et	  al.,	  2006;	  Lee	  &	  Lee,	  2002;	  Mukai	  et	  al.,	  2005).	   Oligomeric	   species	   formed	   from	   the	   Aβ,	   α-­‐synuclein,	   huntingtin,	   IAPP,	  transthyretin	  and	  lysozyme,	  along	  with	  non-­‐disease	  associated	  proteins	  hypf-­‐N	  and	  stefin-­‐B,	   are	   all	   cytotoxic	   (Campioni	   et	   al.,	   2010;	   Rigacci	   et	   al.,	   2008;	   Anderluh	   et	   al.,	   2005;	  Gharibyan	  et	  al.,	  2007;	  Reixach	  et	  al.,	  2004;	  Demuro	  et	  al.,	  2005;	  Nucifora	  et	  al.,	  2012).	  The	  antibody	   A11	   appears	   to	   bind	   a	   generic	   oligomeric	   conformation,	   and	   protects	   against	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cytotoxicity,	   further	  supporting	   the	  role	  of	  oligomers	   in	  disease(Kayed	  et	  al.,	  2003).	  This	  has	  led	  to	  some	  discounting	  amyloid	  fibrils	  as	  ‘tombstones	  representing	  the	  end	  point	  of	  a	  past	  disease	  process’,	  although	  this	  is	  likely	  to	  be	  a	  simplistic	  view	  in	  the	  light	  of	  evidence	  of	  fibrillar	  toxicity	  (Carrell,	  2005;	  Tipping	  et	  al.,	  2015).	  	  	  It	   is	  worth	   noting	   that	   in	  many	   studies,	   full	   biophysical	   characterisation	   of	   the	   amyloid	  species	   is	   not	   performed,	  meaning	   the	   presence	   of	   oligomeric/fibrillar	   species,	   or	   their	  interconversion,	   cannot	  be	  discounted.	  Amyloid	  polymorphism	   is	  now	  well-­‐documented,	  with	  examples	  of	  the	  same	  precursor	  protein	  giving	  rise	  to	  fibrils	  of	  different	  morphology	  and	   distinct	   biological	   activity	   (Petkova	   et	   al.,	   2005;	  Mossuto	   et	   al.,	   2010;	   Tycko,	   2015;	  Stein	  &	  True,	  2014).	  For	  example,	  under	  different	  solution	  conditions	  β2m	  can	  form	  both	  fibrils	  with	   long	  straight	   (Ls)	  morphology	  and	   ‘worm-­‐like’	   fibrils,	  which	  exhibit	  different	  cellular	  effects	  (Gosal	  et	  al.,	  2005;	  Xue	  et	  al.,	  2009)	  The	   length	  of	  amyloid	  fibrils	  can	  also	  modulate	   its	   biological	   activity	   (Xue	   et	   al.,	   2009).	   Both	   amyloid	   polymorphism	   and	   the	  difficulty	   in	   isolating	   a	   stable	   population	   of	   a	   single	   amyloid	   species	   complicate	  investigations	  into	  precise	  mechanisms	  of	  cytotoxicity.	  	  	  Fibril	  and	  oligomer	  cytotoxicity	  need	  not	  be	  mutually	  exclusive.	  Fibril	  disaggregation	  may	  act	   as	   a	   source	   of	   oligomeric	   species	   (Cremades	   et	   al.,	   2012).	   Fibrils	   exhibit	   ‘molecular	  recycling’	  properties,	  and	  cytotoxic	  species	  could	  form	  as	  part	  of	  this	  process	  (Sánchez	  et	  




3.2.1 Expression	  and	  purification	  of	  β2m	  To	   generate	   material	   for	   the	   experiments	   performed	   in	   Chapter	   Three	   and	   Four,	  monomeric	   β2m	   was	   expressed	   and	   purified	   using	   established	   procedures	   (Section	  2.3)(Figure	   3-­‐6)(McParland	   et	   al.,	   2000).	   β2m	   was	   expressed	   in	   a	   pINK	   plasmid	  transformed	   into	   in	   BL21	   (DE3)	   pLysS	   E.coli	   cells	   (Section	   2.3.1).	   After	   induction	   of	  protein	   expression	   with	   IPTG,	   the	   protein	   aggregates	   into	   inclusion	   bodies	   which	   were	  isolated	  and	  solubilised	  (Section	  2.3.1,	  2.3.2)	  (Figure	  3-­‐7	  A)(Kad	  et	  al.,	  2001).	  Protein	  was	  refolded	   by	   dialysis	   (Section	   2.3.3).	   β2m	   was	   separated	   from	   contaminants	   by	   anion	  exchange	   chromatography	   (Section	   2.3.4)(Figure	   3-­‐7	   B).	   Fractions	   8-­‐13	  were	   judged	   by	  peaks	  in	  absorbance	  (280	  nm)	  to	  contain	  protein	  and	  so	  were	  pooled,	  dialysed	  against	  18	  MΩ	   purite	   water	   and	   lyophilised.	   The	   lyophilised	   protein	   was	   re-­‐solubilised	   in	   25	   mM	  sodium	   phosphate	   buffer	   (pH	   8.0)	   prior	   to	   further	   purification	   by	   size	   exclusion	  chromatography,	   to	   separate	   monomeric	   β2m	   from	   higher	   order	   species	   or	   other	  contaminants	  (Section	  2.3.5)(Figure	  3-­‐7,	  C).	  Fractions	  25-­‐35	  corresponding	  to	  monomeric	  β2m	  were	  pooled,	  dialysed	  against	  18	  MΩ	  purite	  water	  and	  lyophilised.	  Protein	  purity	  was	  assessed	   by	   SDS-­‐PAGE	   and	   ESI	   mass	   spectrometry	   (James	   Ault,	   University	   of	  Leeds)(Figure	  3-­‐7	  D,	  E).	  The	  major	  peak	  at	  11859	  ±	  0.86	  Da	  corresponds	  to	  the	  molecular	  weight	   of	   monomeric	   β2m	   protein	   (expected	   mass	   11,860	   Da).	   The	   additional	   low	  intensity	  peaks	  correspond	  to	  mono-­‐	  and	  bi-­‐	  phosphate	  adducts.	  
	  
Figure	  3-­‐6	  Schematic	  of	  β2m	  expression	  and	  purification.	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Figure	   3-­‐7	   Purification	   of	   β2m.	   A)	   Protein	   resolved	   on	   15	  %	   (w/v)	   Tris-­‐Tricine	   SDS-­‐PAGE	  gel	  stained	  with	  Coomassie	  blue.	  P=pellet,	  S=soluble	  fraction.	  No	  protein	  was	  visibly	  lost	   during	  washing	   of	   the	   inclusion	   bodies	   (Wash	   lanes-­‐protein	   remains	   in	   the	   pellet).	  Upon	  being	  solubilised	   into	  8	  M	  urea,	  protein	   is	   fully	   solubilised	   (No	  band	  visible	   in	   the	  pellet).	  Black	  arrow	  indicates	  expected	  mass	  of	  β2m.	  B)	  Ion	  exchange	  chromatography	  of	  solubilised	   inclusion	   bodies.	   Protein	   was	   applied	   to	   a	   Q-­‐Sepharose	   column	   and	   eluted	  using	   0.5	   M	   NaCl,	   fractions	   8-­‐13	   pooled,	   dialysed	   and	   lyopholised.	   C)	   Size	   exclusion	  chromatography	  shows	  a	  single	  major	  peak,	  fractions	  25-­‐35	  were	  pooled	  and	  lyophilised.	  D)	   Protein	   resolved	   on	   15	   %	   Tris-­‐Tricine	   SDS-­‐PAGE	   gel	   stained	   with	   Coomassie	   blue.	  Arrow	  indicates	  expected	  mass	  of	  β2m.	  E)	  Purified	  β2m	  protein	  analysed	  by	  ESI-­‐MS.	  Peak	  B	  (11859	  ±	  0.86	  Da)	  represents	  wild	  type	  β2m	  with	  disulphide	  bond.	  Peak	  A	  represents	  wild	  type	   β2m	   lacking	   N-­‐terminal	   methionine	   residue.	   Other	   peaks	   are	   potassium	   and	  phosphate	   adducts.	   Sample	   analysis	   was	   performed	   by	   James	   Ault,	   Mass	   Spectrometry	  Facility,	  University	  of	  Leeds.	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3.2.2 Formation	  and	  characterisation	  of	  β2m	  amyloid	  fibrils	  	  To	   form	  material	   for	   experiments	   in	   Chapters	   three	   and	   four,	   β2m	   amyloid	   fibrils	   with	  long,	  straight	  morphology	  (Ls)	  were	  generated	  from	  purified	  monomeric	  β2m	  in	  a	  seeded	  reaction	  according	  to	  an	  established	  protocol	  (Section	  2.3.8).	  The	  morphology	  of	  fibrils	  is	  known	   to	   vary	   depending	   on	   the	   solution	   conditions	   (Kad	   et	   al	   2003).	   Additionally,	   de	  




Figure	   3-­‐8	   Characterisation	   of	   β2m	   amyloid	   fibril	   seeds.	   Morphology	   of	   two	  completely	  independent	  de	  novo	  β2m	  seed	  batches,	  imaged	  by	  negative	  stain	  EM.	  Scale	  bar	  100	  nm.	  
	  




	   	  
	  
	  
Figure	   3-­‐10	   Fibril	   length	  
distributions	   determined	  
















Ls-­‐f	  fibrils	  compared	  with	  the	  same	  monomer	  equivalent	  concentration	  of	  monomeric	  β2m	  (Figure	  3-­‐12)	  was	  observed.	  At	  acidic	  pH,	  NIAD-­‐4	  has	  an	  emission	  maxima	  of	  ~	  595	  nm	  and	  at	  pH	  7.4,	  an	  emission	  maxima	  of	  ~	  580	  nm.	  
	  	  	  	  	   	  





























Figure	  3-­‐12	  Characterisation	  of	  NIAD-­‐4	  fluorescence	  upon	  binding	  to	  β2m	  species	  at	  
pH	  2.0,	  4.4	  and	  7.4.	  Fluorescence	  emission	  spectra	  of	  NIAD-­‐4	  (7.5	  μM)	  with	  monomeric	  β2m	  or	  β2m	  Ls-­‐f	   (12	  μM	  monomer	  equivalent)	   at	  pH	  2.0	   (A),	   pH	  4.4	   (B)	   and	  pH	  7.4	   (C).	  Samples	   were	   incubated	   for	   10	   minutes	   before	   a	   fluorescence	   emission	   spectra	   was	  collected	   at	   an	   excitation	  wavelength	   of	   500	   nm	  using	   at	   PTI	  Quantmaster	   fluorescence	  spectrometer,	  slit	  width	  8	  nm.	  Emission	  spectra	  are	  normalised	  to	  NIAD-­‐4	   in	  specific	  pH	  buffer.	  D)	  Structure	  of	  NIAD-­‐4,	  adapted	  from	  (Brandenburg	  et	  al.,	  2012).	  
	  Amyloid	  species	  formed	  from	  a	  range	  of	  precursor	  proteins	  bind	  conformational-­‐specific	  antibodies	   (reviewed	   in	   Glabe,	   2008).	   Here,	   the	   binding	   of	   protein	   samples	   to	  conformational	  antibodies	  A11	  and	  W01	  was	  assessed.	  Protein	  samples	  were	  applied	  onto	  a	  nitrocellulose	  membrane	  and	  immunoblotted	  with	  A11,	  WO1	  or	  β2m	  antibodies	  (Section	  2.2.3).	   Consistent	  with	   previously	   published	   observations,	   both	   Ls	   and	  Ls-­‐F	   fibrils	   show	  binding	  to	  WO1,	  which	  recognises	  an	  amyloid	  fibrillar	  epitope,	  while	  not	  binding	  to	  A11,	  which	  binds	  to	  an	  oligomeric	  conformation	  (Figure	  3-­‐13)(Xue	  et	  al.,	  2009).	  
































































	  	  	  	  
Figure	  3-­‐13	  Binding	  of	  amyloid	  to	  conformation-­‐specific	  antibodies.	  Samples	  of	  β2m	  monomer,	   Ls	   or	   Ls-­‐f	   amyloid	   fibrils	   or	   control	   protein	   (2.8	   μg	   protein	   per	   dot)	   were	  analysed	   by	   dot	   immunoblotting.	   Fibrils	   (Ls,	   Ls-­‐f)	   show	  no	   binding	   to	   the	   anti-­‐oligomer	  antibody	   A11,	   but	   do	   show	   binding	   to	   the	   anti-­‐fibril	   antibody	  WO1.	   Anti-­‐β2m	   antibody	  binding	  was	  detected	  in	  all	  β2m	  samples,	  and	  serves	  as	  a	  loading	  control.	  Antibody	  binding	  was	  detected	  with	   secondary	  anti-­‐rabbit	   IgG-­‐HRP	   for	  A11	  and	  β2m	  antibodies,	   and	  anti-­‐mouse	   IgM-­‐HRP	   for	  WO1	   antibody.	   For	   secondary	   antibody	   only	   control,	   samples	  were	  treated	   in	   the	  same	  manner	  as	  other	  samples,	  but	  with	  no	  primary	  antibody	   incubation.	  Antibody	  binding	  was	  visualised	  by	  chemiluminescence.	  	  









formazan	  crystals	  at	  the	  cell	  periphery,	  compromising	  plasma	  membrane	  integrity.	  Under	  these	  circumstances,	  other	  cell	  viability	  assays	  fail	  to	  detect	  cell	  death	  (Isobe	  et	  al.,	  1999;	  Wogulis	   et	   al.,	   2005;	   Liu	   &	   Hong,	   2005).	   More	   recently,	   it	   has	   been	   shown	   that	   β2m	  amyloid	  species	  alter	  formazan	  crystal	  localisation,	  with	  Ls	  and	  Ls-­‐f	  treated	  cells	  showing	  a	   marked	   increase	   in	   the	   extracellular	   deposition	   of	   formazan	   crystals	   compared	   with	  monomer	   and	   pH	   2.0	   fibril-­‐treated	   controls	   (Jakhria	   et	   al.,	   2014).	   Additionally,	   cell	  viability	   as	  measured	  by	  adenosine	   triphosphate	   (ATP)	   levels	   failed	   to	  detect	   cell	  death,	  indicating	   in	  this	   instance	  the	  MTT	  assay	   is	  not	  an	  accurate	  measure	  of	  cell	  viability,	  but	  does	  reflect	  a	  change	  in	  cellular	  behaviour	  (Jakhria	  et	  al.,	  2014).	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure	   3-­‐14	   Analysis	   of	   the	   effect	   of	   fibrils	   on	   MTT	   reduction.	   MTT	   assays	   were	  performed	  on	  RAW	  264.7	  cells	  using	  β2m	  monomer,	  Ls-­‐	  or	  Ls-­‐f	  fibrils	  at	  a	  final	  monomer	  equivalent	  concentration	  of	  1.2	  μM.	  Cells	  were	  incubated	  treatment	  for	  24	  h	  before	  being	  tested	  for	  MTT	  reduction.	  MTT	  reduction	  (%)	  was	  	  normalised	  against	  the	  signal	  from	  cells	  incubated	  with	  pH	  2.0	  fibril	  buffer	  (100%)	  and	  cells	  treated	  with	  0.1%	  (w/v)	  sodium	  azide	  (0%).	   The	   error	   bars	   represent	   one	   standard	   error	   of	   mean	   (S.E.M.)	   over	   three	  independent	  experiments	  each	  containing	  3-­‐5	  replicates.	  ****=	  P	  ≤	  0.001.	  
3.2.4 Role	   of	   lipid	   composition	   and	   pH	   in	   membrane	   perturbation	   by	   β2m	  



































































Figure	  3-­‐16	  Structure	  of	  lipid	  components	  in	  simple	  LUVs	  
	  
LUV	  name	   DMPS	   POPG	   Cholesterol	  DMPS	  	   100	   0	   0	  POPG:Chol	  	   0	   75	   25	  

















Figure	  3-­‐17	  Ls	  and	  Ls-­‐f	  β2m	  fibrils	  disrupt	  LUVs	  formed	  from	  100	  mol	  %	  DMPS	  at	  pH	  
7.5	   but	   not	   pH	   6.5.	   LUVs	   at	   pH	   6.5	   (A)	  were	   incubated	  with	   6	   μM	   protein	   (monomer	  equivalent)	  and	  5	  μM	  lipid	  molecule	  for	  60	  mins,	  45	  °C,	  after	  which	  pH	  was	  increased	  to	  pH	  7.5	  and	  fluorescence	  intensity	  read.	  End	  point	  fluorescence	  was	  normalised	  to	  Triton	  X-­‐100	   treated	  samples	   (100	  %	  dye	  release)	  and	  appropriate	  buffer	   (0%	  dye	  release).	  At	  pH	   7.5,	   samples	   were	   incubated	   with	   carboxyfluorescein	   fluorescence	   intensity	   was	  measured	  continuously	  over	  60	  minutes	  (B),	  with	  dye	  release	  normalised	  to	  Triton	  X-­‐100	  treated	   samples	   (100	   %	   dye	   release).	   Error	   bars	   represent	   standard	   error	   of	   three	  replicates,	  each	  containing	  four	  repeats.	  C)	  Differential	  fluorescence	  at	  60	  minutes,	  pH	  7.5,	  is	   represented	   in	   a	   box	   plot.	   Statistical	   significance	   was	   calculated	   using	   a	   one-­‐way	  ANOVA,	  ****=	  P	  ≤	  0.001.	  	  	  Next,	  the	  effect	  of	  pH	  on	  the	  ability	  of	  Ls-­‐f	  fibrils	  to	  disrupt	  LUVs	  formed	  from	  POPG:Chol	  (Table	   3.3	   ,Figure	   3-­‐16)	   was	   assessed.	   At	   pH	   7.5,	   POPG:Chol	   LUV	   disruption	   was	   not	  observed	  upon	  incubation	  with	  monomeric	  or	  fibrillar	  β2m,	  even	  with	  a	  longer	  incubation	  period	  (Figure	  3-­‐18).	  To	  assess	  the	  effect	  of	  pH	  on	  β2m	  species	  behaviour	  in	  the	  liposome	  dye	  release	  assay,	  LUVs	  were	  prepared	  in	  pH	  4.5	  or	  6.5	  buffer	  and	  incubated	  with	  protein	  or	   buffer	   treatment	   for	   10	   minutes	   before	   measurement	   of	   carboxyfluorescein	  fluorescence.	  At	  pH	  6.5	  and	  4.5,	  high	  levels	  of	  dye	  release	  were	  observed,	  46	  ±	  3.2	  %	  and	  50	   ±	   1	   %	   respectively,	   indicating	   that	   pH	   plays	   a	   key	   role	   in	   mediating	   β2m	   Ls-­‐f	   fibril	  disruption.	   Addition	   of	   monomeric	   protein	   resulted	   in	   minimal	   dye	   release,	   consistent	  with	  previous	  results	  (<	  10	  %)	  (Xue	  et	  al.,	  2009).	  At	  pH	  7.5,	  fluorescence	  was	  continually	  measured	   over	   60	   minutes.	   Over	   this	   time	   period,	   minimal	   fluorescence	   was	   detected,	  indicating	  no	  detectable	  LUV	  disruption	  by	  monomeric	  and	  Ls-­‐f	  β2m	  species.	  	  



















































Figure	  3-­‐18	  Ls-­‐f	   β2m	   fibrils	  disrupt	  LUVs	   formed	   from	  75	  mol	  %	  POPG,	  25	  mol	  %	  























































Figure	  3-­‐19	  DLS	  of	  LUVs	  formed	  from	  75	  mol	  %	  POPG,	  25	  mol	  %	  cholesterol	  (A)	  and	  
100	  mol	  %	  DMPS	  (B).	  A)	  Rh	  187	  ±	  78	  nm.	  Average	  of	  three	  mean	  readings	  ±	  1	  SD.	  B)	  Rh	  136	  ±	  72	  nm.	  Average	  of	  three	  mean	  readings	  ±	  1	  SD	  Performed	  and	  analysed	  by	  Dr	  Sophia	  Goodchild.	  	  
3.2.5 β2m	  fibrils	  disrupt	  LUVs	  with	  complex	  lipid	  mix	  	  Simple	   lipid	   mixtures	   in	   LUVs	   formed	   from	   DMPS	   and	   POPG:Chol	   are	   different	   from	  biological	   membranes	   in	   several	   key	   ways,	   including	   complexity	   of	   lipid	   composition,	  presence	   of	   integral	   membrane	   proteins	   and	   differences	   in	   membrane	   curvature.	   To	  assess	   the	  propensity	   of	  monomer,	   Ls	   and	  Ls-­‐f	   fibrils	   to	   disrupt	   LUVs	   that	  more	   closely	  mimic	   specific	   biological	   membranes	   in	   lipid	   composition,	   LUVs	   were	   extruded	   from	  synthetic	   lipid	   compositions	   containing	   different	   anionic	   lipids	   against	   a	   background	   of	  common	  cellular	  lipids	  (Figure	  3-­‐20,	  Table	  3-­‐4).	  	  	  Physiologically	   relevant	   complex	   lipid	  mixes	   were	   used	   to	   reflect	   the	   global	   average	   of	  zwitterionic	  lipids	  present	  in	  various	  cellular	  membranes	  (Van	  Meer	  et	  al.,	  2008).	  Several	  different	   anionic	   lipid	   components	   were	   varied	   in	   LUVs	   (Figure	   3-­‐20).	   POPS	   is	   highly	  enriched	  within	  the	  inner	  leaflet	  of	  the	  plasma	  membrane	  (Vácha	  et	  al.,	  2009).	  POPG	  is	  a	  minor	  phospholipid	  component	  of	  many	  intracellular	  membranes,	  accounting	  for	  less	  than	  1%	  of	  total	  phospholipids,	   it	   is	  primarily	  enriched	  in	  mitochondrial	  membranes,	  and	  is	  a	  precursor	  of	  the	  mitochondrially	  enriched	  lipid	  cardiolipin	  (Morita	  &	  Terada,	  2015).	  BMP	  is	   a	   lipid	   highly	   enriched	   in	   endocytic	   compartments,	   it	   can	   comprise	   >	   70	  %	   of	   some	  endocytic	   membranes,	   and	   comprises	   ~15%	   of	   the	   total	   lipid	   composition	   of	   late	  endosomes	  (Kobayashi	  et	  al.,	  2002;	  Kobayashi	  et	  al.,	  1999;	  Kobayashi	  et	  al.,	  1998).	  BMP	  is	  also	  a	  structural	  isomer	  of	  POPG.	  These	  different	  anionic	  lipids	  were	  incorporated	  into	  400	  nm	  extruded	  LUVS	  at	  12	  mol	  %	  or	  50	  mol	  %	  of	  the	  total	  lipid	  composition	  (Table	  3-­‐4).	  In	  the	   complex	   LUVs,	   1-­‐palmitoyl-­‐2-­‐oleoyl-­‐sn-­‐glycero-­‐3-­‐phosphocholine	   (POPC),	   1-­‐palmitoyl-­‐2-­‐oleoyl-­‐sn-­‐glycero-­‐3-­‐phosphoethanolamine	   (POPE),	   sphingomyelin	   and	  cholesterol	  were	  chosen	  for	  their	  high	  levels	  in	  biological	  membranes.	  	  	  





































Performing	   liposome	   dye	   release	   assays	   on	   complex	   lipid	   mix	   LUVs	   demonstrated	   that	  dye-­‐release	  is	  influenced	  both	  by	  lipid	  composition	  and	  pH	  conditions.	  LUVs	  containing	  12	  mol	  %	  or	  50	  mol	  %	  POPS	  show	  minimal	  membrane	  disruption	  in	  the	  presence	  of	  β2m	  Ls-­‐f	  (Figure	  3-­‐21).	  The	  membrane	  disruption	  observed	  was	  comparable	  to	  that	  of	  control	  LUVs	  lacking	   an	   anionic	   lipid	   component.	   Contrastingly,	   for	   LUVs	   enriched	   POPG	   or	   BMP,	   the	  amplitude	  of	  dye	  release	  is	  greater	  for	  LUVs	  enriched	  in	  50	  mol	  %	  anionic	  lipid	  compared	  with	  12%	  anionic	  lipid	  at	  all	  pHs.	  	  	  Dye	  release	  experiments	  were	  performed	  at	  pH	  4.5,	  6.4	  and	  7.4,	  which	  represent	   the	  pH	  values	  present	   through	   the	  endocytic	  pathway	  of	   a	   cell.	  These	  experiments	   showed	   that	  pH	   has	   a	   large	   effect	   on	   the	   propensity	   of	   amyloid	   fibrils	   to	   disrupt	   LUVs.	   For	   LUVs	  enriched	   in	  50	  mol	  %	  POPG	  and	  BMP,	   there	   is	  pH-­‐dependence	  of	  membrane	  disruption,	  with	   a	   significant	   increase	   in	   the	   amplitude	   of	   dye	   release	   from	   pH	   7.4	   to	   pH	   6.4.	   The	  extent	  of	  dye-­‐release	  is	  similar	  for	  these	  liposomes	  at	  pH	  5.5	  and	  6.5,	  but	  decreases	  upon	  reducing	  the	  pH	  further	  to	  pH	  4.5.	  This	  pH-­‐dependent	  trend	  is	   less	  pronounced	  for	  LUVs	  containing	   12	   mol	   %	   BMP	   or	   POPG	   LUVs,	   where	   the	   dye	   release	   does	   not	   change	  significantly	  between	  pH	  6.4,	  5.5	  and	  4.5.	  The	  greatest	  extent	  of	  dye	  release	  is	  seen	  in	  LUVs	  containing	  50	  mol	  %	  BMP,	  where	  ~	  60%	  membrane	  disruption	  is	  observed	  at	  pH	  5.5.	  This	  is	  ~1.5-­‐fold	  greater	   than	  that	  observed	   for	  LUVs	  enriched	   in	  50	  mol	  %	  POPG	  (structural	  isomer	  of	  BMP),	  at	  the	  equivalent	  pH.	  	  
	  















POPC	   POPE	   Sphingomyelin	   Cholesterol	  
0	   41	   23	   8	   28	  12	   36	   20	   7	   25	  50	   21	   11	   4	   14	  
Table	   3.4	   Total	   mol	   %	   lipid	   composition	   of	   complex	   lipid	   LUVs.	   Anionic	   lipid	  component	  was	  POPG,	  POPS	  or	  BMP.	  LUVs	  containing	  0	  (control),	  12	  or	  50	  mol	  %	  anionic	  lipid	  component	  with	   the	  remaining	   lipid	  zwitterionic	  components	   in	  a	  mol/mol	  ratio	  of	  36	  POPC:	  20	  POPE:	  7	  SM:	  25	  cholesterol	  
	  
Figure	   3-­‐21	   Ls-­‐f	   β2m	   fibrils	   disrupt	   LUVs	   in	   a	   lipid-­‐specific	   and	   pH-­‐dependent	  
manner.	   For	  A-­‐D,	   0	  %	   (control,	   black),	   12%	   (open	   symbols,	   dashed	   line)	   or	  50%	   (solid	  symbol,	  solid	  line)	  POPS	  (blue),	  POPG	  (green)	  or	  BMP	  (red).	  Relative	  dye	  release	  induced	  by	  native	  β2m	  monomer	  (A)	  or	  Ls-­‐f	   fibrils	   (C)	   from	  400	  nm	  extruded	  LUVs	  at	  a	  range	  of	  pH.	  The	  corresponding	  bar	  graphs	   (B,D)	  display	   the	  dye	  release	  at	  pH	  4.5	   in	   the	  control	  (black),	   12%	   (open	   bar)	   and	   50%	   (solid	   bar)	   of	   POPG,	   POPS	   or	   BMP	   containing	   LUVs.	  Error	  on	  all	  values	   is	  SE	   from	  n=3,	  each	  of	   three	   replicates.	  Experiments	  performed	  and	  analysed	  by	  Dr	  Sophie	  Goodchild	  (Goodchild	  et	  al.,	  2014).	  
3.2.5.1 Characterisation	  of	  complex	  LUVs	  Differing	  vesicle	   lipid	   composition	  may	  alter	  vesicle	  morphology	  and	   size,	  which	   in	   turn	  may	  influence	  behaviour	  in	  the	  liposome	  dye	  release	  assay.	  For	  example,	  the	  presence	  of	  BMP	  can	  alter	   liposome	  morphology	  at	  different	  pHs	   (Frederick	  et	  al.,	  2009)	  and	  enable	  small	   (<100	   nm)	   vesicles	   to	   form	   spontaneously	   (Chebukati	   et	   al.,	   2010).	   As	   different	  liposome	   morphologies	   may	   rationalise	   variations	   in	   dye	   release	   from	   different	   lipid	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mixes,	   both	   DLS	   and	   cryo-­‐EM	  were	   used	   to	   assess	   liposome	  morphology	   (Figure	   3-­‐22).	  DLS	   revealed	   an	   average	   Rh	   of	   ~200	   nm	   for	   400	   nm	   extruded	   LUV.	   The	   presence	   or	  absence	   of	   cholesterol	   (0	  %	  vs	   25	  mol	  %)	   did	   not	   significantly	   alter	  Rh.	  The	  presence	   of	  BMP	  slightly	  altered	  the	  Rh	  from	  ~160	  nm	  for	  0	  mol	  %	  BMP	  to	  ~120	  nm	  50	  mol	  %	  BMP	  (Table	  3-­‐5).	   If	  vesicle	   size	  were	  a	  key	   factor	   in	   the	   increase	  %	  dye	  release	  seen	   in	  50	  %	  BMP	  liposomes,	  it	  would	  be	  hypothesised	  that	  significantly	  smaller	  liposomes	  would	  show	  an	  increase	  in	  %	  dye	  release.	  Dye	  release	  data	  from	  smaller	  vesicles	  (extruded	  to	  100	  nm,	  
Rh	  ~60	  nm)	  show	  a	   lower	  %	  dye	   release,	   and	   so	   the	   size	  of	  membrane	  appears	  not	   to	  be	  responsible	  for	  the	  efficiency	  of	  fibril	  induced	  liposome	  disruption	  in	  this	  case	  (Goodchild	  
et	  al.,	  2014)	  .	  	  	  Cryo-­‐EM	   of	   lipid	   vesicles	   revealed	   no	   gross	   morphological	   differences	   between	   the	  different	   lipid	   compositions,	   at	   both	   pH	   7.4	   and	   4.5.	   In	   all	   400	   nm	   extruded	   liposome	  preparations	   imaged,	   the	   primary	   species	   were	   unilamellar,	   spherical	   liposomes,	   with	  some	   multilamellar	   species	   present.	   In	   order	   to	   quantitate	   these	   observations,	   200	  liposomes	   for	   each	   condition	   were	   counted	   to	   obtain	   a	   distribution	   of	   radii.	   Radii	  distributions	  suggest	  that	  50	  mol	  %	  BMP	  liposomes	  are	  (on	  average)	  slightly	  smaller	  than	  0	  mol	  %	  BMP	  liposomes	  (85.5	  nm	  vs	  72.5	  nm	  radii,	  average	  of	  both	  pH	  conditions),	  in	  line	  with	  DLS	  data	  (Figure	  3.22).	  	  	  Interestingly,	   for	   the	   400	   nm	   extruded	   vesicles,	   the	   Rh	  reported	   by	   DLS	   ~	   double	   that	  reported	  by	  cryo-­‐EM	  (Table	  3.5).	  This	  is	  consistent	  with	  previous	  studies	  which	  found	  DLS	  measured	  sizes	  to	  be	  30-­‐>100	  %	  larger	  than	  those	  obtained	  by	  cryo-­‐EM	  for	  the	  same	  lipid	  preparation	  (Crawford	  et	  al.,	  2011).	  In	  cryo-­‐EM,	  the	  sample	  must	  become	  embedded	  into	  the	   vitreous	   ice	   layer	   in	   order	   to	   be	   imaged.	   Larger	   membranes	   may	   have	   a	   slightly	  decreased	  tendency	  to	  enter	  the	  thin	  film	  formed	  during	  the	  blotting	  process.	  Supporting	  this	  hypothesis,	   for	  100	  nm	  extruded	  vesicles,	   the	  DLS	  and	  cryo-­‐EM	  measurements	  were	  in	  closer	  agreement	  compared	  with	  400	  nm	  extruded	  vesicles,	  with	  DLS	  reported	  radii	  1.2	  x	  greater	  than	  cryo-­‐EM	  measurements.	  This	  indicates	  that,	  particularly	  for	  objects	  on	  the	  100s	  of	  nm	  scale,	  cryo-­‐EM	  may	  systematically	  under	  represent	  larger	  species	  in	  any	  given	  sample.	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Lipid	  Mixture	  (Mol	  %)	   Rh	  (nm)	  
Median	  






change	  POPC	  400	  nm	  pH	  4.5	   188±8	   83.7	   90.8	   45	   2.1	  POPC	  400	  nm	  pH	  7.4	   178±7	   104.8	   106.4	   43.2	   1.7	  POPG	  400	  nm	  pH	  4.5	   221±8	   101.65	   105.3	   47.2	   2.1	  POPG	  400	  nm	  pH	  7.4	   229±5	   107	   111.1	   38.5	   2.1	  0	  %	  BMP	  400	  nm	  pH	  4.5	   186±6	   73.2	   78.6	   37.2	   2.4	  0	  %	  BMP	  400	  nm	  pH	  7.4	   163±8	   71.6	   78.4	   33.6	   2.1	  12	  %	  BMP	  400	  nm	  pH	  4.5	   168±8	   89	   92.3	   40.4	   1.8	  12	  %	  BMP	  400	  nm	  pH	  7.4	   160±5	   81	   88.7	   41.9	   1.8	  50	  %	  BMP	  400	  nm	  pH	  4.5	   131±5	   68.4	   75.6	   36.6	   1.7	  50	  %	  BMP	  400	  nm	  pH	  7.4	   120±5	   62.8	   69.9	   31.1	   1.7	  0	  %	  cholesterol	  400	  nm	  pH	  4.5	   158±6	   87.2	   96.7	   48.3	   1.6	  0	  %	  cholesterol	  400	  nm	  pH	  7.4	   150±9	   85.6	   92.7	   42.7	   1.6	  12	  %	  BMP	  100	  nm	  pH	  4.5	   56±8	   44.4	   45.4	   15.2	   1.2	  12	  %	  BMP	  100	  nm	  pH	  7.4	   58±5	   47.3	   49	   14	   1.2	  
Table	  3.5	  Radii	  of	  liposomes	  with	  different	  lipid	  compositions	  measured	  by	  DLS	  and	  
cryo-­‐EM.	   Hydrodynamic	   radii	   (Rh)	   from	   DLS	   measurements,	   and	   average	   radii	   and	  standard	   deviation	   by	   cryo-­‐EM	   in	   grey	   shaded	   columns	   (n=200	   liposomes	   for	   cryo-­‐EM	  measurements).	   Fold	   increase	   in	   size	   between	  DLS	   and	   cryo-­‐EM	  Rh	   and	  mean	   radii	   are	  expressed	  in	  the	  final	  column.	  	  




Figure	  3-­‐23	  Monomeric,	  Ls	  and	  Ls-­‐f	  β2m	  fibrils	  do	  not	  disrupt	  L-­‐α-­‐Lecithin	  LUVs	  at	  
pH	  7.5	  and	  6.5.	  A)	  LUVs	  were	  incubated	  with	  6	  μM	  protein	  (monomer	  equivalent)	  and	  5	  μM	   lipid	   molecule	   for	   60	   mins,	   37	   °C	   at	   pH	   7.5	   and	   fluorescence	   intensity	   read	   every	  minute.	   Fluorescence	   was	   normalised	   to	   Triton	   X-­‐100	   treated	   samples	   (100	   %	   dye	  release)	   and	   appropriate	   buffer	   treated	   samples	   (0%	  dye	   release).	   Error	   bars	   shown	   as	  dotted	   lines,	   and	   represent	   standard	   deviation	   of	   three	   repeats	   each	   containing	   three	  replicates.	   B)	   LUVs	  were	   incubated	  with	   6	   μM	  protein	   (monomer	   equivalent)	   and	  5	   μM	  lipid	  molecule	  for	  60	  mins,	  37	  °C,	  after	  which	  pH	  was	  increased	  to	  pH	  7.5	  and	  fluorescence	  intensity	   read.	   End	   point	   fluorescence	  was	   normalised	   to	   Triton	   X-­‐100	   treated	   samples	  (100	   %	   dye	   release)	   and	   appropriate	   buffer	   (0	   %	   dye	   release).	   Error	   bars	   represent	  standard	  error	  of	  three	  replicates,	  each	  containing	  three	  repeats.	  





































where	  within	  the	  same	  bilayer,	  areas	  in	  both	  gel	  and	  liquid	  phases	  can	  exist.	  The	  transition	  temperature	   is	   influenced	  by	   the	  presence	  of	   cholesterol,	   the	   fatty	  acid	  composition	  and	  saturation	  of	   the	  membrane	   lipids	   (Mansilla	  et	  al.,	  2004).	   In	  order	   to	  perform	  extrusion,	  lipids	  must	  be	  in	  the	  liquid	  phase.	  At	  37	  °C,	   it	   is	  known	  cell	  membranes	  exist	   in	  both	  the	  gel	   (lipid	   rafts)	   and	   liquid	  phase.	  Therefore,	   extrusion	  of	  RAW	  267.4	   cell	   lipid	  extract	   at	  room	  temperature	  may	  result	  in	  poor	  efficiency	  of	  extrusion,	  depending	  on	  the	  proportion	  of	   lipid	   in	   the	  gel	  phase.	  As	   the	   transition	   temperature	  of	   this	   lipid	  mixture	   is	  unknown,	  extrusion	   of	   RAW	   264.7	   lipid	   extract,	   and	   subsequent	   dye	   release	   experiments,	   were	  performed	   at	   50	   °C.	   In	   the	   liposome	   dye	   release	   assay,	   LUVs	   extruded	   at	   50	   °C	   and	  incubated	  at	  50	  °C,	  pH	  6.5	  and	  7.5	  with	  protein	  treatment	  revealed	  no	  detectable	  levels	  (>	  5	  %)	  of	  dye	  release	  upon	  incubation	  with	  β2m	  monomer,	  Ls	  or	  Ls-­‐f	  fibrils	  (Figure	  3-­‐25).	  	  
	  
Figure	  3-­‐24	  Monomeric,	  Ls	  and	  Ls-­‐f	  β2m	  fibrils	  no	  not	  disrupt	  crude	  biological	  lipid	  


































Figure	  3-­‐25	  Monomeric,	  Ls	  and	  Ls-­‐f	  β2m	  fibrils	  no	  not	  disrupt	  crude	  biological	  lipid	  































	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure	  3-­‐26	  LUVs	  formed	  from	  L-­‐α-­‐Lecithin	  and	  lipid	  extract	  from	  RAW	  264.7	  cells	  
are	  fully	  disrupted	  by	  mellittin	  at	  pH	  6.5	  and	  7.5.	  LUVs	  at	  pH	  7.5	  or	  6.5	  were	  incubated	  with	  6	  μM	  protein	  (monomer	  equivalent)	  and	  5	  μM	  lipid	  molecule	  for	  10	  mins,	  37	  °C.	  For	  LUV	   preparations	   at	   pH	   6.5,	   pH	   was	   increased	   to	   pH	   7.5	   to	   read	   fluorescent	   intensity.	  Fluorescence	  was	  normalised	  to	  Triton	  X-­‐100	  (100	  %)	  and	  appropriate	  buffer	  (0%).	  Error	  bars	  represent	  S.E	  of	  nine	  replicates.	  	  
	  













































































































Figure	   3-­‐28	   Cryo-­‐EM	   of	   LUVs	   formed	   from	   lipid	   extract	   from	   RAW	   264.7	   cells	  
interactions	  with	   β2m	   Ls-­‐f	   fibrils.	   LUVs	   are	   same	  population	   as	  used	   in	   liposome	  dye	  release	  assay,	  and	  so	  are	  loaded	  with	  carboxyfluorescein.	  LUVs	  were	  mixed	  with	  β2m	  Ls-­‐f	  fibrils	  at	  the	  same	  ratio	  as	  present	  in	  the	  liposome	  dye	  release	  assay	  and	  vitrified	  within	  10	  minutes.	  Scale	  bar	  200	  nm.	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3.3 Discussion	  Amyloid	   species	   are	   dynamic	   and	   heterogeneous,	   both	   in	   vitro	   and	   in	   vivo.	  Here,	   β2m	  amyloid	   species	   were	   produced	   and	   characterised.	   Fragmentation	   of	   β2m	   Ls	   fibrils	  produces	   fibrils	  with	   a	   lower	   average	   length	   distribution	   (Ls-­‐f),	   but	   fragmentation	   does	  not	  alter	  immunological,	  dye-­‐binding,	  or	  morphological	  properties	  as	  assessed	  by	  negative	  stain	  EM.	  However,	  this	  length	  reduction	  alters	  the	  fibrils’	  ability	  to	  inhibit	  MTT	  reduction	  and	  their	  behavior	  in	  the	  liposome	  dye	  release	  assay	  (Sections	  3.2.3,	  3.2.4,	  3.2.5).	  	  By	   using	   LUVs	   formed	   from	   different	   lipid	   compositions,	   it	   was	   demonstrated	   that	   the	  ability	  of	  β2m	   fibrils	   to	  perturb	  membranes	   is	  dependent	  both	  on	   lipid	   composition	  and	  pH.	  LUVs	  formed	  from	  DMPS	  were	  perturbed	  by	  β2m	  fibrils	  at	  pH	  7.5	  but	  not	  6.5,	  whereas	  LUVs	  formed	  from	  POPG:Chol	  were	  perturbed	  at	  pH	  6.5	  but	  not	  7.5.	  This	  suggests	  that	  it	  may	  be	  dangerous	  to	  draw	  conclusions	  from	  liposome	  dye	  release	  assays	  performed	  on	  a	  single	  LUV	  type	  under	  one	  set	  of	  environmental	  parameters.	  	  	  β2m	  Ls-­‐f	  fibrils	  can	  disrupt	  synthetic	  lipid	  LUVs	  under	  conditions	  that	  mimic	  the	  cell’s	  pH	  and	   lipid	   composition.	   By	   comparing	   the	   extent	   of	   dye	   release	   for	   LUVs	   enriched	   in	  different	  anionic	  lipids	  (BMP,	  POPG	  and	  POPS),	  it	  is	  clear	  that	  the	  identity	  of	  anionic	  lipid	  plays	  a	   significant	   role	   in	   the	  amount	  of	  dye	   release.	   Strikingly,	  β2m	  Ls-­‐f	   fibrils	  have	   the	  greatest	  propensity	   to	  disrupt	  LUVs	  highly	   enriched	   in	  BMP	  under	  acidic	  pH	  conditions.	  These	  are	  conditions	  that	  mimic	  in	  the	  late	  endosome	  and	  lysosome	  of	  the	  cell,	  suggesting	  perhaps	  that	  such	  membranes	  are	  more	  susceptible	  to	  membrane	  damage	  by	  β2m	  amyloid	  fibrils.	  	  	  However,	   liposome	   dye	   release	   assays	   performed	   using	   LUVs	   formed	   from	   crude	  biological	  lipid	  (L-­‐α-­‐Lecithin	  and	  RAW	  264.7	  lipid	  extract)	  showed	  that	  these	  LUVs	  are	  not	  perturbed	   by	   either	  monomeric	   or	   fibrillar	   amyloid	   β2m.	   Interestingly,	   this	   discrepancy	  has	   been	   reported	   previously	   for	   amyloid	   species	   formed	   from	   different	   precursor	  proteins,	   but	   not	   discussed.	   For	   example,	   fibrillar	   α-­‐synuclein	   has	   been	   reported	   to	  perturb	  LUVs	  formed	  from	  a	  variety	  of	  synthetic	  LUVs	  with	  one	  or	  two	  lipid	  components,	  but	   perturbation	   of	   LUVs	   formed	   from	   brain	   extract	   was	   negligible,	   despite	   interaction	  being	   demonstrated	   (Pieri	   et	   al.,	   2012).	   Liposome	   dye	   release	   assays	   are	   often	   used	   to	  demonstrate	   the	  propensity	   of	   a	   protein	   to	   disrupt	   synthetic	  membranes,	   and	   from	   this	  propensity,	   extrapolations	   are	   made	   about	   the	   behaviour	   of	   the	   protein	   in	   a	   cellular	  context.	  The	  results	  presented	  here	  show	  that	  extreme	  caution	  should	  be	  applied,	  both	  in	  choosing	   the	   lipid	   system	   to	   examine,	   and	   in	   interpreting	   these	   results	   in	   a	   cellular	  context.	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  Liposome	   dye	   release	   assays	   performed	   on	   LUVs	   formed	   from	   a	   crude	   biological	   lipid	  extract	   showed	   that	   no	   significant	   membrane	   disruption	   occurred	   (Section	   3.2.6),	  indicating	   amyloid	   species’	   ability	   to	   perturb	   membranes	   is	   dependent	   on	   lipid	  composition	   of	   the	   membrane,	   and	   pH.	   β2m	   fibrils	   may	   interact	   with	   biological	  membranes	   in	   a	   different	   manner	   compared	   with	   synthetic	   lipid	   LUVs.	   Based	   on	   this	  precedent,	   the	   intracellular	   trafficking	   and	   subsequent	   membrane	   interactions	   of	  fragmented	  β2m	  fibrils	  was	  selected	  for	  further	  investigation.	  	  	  It	   is	   clear	   from	   this	  work	   that	   variables	   such	   lipid	   composition	   and	   solution	   conditions	  (pH)	   play	   a	   significant	   role	   in	   the	   ability	   of	   amyloid	   fibrils	   to	   perturb	   LUV	  membranes.	  Here,	   other	   variables	   that	   likely	   also	  play	   a	   role	   in	   the	  propensity	   of	   amyloid	   species	   to	  perturb	  membranes	  were	   not	   explored.	   One	   interesting	   avenue	   to	   investigate	  would	   be	  the	   role	   of	   lipid	   phase.	   In	   vivo,	   lipid	   rafts,	   which	   are	   phase-­‐separated	   regions	   of	   a	  membrane	   (Sengupta	   et	   al.,	   2007),	   may	   be	   differentially	   protected	   or	   susceptible	   to	  perturbation	   by	   amyloid	   species.	   Additionally,	   amyloid	   aggregates	   themselves	   may	  perturb	  phase	  separation	  in	  membranes,	  which	  may	  trigger	  cell	  death	  (Walsh	  et	  al.,	  2014;	  Sasahara	  et	  al.,	  2013).	  Amyloid	  forming	  proteins	  have	  been	  shown	  to	  modulate	  local	  lipid	  compositions	   and	  membrane	   curvature,	   for	   example	   IAPP	   has	   been	   shown	   to	   induce	   a	  charge-­‐dependent	  induction	  of	  membrane	  curvature,	  leading	  to	  membrane	  disruption	  and	  leakage	   (Kegulian	   et	  al.,	   2015),	   and	   induction	   of	  membrane	   curvature	   and	   tubulation	   is	  well	   documented	   for	   α-­‐synuclein	   (Varkey	   et	  al.,	   2010).	   In	   the	   next	   Chapter,	   interactions	  between	  β2m	  amyloid	  fibrils	  and	  cellular	  membranes	  are	  explored	  in	  more	  detail.	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4 Probing	  the	  interactions	  of	  β2m	  fibrils	  with	  cellular	  membranes	  
4.1 Introduction	  	  
4.1.1 Amyloid	  mediated	  cytotoxicity	  Despite	   many	   years	   of	   research	   showing	   the	   association	   between	   the	   appearance	   of	  amyloid	   deposits	   and	   the	   onset	   of	   disease	   in	   vivo,	   the	   specific	   mechanisms	   of	   amyloid	  pathogenicity	   remain	   unclear	   (Knowles	   et	   al.,	   2014).	   There	   are	   no	   consistent	   trends	  between	   quantity	   of	   amyloid,	   pathogenicity	   and	   disease	   progression.	   In	   systemic	  amyloidoses	   sometimes	   kilograms	   of	   amyloid	   deposits	   can	   form,	   with	   this	   being	   the	  probable	  cause	  of	  pathogenicity,	  whereas	  in	  some	  neurodegenerative	  disorders	  there	  is	  no	  consistent	   link	  between	  disease	  progression	   and	   the	  deposition	  of	   extracellular	   amyloid	  aggregates	  (Chiti	  &	  Dobson,	  2006;	  Lue	  et	  al.,	  1999;	  Karran	  et	  al.,	  2011;	  Cohen	  et	  al.,	  2013;	  Haass	  &	  Selkoe,	  2007).	  	  
4.1.2 Mechanisms	  of	  amyloid	  cytotoxicity	  Despite	  years	  of	  research,	  precise	  mechanisms	  for	  amyloid-­‐mediated	  cytotoxicity	  by	  both	  fibrils	   and	   oligomers	   remain	   unclear.	   However,	   evidence	   is	   converging	   on	   several	   key	  themes,	  many	  of	  which	  involve	  biological	  membranes.	  
4.1.2.1 Direct	  membrane	  disruption	  Disruption	   of	   cellular	   membranes	   has	   been	   suggested	   as	   a	   mechanism	   for	   amyloid	  cytotoxicity	   (Stefani,	   2010;	   Berthelot	   et	   al.,	   2013).	   Both	   monomers	   and	   higher	   order	  aggregates	   directly	   interact	   with	   membranes	   (Necula	   et	   al.,	   2003;	   Knight	   &	   Miranker,	  2004;	   Choo-­‐Smith	   et	   al.,	   1997;	   Engel	   et	   al.,	   2008).	   Furthermore,	   aggregates	   have	   been	  shown	   (in	   some	   circumstances)	   to	   permeabilise	   membranes,	   a	   potential	   mechanism	   of	  direct	   amyloid	   cytotoxicity	   (Stefani,	   2010).	   There	   are	   several	  models	   for	   this,	   including	  carpeting	   effects,	   detergent	   effects,	   pore	   formation	   and	   raft-­‐like	   insertion	   (Figure	   4-­‐1)	  (Lashuel	  &	  Lansbury,	  2006;	  Luzio	  et	  al.,	  2007).	  In	  the	  carpeting	  model,	  aggregates	  carpet	  one	   leaflet	   of	   the	  membrane,	   causing	   asymmetric	   pressure	   and	   the	   resulting	   leakage	   of	  small	  molecules	  (Hebda	  &	  Miranker,	  2009).	  The	  raft-­‐like	  insertion	  model	  suggests	  amyloid	  forms	  a	  ‘protein	  raft’	  inside	  the	  membrane	  (Berthelot	  et	  al.,	  2013),	  as	  has	  been	  shown	  for	  HET-­‐s	   in	   yeast	   (Ta	   et	   al.,	   2012),	   while	   studies	   on	   monomeric	   Aβ	   show	   it	   inserts	   into	  membranes	   and	   then	   self-­‐assembles	   into	   oligomers	   which	   may	   destabilise	   the	   bilayer	  (Zhang	   et	   al.,	   2012).	   Amyloid	   species	   may	   also	   have	   detergent-­‐like	   effects.	   An	   initial	  electrostatic	   interaction	   allows	   the	   aggregate	   to	   bind	   the	   charged	   phospholipid	   head	  group,	   placing	   the	   hydrophobic	   residues	   of	   the	   aggregate	   near	   the	   membrane’s	  hydrophobic	   core,	   causing	   membrane	   disruption	   (Shai,	   1999).	   IAPP	   aggregates	   extract	  lipids	  from	  cellular	  membranes	  by	  this	  mechanism	  (Engel	  et	  al.,	  2008;	  Sparr	  et	  al.,	  2004).	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β2m	  fibrils	  have	  also	  been	  visualised	  using	  cryo-­‐EM,	  interacting	  with	  synthetic	  liposomes,	  primarily	  by	   their	  ends,	  distorting	   the	   liposome	  and	  possibly	  extracting	   lipids	   (Figure	  4-­‐2)(Milanesi	   et	   al.,	   2012).	   A	   final	   mechanism	   by	   which	   amyloid	   species	   may	   disrupt	  liposomes	  is	  the	  formation	  of	  annular	  oligomers	  that	  may	  form	  a	  pore	  or	  channel	  across	  a	  membrane;	   this	  has	  been	  visualised	   in	   synthetic	   liposomes	   (Lashuel	  &	  Lansbury,	   2006).	  Oligomers	   of	   this	   kind	   are	   known	   to	   form	   from	  many	   disease	   associated	   amyloidogenic	  proteins	   including	  huntingtin,	  Aβ	  and	  α-­‐synuclein	  (Ding	  et	  al.,	  2002;	  Lashuel	  et	  al.,	  2002;	  Wacker	  et	  al.,	  2004).	  	  	  Interestingly,	   the	   presence	   of	   lipids	   can	   directly	   modulate	   fibril	   formation;	   IAPP,	   Aβ	  peptide	  and	  α-­‐synuclein	  fibril	  growth	  is	  accelerated	  in	  the	  presence	  of	  lipid	  (Necula	  et	  al.,	  2003;	   Knight	   &	   Miranker,	   2004;	   Choo-­‐Smith	   et	   al.,	   1997;	   Galvagnion	   et	   al.,	   2015).	  Nucleation	   and	   fibril	   formation	   of	   IAPP	   damages	   membranes,	   causing	   them	   to	   become	  permeable	   to	   small	   molecules,	   with	   membrane	   damage	   directly	   correlated	   with	   fibril	  growth	  (Engel	  et	  al.,	  2008).	  Lipid-­‐induced	  fibrillogenesis	  may	  be	  an	  additional	  mechanism	  by	  which	  fibrils	  damage	  membranes.	  
	  
Figure	  4-­‐1	  Proposed	  models	  of	  amyloid	  mediated	  membrane	  disruption.	  








functions	   and	   reactions	   (Petersen	   et	  al.,	   2005).	  Disruptions	   to	   cytosolic	   Ca2+	   can	   lead	   to	  apoptosis	  via	  caspase	  activation	  and	  cytochrome-­‐c	  release	  (Glabe,	  2006).	  Modulating	  the	  interactions	   of	   amyloid	   with	   membranes	   may	   present	   a	   novel	   therapeutic	   strategy	   in	  tackling	   amyloid	   disease.	   For	   example,	   Europium	   ions	   (Eu3+)	   inhibit	   Aβ1-­‐42	  membrane	  interactions,	  which	  may	  lead	  to	  membrane	  protection	  (Williams	  et	  al.,	  2015).	  	  	  	  	  	  
Figure	  4-­‐2	  Direct	  perturbation	  of	  membranes	  by	  amyloid	  fibrils.	  A)	  Segmented	  cryo-­‐electron	  tomogram	  liposome	  (blue)	  distorted	  by	  β2m	  fibrils	  (yellow).	  Fibrils	  are	  associated	  with	   small	   vesicles	   (red).	   Adapted	   from	  Milanesi	   et	   al.,	   2012.	   B)	   TEM	   images	   of	   freeze	  fractured	   J774A	   cells	   with	   immunogold	   staining	   of	   Aβ	   protein,	   which	   indicates	   fibrils	  penetrating	  membrane	  of	  multivesicular	  body	  (MVB).	  Adapted	  from	  Friedrich	  et	  al.,	  2010.	  




amyloid	  forming	  peptide	  expressed	  in	  the	  cytosol	  of	  cells,	  and	  quantitative	  proteomics	  to	  identify	  more	   than	   2000	   amyloid-­‐aggregate	   binding	   partners	   (Olzscha	   et	  al.,	   2011).	   The	  binding	  partners	  were	  enriched	  with	  proteins	  containing	  unstructured	  regions,	  and	  play	  important	   roles,	   including	   proteostasis,	   chromatin	   organisation,	   transcription	   and	  translation,	   leading	   the	   authors	   to	   suggest	   that	   amyloid	   aggregates	   sequester	   proteins	  with	  key	  functions,	  leading	  to	  multifactorial	  cell	  dysfunction	  (Olzscha	  et	  al.,	  2011).	  	  
4.1.2.3 Proteostasis	  All	   cells	   have	   tightly	   regulated	   machineries	   that	   coordinate	   protein	   homeostasis,	   or	  proteostasis	   (Powers	   et	  al.,	   2009).	   The	   proteostasis	   network	   includes	   pathways	   such	   as	  the	   ubiquitin-­‐proteasome	   system	   (UPS),	   and	   molecular	   chaperones.	   The	   proteostatic	  capacity	  of	  cells	  under	  environmental	  or	  metabolic	  stress,	  decreases	  with	  age,	  as	  well	  as	  in	  various	   disease	   states	   (Balch	   et	   al.,	   2008).	   Increasingly,	   links	   are	   being	   made	   between	  disruptions	  of	  proteostasis	  and	  disease,	  including	  loss-­‐of	  function	  disorders	  such	  as	  cystic	  fibrosis	  and	  gain-­‐of-­‐toxic-­‐function	  disorders,	  which	  are	  thought	  to	  include	  AD,	  Parkinson’s	  and	  Huntington’s	  disease	  (Powers	  et	  al.,	  2009).	  	  The	   unfolded	   protein	   response	   is	   a	  major	  mechanism	   by	  which	   damaged,	  misfolded	   or	  unassembled	  proteins	  are	  degraded,	  via	  ubiquitin	  tagging	  and	  subsequent	  targeting	  to	  the	  proteasome	   (Ciechanover	  et	  al.,	   2000).	   Polyubiquitinated	  proteins	   are	  usually	   efficiently	  degraded	   by	   proteasomes,	   but	   in	   intracellular	   deposits	   within	   diseased	   neurons	  ubiquitinylation	  is	  elevated,	  suggesting	  a	  link	  between	  UPS	  dysfunction	  and	  pathogenesis	  (Mayer	  et	  al.,	  1988).	  Genetic	  analysis	  has	  also	  demonstrated	  a	   link	  between	  the	  UPS	  and	  several	   neurodegenerative	   diseases;	   for	   example	   mutations	   in	   UPS	   components	   parkin	  and	   ubiquitin	   carboxy-­‐terminal	   hydrolase	   L1	   are	   associated	   with	   PD	   (Cummings	   et	   al.,	  1999;	  Bence	  et	  al.,	   2001;	  Shimura	  et	  al.,	   2000).	   In	  one	   study,	   injection	  of	   adult	   rats	  with	  proteasome	   inhibitors	   caused	   PD	   like	   symptoms,	   including	   Lewy	   body	   formation	  (McNaught	   et	   al.,	   2004)	   Other	   studies	   have	   shown	   a	   huntingtin	   fragment	   containing	   a	  pathogenic	  poly-­‐Q	  repeat	   inhibits	  degredation	  by	  the	  UPS	  (Bence	  et	  al.,	  2001;	  Park	  et	  al.,	  2013).	   Such	   evidence	   suggests	   a	   possible	   positive	   feedback	   loop	   in	   which	   aggregates	  inhibit	   the	  UPS,	   causing	  more	   aggregation	   (Bence	  et	  al.,	   2001).	  Molecules	   that	  modulate	  and	   regulate	   proteostasis,	   or	   pharmacological	   chaperones	   are	   being	   developed	   as	  potential	  therapeutics	  (Powers	  et	  al.,	  2009).	  
4.1.2.4 Organelle	  dysfunction	  There	  is	  increasing	  evidence	  that	  amyloid	  aggregates	  perturb	  cellular	  function	  by	  causing	  organelle	   dysfunction.	   They	   induce	   endoplasmic	   reticulum	   stress,	   golgi	   body	  fragmentation	   and	   autophagy	   dysfunction,	   amongst	   other	   effects	   (Mercado	   et	   al.,	   2013;	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Gosavi	   et	   al.,	   2002;	   Schon	   &	   Przedborski,	   2011;	   Sarafian	   et	   al.,	   2013;	   Rugarli	   &	   Langer,	  2012).	  In	  many	  studies,	  mitochondrial	  damage	  and	  oxidative	  stress	  have	  been	  implicated	  (Umeda	  et	  al.,	  2011;	  Schon	  &	  Przedborski,	  2011;	  Kaminsky	  et	  al.,	  2015).	  
4.1.2.4.1 Mitochondrial	  dysfunction	  Mitochondria	   play	   a	   vital	   role	   in	   energy	   production,	   as	  well	   as	   in	   calcium	  buffering	   and	  apoptotic	   signalling	   (MacAskill	   &	   Kittler,	   2010),	   but	   their	   complex	   biosynthesis	   makes	  them	   particularly	   vulnerable	   to	   accumulation	   of	   damage	   over	   their	   lifetimes	   (Rugarli	   &	  Langer,	  2012).	  A	  complex	  system	  of	  surveillance	  monitors	  mitochondria	   for	  damage	  and	  removes	  dysfunctional	  mitochondria,	  and	  the	  failure	  of	  this	  system	  is	  associated	  with	  cell	  death.	  Neurons	  are	  particularly	  susceptible	  to	  mitochondrial	  damage	  as	  they	  require	  high	  levels	   of	   ATP	   to	   transport	  macromolecules	   and	   organelles	   over	   long	   distances,	   perform	  Ca2+	   homeostasis,	   and	   defend	  membrane	   potentials.	   The	   brain	   is	   an	   energetically	   costly	  organ	   to	  maintain,	   comprising	  ~2	  %	  of	   body	  mass,	   but	   consuming	  20	  %	  of	   resting	  ATP	  (MacAskill	   &	   Kittler,	   2010).	   Therefore,	   although	   all	   cells	   have	   similar	   mitochondrial	  quality	  control	  systems,	  the	  demands	  placed	  on	  a	  typical	  neuronal	  cell	  are	  greater	  than	  for	  the	  average	  non-­‐neuronal	  cells	  (Rugarli	  &	  Langer,	  2012).	  Many	  neurons	  are	  long	  (up	  to	  1	  m	  in	  humans),	  and	  so	  ATP	  diffusion	  cannot	  meet	  the	  energy	  needs	  of	  the	  cell	  (MacAskill	  &	  Kittler,	   2010).	  Mitochondria	   in	   neurons	   are	   transported	   away	   from	   the	   cell	   body	  where	  mitochondrial	   biogenesis	  primarily	  occurs,	   along	  axons	   to	   regions	  with	  high	  energy	  and	  Ca2+	   homeostasis	   requirements.	   Because	   of	   this	   spatial	   arrangement,	   it	   is	   energetically	  expensive	  to	  repair	  or	  degrade	  damaged	  mitochondria,	  as	  either	  the	  mitochondrion	  has	  to	  travel	  back	  to	  the	  cell	  body,	  or	  mitophagy	  machinery	  needs	  to	  be	  transported	  to	  the	  site	  of	  damaged	   mitochondria	   (Wang	   et	   al.,	   2006).	   Mitochondria	   have	   a	   longer	   half-­‐life	   in	  neuronal	   cells	   compared	   with	   other	   post-­‐mitotic	   cells;	   resulting	   in	   accumulation	   of	  damage	  (Rugarli	  &	  Langer,	  2012).	   In	  addition,	  newly	  synthesised	  mitochondrial	  proteins	  are	  imported	  into	  the	  mitochondria	  at	  the	  cell	  body	  and	  therefore	  the	  mitochondria	  at	  the	  cell	   periphery	   may	   be	   less	   efficient	   at	   coping	   with	   misfolded	   protein	   or	   Ca2+	   overload	  (Kaplan	  et	  al.,	   2009;	  Brown	  et	  al.,	   2006).	  Genetic	  mutations,	   or	   accumulation	  of	   amyloid	  aggregates	   that	   affect	   quality	   control	   in	   mitochondria,	   preferentially	   affect	   neurons	  compared	  with	  other	  cell	  types.	  It	  is	  therefore	  unsurprising	  that	  mitochondrial	  damage	  is	  strongly	   implicated	   in	   neurodegenerative	   diseases	   such	   as	   PD	   and	   AD	   (Alikhani	   et	   al.,	  2011;	  Valente	  et	  al.,	  2004;	  Umeda	  et	  al.,	  2011).	  	  	  In	   PD,	   there	   is	   a	   strong	   correlation	   between	   and	   mutations	   in	   PINK1	   and	   parkin	   and	  incidence	   and	   progression	   of	   the	   disease,	  which	   play	   roles	   in	  mitophagy	   (Valente	   et	  al.,	  2004;	  Vives-­‐Bauza	  &	  Przedborski,	  2011;	  Pimenta	  de	  Castro	  et	  al.,	  2012).	  Aβ	  peptides	  have	  an	  adverse	  effect	  on	  mitochondria,	  whether	   they	  are	   isolated,	   inside	  cultured	  cells,	  or	   in	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whole	   organisms,	   including	   decreases	   in	   mitochondrial	   enzymes	   (Complex	   II,	   III)	   and	  ATPase	  activity,	  mitochondrial	  Ca2+	  overload	  and	  increased	  hydrogen	  peroxide	  production,	  all	  of	  which	  could	  contribute	  to	  amyloid	  mediated	  cytotoxicity	  (Kaminsky	  et	  al.,	  2015).	  	  	  
4.1.2.4.2 Lysosomal	  dysfunction	  Lysosomes	   are	   a	   membrane-­‐bound,	   acidified	   organelle,	   containing	   ~	   50	   different	  hydrolases	   (Settembre	   et	   al.,	   2013;	   Lüllmann-­‐Rauch,	   2005).	   Lysosomes	   play	   a	   role	   in	  degradation	   of	   cellular	   components,	   plasma	   membrane	   repair,	   signalling	   pathways	  including	   apoptosis,	   energy	   metabolism,	   cholesterol	   homeostasis,	   antigen	   presentation	  and	   autophagy	   (Saftig	   &	   Klumperman,	   2009;	   Settembre	   et	   al.,	   2013).	   Cell	   death	   can	   be	  initiated	   by	   lysosomal	   membrane	   permeabilisation	   (LMP),	   where	   lysosomal	   hydrolases	  are	  released	  from	  the	  lysosome	  into	  the	  cytosol	  (Boya	  &	  Kroemer,	  2008)(Section	  4.1.2.1).	  Proteases	   that	   are	   active	   at	   cytosolic	   pH,	   including	   cathepsins	   B,D	   and	   L	   have	   been	  implicated	   in	   triggering	   cell	   death	   via	   caspase	   and	   mitochondria-­‐dependent	   pathways,	  depending	  on	  the	  cellular	  context	  (Boya	  &	  Kroemer,	  2008).	  	  Amyloid	   aggregates	   perturb	   cellular	   functions	   via	   perturbation	   of	   the	   lysosomal	  membrane	  and	  via	  accumulation	  of	   aggregates	   (Soura	  et	  al.,	   2012;	  Freeman	  et	  al.,	   2013;	  Boland	  &	  Campbell,	  2004;	  Dehay	  et	  al.,	  2010;	  Ji	  et	  al.,	  2002;	  Ditaranto	  et	  al.,	  2001;	  Liu	  et	  al.,	  2010;	   De	   Kimpe	   et	   al.,	   2012).	   Extracellular	   amyloid	   can	   gain	   access	   to	   intracellular	  compartments	   via	   endocytosis,	   and	   a	   range	   of	   disease-­‐associated	   amyloid	   species	   have	  been	  shown	  to	  be	  internalised,	  including	  Aβ,	  α-­‐synuclein,	  β2m	  and	  poly-­‐Q	  (Chafekar	  et	  al.,	  2008;	  Zhao	  et	  al.,	   2010;	   Soura	  et	  al.,	   2012;	  H.J.	   Lee	  et	  al.,	   2005;	  Freeman	  et	  al.,	   2013;	  M.	  Porter	   et	   al.,	   2011;	   Morten	   et	   al.,	   2007;	   Ren	   et	   al.,	   2009).	   Increasing	   evidence	   points	  towards	   lysosomal	   dysfunction,	   and	   other	   related	   mechanisms	   such	   as	   autophagy	   and	  mitophagy,	   as	   an	   underlying	   mechanism	   of	   pathology	   in	   amyloid-­‐associated	   diseases	  including	   AD,	   Parkinson’s	   and	   Huntington’s	   disease	   (Settembre	   et	   al.,	   2013).	   In	   many	  cases,	  amyloid	  aggregates	  are	  trafficked	  through,	  and	  concentrated	  in	  the	  endolysosomal	  system,	   making	   it	   a	   focus	   of	   research	   efforts	   (Soura	   et	   al.,	   2012;	   Dehay	   et	   al.,	   2010;	  Ditaranto	  et	  al.,	  2001;	  De	  Kimpe	  et	  al.,	  2012).	  	  Perturbation	  of	  lysosomal	  membranes	  may	  be	  a	  key	  site	  at	  which	  amyloid	  species	  exert	  a	  cytotoxic	   effect.	   Aβ1-­‐42	   has	   been	   shown	   to	   insert	   into	   lysosomal	   membranes,	   leading	   to	  LMP	  (Liu	  et	  al.,	  2010).	  Other	  mechanisms	  of	  lysosome-­‐related	  Aβ	  cytotoxicity	  include	  the	  generation	   of	   free	   radicals	  which	   disrupt	   lysosomal	   acidification,	   ultimately	   resulting	   in	  cell	   death	   (White	  et	  al.,	   2005).	   LMP	  and	   consequent	   cell	   death	  has	  been	  observed	  when	  Aβ1-­‐42	  oligomers	   are	   exogenously	   applied,	  while	  mouse	  models	   of	   familial	  AD	   containing	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the	   Aβ	   E693Δ	   (Osaka)	   mutation,	   show	   lysosomal	   leakage,	   ER	   stress	   and	   mitochondrial	  dysfunction	  (Soura	  et	  al.,	  2012;	  Umeda	  et	  al.,	  2011).	  These	  studies	  suggest	  a	  central	  role	  for	  the	  lysosome	  in	  the	  pathogenesis	  of	  AD.	  	  	  In	  addition	   to	  LMP,	  amyloid	   can	  also	   inhibit	   lysosome	   function.	   Indeed,	   the	   inhibition	  of	  lysosomal	  function	  in	  the	  absence	  of	  amyloid	  aggregates	  results	  in	  very	  similar	  effects	  to	  amyloid	  disease	  (Lee	  et	  al.,	  2011).	  For	  example,	  inhibition	  of	  lysosomal	  proteolysis	  results	  in	  the	  accumulation	  of	  lysosomes	  on	  axonal	  swellings,	  which	  has	  been	  observed	  in	  mouse	  models	  of	  AD	  (Lee	  et	  al.,	  2011).	  Another	  striking	  study	  demonstrated	  that	  the	  compound	  scyllo-­‐inositol	  can	  prevent	  accumulation	  and	  toxicity	  of	  Aβ	  and	  Huntingtin	  aggregates	  by	  increasing	  lysosomal	  and	  proteasomal	  degradation	  (Lai	  et	  al.,	  2014;	  McLaurin	  et	  al.,	  2000).	  Lysosomal	  dysfunction	  is	  also	  proposed	  to	  play	  a	  role	  in	  non-­‐neurodegenerative	  amyloid-­‐associated	   diseases.	   IAPP	   disrupts	   lysosome-­‐dependent	   degradation,	   which	   impairs	  autophagy	   in	   mouse	   models	   of	   diabetes	   (Rivera	   et	   al.,	   2011).	   β2m	   amyloid	   fibrils	  accumulate	  in	  the	  lysosome	  where	  they	  inhibit	  the	  degradation	  of	  substrates,	  which	  could	  in	   turn	   disrupt	   proteostasis	   by	   inhibiting	   the	   overall	   degradative	   capacity	   of	   the	   cell	  (Jakhria	  et	  al.,	  2014).	  	  Increasing	  evidence	  has	  indicated	  a	  central	  role	  for	  lysosomal	  and	  autophagy	  dysfunction	  in	   neurodegenerative	   diseases	   (Settembre	   et	   al.,	   2013).	   One	   of	   the	   first	   pathological	  features	   of	   many	   such	   diseases	   including	   AD,	   Parkinson’s	   and	   Huntington’s,	   is	   the	  accumulation	  of	  autophagosomes	  (Wong	  &	  Cuervo,	  2010;	  Dehay	  et	  al.,	  2010;	  Kegel	  et	  al.,	  2000;	  Nixon	  et	  al.,	  2005).	  Autophagy	  is	  complex	  and	  dynamic,	  and	  it	  is	  extremely	  difficult	  to	  define	  the	  mechanisms	  of	  autophagic	  failure	  in	  different	  diseases.	  Different	  pathways	  of	  autophagic	   dysfunction	   may	   help	   to	   rationalise	   differential	   disease	   progression	   and	  pathology	  (Wong	  &	  Cuervo,	  2010).	  An	  example	  of	  complexity	  in	  studying	  autophagy	  is	  that	  the	  accumulation	  of	  autophagosomes.	  This	  observation	  could	  be	  rationalised	  by	  both	  the	  up-­‐regulation	   of	   autophagy,	   meaning	   more	   autophagosomes	   are	   formed,	   or	   by	   the	  disruption	   in	   their	   clearance,	   phenomena	   that	   are	   difficult	   to	   disentangle	   (Boland	   et	  al.,	  2008;	   Wong	   &	   Cuervo,	   2010;	   Rubinsztein	   et	   al.,	   2009).	   Cell	   biological	   experiments	   are	  needed	   to	   tease	   these	   mechanisms	   apart.	   There	   is	   evidence	   for	   disrupted	   autophagic	  clearance	  via	  autophagosome	  accumulation,	  uncoupled	  with	  increased	  autophagic	  flux	  in	  a	  number	   of	   neurodegenerative	   diseases,	   which	   could	   be	   due	   to	   either	   disrupted	  autophagosome	   trafficking,	   decreased	   fusion	   with	   endosomes/lysosomes	   or	   decreased	  proteolysis	   inside	   lysosomes	  (Wong	  &	  Cuervo,	  2010).	  A	  decrease	   in	  proteolysis	  could	  be	  due	  to	  any	  combination	  of	  altered	  lysosomal	  pH,	  accumulation	  of	  undigested	  substrates	  or	  impaired	   activity/trafficking/expression	   of	   lysosomal	   hydrolases.	   Identifying	   different	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kinds	   of	   autophagy	   dysfunction	   may	   enable	   the	   development	   of	   targeted	   therapies	   for	  these	  neurodegenerative	  diseases	   (Wong	  &	  Cuervo,	  2010).	  For	  example,	  autophagosome	  clearance	  could	  be	   increased	  by	  overexpression	  of	   transcription	   factor	  EB,	  up-­‐regulating	  lysosomal	  biogenesis	   (Sardiello	  et	  al.,	   2009;	  Wong	  &	  Cuervo,	   2010).	  The	   contribution	  of	  lysosomal	   and	   autophagic	   dysfunction	   in	   a	   range	   of	   neurodegerative	   diseases	   bring	   to	  mind	  some	  striking	  parallels	  between	  amyloid	  diseases	  and	   lysosomal	  storage	  disorders	  (Wong	  &	  Cuervo,	  2010;	  Settembre,	  Fraldi,	  Jahreiss,	  et	  al.,	  2008).	  	  There	  are	  over	  40	  metabolic	  disorders	  characterised	  as	  lysosomal	  storage	  diseases,	  which	  are	  caused	  by	  mutations	  in	  lysosomal	  hydrolases,	  integral	  lysosomal	  membrane	  proteins,	  and	   proteins	   involved	   in	   trafficking	   and	   post-­‐translational	   modification	   of	   lysosomal	  proteins	  (Schultz	  et	  al.,	  2011;	  Settembre,	  Fraldi,	  Rubinsztein,	  et	  al.,	  2008).	  Many	  patients	  with	  lysosomal	  storage	  diseases	  display	  defects	  in	  the	  central	  nervous	  system,	  which	  can	  cause	   progressive	   cognitive	   and	  motor	   decline	   (Schultz	   et	  al.,	   2011).	   There	   are	   striking	  parallels	  between	  lysosomal	  storage	  disorders	  and	  neurodegenerative	  disease	  (Settembre,	  Fraldi,	  Jahreiss,	  et	  al.,	  2008;	  Ravikumar	  et	  al.,	  2002;	  Settembre	  et	  al.,	  2007).	  Niemann-­‐Pick	  type	  C	  (NPC)	  disease	  is	  an	  autosomal	  recessive	  defect	  in	  endosomal	  cholesterol	  trafficking	  and	   shares	   many	   features	   with	   AD	   (Kresojević	   et	   al.,	   2014;	   Chang	   et	   al.,	   2005).	   These	  include	  endosomal	  abnormalities	  in	  neurones,	  (Nixon,	  2004),	  accumulation	  of	  APP	  and	  Aβ,	  and	   neurofibrillary	   tangles	   of	   tau,	   but	   in	   the	   absence	   of	   Aβ	   deposition	   (Nixon,	   2004;	  Yamazaki	  et	  al.,	  2001;	   Jin	  et	  al.,	  2004;	  Love	  et	  al.,	  1995).	  Cholesterol	   is	  a	  unifying	   theme;	  aberrant	   cholesterol	   trafficking	   is	   the	   primary	   factor	   in	  NPC,	  while	   high	   cholesterol	   is	   a	  risk	   factor	   in	  AD	   and	   aberrant	   cholesterol	   trafficking	   is	   associated	  with	   cell	   dysfunction	  (Malnar	  et	  al.,	  2014;	  Poirier,	  2003;	  Nomura	  et	  al.,	  2013).	  	  Parallels	  have	  also	  been	  shown	  between	  the	  lysosomal	  storage	  disorder	  Gaucher’s	  disease	  and	   PD.	   Gaucher’s	   disease	   is	   the	   most	   common	   lysosomal	   storage	   disorder,	   it	   is	   an	  autosomal	   recessive	   disease	   caused	   by	   loss-­‐of-­‐function	  mutations	   in	   the	   gene	   encoding	  glucocerebrosidase,	   GBA1,	   a	   lysosomal	   enzyme	   (Li	   et	   al.,	   2015).	   Gathering	   clinical,	  pathological	  and	  genetic	  evidence	  points	  to	  an	  association	  between	  Gaucher’s	  and	  PD	  (Li	  
et	   al.,	   2015;	   Stern,	   2014).	   Type	   1	   Gaucher’s	   disease	   patients	   clinically	   present	  Parkinsonism,	  with	   genetic	   evidence	   further	   supporting	   a	   strong	   link	   (Mao	   et	  al.,	   2010;	  McNeill	   et	  al.,	   2012;	   Sidransky	  &	   Lopez,	   2012).	  Mutations	   in	  GBA1	   is	   the	  most	   common	  genetic	  risk	  factor	  for	  PD	  known	  to	  date	  (Mazzulli	  et	  al.,	  2011;	  Sidransky	  et	  al.,	  2009).	  The	  aggregation	  of	  α-­‐synuclein	  has	  been	  implicated	  in	  the	  progression	  of	  Gaucher’s	  disease,	  as	  α-­‐synuclein	   positive	   Lewy	   bodies	   are	   found	   in	   the	   brains	   of	   Gaucher’s	   disease	   patients	  (Wong	   et	   al.,	   2004)	   One	   interesting	   observation	   potentially	   links	   these	   diseases	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mechanistically;	   the	   accumulation	   of	   α-­‐synuclein	   species	   depletes	   lysosomal	  glucocerebrosidase,	   leading	   to	   a	   build	   up	  of	   glucocerebroside	   inside	   cells,	  which	   in	   turn	  stabilises	  α-­‐synuclein	  aggregates	  in	  a	  positive	  feedback	  loop	  (Mazzulli	  et	  al.,	  2011).	  These	  parallels,	  as	  well	  as	  evidence	  that	  amyloid	  species	  perturb	  lysosomal	  membranes,	  indicate	  the	  lysosome	  is	  an	  interesting	  subject	  for	  investigating	  amyloid-­‐membrane	  interactions.	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4.2 Results	  In	  the	  previous	  Chapter,	  the	  ability	  of	  β2m	  amyloid	  fibrils	  to	  perturb	  synthetic	   liposomes	  enriched	   in	   the	   lipid	   BMP	   indicted	   the	   lysosome	   may	   be	   an	   important	   site	   at	   which	  amyloid	   species	   exert	   toxic	   effects.	   Liposome	   dye	   release	   experiments	   in	   Chapter	   three	  suggest	   that	   there	  may	   be	   significant	   differences	   in	   the	   ability	   of	   β2m	   amyloid	   fibrils	   to	  perturb	   synthetic	   liposomes	   and	   LUVs	   formed	   from	   crude	   eukaryotic	   lipids.	   In	   this	  Chapter,	   the	   intracellular	   trafficking	  of	  β2m	  amyloid	   fibrils	  and	   interactions	  with	  cellular	  membranes	  were	  investigated.	  
4.2.1 Intracellular	  trafficking	  of	  amyloid	  It	   has	   been	   demonstrated	   that	   amyloid	   species	   formed	   from	   a	   variety	   of	   different	  precursor	   proteins	   can	   be	   internalised	   in	   cells	   (Section	   4.1.2).	   Here,	   the	   intracellular	  trafficking	  of	  Ls-­‐f	  β2m	  amyloid	  fibrils	  in	  the	  cell	  line	  RAW	  264.7	  cells	  was	  assessed.	  	  
4.2.1.1 Fluorescent	  labelling	  and	  characterisation	  of	  β2m	  amyloid	  fibrils	  To	   generate	   fluorescently	   labelled	   amyloid	   fibrils	   for	   confocal	   imaging,	  monomeric	   β2m	  was	  labelled	  with	  Alexa	  Fluor®	  647	  (AF647)	  succinimidyl	  ester,	  which	  reacts	  with	  primary	  amines	  (Section	  2.3.7).	  Labelled	  protein	  exhibited	  the	  predicted	  absorbance	  profile,	  with	  a	  peak	   at	   280	   nm	   corresponding	   to	   tryptophan	   and	   tyrosine	   of	   the	   protein	   and	   647	   nm,	  corresponding	   to	   AF647	   (Figure	   4-­‐3A).	   The	   absorbance	   profile	   of	   AF647	   succinimidyl	  ester	  alone,	  and	  conjugated	  to	  protein,	  was	  the	  same	  as	  expected	  (Figure	  4-­‐3	  B).	  ESI	  mass	  spectrometry	  was	  used	  to	  confirm	  labelling.	  The	  major	  peak	  corresponds	  to	  the	  predicted	  mass	  of	  unlabelled	  protein	  (11858	  ±	  0.97	  Da),	  the	  minor	  to	  labeled	  protein	  (12701	  ±	  0.44	  Da)	   (Figure	   4-­‐3	   C).	   The	   ratio	   between	   the	   peaks	   suggests	   that	   approximately	   a	   third	   of	  monomeric	  protein	  was	  labeled	  with	  a	  single	  AF647	  molecule.	  	  	  To	  generate	  labelled	  amyloid	  fibrils,	  AF647	  labelled	  β2m	  was	  introduced	  into	  seeded	  fibril	  formation	  reaction	  as	  described	  (Section	  2.3.8)	  in	  a	  ratio	  of	  1:9	  labelled	  to	  unlabelled	  β2m	  monomer.	  Fibrils	  with	  Ls	  morphology	  were	  produced,	  and	  fragmented	  to	  produce	  AF647	  Ls-­‐f	   fibrils.	   In	   order	   to	   confirm	   fibril	  morphology	  was	   not	   altered	   in	   a	   gross	   fashion	   by	  incorporation	   of	   AF647,	   negative	   stain	   EM	   was	   performed.	   No	   gross	   morphological	  differences	  were	  observed	  between	  AF647	  Ls	  and	  Ls-­‐f	  fibrils	  compared	  with	  non-­‐labelled	  fibrils	  (Figure	  4-­‐4).	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Figure	  4-­‐4	  Structural	   characterisation	  of	  AF647	  β2m	   fibrils.	  AF647	  β2m	  Ls	  (A,B)	  and	  AF647	   β2m	   Ls-­‐f	   fibrils	   (C,D)	   were	   visualised	   using	   negative	   stain	   EM.	   No	   gross	  morphological	  changes	  were	  observed	  compared	  with	  unlabelled	  fibrils	  (Figure	  3-­‐9).	  Scale	  bar	  200	  nm	  (A,C)	  or	  50	  nm	  (B,D).	  
4.2.1.2 β2m	  amyloid	  fibrils	  are	  trafficked	  to	  the	  lysosome	  	  In	   many	   amyloid-­‐associated	   disease	   states,	   aggregates	   are	   present	   in	   the	   extracellular	  environment,	  and	  fibrillar	  or	  oligomeric	  species	  are	  endocytosed	  by	  neighbouring	  cells.	  In	  DRA,	  macrophages	  infiltrate	  the	  joints	  where	  they	  endocytose	  β2m	  aggregates	  (Argiles	  et	  





imaging	  of	   cells	   labelled	  with	   the	   lysosomal	  marker	   lysotracker	  and	  AF647	   labelled	  β2m	  species	  revealed	  that	  both	  AF647	  labelled	  β2m	  monomer	  and	  Ls-­‐f,	  AF647	  labelled	  β2m	  Ls-­‐f	  fibrils	  were	  trafficked	  to	  the	  lysosome	  within	  4	  h,	  and	  were	  still	  present	  at	  24	  h	  (Section	  2.8)(Figure	  4-­‐5).	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Figure	  4-­‐6	  Emission	  spectra	  of	  NIAD-­‐4	  in	  the	  presence	  and	  absence	  of	  Ls	  β2m	  fibrils.	  7.5	  μM	  NIAD-­‐4	  +/-­‐	  12	  μM	  monomer	  equivalent	   excited	  at	  405,	  488,	  555	  and	  639	  nm	   to	  correspond	  with	  common	   lasers	   fitted	   to	  confocal	  microscopes.	  Samples	  were	   incubated	  at	  pH	  6.4	  for	  10	  minutes	  before	  a	  fluorescence	  emission	  spectra	  was	  collected	  at	  variable	  excitation	   wavelengths	   using	   at	   PTI	   Quantmaster	   fluorescence	   spectrometer.	   Lines	   for	  samples	   555	   nm	   –	   Ls,	   and	   639	   nm	   +/-­‐	   Ls	   cannot	   be	   seen	   as	   they	   sit	   very	   close	   to	   the	  baseline.	  	  	  In	  Section	  4.2.1.2	  it	  was	  demonstrated	  that	  β2m	  Ls-­‐f	  fibrils	  are	  trafficked	  to	  the	  lysosome	  within	  4	  hours,	  but	   this	  does	  not	  provide	  any	   information	  about	   the	   fibril’s	   intracellular	  conformation.	  NIAD-­‐4	  was	  shown	  to	  be	  suitable	  as	  a	  tool	  for	  probing	  intracellular	  amyloid	  conformation,	   and	   so	  was	  used	  here	   in	   conjunction	  with	   lysotracker	   lysosome	  stain	  and	  AF647	   β2m	   monomer	   and	   fibrils	   to	   investigate	   intracellular	   conformation	   of	   amyloid	  species.	  NIAD-­‐4	  staining	  with	  cells	  exposed	  to	  AF647	  labelled	  β2m	  species	  demonstrated	  AF647	  labelled	  β2m	  Ls-­‐f	  puncta	  colocalise	  with	  NIAD-­‐4	  staining,	  indicating	  the	  AF647	  Ls-­‐f	  retains	   an	   amyloid	   conformation	   (Figure	   4-­‐7A,	   C).	   Cells	   exposed	   to	   AF647	   labelled	   β2m	  monomer	  do	  not	  show	  any	  NIAD-­‐4	  staining,	   indicating	  no	  detectable	  NIAD-­‐4	  species	  are	  forming	   over	   the	   time-­‐course	   of	   the	   experiment	   (Figure	   4-­‐7	   A,	   C).	   In	   line	   with	   the	  observation	   that	   fluorescently	   labelled	   species	   reach	   the	   lysosome	   by	   4	   hours,	  colocalisation	  of	  NIAD-­‐4	  staining	  with	  Alexafluor647	  labelled	  β2m	  Ls-­‐f	  was	  observed	  at	  4	  hours	  and	  24	  hours.	  	  	  It	  may	  be	  possible	  that	  fibrils	  are	  degraded	  upon	  entry	  to	  the	  lysosome,	  and	  fluorescence	  at	  24	  h	   is	  a	  result	  of	  β2m	  species	  being	  continually	   internalised.	  To	   investigate	   this,	  cells	  were	  exposed	  to	  AF647	  β2m	  monomer	  or	  Ls-­‐f	   for	  4	  h	  or	  24	  h,	  washed,	  and	   incubated	   in	  fresh	  cell	  culture	  medium	  for	  a	  further	  2	  h	  before	  imaging.	  Colocalisation	  of	  AF647	  β2m	  Ls-­‐f	  with	  NIAD-­‐4	  was	  observed	  at	  both	  4+2	  h	  and	  24+2	  h	  was	   seen,	   indicating	  Ls-­‐f	   species	  persist	  in	  a	  NIAD-­‐4	  positive	  state	  over	  this	  time	  period.	  	  	  






















To	  confirm	  that	  NIAD-­‐4	  positive	  species	  are	   trafficked	   to	   the	   lysosome,	   live	  cell	   confocal	  imaging	  was	  used	  to	  image	  cells	  stained	  with	  the	  lysosomal	  marker	  lysotracker	  and	  NIAD-­‐4.	  Imaging	  demonstrated	  that	  NIAD-­‐4	  positive	  species	  colocalise	  with	  the	  lysosome	  at	  4	  h	  and	  24	  h	  (Figure	  4-­‐8).	  	  	  Throughout	   live	   cell	   imaging,	   fluorescence	   associated	   with	   β2m	   species	   was	   primarily	  observed	   as	   intracellular	   puncta.	   However,	   in	   some	   samples	   exposed	   to	   Ls-­‐f	   species,	  extracellular	  aggregates	  were	  seen,	  including	  in	  cells	  that	  were	  washed	  and	  incubated	  for	  a	   further	  2	  h	  (Figure	  4-­‐7	  B,	  Figure	  4-­‐8).	  This	   indicates	  Ls-­‐f	  amyloid	   fibrils	  may	  associate	  with	   the	   plasma	   membrane	   and	   not	   become	   internalised	   in	   some	   cases.	   It	   is	   also	  interesting	   to	   note	   NIAD-­‐4	   puncta	   are	   occasionally	   not	   associated	   with	   labelled	   Ls-­‐f	  species,	  the	  origin	  of	  this	  is	  unclear	  (Figure	  4-­‐7	  D).	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4.2.2 β2m	  fibrils	  are	  stabilised	  by	  cell	  culture	  growth	  medium	  The	  results	  presented	  in	  Section	  4.2.1.3	  demonstrate	  that	  β2m	  Ls-­‐f	  fibrils	  are	  trafficked	  to	  lysosomes	  within	  ~4	  hours,	  where	   they	   retain	  an	  amyloid	   (i.e.	  NIAD-­‐4	  positive)	   state.	   It	  has	  been	  shown	  previously	  that	  β2m	  fibrils	  formed	  in	  vitro	  at	  pH	  2.0	  rapidly	  depolymerise	  (within	  30	  minutes)	  into	  monomeric	  β2m	  when	  incubated	  at	  pH	  7.4	  (Tipping	  et	  al.,	  2015).	  Here,	  negative	  stain	  EM	  was	  used	  to	  investigate	  the	  state	  of	  β2m	  amyloid	  species	  formed	  in	  
vitro	  at	  pH	  2.0	  upon	  exposure	  to	  cell	  culture	  medium,	  as	  occurs	  during	  cell-­‐based	  assays.	  β2m	  Ls	  fibrils	  were	  incubated	  at	  a	  final	  monomer	  equivalent	  concentration	  of	  1.2	  μM	  in	  cell	  culture	  medium	  (Section	  2.5)	  and	  imaged	  using	  negative	  stain	  EM	  (Figure	  4-­‐9).	  Negative	  stain	   EM	   provides	   a	   qualitative	   view	   of	   morphological	   changes	   to	   fibril	   samples.	   Upon	  dilution	   of	   Ls	   fibrils	   into	   cell	   medium,	   the	   fibrils	   appear	   to	   bind	   components	   of	   the	  medium,	  a	  trend	  which	  continues	  over	  the	  course	  of	  the	  time	  series.	  Over	  time,	  the	  twist	  of	  the	  fibril	  becomes	  less	  visible.	  This	  could	  be	  the	  binding	  of	  protein	  obscuring	  the	  twist,	  a	  morphological	  change	  in	  fibril	  structure,	  or	  a	  combination	  of	  the	  two.	  There	  also	  appeared	  to	  be	  a	  progressive	  increase	  in	  fibril	  bundling,	  in	  contrast	  to	  pH	  2.0	  fibrils.	  After	  24	  hours,	  fibrils	  are	  still	  clearly	  visible,	  although	  they	  look	  different	  to	  their	  pH	  2.0	  counterparts,	  as	  they	  appear	  to	  be	  coated	  with	  additional	  material	  (Figure	  4-­‐9	  A,B,O,P).	  	  	  While	   negative	   stain	  EM	   is	   a	   useful	   tool	   for	   assessing	  morphology	   changes,	   it	   is	   hard	   to	  assess	   changes	   in	   length	   distribution,	   formation	   of	   other	   species	   through	  depolymerisation,	   alterations	   to	   fine	   fibril	   structure	   such	   as	   twist	   crossover	   length,	   or	  other	   subtle	   structural	   changes.	   Both	   the	   morphological	   changes	   observed,	   such	   as	   the	  bundling,	  binding	   to	  FCS	  components,	  as	  well	  as	  other	  structural	  changes	   that	  may	  have	  occurred,	  may	  alter	  the	  behaviour	  of	  amyloid	  species	  in	  cell-­‐based	  assays	  compared	  with	  










Figure	  4-­‐9	  β2m	  fibrils	  persist	  in	  cell	  culture	  media.	  β2m	  Ls	  fibrils	  were	  diluted	  to	  a	  final	  concentration	   of	   1.2	   μM	   monomer	   equivalent	   in	   pH	   2.0	   fibril	   buffer	   (A,B),	   or	   DMEM	  supplemented	  with	   10	  %	   (v/v)	   foetal	   calf	   serum	   (FCS),	   2	  mM	   L-­‐	   glutamine,	   100	   IU/ml	  penicillin	   and	   100	   μg/ml	   streptomycin	   (E-­‐P)	   for	   the	   stated	   time	   period.	   After	   24	   hours,	  structures	  with	   fibrillar	  morphology	  were	   still	   clearly	  visible	   (O,P).	  For	   comparison,	  FCS	  alone	  was	  imaged	  (C,D).	  Representative	  micrographs	  shown	  for	  each	  condition.	  Scale	  bar	  left	  column,	  100	  nm;	  right	  column	  50	  nm.	  	  











perturbations	   (Section	   4.1.2).	   To	   assess	   the	   propensity	   of	   β2m	   species	   to	   perturb	  lysosomal	   membranes,	   a	   crude	   lysosomal	   pellet	   (CLP)	   fraction	   enriched	   in	   lysosomes,	  mitochondria	   and	   endoplasmic	   reticulum	  was	   extracted	   from	  RAW	  264.7	   cells	   (2.7.6.2).	  CLP	  was	  incubated	  with	  β2m	  monomer,	  Ls-­‐f,	  Ls	  buffer	  or	  detergent,	  and	  incubated	  at	  37	  °C	  for	   one	   hour.	   These	   were	   then	   centrifuged	   to	   separate	   membrane	   bound	   (pellet)	   and	  soluble	   fractions,	   and	   the	   NAGA	   (soluble	   lysosomal	   enzyme,	   (Sellinger	   et	   al.,	   1960))	  activity	   of	   each	   fraction	   assessed.	   If	   the	   lysosomal	   membranes	   remain	   intact,	   NAGA	  activity	   would	   localise	   primarily	   to	   the	   pellet.	   Upon	   perturbation,	   NAGA	   activity	   would	  localise	  to	  the	  soluble	  fraction.	  At	  both	  pH	  7.5	  and	  6.5,	  monomeric,	  Ls	  and	  Ls-­‐f	  β2m	  species	  do	   not	   appear	   to	   perturb	   lysosomal	  membranes,	   as	  NAGA	   activity	   primarily	   localises	   to	  the	  pellet	   fraction.	  NAGA	   is	  45	  kDa,	  and	  so	   it	   is	  possible	   that	  membrane	  disruption	  does	  occur,	   but	   not	   to	   the	   extent	   that	   NAGA	   is	   liberated	   from	   the	   lumen	   of	   the	   lysosome.	  Additionally,	   the	   assay	   may	   not	   be	   sensitive	   enough	   to	   detect	   low	   levels	   of	   membrane	  perturbation	   (~	  <	  5-­‐10	  %).	  However,	   this	  assay	  suggests	   that	  β2m	  species	  are	  unable	   to	  perturb	  isolated	  lysosomal	  membranes	  under	  these	  conditions.	  	  
	  
Figure	   4-­‐10	   Isolated	   cellular	   membranes	   are	   not	   perturbed	   by	   β2m	   amyloid	   or	  
monomer.	  CLP	  from	  RAW	  264.7	  cells	  were	  incubated	  with	  a	  final	  concentration	  of	  6	  μM	  β2m	  monomer,	  Ls,	  Ls-­‐f,	  Optiprep™	  homogenisation	  buffer	  or	  0.5	  %	  (v/v)	  Triton	  X-­‐100	  for	  1	  hour	  at	  37	  °C	  at	  pH	  7.5	  (A)	  or	  6.5	  (B),	  centrifuged,	  and	  NAGA	  activity	  in	  the	  soluble	  and	  pellet	   fractions	   assessed.	   Data	   for	   each	   treatment	   (sum	   of	   soluble	   and	   pellet	   NAGA	  fraction)	   normalised	   to	   100	   %	   NAGA	   activity	   (Soluble	   +	   pellet	   fraction).	   Error	   bars	  represent	  standard	  deviation	  of	  3	  replicates.	  	  
















































































Ficoll,	   Percoll,	   Nycodenz	   and	   Iodixanol	   (Lee	   et	   al.,	   2010).	   In	   density-­‐gradient	  centrifugation,	  the	  sedimentation	  rate	  of	  an	  organelle	  is	  dependent	  on	  its	  density	  relative	  to	  medium,	  which	   in	   turn	   is	   determined	  by	   the	   organelle’s	   contents,	   lipid/protein	   ratio,	  size	   and	   shape	   (Lee	   et	   al.,	   2010).	   Firstly,	   the	   utility	   of	   two	   density	   gradient	   media	   to	  generate	  fractions	  for	  imaging	  by	  cryo-­‐EM	  was	  assessed.	  	  
4.2.3.1 Subcellular	  fractionation	  using	  a	  percoll	  gradient	  It	   has	   been	   demonstrated	   previously	   that	   lysosomes	   can	   be	   enriched	   using	   gradient	  centrifugation	  with	  percoll	   (Casey	  et	  al.,	   2007;	  Morten	  et	  al.,	   2007).	  Percoll	   is	   a	   sodium-­‐stabilized	  colloid	  particle	  coated	  with	  polyvinylpyrrolidone,	  with	  an	  average	  diameter	  of	  15-­‐35	   nm	   (Pertoft,	   2000).	   Percol	   gradients	   are	   iso-­‐osmotic,	   making	   it	   an	   attractive	  gradient	  density	  medium.	  	  	  An	   enriched	   lysosomal	   population	   from	   RAW	   264.7	   cells	   was	   generated	   by	   performing	  subcellular	   fractionation	   of	   the	   post	   nuclear	   supernatant	   (PNS)	   on	   a	   percoll	   gradient	  (Section	   2.7.4).	   To	   determine	   the	   location	   of	   organelles,	   fractions	   were	   assayed	   for	   the	  enzymatic	  activity	  of	  alkaline	  phosphatase	  (a	  plasma	  membrane	  marker),	  NAGA	  and	  acid	  phosphatase	   (lysosomal	   markers)(Figure	   4-­‐11)(Sellinger	   et	   al.,	   1960;	   Emmelot	   et	   al.,	  1964;	   Bull	   et	   al.,	   2002).	   Fraction	   nine	   contained	   a	   peak	   in	   NAGA	   and	   acid	   phosphatase	  enzyme	   activity,	   and	   a	   de-­‐enrichment	   in	   alkaline	   phosphatase	   activity,	   indicating	  lysosomes	  were	  enriched	   in	   this	   fraction	  and	  plasma	  membrane	  was	  depleted.	  This	  was	  confirmed	   by	   western	   blotting	   with	   primary	   antibodies	   directed	   against	   cathepsin	   D,	   a	  luminal	   lysosomal	   marker	   (Sardiello	   et	   al.,	   2009).	   Fraction	   nine	   was	   depleted	   in	  contaminating	   membranes	   such	   as	   the	   plasma	   membrane,	   as	   assessed	   by	   alkaline	  phosphatase	   enzyme	   activity	   and	   immunoblotting	   against	   calreticulin	   (soluble	  endoplasmic	   reticulum	   marker)(Müller-­‐Taubenberger	   et	   al.,	   2001).	   Membranes	   from	  fraction	   nine	   were	   subject	   to	   an	   additional	   centrifugation	   step	   to	   attempt	   to	   remove	  percoll,	  then	  imaged	  using	  cryo-­‐EM.	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Figure	  4-­‐11	  Subcellular	  fractionation	  of	  RAW	  264.7	  cells	  PNS	  on	  a	  percoll	  gradient.	  Subcellular	  fractions	  of	  RAW	  264.7	  cells	  were	  obtained	  by	  centrifugation	  on	  a	  27	  %	  (v/v)	  percoll	   gradient.	   10	   x	   1	  ml	   fractions	  were	   collected	   from	   the	   top	   and	   assayed	   for	  NAGA	  (lysosome	   marker),	   acid	   phosphatase	   (lysosome	   marker)	   and	   alkaline	   phosphatase	  (plasma	  membrane	  marker).	   Fractions	  were	   immunoblotted	  with	   antibodies	   specific	   for	  calreticulin	   (endoplasmic	   reticulum	  marker)	   and	   cathepsin	   D	   (lysosome	  marker).	   Error	  bars	   represent	   standard	  deviation	  of	  3	   replicates,	  which	   in	   some	   cases	   are	   smaller	   than	  the	  marker.	   Fraction	   1	   represents	   the	   top	   of	   the	   gradient	   (least	   dense),	   fraction	   10	   the	  bottom	  of	  the	  gradient.	  


















Figure	   4-­‐12	   Membranes	   isolated	   from	   percoll	   gradient.	   Images	   are	   representative	  examples	   of	   membranes	   isolated	   from	   fraction	   9	   of	   a	   percoll	   gradient.	   A)	   Dense	   core	  lysosome.	  B)	  Granular	  lysosome.	  C)	  Percoll	  background	  D)	  Multivesicular	  body.	  E)	  Carbon	  support	  film.	  F)	  Tubular	  structure.	  G)	  Hybrid	  organelle.	  Scale	  bar	  100	  nm	  




Figure	   4-­‐13	   Cryo-­‐ET	   of	   membranes	   from	   a	   percoll	   gradient	   A)	   -­‐1°	   tilt	   image	   (Tilt	  series	  ‘Percoll-­‐tilt1.mov,	  Appendix	  B.	  B)	  Section	  of	  z	  stack	  of	  the	  tomogram	  generated	  from	  image	  stack	  A	  is	  taken	  from	  image	  (Tomogram	  ‘Percoll-­‐tomo1.mov,	  Appendix	  B)	  C)	  -­‐1°	  tilt	  image	   (Tilt	   series	   ‘Percoll-­‐tilt2.mov,	   Appendix	  B)	  D)	   Section	   of	   z	   stack	   of	   the	   tomogram	  generated	   from	   image	   stack	   C	   is	   taken	   from	   image	   (Tomogram	   ‘Percoll-­‐tomo2.mov,	  Appendix	   B).	   Lines	   on	   the	   edges	   of	   B	   and	   D	   are	   artefacts	   from	   tomogram	   generation.	  Features	   indicated	   by	   numbers	   in	   A	   and	   C	   are	   multilamellar	   membranes	   (1),	   electron	  lucent	   structures	   (2),	   lysosomes	   (3),	   structures	   containing	   granular	  material	   (4)	   percoll	  packground	  (5),	  lacy	  carbon	  support	  film	  (6).	  Scale	  bar	  100	  nm.	  	  
4.2.4 Subcellular	  fractionation	  using	  an	  Optiprep™	  gradient	  To	   circumvent	   difficulties	   with	   residual	   percoll	   in	   the	   enriched	   lysosomal	   membranes,	  alternative	  subcellular	   fractionation	  procedures	  were	   investigated.	  Optiprep™,	  a	  solution	  of	  60%	  (v/v)	  iodixanol	  can	  form	  iso-­‐osmotic	  solutions	  at	  densities	  up	  to	  1.32	  g/ml	  (Ford	  et	  
al.,	   1994),	   and	   so	   is	   also	   suitable	   for	   separations	   of	   biological	   organelles	   (Figure	   4-­‐14).	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Subcellular	  fractionation	  was	  performed	  using	  a	  modified	  version	  of	  a	  published	  protocol	  (Section	  2.7.5)(Schmidt	  et	  al.,	  2009).	  Firstly,	  primary	  organelle	  enrichment	  was	  performed	  by	  differential	  centrifugation	  to	  obtain	  a	  fraction	  enriched	  in	  lysosomes,	  mitochondria	  and	  endoplasmic	   reticulum,	   known	   as	   the	   crude	   lysosomal	   pellet	   (CLP).	   These	   were	   then	  separated	   on	   a	   discontinuous	   Optiprep™	   gradient.	   Six	   fractions	   were	   collected	   at	   the	  individual	  interphases	  between	  different	  densities	  of	  Optiprep™.	  These	  were	  concentrated	  by	   centrifugation,	   and	  used	   for	   subsequent	   analysis	   (Figure	   4-­‐14).	   Enzymatic	   activity	   of	  NAGA	   enzyme	   was	   assessed	   in	   each	   fraction,	   and	   demonstrated	   that	   fraction	   two	   was	  most	  highly	  enriched	  in	  NAGA	  activity,	   indicating	  this	   fraction	  is	  most	  highly	  enriched	  in	  lysosomes.	   This	   was	   corroborated	   by	   western	   blotting	   against	   the	   lysosomal	   marker	  cathepsin	  D.	  Complex	  1,	  a	  mitochondrial	  marker,	  localised	  to	  fraction	  five	  on	  the	  gradient,	  indicating	  this	  Optiprep™	  gradient	  was	  able	  to	  separate	  lysosomes	  from	  contaminants.	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Figure	   4-­‐14	   Subcellular	   fractionation	   of	   RAW	   264.7	   cells	   PNS	   on	   an	   Optiprep™	  
gradient.	  A)	  Structure	  of	  iodixanol.	  Optiprep™	  is	  formed	  from	  a	  60	  %	  (v/v)	  iodixanol.	  B)	  Schematic	   of	   discontinuous	   Optiprep™	   gradient.	   CLP	   was	   resuspended	   to	   19	   %	   (v/v)	  Optiprep™	   and	   loaded	   between	   22.5	   and	   16%	   layers	   into	   a	   discontinuous	   gradient	   of	  27,22.5,16,12,8	   %	   (v/v)	   Optiprep™,	   with	   the	   densest	   fractions	   at	   the	   bottom	   of	   the	  ultracentrifuge	  tube.	  6	  x	  200	  μl	  fractions	  were	  collected	  as	  indicated.	  Fraction	  1	  represents	  the	  top	  of	   the	  gradient	  (least	  dense),	   fraction	  6	  the	  bottom	  of	   the	  gradient.	  C)	  Activity	  of	  NAGA	  across	   fractions.	  Error	  bars	   represent	  standard	  deviation	  of	  3	   replicates,	  which	   in	  some	   cases	   are	   smaller	   than	   the	   marker.	   D)	   Fractions	   were	   immunoblotted	   with	  antibodies	   specific	   for	   cathepsin	   D	   (lysosomal	   marker)	   and	   Complex	   I	   (mitochondrial	  marker).	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4.2.4.1 Morphological	   characterisation	   of	   membranes	   from	   Optiprep™	  
gradient	  Cryo-­‐EM	  was	  used	  to	  image	  fractions	  from	  the	  Optiprep™	  gradient.	  Unlike	  fractionation	  on	  a	  percoll	  gradient,	  2D	  images	  of	  all	  fractions	  from	  an	  Optiprep™	  gradient	  had	  no	  obvious	  background	   contamination,	   enabling	   some	   organelles	   and	   cellular	   components	   such	   as	  cytoskeleton	   to	   be	  morphologically	   identified	   through	   2D	   cryo-­‐EM	   images	   (Figure	   4-­‐15,	  Figure	   4-­‐16).	  Multivesicular	   bodies	   are	   single	  membrane	   bound	   organelles	   that	   contain	  intraluminal	   vesicles	   of	   varying	   sizes,	   a	   feature	   which	   is	   clearly	   identifiable	   in	   the	   EM	  (Figure	  4-­‐15,	  1)(Piper,	  2007).	  During	  ball	  bearing	  homogenisation	  and	  centrifugation,	  the	  endoplasmic	  reticulum	  vesiculates,	  producing	  artificial	  structures	  known	  as	  microsomes.	  Where	  these	  are	  formed	  from	  rough	  endoplasmic	  reticulum,	  the	  resulting	  membranes	  are	  studded	  with	  ribosomes	  (Figure	  4-­‐15,	  2).	  Some	  structures	  are	  regularly	  observed	  but	  are	  not	   clearly	   identifiable	   from	   their	  morphology.	   One	   such	   structure	   is	   bound	   by	   a	   single	  membrane,	  with	  an	  often-­‐elongated	  appearance,	  containing	  material	  that	  gives	  a	  striated	  appearance,	  highly	  similar	  to	  structures	  seen	  in	  the	  percoll	  gradient	  (Figure	  4-­‐12,	  Figure	  4-­‐15,	   3).	   These	   structures	   could	   be	   products	   of	   the	   homogenisation	   and	   centrifugation	  processes,	  such	  as	  microsomes.	  Their	  identity	  will	  be	  discussed	  further	  in	  Section	  4.2.4.4.	  Mitochondria	  are	  easily	  identified	  by	  their	  double	  membrane	  and	  cristae	  (Figure	  4-­‐15,	  4).	  Lysosomes	   are	   morphologically	   heterogeneous	   and	   resemble	   other	   organelles	   on	   the	  endocytic	   pathway,	   and	   as	   a	   result	   are	   often	   functionally	   rather	   than	   morphologically	  defined.	  Functionally,	  lysosomes	  are	  acidic	  organelles	  that	  contain	  mature	  acid-­‐dependent	  hydrolases	  and	  lysosome-­‐associated	  membrane	  glycoproteins	  (LAMPs)	  but	  lack	  mannose	  6-­‐phosphate	  receptors	  (MPRs)	  (Dell'Angelica	  et	  al.,	  2000).	  The	  organelles	  shown	  in	  Figure	  4-­‐15,	  5	  are	  consistent	  with	  previously	  described	  lysosome	  morphologies,	  and	  are	  enriched	  in	   lysosomal	   markers.	   Non-­‐membrane	   bound	   cellular	   components	   can	   also	   be	  morphologically	  identified,	  such	  as	  cytoskeletal	  filaments	  including	  actin	  and	  microtubules	  (Figure	  4-­‐16,	  A,B).	  When	  imaging	  of	  cruder	  cell	  fractions,	  a	  background	  of	  macromolecular	  complexes	  was	  seen	  (Figure	  4-­‐16,	  C),	  	  	  	  As	  many	   different	   cellular	   components	   can	   be	   identified	   by	   their	  morphology,	   fractions	  were	   imaged	   using	   cryo-­‐EM.	   Fraction	   numbers	   correspond	   to	   those	   in	   Figure	   4-­‐14.	  Imaging	   by	   cryo-­‐EM	  provides	   a	   qualitative	   indication	   of	   the	   success	   of	   the	   fractionation	  process,	   to	   complement	   biochemical	   analysis.	   Imaging	   of	   whole	   cell	   lysate	   and	   PNS	  revealed	   the	   expected	   diverse	   range	   of	   organelles	   and	   cellular	   components,	   including	  mitochondria,	  microsomes	  and	  cytoskeleton	  (Figure	  4-­‐17,	  4-­‐18).	  The	  CLP	  is	  generated	  by	  centrifugation	   of	   the	   PNS,	   separating	   denser	   organelles	   including	   lysosomes	   and	  mitochondria,	   from	   lighter	   membranes	   such	   as	   the	   plasma	   membrane	   and	   soluble	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4.2.4.2 Subcellular	  fractionation	  of	  cells	  exposed	  to	  β2m	  Ls-­‐f	  It	   has	   been	   shown	   previously	   that	   β2m	   amyloid	   fibrils	   are	   endocytosed	   by	   RAW	   264.7	  cells,	  and	  trafficked	  to	  the	  lysosome,	  where	  they	  retain	  an	  amyloid	  conformation	  as	  judged	  by	   their	   ability	   to	   bind	   NIAD-­‐4	   (Section	   4.2.1).	   To	   investigate	   the	   interactions	   between	  amyloid	  fibrils	  and	  lysosomal	  membranes,	  cells	  were	  incubated	  with	  Ls-­‐f	  β2m	  fibrils	  (fibril	  fed),	   or	   pH	  2.0	   fibril	   growth	  buffer	   (control)	   for	   24	  h	   before	   cell	   harvesting.	   Subcellular	  fractionation	  was	  performed	  on	  a	  discontinuous	  Optiprep™	  gradient	  as	  in	  Section	  4.2.4.	  	  	  The	   control	   fractionation	   displayed	   a	   similar	   distribution	   of	   subcellular	   components	   as	  previously	   presented	   (Figure	   4-­‐14),	   with	   fraction	   two	   most	   highly	   enriched	   in	   the	  lysosomal	  markers	  cathepsin	  D	  and	  NAGA	  enzyme,	  while	   fraction	  5	   is	  highly	  enriched	   in	  mitochondrial	   marker	   Complex	   I.	   However,	   upon	   exposure	   of	   cells	   to	   Ls-­‐f	   β2m	   fibrils,	  biochemical	   markers	   migrated	   differently	   within	   the	   gradient.	   Lysosomal	   markers	  (Cathepsin	  D	  and	  NAGA	  enzyme)	  were	  both	  present	  fraction	  one,	  two	  and	  three,	  compared	  with	   the	   control	   gradient,	   while	   lysosomal	   markers	   were	   almost	   exclusively	   present	   in	  fractions	  one	  and	  two.	  Both	  NAGA	  and	  cathepsin	  D	  are	  soluble	  lysosomal	  proteins,	  and	  so	  their	   presence	   in	   fraction	   one	   may	   be	   due	   to	   a	   proportion	   of	   lysosomes	   becoming	  structurally	  compromised,	  and	  leaking,	  which	  then	  localise	  to	  the	  top	  the	  gradient	  due	  to	  their	   low	   density.	   However,	   it	   was	   demonstrated	   in	   Section	   4.2.1	   that	   Ls-­‐f	   β2m	   fibrils	  trafficked	   to	   the	   lysosome,	   so	   the	   fibrillar	   amyloid	   cargo	  may	   change	   the	   density	   of	   the	  lysosomes,	   altering	   their	   position	   in	   the	   gradient.	   To	   monitor	   the	   location	   of	   Ls-­‐f	   β2m	  fibrils	  across	  the	  gradient,	  western	  blotting	  with	  an	  anti-­‐β2m	  antibody	  was	  performed.	  In	  control	   samples,	   no	   bands	   were	   observed;	   indicating	   endogenous	   expression	   of	   β2m	   is	  undetectable	   at	   the	   concentrations	   isolated	   from	   the	   gradient.	   In	   the	   sample	   exposed	   to	  Ls-­‐f	   fibrils,	   β2m	  was	   shown	   primarily	   to	   localise	   to	   fractions	   three,	   five	   and	   six.	   Fibrils	  localised	  to	  fraction	  three	  may	  thus	  be	  associated	  with,	  or	  internalised	  within,	  lysosomes.	  	  	  Interestingly,	  in	  fibril	  fed	  samples,	  Complex	  I	  also	  changed	  its	  distribution	  in	  the	  gradient.	  While	   the	   highest	   levels	   of	   enrichment	   were	   observed	   in	   fraction	   five,	   as	   seen	   in	   the	  control	  sample,	  an	  additional	  small	  band	  was	  observed	  in	  fraction	  three.	  There	  are	  several	  explanations	   for	   this.	   Firstly,	   that	   a	   small	   population	   of	   mitochondria	   have	   changed	  density,	   altering	   their	   position	   in	   the	   gradient.	   Secondly,	   the	   turnover/degradation	   of	  mitochondria	  in	  the	  cell	  could	  be	  affected,	  a	  process	  known	  as	  mitophagy.	  The	  removal	  of	  mitochondria	   requires	   two	   steps;	   firstly,	   induction	   of	   general	   autophagy	   and	   secondly,	  marking	  of	  mitochondria	  for	  selective	  autophagic	  recognition.	  Degradation	  by	  mitophagy	  relies	   on	   autophagosomes	   fusing	   with	   lysosomes.	   Complex	   I,	   present	   in	   fraction	   three,	  could	   be	   due	   to	   β2m	   amyloid	   fibrils	   inhibiting	   the	   function	   of	   lysosomal	   hydrolases,	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leading	   to	   Complex	   I	   remaining	   in	   this	   fraction.	   This	   is	   consistent	   with	   the	   previous	  observation	  that	  β2m	  amyloid	  fibrils	  inhibit	  the	  ability	  of	  the	  lysosome	  to	  degrade	  protein	  substrates	  (Jakhria	  et	  al.,	  2014).	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure	  4-­‐23	  Subcellular	  fractionation	  of	  RAW	  264.7	  cells	  on	  an	  Optiprep™	  gradient.	  Cells	  were	  either	  incubated	  with	  1.2	  μM	  final	  concentration	  Ls-­‐f	  β2m	  fibrils	  (fibril	  fed)	  or	  equivalent	   volume	  of	   pH	  2.0	   fibril	   buffer	   (control).	   CLP	  was	   resuspended	   to	  19	  %	   (v/v)	  Optiprep™	   and	   loaded	   between	   22.5	   and	   16%	   layers	   into	   a	   discontinuous	   gradient	   of	  27,22.5,16,12,6	   %	   (v/v)	   Optiprep™,	   with	   the	   densest	   fractions	   at	   the	   bottom	   of	   the	  ultracentrifuge	   tube.	  6	  x	  200	  μl	   fractions	  were	  collected	   from	  each	  gradient	  and	  assayed	  for	   NAGA	   activity	   (lysosomal	   marker).	   Fractions	   were	   immunoblotted	   with	   antibodies	  specific	   for	   cathepsin	  D	   (lysosomal	  marker)	   and	   Complex	   I	   (mitochondrial	  marker)	   and	  β2m,	  to	  follow	  the	  presence	  of	  β2m	  species	  in	  the	  gradient.	  Error	  bars	  represent	  standard	  deviation	   of	   3	   replicates,	   which	   in	   some	   cases	   are	   smaller	   than	   the	  marker.	   Fraction	   1	  represents	  the	  top	  of	  the	  gradient	  (least	  dense),	  fraction	  6	  the	  bottom	  of	  the	  gradient.	  	  	  	  	  














































4.2.4.3 2D	  imaging	  of	  Optiprep™	  fractions	  exposed	  to	  β2m	  fibrils	  As	   shown	   in	   Section	   4.2.4.1,	   enrichment	   of	   membranes	   on	   an	   Optiprep™	   gradient	   is	  compatible	   with	   imaging	   by	   cryo-­‐EM.	   To	   investigate	   β2m	   Ls-­‐f	   fibril	   interactions	   with	  membranes,	  the	  CLP	  and	  fraction	  three	  from	  an	  Optiprep™	  gradient	  was	  imaged	  by	  cryo-­‐EM	  (Figure	  4-­‐23,	  Figure	  4-­‐24).	  In	  both,	  membranes	  were	  seen	  which	  appeared	  to	  contain	  fibrillar	   material	   (Figure	   4-­‐24,	   A,B).	   To	   confirm	   that	   such	   structures	   were	   not	   a	  consequence	   of	   cells’	   exposure	   to	   a	   protein	   substrate,	   a	   CLP	   was	   generated	   from	   cells	  exposed	   to	   1.2	   μM	   β2m	   monomer	   for	   24	   h	   before	   cell	   harvesting.	   Images	   of	   this	   CLP	  revealed	   the	   usual	   range	   of	   organelles	   present,	   including	   multivesicular	   bodies	   and	  lysosomes,	  but	  no	  structures	  resembling	  β2m	  Ls-­‐f	  fibrils	  (Figure	  4-­‐25).	  	  Interestingly,	   in	   both	   the	   CLP	   and	   fraction	   three,	   β2m	   amyloid	   fibrils	   not	   confined	   by	   a	  membrane	   were	   identified.	   These	   fibrils	   are	   morphologically	   consistent	   with	   β2m	   Ls-­‐f	  fibrils,	   and	   their	   presence	   outside	   of	   membranes	   may	   be	   due	   to	   fibrils	   escaping	   the	  endocytic	   pathway	   inside	   cells	   before	   homogenisation	   and/or	   subcellular	   fractionation.	  Alternatively,	   it	   could	   be	   an	   artefact	   of	   homogenisation	   and/or	   centrifugation,	   which	   is	  know	  to	  perturb	  cellular	  membranes	  and	  can	  generate	  structures	  not	  present	  inside	  cells,	  such	   as	   microsomes.	   Finally,	   it	   could	   be	   a	   result	   of	   fibril	   clumps	   associating	   with	   the	  plasma	   membrane.	   Although	   the	   cells	   are	   washed	   thoroughly	   before	   homogenisation,	  confocal	   imaging	   shows	   some	   fibrils	   remain	   associated	   (Section	   4.2.1).	   Consistent	   with	  imaging	  of	  β2m	  in	  cell	  culture	  medium	  (Section	  4.2.2),	  fibrils	  outside	  of	  membranes	  were	  bundled,	   and	   were	   always	   seen	   in	   association	   with	   membranes.	   Some	   of	   these	  interactions,	   such	   as	   in	   Figure	   4-­‐24	   C,	   are	   reminiscent	   of	   side-­‐on	   interactions	   seen	   by	  Milanesi	  et	  al	  when	  imaging	  synthetic	   liposomes	   interacting	  with	  β2m	  fibrils	  (Milanesi	  et	  




Figure	  4-­‐24	  2D	  cryo-­‐EM	  images	  of	   fractionated	  RAW	  264.7	  cells	  exposed	  to	  1.2	  μM	  





Figure	  4-­‐25	  Imaging	  of	  membranes	  form	  CLP	  of	  RAW	  264.7	  cells	  exposed	  to	  1.2	  μM	  
β2m	  monomer	  for	  24	  h	  before	  cell	  harvesting	  and	  processing.	  A)	  Multivesicular	  body	  B)	  Lysosome.	  Scale	  bar	  200	  nm.	  	  
4.2.4.4 Imaging	  Optiprep™	  fractions	  in	  3D	  CLP	  enriched	   fraction	   from	  RAW	  264.7	  cells	  exposed	   to	  1.2	  μM	  β2m	  Ls-­‐f	   for	  24	  h	  before	  cell	   harvesting	   and	   processing	   was	   imaged	   by	   cryo-­‐ET.	   ET	   was	   performed	   at	   Birkbeck	  College	   on	   an	   FEI	   Polara	  microscope	   equipped	  with	   an	   energy-­‐filtered	  K2	  DED	  with	   tilt	  series	  collected	  at	  ±60°,	  and	  processed	  into	  tomograms	  using	  Imod	  (Section	  2.14.2).	  	  	  To	   visualise	   interactions	   more	   clearly	   (Figure	   4-­‐26),	   tomograms	   were	   segmented	   in	   a	  semi-­‐automated	   fashion	   using	   Amira	   (Section	   2.14.3).	   Tomograms	   were	   first	   filtered	  (Figure	  4-­‐26	  B),	   and	   then	   the	   interactive	   thresholding	   tool	  was	  used	   to	   select	  density	   in	  each	  2D	  Section	  through	  the	  tomogram	  (Figure	  4-­‐26	  C).	  In	  2D	  projection	  images,	  features	  can	  overlap	  and	  interpretation	  can	  be	  impossible,	  but	  such	  difficulties	  are	  much	  reduced	  in	  3D	  (Figure	  4-­‐26	  B).	  To	  aid	   interpretation	  of	   the	  3D	  volumes,	  voxels	  of	   interest	  can	  be	  assigned	   as	   specific	   materials,	   such	   as	   membranes	   or	   amyloid	   fibrils	   and	   displayed	  separately.	   In	   the	   tomogram	   in	   Figure	   4-­‐26,	   voxels	   were	   either	   assigned	   to	   membrane	  (blue)	  or	   fibril	   (green).	  The	  β2m	  amyloid	   fibril	  shown	  is	  morphologically	  consistent	  with	  previous	  reports	  of	  fibril	  dimensions,	  including	  a	  visible	  twist.	  The	  fibril	  is	  seen	  interacting	  in	  an	  end-­‐on	  fashion	  with	  the	  biological	  membrane.	  A	  reduction	  in	  density	  associated	  with	  the	  membrane	  is	  observed	  at	  the	  point	  where	  the	  fibril	  meets	  the	  membrane.	  Within	  the	  membrane,	  integral	  membrane	  proteins	  are	  also	  observed	  (Figure	  4-­‐27).	  	  	  In	   2D,	   imaging	   of	   enriched	   lysosomal	   populations	   from	   both	   percoll	   and	   Optiprep™	  gradients,	  and	  imaging	  of	  the	  CLP,	  revealed	  membrane	  compartments	  containing	  striated	  material	  (Figure	  4-­‐12,Figure	  4-­‐15).	  The	  morphology	  of	  these	  structures	  does	  not	  resemble	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any	   known	   organelle,	   and	   so	   it	   was	   hypothesised	   that	   they	   were	   a	   product	   of	   cellular	  homogenisation	  and/or	   the	   centrifugation	  process.	  Cryo-­‐ET	  of	   these	   structures	   revealed	  that	   the	   dimensions	   of	   this	   striated	   material	   within	   these	   structures	   is	   consistent	   with	  actin,	  with	  a	  diameter	  of	  ~	  7	  nm	  (Figure	  4-­‐28).	  RAW	  267.4	  cells	  are	  a	  motile	  cell	  line	  that	  uses	  actin	  to	  generate	   lamellipodia	  and	  other	  structures	  during	  cell	  motility	  (S.	  Müller	  et	  




Figure	   4-­‐26	   Cryo-­‐ET	   and	   tomogram	   segmentation	   of	   CLP	   from	   RAW	   264.7	   cells	  
exposed	  to	  1.2	  μM	  monomer	  equivalent	  Ls-­‐f	  β2m	  fibrils	  24	  h	  before	  cell	  harvesting	  





Figure	  4-­‐27	  Integral	  membrane	  proteins	  observed	  in	  tomogram	  visualised	  in	  Figure	  




Figure	   4-­‐28	   Tomogram	   with	   actin.	   Section	   through	   the	   tomogram	   (A).	   White	   arrow	  delineates	   the	   membrane.	   Dotted	   white	   box	   shows	   area	   where	   volume	   is	   segmented,	  shown	   in	   B.	   Approximate	   width	   of	   filaments	   (C)	   and	   crossover	   lengths	   (D).	   Crossover	  lengths	   are	   shown	   in	   pixels,	   and	   range	   from	   26	   nm	   to	   34.5	   nm	   (0.53	   nm/pixel).	   Data	  collected	  at	  Birkbeck,	  London	  (Section	  2.12.1).	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4.2.5 Methods	  for	  investigating	  amyloid	  membrane	  interactions	  in	  cells	  As	  discussed	  above,	  ball-­‐bearing	  homogenisation	  and	  subcellular	  fractionation	  may	  cause	  non-­‐native	  species	  to	  form,	  and	  existing	  membrane	  species	  to	  break	  open	  or	  fuse	  in	  a	  non-­‐native	   manner.	   As	   a	   result,	   interpretation	   of	   images	   from	   these	   fractions	   must	   always	  reflect	  the	  fact	  that	  the	  membranes	  may	  not	  be	  in	  their	  native	  state.	  As	  a	  result,	  imaging	  of	  these	   interactions	   inside	   cells	   would	   be	   preferable.	   Here	   two	   methods	   to	   image	  membranes	  inside	  cells	  are	  discussed.	  




Figure	  4-­‐29	  A	  range	  of	  cell	  lines	  can	  be	  grown	  on	  electron	  microscopy	  grids.	  A)	  Gold	  finder	   grid	  R2/2	  B)	  HeLa	   cells	   grown	  on	  Quantifoil	   gold,	   200	  mesh	  R2/2	   grids	  D)	  RAW	  264.7	  cells	  grown	  on	  Quantifoil	  gold,	  200	  mesh	  R2/2	  grids.	  D-­‐F)	  SH-­‐SY5Y	  cells	  grown	  on	  Quantifoil	  gold	  R2/2	  grids	  and	  labelled	  with	  Hoechst	  nuclear	  stain.	  Hoechst	  fluorescence	  (D),	  brightfield	  (E)	  and	  merge	  (F)	  images	  shown.	  Scale	  bar	  A-­‐C,	  10	  μm.	  Scale	  bar	  D-­‐F,	  6	  μm.	  
	  
	  
Figure	  4-­‐30	  Cryo-­‐confocal	  microscopy	  of	  RAW	  264.7	  cells	  labelled	  with	  lysotracker	  








Figure	  4-­‐31	  Cryo-­‐EM	  of	  RAW	  264.7	   cell	   (A).	  Cell	  adopts	   ‘fried	  egg’	  shape,	  where	  thick	  nuclear	  region	  of	  the	  cell	   is	  too	  thick	  for	  electrons	  to	  penetrate,	  while	  cytoplasm	  extends	  outwards.	   White	   box	   indicates	   area	   shown	   at	   increased	   magnification	   in	   B.	   Plasma	  membrane	   indicated	   by	   black	   arrow,	   internal	   vesicles	   indicated	   by	   white	   arrow	   and	  nulceus/thick	  perinuclear	  region	  by	  N.	  Scale	  bar	  2	  μm.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure	  4-­‐32	  Cryo-­‐electron	  tomography	  of	  a	  whole,	  vitrified	  SH-­‐SY5Y	  neuroblastoma	  






4.2.5.2 Soft	  X-­‐ray	  microscopy	  	  While	   cryo-­‐ET	   can	   provide	   high-­‐resolution	   (better	   than	   10	   nm)	   information,	   at	   the	  magnification	  used	  to	  achieve	  these	  resolutions,	   the	   field	  of	  view	  is	   limited.	  Additionally,	  the	   nuclear	   and	   perinuclear	   regions	   of	   eukaryotic	   cells	   are	   too	   thick	   for	   electrons	   pass	  through,	  and	  so	  are	  not	  suitable	  for	  cryo-­‐ET.	  Cryo-­‐XM	  is	  an	  alternative	  imaging	  technique	  that	  may	  be	  useful	  for	  investigating	  gross	  changes	  to	  membranes	  in	  cells	  upon	  exposure	  to	  amyloid	  fibrils.	  	  	  	  The	   B24	   beamline	   facility	   at	   Diamond	   Light	   Source	   was	   used	   to	   collect	   cryo-­‐XM	   data	  (Section	  2.13),	  where	  collection	  of	  a	  tilt	  series	  takes	  24	  h,	  and	  resolutions	  of	  better	  than	  70	  nm	  can	  be	  achieved.	  Sufficient	  time	  was	  available	  to	  collect	  a	  single	  tilt	  series	  and	  some	  2D	  images,	  as	  a	  proof	  of	  principle.	  RAW	  264.7	  cells	  were	  exposed	  to	  Ls-­‐f	  fibrils	  for	  24	  h	  before	  vitrification.	   2D	   imaging	   of	   the	   cells	   shows	   they	   adopt	   the	   same	   ‘fried	   egg’	  morphology	  that	  was	  observed	  in	  cryo-­‐EM,	  but	  X-­‐rays	  at	  these	  wavelengths	  can	  pass	  through	  the	  cell,	  allowing	   visualisation	   of	   nuclear	   and	   perinuclear	   regions	   (Figure	   4-­‐33).	   An	   interesting	  feature	  of	  these	  cells	  are	  large,	  lucent	  structures,	  which	  have	  been	  previously	  identified	  as	  endosomes	   by	   correlative	   fluorescence	   and	   cryo-­‐XM	   (Duke	   et	  al.,	   2014).	   In	   the	   cryo-­‐XM	  tomogram,	   the	   nuclear	   envelope,	   and	   several	   lucent	   structures	   were	   identified.	  Unfortunately,	  we	  were	  unable	  to	  collect	  images	  of	  cells	  not	  exposed	  to	  amyloid	  fibrils,	  and	  therefore	   cannot	   say	   if	   these	   unusual	   lucent	   structures	   form	   as	   a	   result	   of	   exposure	   to	  amyloid	  fibrils,	  or	  if	  they	  are	  simply	  a	  feature	  of	  this	  cell	  line.	  These	  images	  do,	  however,	  suggest	   that	   cryo-­‐XM	   may	   be	   a	   powerful	   and	   useful	   tool	   for	   assessing	   gross	   cellular	  response	  to	  amyloid	  fibrils.	  	  
	  




Figure	  4-­‐34	  Soft	  X-­‐ray	  tomography	  of	  RAW	  264.7	  cell	  exposed	  to	  Ls-­‐f	  β2m	  fibrils	  for	  
24	   h.	   2D	   image	   of	   cell	   (A),	  white	   dashed	   box	   is	   area	  where	   tomogram	  was	   performed.	  Section	   through	   tomogram	   is	   shown	   in	   B	   (Full	   tomogram	   ‘X-­‐ray.mov’,	   Appendix	   B)	  Features	  of	  interest	  are	  indicated,	  including	  fiducial	  marker	  (red	  arrow),	  nuclear	  envelope	  (blue	  arrow)	  and	  lucent	  structures	  (green	  arrow).	  Scale	  bar	  A,	  10	  µm.	  
4.3 Discussion	  	  While	  the	   link	  between	  amyloid	  deposition	  and	  disease	  has	  been	  known	  for	  many	  years,	  the	   mechanisms	   of	   cytotoxicity	   remain	   unclear	   (Knowles	   et	   al.,	   2014).	   Accumulating	  evidence	   suggests	   that	   amyloid	   fibrils,	   alongside	   oligomeric	   species,	   exert	   toxic	   cellular	  effects	   (Gharibyan	  et	  al.,	  2007;	  Anderluh	  et	  al.,	  2005;	  Mossuto	  et	  al.,	  2011;	  Novitskaya	  et	  
al.,	   2006).	   The	   experiments	   described	   in	   Chapters	   three	   and	   four	   have	   probed	   the	  interactions	  between	  amyloid	  fibrils	  and	  membranes	  of	  various	  compositions.	  	  
4.3.1 Intracellular	  trafficking	  of	  β2m	  amyloid	  fibrils	  Amyloid	   species	   formed	   from	   a	   variety	   of	   different	   precursor	   proteins	   applied	   to	   cells	  exogenously	  can	  gain	  access	  to	  endocytic	  compartments	  (4.1.2).	  In	  a	  disease	  context,	  many	  amyloid	   aggregates	   form	   in	   the	   extracellular	   environment,	   including	  Aβ,	   IAPP	   and	   β2m.	  Disease-­‐associated	  amyloid	  proteins	   that	   form	   intracellular	   inclusions	   in	  vivo,	  such	  as	  α-­‐synuclein,	   may	   also	   become	   internalised,	   altering	   disease	   progression.	   α-­‐synuclein	   is	  thought	   to	   be	   secreted	   into	   cerebrospinal	   fluid	   where	   it	   may	   aggregate	   prior	   to	  internalisation	  (Borghi	  et	  al.,	  2000).	  Intracellular	  α-­‐synuclein	  amyloid	  aggregates	  may	  also	  access	   the	   extracellular	   environment	   during	   neuronal	   cell	   death,	   where	   membranes	  become	   destabilised	   and	   cytosolic	   components	   leak	   from	   the	   cell.	   At	   this	   point,	  neighbouring	  cells	  may	  internalise	  these	  amyloid	  aggregates,	  allowing	  access	  to	  endocytic	  compartments	  (Mougenot	  et	  al.,	  2011;	  Angot	  et	  al.,	  2010;	  Visanji	  et	  al.,	  2013).	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With	   amyloid	   aggregates	   formed	   outside	   the	   cell	   (Aβ,	   IAPP	   and	   β2m)	   and	   those	   formed	  inside	  but	  can	  escape	  to	  the	  extracellular	  environment	  (α-­‐synuclein),	  endocytosis	  can	  lead	  to	   amyloid	   accumulating	   in	   the	   lysosome.	   Much	   evidence	   points	   towards	   lysosomal	  dysfunction	  in	  amyloid	  disease	  (Section	  4.1.2.4).	  In	  this	  Chapter,	  it	  has	  been	  demonstrated	  that	   β2m	  Ls-­‐f	   species	   are	   endocytosed	   and	   trafficked	   to	   lysosomes,	  where	   they	   retain	   a	  NIAD-­‐4	  binding	  state	  for	  at	  least	  24	  h,	  indicating	  retention	  of	  at	  least	  elements	  of	  amyloid	  structure	  (Section	  4.2.1).	  	  An	  interesting	  aspect	  of	  intracellular	  trafficking	  that	  may	  play	  a	  role	  in	  the	  transmission	  of	  toxic	  amyloid	  species	  in	  vivo	  are	  exosomes	  (Bellingham	  et	  al.,	  2012).	  Exosomes	  are	  formed	  upon	  the	  exocytosis	  of	  late	  endosomes	  (also	  known	  as	  multivesicular	  bodies)	  that	  contain	  small	  (<	  100	  nm)	  intraluminal	  vesicles,	  which	  can	  contain	  protein	  and	  nucleic	  acid	  cargo.	  Upon	   exocytosis,	   these	   intraluminal	   vesicles	   are	   known	   as	   exosomes.	   Aβ-­‐containing	  exosomes	  may	  fuse	  with	  the	  plasma	  membranes	  of	  recipient	  cells,	  causing	  the	  release	  of	  potentially	   toxic	   cargo	   into	   the	   cytoplasm	   (Bellingham	   et	   al.,	   2012).	   Aβ-­‐containing	  exosomes	  may	  also	  play	  a	  role	  in	  plaque	  formation,	  exosomal	  proteins	  including	  Alix	  and	  Flotillin-­‐1	  have	  been	  found	  in	  plaques	  isolated	  from	  the	  brains	  of	  AD	  patients,	  suggesting	  exosomes	  may	  traffic	  Aβ	  (Rajendran	  et	  al.,	  2006).	  As	  β2m	  fibrils	  are	  known	  to	  be	  trafficked	  along	   the	   endocytic	   pathway,	   it	   may	   be	   interesting	   to	   investigate	   the	   potential	   role	   of	  exosomes	  in	  trafficking	  of	  β2m	  amyloid	  species.	  	  
4.3.2 Different	   membrane	   species	   enriched	   by	   percoll	   and	   Optiprep™	  
gradients	  Here,	   subcellular	   fractionation	   of	   homogenised	   RAW	   264.7	   on	   percoll	   and	   Optiprep™	  gradients	  was	  performed.	  Biochemical	  assays	  (both	  enzyme	  assays	  and	  immunoblotting),	  enabled	  fractions	  to	  be	  identified	  as	  enriched	  for	  lysosomes,	  and	  depleted	  in	  other	  cellular	  membranes.	   Interestingly,	   cryo-­‐EM	   of	   these	   enriched	   lysosomal	   fractions	   from	   different	  gradient	   systems	   showed	   differences	   in	   the	   morphology	   of	   species	   present.	   Enriched	  lysosomal	   fractions	   from	   a	   percoll	   gradient	   possessed	   many	   multilamellar	   species,	   and	  membranes	   containing	   granular	   material,	   which	   were	   absent	   from	   equivalent	   fractions	  from	   an	  Optiprep™	   gradient,	   or	   the	   CLP.	   One	   challenge	  with	   subcellular	   fractionation	   is	  that	  biochemical	  assessment	  of	  membrane	  preparations	  only	  gives	  a	  global	   indication	  of	  the	   cellular	   markers	   present.	   Even	   where	   high	   levels	   of	   enrichment	   in	   a	   particular	  membrane	  are	   seen,	  unambiguous	   identification	  of	   a	  particular	   structure	  as	   a	  particular	  organelle	  can	  be	   impossible	  by	  cryo-­‐EM,	  unless	  a	  distinctive	  morphology	   is	  observed	  (as	  for	  mitochondria).	   Lysosomes	   are	   traditionally	   defined	   functionally,	   can	   exhibit	   a	   broad	  range	  of	  morphologies,	  and	  are	  potentially	  difficult	  to	  separate	  from	  other	  membranes	  in	  the	   endocytic	   pathway	   such	   as	   early	   endosomes	   and	   multivesicular	   bodies	   (late	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endosomes).	  Here,	   relatively	   few	   cellular	  markers	  were	   used	   to	   characterise	  membrane	  separation	   on	   gradients.	   Differences	   in	   the	   membranes	   isolated	   from	   the	   two	   gradient	  systems	  could	  be	  due	  to	  the	  range	  of	  organelle	  morphologies	  present	  in	  the	  cell	  displaying	  different	   buoyancies	   in	   percoll	   and	   Optiprep™,	   leading	   to	   poor	   separation.	   Given	   that	  lysosomes	   sediment	   towards	   the	   bottom	   of	   percoll	   gradients,	   and	   towards	   the	   top	   of	  Optiprep™	  gradients,	  it	  is	  likely	  that	  this	  rationalises	  at	  least	  some	  of	  the	  differences	  seen	  between	   the	   two	   gradient	   systems.	   As	   a	   subset	   of	   morphologies	   are	   conserved	   in	   the	  enriched	  lysosomal	  fraction	  from	  both	  gradient	  systems,	  this	  increases	  confidence	  that	  the	  qualitatively	   assessed	   most	   commonly	   observed	   species	   in	   both	   gradients,	   single	  membrane	  bound	  organelles	  with	  dark	  interior,	  are	  lysosomal	  species.	  	  
4.3.3 Creation	   of	   non-­‐native	   membranes	   through	   homogenisation	   and	  
centrifugation	  As	  discussed	   in	  Section	  4.2.4.4,	   some	  structures	  observed	  by	   cryo-­‐ET	  do	  not	   conform	   to	  known	  cellular	  organelle	  morphologies.	  It	  is	  known	  that	  ball	  bearing	  cell	  homogenisation,	  as	  well	  as	  centrifugation,	  can	  cause	  organelles	  such	  as	  the	  ER	  to	  undergo	  vesiculation	  into	  non-­‐native	   structures.	   The	   membrane	   leaflet	   of	   the	   resulting	   microsomes	   may	   be	  orientated	  the	  same	  as	  in	  the	  cellular	  environment,	  be	  inside	  out,	  or	  a	  chimera	  of	  different	  membranes	   (Stillwell,	  2013).	  Here,	  membrane-­‐bound	  structures	   that	  most	   likely	  contain	  actin	   may	   be	   a	   product	   of	   homogenising	   cells	   that	   contain	   an	   extensive	   network	   of	  cytoskeletal	  actin	  filaments.	  The	  identity	  of	  the	  striated	  cargo	  could	  be	  made	  as	  fractions	  were	   imaged	   using	   cryo-­‐EM,	   which	   provided	   sufficient	   resolution	   to	   characterise	   the	  cargo.	   This	   is	   the	   first	   time	   structures	   such	   as	   these	   have	   been	   described.	   Biochemical	  characterisation	  of	  the	  gradient	  would	  not	  have	  revealed	  the	  identity	  of	  these	  non-­‐native	  structures,	   illustrating	   the	   power	   of	   using	   cryo-­‐EM	   to	   characterise	   subcellular	   fractions.	  Additionally,	   this	   shows	   clearly	   that	   great	   care	   should	   be	   taken	   when	   performing	   cell	  homogenisation	   and	   subcellular	   fractionation	   to	   minimise	   the	   formation	   of	   non-­‐native	  species,	  although	  it	  is	  likely	  that	  procedures	  to	  disrupt	  cells	  will	  result	  in	  some	  non-­‐native	  structures	   forming.	   Cryo-­‐EM	   can	   be	   a	   valuable	   tool	   for	   assessing	   the	   morphology	   of	  species	  present	  in	  sub-­‐cellular	  fractions.	  
4.3.4 Propensity	   of	   amyloid	   fibrils	   to	   disrupt	   synthetic	   vs	   biological	  
membranes	  In	  Chapter	  three,	  the	  liposome	  dye	  release	  assay	  was	  used	  to	  assess	  the	  propensity	  of	  β2m	  amyloid	  fibrils	  to	  disrupt	  synthetic	  liposomes.	  This	  revealed	  that	  LUVs	  formed	  from	  lipids	  more	   accurately	   reflecting	   average	   biological	   membranes	   are	   not	   perturbed	   by	   β2m	  amyloid	   fibrils,	   while	   synthetic	   LUVs	   enriched	   in	   BMP	   are	   highly	   susceptible	   to	  perturbation	  under	  the	  same	  conditions.	  In	  this	  Chapter,	  biochemical	  assays	  to	  detect	  the	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location	   of	   soluble	   lysosomal	   proteins,	   alongside	   visualisation	   of	   fibril	   interactions	  with	  biological	  membranes	  showed	  that	  fibrils	  interact	  with	  biological	  membranes.	   	  Both	  end-­‐on	   and	   side-­‐on	   interactions	   were	   observed,	   as	   previously	   described	   for	   synthetic	  liposomes	  (Milanesi	  et	  al.,	  2012).	  These	  observations	  could	  help	  rationalise	  discrepancies	  between	  liposome	  dye	  release	  data	  and	  cell-­‐based	  experiments	  using	  β2m	  fibrils.	  In	  vitro	  liposome	   dye	   release	   assays	   performed	   in	   Chapter	   three	   demonstrate	   that	   β2m	   fibrils	  perturb	   synthetic	   LUVs	   enriched	   in	   the	   anionic	   lipid	   BMP	   under	   acidic	   conditions,	  reflecting	   conditions	   found	   in	   late	   endosomes	   and	   lysosomes	   of	   cells.	   However,	   in	   cell-­‐based	   assays	   on	   SH-­‐SY5Y	   cells	   treated	   with	   β2m	   fibrils,	   no	   detectable	   increases	   in	  lysosomal	  membrane	  permeability	  were	  seen,	  indicating	  gross	  membrane	  perturbation	  is	  not	   occurring	   (Jakhria	   et	   al.,	   2014).	   These	   results	   demonstrate	   that	   extreme	   caution	  should	  be	  applied,	  both	  in	  choosing	  an	  appropriate	  model	  lipid	  system	  to	  study	  amyloid-­‐lipid	  interactions,	  and	  in	  interpreting	  these	  results	  in	  a	  cellular	  context.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  




4.3.5 Summary	  and	  future	  perspectives	  	  In	  summary,	  work	  in	  Chapters	  three	  and	  four	  demonstrates	  that	  the	  interactions	  between	  β2m	   amyloid	   fibrils	   and	   synthetic	   liposomes	   or	   biological	   membranes	   are	   profoundly	  different.	   Biological	   membranes	   appear	   to	   be	   more	   resistant	   to	   perturbation	   by	   β2m	  amyloid	   fibrils	   than	   their	   synthetic	   membrane	   counterparts.	   These	   findings	   rationalise	  previous	  studies	  which	  have	  found	  that	  synthetic	  LUVs	  resembling	  lysosomal	  membranes	  are	  perturbed	  by	  Ls-­‐f	  β2m	  fibrils,	  while	  no	  disruption	  of	  lysosomal	  membranes	  is	  detected	  in	  cells	  (Goodchild	  et	  al.,	  2014;	  Jakhria	  et	  al.,	  2014).	  	  	  Over	  the	  period	  of	  this	  project,	  imaging	  technologies	  have	  developed	  rapidly.	  This	  chapter	  describes	   progress	   towards	   understanding	   the	   nature	   of	   amyloid	   fibril-­‐biological	  membrane	  interactions,	  but	  this	  does	  not	  yet	  allow	  us	  to	  draw	  extensive	  conclusions	  about	  their	  behaviour	   in	   cells.	  However,	   the	  new	   technologies	  described	  above,	   such	  as	  CLEM,	  cryo-­‐ET	  at	  the	  thin	  edge	  of	  cells,	  and	  cryo-­‐XM,	  would	  be	  powerful	  tools	  to	  investigate	  the	  nature	  of	  membrane-­‐fibril	  interactions	  inside	  cells	  (Section	  4.2.5).	  Fluorescent	  co-­‐labelling	  of	   lysosomal	   compartments	   and	   amyloid	   fibrils	   would	   enable	   lysosomes	   containing	  material	   of	   interest	   to	   be	   identified	   unambiguously,	   and	   in	   a	   cellular	   setting.	   Beyond	  imaging	   the	   thin	   edge	   of	   the	   cell,	   FIB	   milling	   could	   be	   used	   to	   generate	   a	   thin	   section	  through	  a	  vitrified	  cell	  for	  cryo-­‐ET,	  allowing	  3D	  structure	  determination	  in	  the	  nuclear	  and	  perinuclear	   regions.	   Future	   work	   seems	   almost	   certain	   to	   make	   use	   of	   these	   emerging	  imaging	  technologies	  to	  offer	  exciting	  opportunities	  to	  extend	  the	  work	  carried	  out	  in	  this	  thesis.	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Figure	  5-­‐1	  History	  of	  virus	  structure	  determination	  by	  EM.	  Early	  example	  of	  negative	  staining	   (A)	   TMV	   embedded	   in	   phosphotungstic	   acid,	   adapted	   from	   (Brenner	   &	   Horne,	  1959).	  3D	  reconstruction	  of	  rotavirus	  (shown	  in	  B)	  VP6	  to	  2.6	  Å,	  with	  the	  docked	  atomic	  model	  (C).	  B,C	  adapted	  from	  Grant	  &	  Grigorieff,	  2015.	  
5.1.1 The	  life	  of	  an	  obligate,	  intracellular	  parasite	  Viruses	   survive	   and	   replicate	   by	   subverting	   their	   host	   cells’	  machinery	   to	   produce	   new	  viral	   particles	   that	   are	   capable	   of	   infecting	   another	   host	   cell.	   Viruses	   are	   ubiquitous,	  infecting	   all	  Kingdoms	  of	   life.	  Metagenomic	   analysis	   of	   environments	   from	  pristine	   artic	  lakes,	   to	   fecal	   samples	   and	   sewage	   shows	   that	  many	   viruses	   persist	   in	   an	   extracellular	  environment,	  and	  there	  are	  likely	  a	  vast	  number	  of	  uncharacterised	  viruses	  (Cantalupo	  et	  
al.,	   2011).	   The	   study	   of	   viruses	   is	   important	   for	   human	   health,	   and	   because	   of	   their	  impacts	  on	  animal	  and	  plant	  health,	  which	  have	  huge	  in	  implications	  for	  food	  security	  and	  the	  agriculture	  economy.	  	  
5.1.2 Virus	  classification	  The	  most	  common	  scheme	  for	  virus	  classification	  is	  from	  the	  International	  Committee	  on	  Taxonomy	   of	   Viruses	   (ICTV),	   which	   uses	   genome	   sequence,	   biochemistry,	   structural	  biology	  and	  host	   to	  classify	  viruses.	   ICTV	  defines	  orders,	   families,	  subfamilies,	  genra	  and	  species.	   Order	   principally	   describes	   the	   genome	   type	   and	   particle	   morphology.	   Nucleic	  acid	  sequence	  is	  generally	  only	  useful	  within	  families	  due	  to	  high	  rates	  of	  genome	  change.	  Virus	   evolution	   at	   both	   the	   protein	   or	   nucleic	   acid	   sequence	   level	   may	   be	   very	   high;	  especially	   within	   viruses	   with	   RNA	   genomes,	   as	   RNA	   polymerases	   lack	   proofreading	  mechanisms	  (Holmes,	  2003).	  	  	  Schemes	  for	  classification	  have	  also	  been	  suggested	  that	  are	  based	  on	  the	  structure	  of	  the	  capsid	   used	   to	   package	   the	   genome.	   The	   rationale	   is	   that	   as	   there	   is	   a	   high	   level	   of	  redundancy	  in	  sequence-­‐structure	  space,	   it	   is	  the	  structure	  of	  the	  capsid	  that	  is	  the	  most	  persistent	   feature	   of	   a	   particular	   virus.	   The	   authors	   claim	   to	   identify	   more	   distant	  evolutionary	  relationships	  than	  is	  possible	  via	  sequence-­‐based	  methods	  alone.	  Using	  this	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approach,	  four	  major	  evolutionary	  lineages	  were	  defined;	  Blue	  Tongue	  Virus-­‐like,	  PRD1	  or	  adenovirus	  like,	  HK97-­‐like,	  and	  Picorna-­‐like	  lineages	  (Butcher	  et	  al.,	  2011;	  Abrescia	  et	  al.,	  2012).	  
5.1.3 Virus	  morphology	  A	   range	   of	   viral	   morphologies	   exist,	   broadly	   split	   into	   isometric	   or	   spherical,	   such	   as	  Poliovirus;	  filamentous	  or	  rod-­‐shaped	  such	  as	  tobacco	  mosaic	  virus;	  or	  pleomorphic	  such	  as	  HIV	  and	  influenza.	  The	  protein	  assemblies	  of	  each	  morphology	  protect	  the	  genome,	  and	  are	   composed	   from	   multiple	   copies	   of	   a	   single,	   or	   small	   number	   of	   different,	   protein	  subunits.	  This	   is	  an	  elegant	  solution	  to	  the	  problem	  of	   ‘genetic	  economy’	   that	   faces	  most	  viruses.	   A	   single	   (or	   small	   number	   of)	   protein(s),	   that	   has	   the	   capacity	   to	   self-­‐interact	  means	   that	   large,	   highly	   symmetric	   capsids	   can	   be	   built	   from	   a	   simple	   building	   block.	  Utilisation	   of	   symmetry	   means	   that	   only	   a	   few	   simple,	   local	   rules	   of	   association	   are	  required,	  and	   these	  can	  be	  encoded	   in	  a	   single	  protein.	  The	   icosahedron	  has	   the	  highest	  closed	   point	   group	   symmetry	   of	   all	   shapes,	   allowing	   the	   highest	   internal	   volume	   for	   a	  given	  subunit	  size	  (Figure	  5.2).	  	  Only	   a	   small	   number	   of	   protein	   folds	   are	   currently	   known	   to	   form	   viral	   capsids.	   This	  includes	   	   the	   jelly-­‐roll	  β	  barrel	   (e.g.	   tomato	  bushy	  stunt	  virus	  (TBSV))	  and	  the	   four-­‐helix	  bundle	   (e.g.	   tobacco	  mosaic	  virus)	   (Chapman	  &	  Liljas,	  2003).	  These	  units	  can	   interact	   to	  self-­‐assemble	   into	   symmetrical	   structures	   based	   on	   the	   structural	   and	   energetic	  complementarity	  of	  their	  surfaces.	  The	  most	  common	  fold	  found	  in	  virus	  capsid	  is	  the	  β-­‐sandwich	   fold	   (Harrison	   et	   al.,	   1978).	   At	   the	   core	   of	   this	   fold	   are	   eight	   antiparallel	   β-­‐strands,	   arranged	   into	   two	   sheets	   that	   associate	   via	   hydrophobic	   residues	   to	   form	   the	  barrel.	   Outside	   of	   this	   core	   region,	   N-­‐	   and	   C-­‐termini	   and	   loop	   regions	   between	   the	   β-­‐strands	   are	   highly	   variable	   from	   virus	   to	   virus,	   but	   often	   have	   specific	   functional	   roles	  (Liljas,	   2004).	   Because	   of	   sequence-­‐structure	   redundancy,	   two	   viruses	   that	   have	   high	  levels	   of	   structural	   homology,	   may	   be	   not	   appear	   to	   be	   related	   at	   the	   sequence	   level,	  highlighting	  the	  need	  for	  structural	  studies	  on	  viruses.	  	  	  Around	   half	   of	   characterised	   virus	   families	   have	   capsids	   with	   icosahedral	   symmetry	  (Zlotnick	   et	   al.,	   2000).	   Icosahedrons	   can	   be	   simply	   built	   from	   protein	   subunits	   if	   three	  identical	  subunits	  are	  placed	  in	  symmetry-­‐related	  positions	   in	  each	  triangular	   face.	  They	  are	   thus	   minimally	   composed	   of	   60	   equivalent	   (or	   asymmetric)	   units,	   with	   5:3:2	  symmetry.	  The	  simplest	  viruses	  follow	  precisely	  this	  arrangement,	  such	  as	  seen	  in	  the	  X-­‐ray	  crystallography	  structure	  of	  satellite	  tobacco	  necrosis	  virus	  (Larson	  et	  al.,	  1998).	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Figure	   5-­‐3	   Formation	   of	   a	   T=3	   (h,k=1,1)	   icosohedron	   from	   a	   hexagonal	   lattice.	   A	  hexagonal	  lattice	  (top)	  has	  two	  vectors	  termed	  h	  and	  k	  separated	  by	  60°	  from	  an	  arbitrary	  origin.	  An	   equilateral	   triangle	   is	   defined	   in	   grey	   on	   the	  hexagonal	   lattice	  with	   one	   of	   its	  vertices	  at	   the	  point	  of	  origin	  of	  one	  of	   the	  vectors.	  This	   initial	   triangle	  placement	  seeds	  how	   the	   next	   19	   triangles	   lie.	   This	   triangular	   pattern	   can	   then	   be	   folded	   to	   form	   the	  icosohedron.	  Adapted	  from	  	  Baker	  et	  al.,	  1999.	  	  The	   ability	   of	   viral	   coat	   proteins	   to	   adopt	   quasi-­‐equivalent	   positions	   in	   a	   lattice	   that	  tessellates	   the	   surface	   of	   a	   spherical	   capsid	   is	   fundamental	   to	   the	   diversity	   of	   size	   and	  architectures	   found	   in	   the	   virosphere.	   Subtle	  differences	   in	  bonding	  between	   the	   capsid	  subunits	  allow	  triangulation	  to	  occur.	  Conformational	  switching	  determines	  the	  role	  each	  subunit	   plays	   within	   the	   lattice.	   In	   T=3	   viruses,	   flexible	   loop	   regions	   may	   control	  interactions	   between	   quasi-­‐equivalent	   subunits.	   For	   example,	   the	   N-­‐terminal	   arms	   of	  TBSV	   are	   either	   ordered	   or	   disordered,	   defining	   the	   nature	   of	   subunit	   interactions	  (Harrison	  et	  al.,	  1978).	  	  
5.1.4 Bacteriophages	  Bacteriophages	   are	   viruses	   that	   infect	   bacteria	   or	   archaea,	   and	   their	   study	   has	   played	   a	  major	  role	  in	  expanding	  our	  knowledge	  of	  basic	  molecular	  biology	  and	  virology	  (Friedman	  
et	   al.,	   2012).	   Bacteriophages	   are	   classified	   into	   19	   families,	   with	   all	   genome	   types	  represented	   (Ackermann,	   2009).	   Tailed	   dsDNA	   viruses	   represent	   ~	   96	   %	   of	   known	  phages,	   with	   the	   remaining	   4%	   consisting	   of	   a	   range	   of	   viruses	   such	   as	   the	   ssDNA	  
Microviridae	  and	  ssRNA	  viruses	  such	  as	  Leviviridae	  (Fokine	  &	  Rossmann,	  2014).	  They	  may	  be	  as	  much	  as	  10x	  more	  abundant	  than	  bacterial	  cells,	  and	  so	  are	  easily	  the	  most	  abundant	  entities	  in	  the	  biosphere	  (Fokine	  &	  Rossmann,	  2014).	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Figure	   5-­‐4	   Genomic	   and	   structural	   diversity	   of	   the	   bacteriophages.	   Adapted	   from	  Ackermann,	  2009.	  Bacteriophages	   have	   several	   commercial	   uses,	   such	   as	   phage	   display	   which	   is	   used	   to	  study	  protein	  interactions	  (Sidhu	  et	  al.,	  2000).	  In	  the	  food	  industry,	  LMP-­‐102	  (Intralytix)	  is	  an	  FDA	  approved	  cocktail	  of	  bacteriophages	  designed	  to	  prevent	  Listeria	  contamination	  in	  meat	  products	  (Sulakvelidze,	  2013).	  For	   in	  vitro	  diagnostics,	  KeyPath	  MRSA/MSSA	  Blood	  Culture	   Test	   detects	   Staphylococcus	   aureus	   using	   bacteriophages,	   and	   determines	  antibiotic	  resistance	  or	  susceptibility	  (Sullivan	  et	  al.,	  2013).	  Bacteriophages	  may	  also	  have	  potential	   use	   as	   therapeutics,	   particularly	  where	   antibiotic	   resistance	   has	   arisen.	   In	   one	  study,	   bacteriophage	   therapy	   was	   effective	   in	   the	   treatment	   of	   antibiotic-­‐resistant	  
Pseudomonas	   aeruginosa	   (Wright	   et	   al.,	   2009),	   although	   no	   treatments	   are	   currently	  approved	  for	  use.	  	  
5.1.5 Leviviridae	  Originally	   isolated	   from	   the	  New	  York	   sewerage	   system,	   the	  Leviviridae	  are	   icosahedral,	  non-­‐enveloped	   ssRNA(+)	   viruses	   comprising	   of	   two	   genera,	   Alloleviviruses	   and	  Leviviruses,	   of	   which	   the	   best	   characterised	   are	   Qβ	   and	   MS2	   respectively	   (Bollback	   &	  Huelsenbeck,	  2001).	  ‘Levi’	  is	  translated	  as	  ‘light’	  as	  these	  viruses	  have	  very	  small	  genome	  sizes.	  The	  two	  genera	  are	  divided	  on	  serological	  properties	  and	  genome	  organisation.	  The	  genome	   of	   Leviviruses	   is	   smaller	   than	   Alloleviviruses,	   ~3500	   nucleotides	   vs	   ~4200	  respectivley	  (Olsthoorn	  &	  Duin,	  2011).	  The	  Leviviridae	  specifically	  infect	  host	  bacteria	  via	  their	   pili,	   including	   F-­‐pili	   expressing	   members	   of	   the	   Enterobacteria,	   and	   polar	   pili	  expressing	   Caulobacter	   and	   Pseudomonas.	   As	   a	   result	   the	   Leviviridae	   are	   sometimes	  described	   as	   plasmid-­‐specific	   coliphages	   (Ackermann,	   2009).	   Enterobacteria	   including	  


















for	   example	   recently	   from	   the	   San	   Francisco	   wastewater	   system	   (Greninger	   &	   DeRisi,	  2015).	  	  The	  Leviviridae	  have	  a	  long	  history	  as	  model	  systems	  for	  the	  study	  of	  ssRNA	  viruses,	  one	  of	  the	  largest	  classes	  of	  viral	  pathogens.	  Positive	  sense	  ssRNA	  viruses	  infect	  all	  kingdoms	  of	  life,	  and	  include	  pathogens	  in	  the	  Picornaviridae,	  Flaviviridae	  and	  Togaviridae	  families	  that	  each	  contain	  viruses	  that	  have	  major	  impacts	  on	  human	  health.	  RNA	  phages	  have	  the	  same	  morphology	  and	  chemical	  properties	  as	  many	  of	  these	  (Duin,	  2006).	  The	  Leviviridae	  can	  be	  safely	  and	  easily	  grown,	  allowing	  their	  structural	  and	  functional	  states	  to	  be	  studied.	  While	  there	  has	  been	   some	   interest	   in	  bacteriophages	  as	   therapeutics,	   it	   is	  unlikely	   coliphages	  will	  be	  effective	  as	  bacteria	  adapt	  by	  loosing	  their	  pili	  (Duin,	  2006).	  	  	  
Host	   Genus	   Species	   Example	  members	   Sequence	  
Escherichia	  	  
Levivirus	  	   I	   MS2
	  	  Fr	  	   Fully	  sequenced	  Fully	  sequenced	  II	   GA	  JP34	   Fully	  sequenced	  Partially	  sequenced	  Allolevivirus	  	   III	   Qβ	  M11	   Fully	  sequenced	  Fully	  sequenced	  IV	   SP	  NL95	   Fully	  sequenced	  Fully	  sequenced	  
Acinetobacter	   Levivirus	  (AP205)	  	   Unknown	   AP205	  	   Fully	  sequenced	  
Caulobacter	  	   Unknown	   Unknown	   ØCb5	  	   None	  
Pseudomonas	  	   Levivirus	  (PP7)	  	  	   Unknown	   PP7	  	  	  	   Fully	  sequenced	  Polyvalent	  	   Unknown	   Unknown	   PRR1	   None	  
Table	  5.1	  Example	  members	  of	  the	  Leviviridae	  family.	  Adapted	  from	  Olsthoorn	  &	  Duin,	  2011.	  Best	   characterised	  members	   shown	   in	  bold.	  Group	   I	   and	   II	   viruses	  are	   sometimes	  grouped	  into	  group	  A	  and	  III	  and	  IV	  into	  group	  B.	  	  
5.1.5.1 Genome	  	  MS2	  was	  the	  first	  genome	  of	  an	  organism	  to	  be	  fully	  sequenced	  at	  3569	  nucleotides	  (Fiers	  
et	  al.,	   1976).	  Biochemical	   experiments	   indicate	   that	   the	   genomes	  of	   the	  Leviviridae	   have	  extensive	  secondary	  structure,	  which	   is	   implicated	   in	   the	  regulation	  of	   the	  expression	  of	  viral	  proteins.	  The	  5’	  and	  3’	  ends	  of	  the	  genome	  have	  untranslated	  regions	  which	  form	  ~	  10	  %	  of	   the	  genome.	  All	   known	  ssRNA	  phages	   start	  with	  5’	  pppGG	  and	  end	  with	  CCAOH,	  where	  the	  terminal	  A	  is	  a	  non-­‐coded	  base	  added	  by	  the	  terminating	  replicase	  (Duin,	  2006).	  The	   four	   bases	   occur	   at	   roughly	   equal	   ratios	   in	   the	   Leviviridae	   (Duin,	   2006).	  Alloleviviruses	  and	  Leviviruses	  each	  have	  coat	  protein,	  maturation	  protein	  and	  subunit	  II	  of	   replicase,	   but	   Alloleviviruses’	   genome	   is	   ~700	   nucleotides	   longer	   and	   has	   a	   read-­‐through	  frame,	  while	  Leviviruses	  have	  a	  separate	  lysis	  gene,	  an	  out-­‐of-­‐frame	  overlapping	  gene	  encoding	  a	  ~70	  amino	  acid	  hydrophobic	  peptide	  (Figure	  5-­‐5).	  In	  Alloleviviruses,	  the	  
185	  
	  
maturation	  protein	  is	  thought	  to	  trigger	  cell	  lysis	  (Duin,	  2006).	  In	  Alloleviviruses	  the	  coat	  protein	  ends	  in	  a	  leaky	  stop	  codon	  (UGA)	  that	  is	  read	  as	  a	  tryptophan	  with	  a	  probability	  of	  5	  %,	   creating	   a	   C-­‐terminal	   extended	   coat	   protein,	   sometimes	   termed	   A1.	   The	   extended	  coat	  protein	  is	  required	  for	  infectivity,	  and	  a	  crystal	  structure	  is	  available	  for	  this	  protein	  (Figure	  5-­‐8)(Rumnieks	  &	  Tars,	  2014).	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
Figure	  5-­‐5	  Genome	  structure	  of	  Alloleviviruses	  and	  Leviviruses.	  Adapted	  from	  Duin,	  2006.	  Genome	   replication	   is	   inaccurate,	   but	   despite	   this,	   there	   is	   little	   evidence	   for	   rapid	  evolution	  or	  sequence	  drift	  in	  Leviviridae.	  Despite	  many	  years	  of	  cultivation	  in	  the	  lab,	  Qβ	  and	  MS2	  sequences	  have	  not	  changed	  significantly.	   In	  nature,	  phage	  sequences	  have	  not	  diverged	   substantially	   from	   the	   subgroup	  prototype.	   For	   example,	   group	   I	  MS2,	   f2,	  R17,	  M12	  and	   JP501,	   isolated	   from	  across	   the	   globe	   show	  more	   than	  95%	  sequence	   identity,	  indicating	   there	   must	   be	   strong	   selective	   pressure	   limiting	   drift	   rate	   (Friedman	   et	   al.,	  2009).	  	  
5.1.6 Leviviridae	  lifecycle	  
Leviviridae	  infect	  bacteria	  by	  introducing	  a	  maturation	  protein	  (MP)-­‐genome	  complex	  into	  the	  host	  cell	  cytoplasm.	  Leviviridae	  attach	  to	  pili	  or	  filaments,	  depending	  on	  their	  host,	  and	  use	  this	  to	  gain	  entry	  to	  the	  cell.	  F-­‐pili	  are	  used	  by	  bacteria	  such	  as	  E.coli	  to	  aid	  bacterial	  conjugation,	   and	   are	   involved	   in	   horizontal	   gene	   transfer	   between	   F-­‐plasmid	   carrying	  bacteria,	  and	  F-­‐	  bacteria.	  The	  F-­‐pili	  is	  a	  retractable	  structure,	  formed	  from	  subunits	  of	  a	  70	  amino	  acid	  Pilin	  protein.	  Pili	  are	  85-­‐95	  Å	  in	  diameter,	  with	  a	  20-­‐30	  Å	  wide	  lumen	  (Wang	  et	  







slow	   retraction	   (Clarke	  et	  al.,	   2008).	  Multiple	  F-­‐pili	   can	  be	  present	  on	  a	   single	   cell,	  with	  extension	   and	   retraction	   of	   these	   independent	   from	   each	   other.	   The	   attachment	   of	   the	  phage	  to	  the	  sides	  of	  the	  pili	  requires	  the	  maturation	  protein	  (Dent	  et	  al.,	  2013).	  The	  coat	  protein	   is	   not	   needed	   for	   pili	   adhesion,	  but	   in	   Alloleviviruses	   the	  minimal	   infection	   set	  does	  requires	  the	  additional	  presence	  of	  the	  coat	  read-­‐through	  protein	  (Olsthoorn	  &	  Duin,	  2011).	  	  Phage	  binding	  to	   the	  pilus	  results	   in	  cleavage	  of	   its	  MP	   into	   two	  fragments	  (Krahn	  et	  al.,	  1972).	   It	   is	  hypothesised	  this	  cleavage	  triggers	  the	  ordered	  ejection	  of	   the	  RNA	  from	  the	  virus	   capsid.	   The	   two	   MP	   fragments	   remain	   associated	   with	   the	   genome	   during	  penetration	  of	  the	  cell	  envelope,	  but	  it	  is	  unlikely	  they	  play	  any	  further	  role	  in	  infection,	  as	  naked	  RNA	  in	  a	  spheroplast	  can	  generate	  infectious	  progeny	  (Olsthoorn	  &	  Duin,	  2011).	  	  	  The	  positive	  sense,	  ssRNA	  genome	  that	  enters	  the	  cell	  acts	  directly	  as	  the	  message	  for	  viral	  protein	   synthesis,	   including	   the	   viral	   replicase.	   The	   replicase	   holoenzyme	   contains	   four	  different	   proteins	   (Olsthoorn	   &	   Duin,	   2011),	   three	   of	   which	   are	   host	   proteins	   that	   are	  recruited	  to	  allow	  RNA	  synthesis.	  Subunit	  I	  is	  ribosomal	  protein	  S1,	  and	  subunits	  III	  and	  IV	  are	   the	   translation	   elongation	   factors	   EF-­‐Tu	   and	   EF-­‐Ts	   respectively	   (Olsthoorn	   &	   Duin,	  2011).	   The	   virally	   encoded	   subunit	   II	   has	   RNA	   polymerisation	   activity.	   To	   copy	   the	  negative	   strand,	   only	   subunits	   II,	   III	   and	   IV	   are	   required,	   whereas	   copying	   the	   positive	  strand	  also	  needs	  subunit	  I.	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Figure	   5-­‐6	   Life	   cycle	   of	   Leviviridae.	   Virions	   attach	   to	   the	   bacteria	   pili	   (1).	   The	   viral	  genome	  enters	  the	  cell	  (2)	  where	  it	  is	  translated	  and	  replicated	  (3).	  The	  newly	  synthesised	  viral	   components,	   including	   ssRNA	   genome	   (green),	   maturation	   protein	   (red)	   and	   coat	  protein	   dimers	   (black)	   are	   assembled	   (4).	   Cell	   lysis	   then	   occurs	   by	   the	   lysis	   protein	   in	  Leviviruses	  and	  C-­‐terminally	  extended	  coat	  protein	  in	  Alloleviviruses.	  	  Expression	   of	   phage-­‐encoded	   proteins	   is	   temporally	   controlled.	   Small	   quantities	   of	  replicase	   are	   expressed	   early	   in	   infection,	  while	   very	   large	   amounts	   of	   coat	   protein	   are	  expressed	  later	  on.	  RNA	  secondary	  structure	  is	  thought	  to	  play	  a	  key	  role	  regulating	  access	  of	  the	  ribosome	  to	  initiation	  regions.	  	  	  Once	   translated,	   viral	   components	   can	   assemble	   in	   the	   cytoplasm.	   In	   principle,	   capsid	  formation	   can	   occur	  without	   viral	   RNA	   present,	   but	   in	   the	   presence	   of	   viral	   RNA	  much	  lower	   coat	   protein	   concentrations	   are	   sufficient	   to	   form	   capsids.	   The	   RNA	   directs	   the	  assembly	  of	   the	  T=3	   capsid	   (Basnak	  et	  al.,	   2010)	   It	   is	   thought	   that	   the	  binding	  of	  MP	   to	  RNA	   is	   an	   early	   assembly	   event,	   preceding	   capsid	   formation.	   Cell	   lysis	   and	   release	   of	  virions	   occurs	   via	   the	   action	   of	   the	   lysis	   protein	   in	   Leviviruses	   and	   the	   MP	   in	  Alloleviviruses.	   A	   single	   copy	   of	   the	   genomic	   RNA	   is	   sufficient	   to	   infect	   a	   cell.	   Several	  thousands	  of	  phage	  can	  be	  produced	  within	  a	  few	  hours	  from	  a	  single	  parent	  virus	  particle	  
5.1.6.1 Structure	  The	  Leviviridae	   form	  spherical	   capsid	   shells	  260-­‐300	  Å	   in	  diameter	  with	  a	  ~	  2	  nm	   thick	  protein	   shell	   that	   has	  T=3	   quasi-­‐icosahedral	   symmetry,	   and	   containing	   one	  molecule	   of	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Figure	  5-­‐7	  Crystal	  structure	  of	  Qβ	  bacteriophage.	  A)	  Schematic	  drawing	  of	  the	  subunit	  arrangement	  in	  Qβ	  as	  seen	  from	  the	  outside	  of	  the	  capsid	  down	  a	  twofold	  axis.	  The	  three	  subunits	   are	   shown;	  A	   (yellow),	   B	   (green),	   and	  C	   (purple),	   representing	   the	   icosahedral	  asymmetric	   unit	   are	   shown	   in	   colours,	   and	   the	   three	   symmetry-­‐related	   subunits	  completing	   the	  dimers	  are	   shown	   in	   light	   colours.	  The	   loops	   forming	   the	   interactions	  at	  the	  five-­‐fold	  and	  three-­‐fold	  axes	  are	  shown.	  (Adapted	  from	  Golmohammadi	  et	  al.,	  1996.	  B)	  Biological	  unit	  capsid	  structure	  of	  Qβ	  CE)	  Icosohedral	  structure	  of	  capsid	  facing	  3-­‐fold	  (C),	  5-­‐fold	  (D)	  and	  2	  fold	  (E)	  axes.	  B-­‐E	  from	  PDB	  1QBE	  visualised	  in	  Chimera.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Figure	  5-­‐8	  X-­‐ray	  crystal	  structure	  of	  residues	  144–
328	   of	   full-­‐length	   A1	   protein,	   representing	   part	   of	  
the	   C-­‐terminal	   extension	   to	   the	   coat	   protein.	   PDB	  accession	  codes	  3RLK.	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5.1.7 Coat	  protein-­‐RNA	  interactions	  
Leviviridae	   coat	   protein	   dimers	   recognize	   and	   bind	   to	   stem	   loop	   structures	   in	   their	  genomes	   that	   incorporate	   the	   start	   codons	   of	   their	   replicase	   genes.	   This	   well	   known,	  single-­‐copy,	   high	   affinity	   coat	   protein	  binding	   side	   (TR)	   acts	   as	   a	   translational	   operator,	  directly	  linking	  expression	  of	  the	  replicase	  to	  coat	  protein	  dimer	  concentration,	  and	  acting	  as	  a	  trigger	  for	  genome	  assembly	  (although	  additional	  sites	  within	  Leviviridae	  genome	  also	  promote	  assembly)(Dykeman	  et	  al.,	  2013).	  The	  interaction	  between	  TR	  and	  coat	  protein	  is	  thought	  to	  contribute	  to	  the	  specificity	  of	  encapsidation	  of	  genomic	  rather	  than	  host	  RNA.	  Upon	   binding	   to	   RNA	   stem-­‐loop	   structures	   such	   as	   the	   TR	   sequence,	   and	   other	  weaker	  packaging	   signal,	   coat	   protein	   dimers	   switch	   from	   the	   symmetric	   C/C-­‐like	   dimer	   to	   an	  asymmetric	  A/B	  conformation,	  with	  this	  dimer	  switching	  coordinating	  the	  assembly	  of	  the	  T=	  3	  capsid	  (Dykeman	  et	  al.,	  2010;	  Stockley	  et	  al.,	  2007).	  	  	  A	  crystal	  structure	  has	  been	  solved	  for	  Qβ	  coat	  protein	  bound	  to	  its	  cognate	  translational	  operator	   (Rumnieks	  &	  Tars,	  2014).	  The	  structure	  shows	   that	  a	   single	  nucleotide	  base	   in	  the	  hairpin	  loop	  makes	  sequence-­‐specific	  contacts	  with	  the	  coat	  protein.	  Some	  Leviviridae	  including	  MS2	  use	  an	  adenine-­‐recognition	  pocket	  for	  binding	  a	  bulged	  adenine	  base	  in	  the	  hairpin	   stem,	   but	   Qβ	   uses	   a	   stacking	   interaction	   with	   a	   tyrosine	   side	   chain	   to	  accommodate	   the	  base	   instead.	  The	  extended	   loop	  between	   the	  E	  and	  F	  β-­‐strands	  of	   the	  Qβ	  coat	  protein	  makes	  contacts	  with	  the	  lower	  part	  of	  the	  RNA	  stem.	  Despite	  Qβ	  requiring	  a	   smaller	   amount	   of	   sequence	   specific	   information,	   the	   coat	   protein	   is	   still	   able	   to	  discriminate	   its	   cognate	   operator	   from	   host	   RNA,	   which	   suggests	   the	   protein	   and	   RNA	  have	  co-­‐evolved	  (Rumnieks	  &	  Tars,	  2014).	  Crystal	  structures	  of	  the	  coat	  protein-­‐operator	  complex	  are	  known	  for	  several	  members	  of	  the	  Leviviridae,	  and	  the	  overall	  binding	  mode	  is	  similar	  in	  each	  of	  these	  structures.	  	   	  Cryo-­‐EM	   has	   been	   used	   to	   probe	   the	   structure	   of	   the	   packaged	   genome	   in	  MS2	   to	   sub-­‐nanometer	   resolution	   (Toropova	   et	   al.,	   2008).	   The	   icosahedrally-­‐averaged	   genome	   is	  organised	   into	   two	   concentric	   shells	   of	   density.	   The	   outer	   shell	   contains	   approximately	  two	   thirds	   of	   the	   genome	   and	   is	   associated	   with	   the	   coat	   protein	   shell.	   An	   inner	   shell	  contains	  the	  remained	  of	  the	  genome.	  Structures	  of	  recombinant	  MS2	  virus-­‐like	  particles	  (VLPs)	  packaging	  a	  range	  of	  different	  sub-­‐genomic	  RNAs	  demonstrate	   that	  particles	   that	  have	  packaged	  shorter	  RNAs	  maintain	  the	  outer	  shell	  but	  not	  the	  inner.	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5.2 Results	  X-­‐ray	   crystallography	   has	   provided	   high-­‐resolution	   information	   about	   the	   structure	   of	  
Leviviridae	  members.	  However,	  crystal	  structures	  are	  a	  representation	  of	  the	  virus	  packed	  in	   a	   crystal,	   which	   may	   not	   always	   be	   representative	   of	   the	   solution	   structure.	  Additionally,	   information	   about	   the	   genome	   and	   its	   interactions	   with	   the	   capsid	   is	  frequently	   lost	   in	  X-­‐ray	  structures	  (Section	  1.1.3).	  Here,	  cryo-­‐EM	  was	  used	  to	   investigate	  structural	  properties	  of	  MS2	  and	  Qβ	  bacteriophage.	  




Figure	  5-­‐9	  Binding	  of	  MS2	  to	  F-­‐pili	  is	  mediated	  by	  the	  maturation	  protein.	  Cryo-­‐EM	  of	  wild-­‐type	  MS2	   (A)	   or	   recombinant	   MS2	   lacking	  maturation	   protein	   (C).	   For	   clarity,	   pili	  (green),	   bound	   (blue)	   and	   unbound	   (purple)	   particles	   are	   highlighted	   in	   B,E.	   Schematic	  (C,F)	  shows	  particles	  containing	  maturation	  protein	  (black)	  are	  bound	  (blue	  capsid)	  to	  the	  pili	  (green).	  Unbound	  particles	  in	  C	  may	  either	  not	  contain	  maturation	  protein.	  Particles	  in	  F	  do	  not	  contain	  maturation	  protein,	  and	  so	  do	  not	  bind.	  Scale	  bar	  100	  nm.	  	  
5.2.2 Structure	  of	  Qβ	  bacteriophage	  Owing	   to	   improvements	   in	   EM	   detectors,	   microscope	   hardware	   and	   image	   processing	  algorithms,	   achieving	   high-­‐resolution	   (better	   than	   5	   Å)	   structures	   by	   SPA	   cryo-­‐EM	   is	  becoming	   possible.	   Here,	   we	   used	   cryo-­‐EM	   and	   SPA	   to	   generate	   a	   high-­‐resolution	  structure	   of	  Qβ,	   in	   order	   to	   investigate	   properties	   of	   the	   protein	   capsid	   in	   solution,	   and	  investigate	  asymmetric	  properties	  of	  the	  virus	  such	  as	  the	  genome.	  
5.2.2.1 Cryo-­‐EM	  of	  Qβ	  	  Cryo-­‐EM	  grids	  of	  Qβ	  were	  prepared,	  and	  particle	  distribution	  and	  ice	  thickness	  optimised	  at	   the	  University	   of	   Leeds	   on	   an	   FEI	   F20	  microscope	   (Section	  2.11.3,	   2.12.1).	  Optimised	  grids	  were	  imaged	  at	  the	  MRC	  LMB	  using	  an	  FEI	  Titan	  Krios	  microscope	  with	  a	  Falcon	  II	  detector	  at	  a	  magnification	  of	  103,704	  x,	  resulting	  in	  a	  sampling	  of	  1.35	  Å	  per	  pixel	  and	  a	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total	   dose	   of	   ~50	   e-­‐/Å2.	   Dose	  was	   fractionated	   across	   34	   frames	   during	   a	   2	   s	   exposure	  (Figure	  5-­‐10).	  A	  total	  of	  1206	  micrograph	  ‘movies’	  were	  recorded.	  Micrographs	  and	  their	  power	   spectra	   were	   manually	   inspected,	   and	   any	   showing	   significant	   drift	   or	   charging	  were	   removed,	   yielding	   1170	  micrographs	   which	   were	   taken	   forward	   to	   further	   image	  processing	  steps.	  	   	  
	  
Figure	   5-­‐10	   Collection	   of	  
data	   on	   a	   direct	   electron	  
detector.	  A)	  One	   frame.	   B)	  Sum	   of	   frames	   1-­‐8.	   C)	   Sum	  of	   frames	   1-­‐17.	   D)	   Sum	   of	  frames	  1-­‐34.	  	  	  	  	  	  	  	  	  
5.2.2.2 Initial	  processing	  	  Initial	  processing	  of	   the	  micrographs	  was	  performed	  to	  produce	  a	  stack	  of	  particles	   that	  could	   be	   taken	   forward	   for	   high-­‐resolution	   3D	   structure	   determination.	   All	   data	  processing	  was	  carried	  out	  using	  RELION	  1.3	  unless	  otherwise	  specified.	  EM	  micrographs	  are	  distorted	  by	  a	  point	  spread	  function	  that	  is	  introduced	  by	  the	  defocus	  used	  to	  generate	  phase	   contrast,	   and	   aberrations	   resulting	   from	   imperfections	   in	   the	   optics	   of	   the	  microscope	  (Section	  1.3.8).	  To	  correct	  for	  this,	  defocus	  parameters	  were	  determined	  using	  CTFFIND4	  (Rohou	  &	  Grigorieff,	  2015).	  Micrographs	  had	  a	  defocus	  range	  of	  –	  0.8	  μm	  to	  –	  3.8	  μm.	  Example	  micrographs	  and	  power	  spectrum	  fitting	  are	  shown	  in	  Figure	  5-­‐11.	  	  	  2000	  particles	  were	  picked	  manually	  and	  subject	  to	  reference-­‐free,	  2D	  class	  averaging.	  For	  all	  processing,	  a	  box	  size	  of	  288	  pixels	  (388.9	  Å)	  and	  a	  mask	  with	  a	  diameter	  of	  300	  Å	  was	  used.	   These	   particles	  were	   then	   used	   as	   templates	   for	   automatic	   picking	   of	   particles	   in	  RELION	  1.3	  (Scheres,	  2015).	  28,156	  total	  particles	  were	  then	  picked	  automatically.	  These	  were	   subject	   to	   reference	   free	   2D	   classification	   into	   50	   classes	   over	   25	   iterations.	   2D	  classification	   allows	   the	   removal	   of	   particles	   erroneously	   picked	   during	   automated	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particle	   picking,	   and	   also	   for	   the	   quality	   of	   the	   data	   to	   be	   assessed.	   2D	   class	   averages	  revealed	   most	   particles	   (24,109)	   contributed	   to	   classes	   that	   clearly	   resembled	   Qβ	  bacteriophage,	   with	   the	   remaining	   classes	   resembling	   the	   edge	   of	   carbon	   film	   or	  contaminant	   (Figure	   5-­‐12).	   Particle	   sorting	   by	   Z-­‐score	   and	   log-­‐likelihood	   was	   used	   to	  remove	  particles	   not	   resembling	  Qβ	  bacteriophage.	   This	   yielded	   a	   final	   particle	   stack	   of	  21,767	  that	  was	  taken	  forward	  for	  3D	  structure	  determination.	  	  	  	  	  
Figure	  5-­‐11	  CTF	  and	  
defocus	  determination	  by	  
CTFFIND4.	  Two	  representative	  micrographs	  at	  -­‐1.7	  (A)	  -­‐2.2	  (B)	  microns	  defocus,	  as	  determined	  by	  CTFFIND4.	  ¾	  of	  micrograph	  FFT	  is	  shown,	  with	  ¼	  CTFFIND4	  fitting.	  	  	  
	  	  
Figure	  5-­‐12	  Representative	  2D	  class	  averages	  of	  Qβ	  bacteriophage.	  First	  four	  classes	  show	  Qβ	  bacteriophage,	  fifth	  class	  shows	  carbon	  film.	  	  
5.2.2.3 3D	  structure	  determination	  of	  Qβ	  bacteriophage	  Unsupervised	  3D	  classification	  with	  icosahedral	  symmetry	  imposed,	  into	  two	  classes	  was	  performed	   in	  RELION	   to	   assess	   dataset	   heterogeneity.	   A	   sphere	  with	   a	   radius	   of	   26	   nm	  was	  used	  as	  a	  starting	  model.	  One	  3D	  class	  was	  selected	  from	  this	  was	  Fourier	  filtered	  to	  50	  Å	  to	  aid	  prevention	  of	  model	  bias,	  then	  used	  as	  the	  starting	  model	  for	  a	  second	  round	  of	  3D	   structure	   determination.	   The	   full	   particle	   stack	   split	   roughly	   evenly	   between	   two	  classes	  during	  3D	  classification,	  and	  the	  resulting	  3D	  structures	  converged	  to	  a	  marginally	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Figure	   5-­‐13	   Descriptive	   statistics	   during	   refinement	   of	   Qβ	   bacteriophage.	   A)	  Calculated	  B-­‐factors	  across	  movie	   frames.	  B)	  Gold	  standard	  FSC	  resolution	  estimation	  of	  unmasked	  (red)	  and	  masked	  (green)	  structures,	  the	  FSC	  cut-­‐off	  of	  at	  0.143	  is	  shown	  as	  a	  dotted	  line.	  	  
	  
Figure	  5-­‐14	  Structure	  of	  Qβ	  bacteriophage.	  Capsid	  exterior	  (A)	  and	  slice	  through	  into	  interior	  (B).	  Structure	  radially	  coloured	  and	  visualised	  at	  0.1	  threshold	  in	  Chimera.	  	  



































Figure	   5-­‐15	   Fitting	   of	   crystal	   structure	   into	   electron	   density	  map.	  Electron	  density	  map	  with	  crystal	  structure	  (1QBE)	  fitted	  (A).	  EM	  density	  map	  visualised	  at	  0.1	  threshold.	  Chain	  A	  shown	  in	  blue,	  chain	  B	   in	  green	  and	  chain	  C	   in	  purple.	  Examples	  of	  α-­‐helical	  (C)	  and	  β-­‐sheet	  density	  with	  crystal	  structure	  fitted.	  	  
5.2.2.4 Local	  resolution	  determination	  While	  a	  global	  resolution	  estimation,	  such	  as	  that	  obtained	  by	  the	  ‘gold-­‐standard’	  FSC,	  can	  be	   very	   useful,	   there	   can	   be	   significant	   differences	   in	   resolution	   across	   the	   map.	   Local	  resolution	  estimations	  can	  be	  performed	  to	  estimate	  the	  resolution	  variations	  throughout	  a	  map.	  Local	  resolution	  estimations	  were	  performed	  using	  ResMap	  software	  (Kucukelbir	  
et	  al.,	  2014)(2.14.1).	  Resolution	  was	  assessed	  between	  3	  and	  9	  Å	  with	  a	  step	  size	  of	  0.5	  Å.	  This	   shows	   that	  much	  of	   the	  protein	   capsid	   is	   at	  3	  Å	   (Figure	  5-­‐16	  A).	  When	   the	  density	  map	  is	  contoured	  to	  show	  genome	  density	  on	  the	  interior	  of	  the	  map,	  this	  is	  a	  significantly	  poorer	   resolution	  compared	  with	   the	  protein	  capsid	  density.	  Therefore,	  while	   the	  global	  resolution	  value	  reports	  resolution	  as	  4.2	  Å,	  much	  of	  the	  protein	  capsid	  is	  of	  significantly	  better	   resolution,	  while	   the	   genome	   is	   significantly	   poorer.	   In	   the	   global	   FSC	   resolution	  estimates,	  this	  evens	  out	  at	  an	  intermediate	  resolution	  that	  underrepresents	  the	  quality	  of	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parts	   of	   the	   map.	   This	   highlights	   the	   value	   of	   performing	   local	   resolution	   estimates	   to	  assess	  resolution.	  	  
	  
Figure	  5-­‐16	  Local	  resolution	  estimation	  of	  Qβ	  bacteriophage	  electron	  density	  map.	  Histogram	   output	   from	   ResMap	   software,	   showing	   number	   of	   voxels	   in	   different	  resolution	   bins	   (A).	   B)	   Slice	   through	   density	   map	   showing	   capsid	   and	   shell	   of	   density	  attributed	  to	  genome.	  C)	  View	  of	  the	  outside	  of	  the	  capsid.	  D)	  View	  of	  the	  inside	  of	  capsid.	  Electron	  density	  maps	  shown	  are	  coloured	  by	  local	  resolution	  at	  0.04	  threshold	  (B)	  or	  0.1	  threshold	  (C,D).	  Key	  for	  local	  resolution	  shown	  bottom	  right	  (Å.).	  	  
5.2.3 Refining	  the	  crystal	  structure	  of	  Qβ	  bacteriophage	  As	  discussed	  in	  Section	  5.1.6.1,	  the	  T	  =	  3	  capsid	  is	  formed	  from	  a	  single	  coat	  protein	  which	  is	   found	   in	   three	  distinct	  qausi-­‐equivalent	  conformations,	   termed	  A,	  B	  and	  C.	  The	  capsid	  contains	   two	   types	   of	   dimer,	   A/B	   and	   C/C;	   formation	   of	   the	   3-­‐fold	   axis	   occurs	   by	   the	  interdigitation	   of	   A/B	   and	   C/C	   coat	   protein	   dimers.	   To	   better	   understand	   the	   detailed	  structure	   of	   Qβ,	   density	   corresponding	   to	   the	   A/B	   and	   C/C	   dimers	   was	   segmented	   out	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using	  Chimera.	  The	   corresponding	  dimers	   from	   the	  X-­‐ray	   crystal	   structure	  were	   refined	  into	   the	   EM-­‐derived	   electron	   density	   using	   Rosetta	   (DiMaio	   et	   al.,	   2015).	   The	   crystal	  structure	   of	   Qβ	   bacteriophage	   is	   at	   3.5	   Å,	   and	   significant	   portions	   of	   the	   density	   were	  disordered.	  18	  amino	  acids	  per	  coat	  protein	  subunit	  could	  not	  be	  modelled	  at	  all,	  and	  six	  residues	  were	  not	  modelled	  beyond	  their	  Cβ	  (Lys16,	  Ser56,	  Arg57,	  Asn58,	  Arg59,	  Lys60).	  	  	  Regions	  in	  both	  the	  A/B	  and	  C/C	  dimer	  could	  not	  be	  modelled	  using	  data	  from	  the	  X-­‐ray	  crystal	  structure	  (Residues	  76-­‐79	  and	  56-­‐60).	  The	  electron	  density	  map	   for	   the	  A/B	  and	  C/C	  dimers	  was	  visualised	  at	  different	  contour	  levels	  to	  see	  if	  any	  density	  for	  these	  regions	  was	  present.	  At	  high	  contour	  there	  is	  no	  evidence	  for	  density	  relating	  to	  the	  extra	  residues.	  In	  all	  cases,	  even	  at	  low	  contour	  level,	  no	  additional	  density	  that	  could	  correspond	  to	  the	  missing	  residues	  is	  present.	  One	  region	  with	  missing	  residues	  75-­‐79	  from	  the	  A/B	  dimer	  is	  shown	  in	  Figure	  5-­‐17	  to	  illustrate	  this.	  This	  lack	  of	  density	  indicates	  these	  residues	  must	  be	  extremely	  flexible	  or	  missing.	  There	  is	  no	  evidence	  for	  cleavage	  at	  present,	  and	  further	  mass	  spectrometry	  studies	  would	  be	  needed	  to	  test	  this	  idea.	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
Figure	  5-­‐17	  Electron	  density	  map	  and	  crystal	   structure	   (1QBE)	   for	   the	  A/B	  dimer.	  Dotted	  line	  illustrates	  missing	  residues	  76-­‐79.	  EM	  density	  map	  shown	  at	  0.1	  (A)	  and	  0.011	  (B).	  	  Atomic	   refinement	   in	   Rosetta	   is	   based	   on	   the	   ‘relax’	   protocol	  with	   an	   additional	   tool	   to	  assess	  agreement	  with	  the	  density	  (DiMaio	  et	  al.,	  2015).	  For	  both	  the	  A/B	  and	  C/C	  dimer	  structures,	  refinement	   in	  Rosetta	  only	  resulted	  in	  subtle	  changes	  to	  backbone	  alignment.	  However,	  Rosetta	  was	  able	  to	  build	   in	  residues	  that	  were	  only	  modelled	  to	  the	  Cβ	  in	  the	  original	  X-­‐ray	  crystal	  structure	  (Figure	  5-­‐18).	  Statistical	  analysis	  was	  performed	  to	  assess	  the	  quality	  of	  refinement	   in	  Rosetta.	  The	   ‘Rosetta	   total	  score’,	  which	  represents	   the	  total	  energy	  of	   the	  conformation,	   improves	   for	  both	   the	  A/B	  and	  C/C	  dimers.	  The	  MolProbity	  score	   is	   a	   log-­‐weighted	   combination	   of	   the	   clashscore,	   percentage	   of	   unfavoured	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Ramachandran	   residues	   and	   percentage	   of	   bad	   side-­‐chain	   rotamers.	   It	   is	   a	   standard	  validation	   tool	   for	   crystallographic	   structures,	   and	   is	   calculated	   using	   the	   MolProbity	  server	   (Chen	   et	   al.,	   2010).	   As	   Rosetta	   uses	   a	   rotamer	   library	   to	   introduce	   idealised	  rotamers,	  we	  would	   expect	   this	   number	   to	   improve	   for	   the	  Rosetta	   structures,	  which	   it	  does.	   The	   Clashscore	   is	   the	   number	   of	   ‘serious’	   (non-­‐donor–acceptor	   atoms	   overlap	   by	  more	  than	  0.4	  Å)	  clashes	  per	  1000	  atoms.	  This	  score	  significantly	  improves	  in	  the	  Rosetta	  refined	   structures	   compared	   with	   the	   X-­‐ray	   crystal	   structure	   derived	   model.	   The	   total	  number	   of	   favoured	   residues	   on	   a	   Ramachandran	   plot	   also	   improves	   for	   the	   refined	  Rosetta	  structures	  compared	  with	  X-­‐ray	  crystal	  derived	  structures.	  	  
	  
Figure	   5-­‐18	   Refining	   crystal	   structure	   of	   A/B	   and	   C/C	   dimers	   into	   corresponding	  
electron	  density.	  A)	  A/B	  dimer	  crystal	  structure	  shown	  in	  light	  blue	  (A	  subunit)	  and	  light	  green	   (B	  subunit)	   (1QBE),	  Rosetta	   structure	   shown	   in	  dark	  green	  and	  dark	  blue.	  B)	  C/C	  dimer	   crystal	   structure	   shown	   in	  pink	   (1QBE),	  Rosetta	   structure	   show	   in	  white.	   In	  both	  the	  A/B	  and	  C/C	  dimer,	  there	  is	  close	  agreement	  between	  the	  backbone	  traces.	  	  
	   Rosetta	  total	  score	   MolProbity	  score	   Clashscore	   Ramachandran	  favoured	  (%)	  A/B	  PDB	   -­‐2274.642	   2.81	   18.32	   93.12	  
A/B	  
Rosetta	   -­‐3095.716	   1.1	   1.55	   96.76	  
C/C	  PDB	   -­‐2355.823	   2.63	   13.54	   94.02	  
C/C	  
Rosetta	   -­‐3022.104	   0.97	   0.81	   96.58	  
Table	   5.2	   Statistical	   analysis	   of	   atomic	   model	   refinement.	   Rosetta	   total	   score	   is	   a	  measure	  of	  total	  energy,	  calculated	  in	  Rosetta	  (DiMaio	  et	  al.,	  2015).	  MolProbity,	  Clashscore	  and	  Ramachandran	  favoured	  residues	  (%)	  calculated	  in	  MolProbity	  (Chen	  et	  al.,	  2010).	  	  
5.2.4 Genome	  organisation	  	  In	   the	  X-­‐ray	  structure	  of	  Qβ,	  no	   information	  about	   the	  encapsidared	  4.2	  kb	  genome	  was	  revealed	   (Rumnieks	   &	   Tars,	   2014).	   Icosohedrally-­‐averaged	   EM-­‐dreived	   density	   maps	  generated	  in	  Section	  5.2.2.3	  retain	  some	  information	  about	  the	  genome.	  The	  challenge	  of	  interpreting	   density	   within	   the	   capsid	   is	   that	   icosahedral	   symmetry	   is	   imposed	   during	  refinement,	   meaning	   that	   the	   genome,	   which	   is	   an	   asymmetric	   RNA	   molecule,	   is	  inappropriately	   icosahedral	   averaged.	   An	   asymmetric	   reconstruction	   of	   Qβ	   was	   also	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therefore	   generated	   to	   7.7	   Å	   (Section	   2.14.1)(Figure	   5-­‐19).	   Even	   in	   this	   asymmetric	  reconstruction,	  the	  refinement	  process	  is	  dominated	  by	  the	  strong	  icosahedral	  symmetry	  of	   the	   capsid.	   Despite	   this,	   interesting	   information	   regarding	   the	   genome	   can	   still	   be	  extracted	  from	  these	  models.	  	  	  Electron	  density	  maps	  generated	  and	  shown	  in	  Section	  5.2.2.3	  as	  well	  as	  Figure	  5-­‐19	  were	  subjected	   to	   masking	   and	   B-­‐factor	   sharpening	   to	   calculate	   resolution	   and	   more	   easily	  visualise	   features	  of	   the	  protein	  capsid.	  However,	   in	   this	  process,	  many	   lower	  resolution	  features	  including	  part	  of	  the	  internal	  density	  attributed	  to	  the	  genome	  is	  masked	  out.	  In	  this	  section,	  only	  the	  unmasked	  density	  will	  be	  assessed.	  	  	  In	   the	   unmasked	   density	   for	   both	   asymmetric	   and	   icosahedral	   structures,	   within	   the	  capsid	   two	   concentric	   shells	   of	   density	   are	   observed	   (Figure	   5-­‐20).	   The	   outer	   shell	   lies	  directly	  under	  the	  protein	  capsid	  (Figure	  5-­‐20,	  yellow	  density),	  and	  consists	  of	  a	  regular,	  connected	  network	  of	  density	  with	  discrete	  ‘packets’	  of	  density,	  and	  appears	  similar	  in	  the	  asymmetric	   and	   icosahedral	   averaged	   structures.	   The	   positions	   of	   the	  RNA	   in	   this	   layer	  precisely	  map	   to	   the	   lattice	  of	  RNA	  binding	   sites	  on	   the	   inner	   surface	  of	   the	   capsid.	  The	  density	  appears	  to	  be	  different	  beneath	  each	  type	  of	  quasi-­‐equivalent	  coat	  protein	  dimer,	  and	  this	  difference	  is	  more	  pronounced	  in	  the	  asymmetric	  structure	  (Figure	  5-­‐20	  D)	  than	  the	  icosohedrally-­‐averaged	  structure	  (Figure	  5-­‐20	  B).	  The	  second	  density	  shell	  is	  at	  lower	  radius;	  maps	  must	  be	  visualised	  at	  a	  lower	  threshold	  to	  show	  this	  density	  (Figure	  5-­‐20	  A,	  C,	  orange).	  The	  central	  density	  appears	  very	  different	   in	  the	  icosahedral	  and	  asymmetric	  structures.	  	  Crystal	   structures	   are	   available	   for	   Leviviridae	   in	   complex	   with	   various	   RNA	  oligonucleotides	   (Rumnieks	   &	   Tars,	   2014;	   Persson	   et	   al.,	   2013;	   van	   den	   Worm	   et	   al.,	  1998).	  Here,	  in	  order	  to	  guide	  interpretation	  of	  the	  genome-­‐associated	  density	  observed	  in	  the	   outermost	   ring,	   the	   crystal	   structure	   of	  MS2	   complexed	  with	   the	  wild-­‐type	  TR	   stem	  loop	   (1AQ3)	  was	   fitted	   into	   the	  EM-­‐derived	  density	  map.	  The	   structures	  of	   coat	  protein	  from	  MS2	   and	  Qβ	  overlay	   closely	   and	  both	   fit	   into	   the	  Qβ	  map	   (Figure	  5-­‐21	  A).	   The	  TR	  RNA	  is	  a	  type	  A	  helical	  structure,	  and	  fits	  well	  into	  the	  density	  immediately	  beneath	  each	  coat	   protein	   dimer	   (Figure	   5-­‐21	   B,	   C).	   Dimers	   in	   the	   A/B	   conformation	   display	   RNA	  associated	  density	  directly	  beneath	  the	  dimer	  interface,	  extending	  towards	  the	  icosahedral	  5-­‐fold	  axes.	  A	  connected	  ring	  of	  density	  is	  therefore	  formed	  around	  the	  5-­‐fold	  axes.	  Close	  inspection	   of	   the	   density	   beneath	   A/B	   and	   C/C	   dimers	   in	   both	   the	   icosahedral	   and	  asymmetric	   averaged	   structures	   shows	   slightly	   different	   density	   beneath	   each	   quasi-­‐equivalent	  coat	  protein	  dimer,	  with	  a	  larger	  density	  beneath	  C/C	  dimer	  compared	  with	  the	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A/B	   dimer	   (Figure	   5-­‐21	   D,	   F).	   This	   is	   expected	   as	   RNA	   binds	   in	   two,	   symmetry	   related	  orientations	  at	  the	  C/C	  dimer,	  but	  only	  in	  one	  conformation	  to	  the	  A/B	  dimer.	  This	  is	  due	  to	  the	  conformation	  of	   the	  FG	   loop	   in	  the	  B	  subunit	  of	   the	  A/B	  dimer	  appears	  to	  restrict	  the	   binding	   of	   the	   RNA.	   Therefore,	   in	   the	   averaged	   structures,	   an	   averaging	   of	   the	   two	  conformations	  occurs,	  leading	  to	  a	  larger	  density	  beneath	  the	  C/C	  dimer	  compared	  to	  that	  found	  bound	  to	  A/B	  dimers.	  This	  suggests	  that,	  on	  average,	  there	  is	  a	  different	  interaction	  between	  RNA	  and	  each	  type	  of	  quasi-­‐equivalent	  coat	  protein	  dimer.	  This	  feature	  has	  been	  observed	  at	  lower	  resolution	  using	  cryo-­‐EM	  in	  the	  related	  virus	  MS2.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  








Figure	   5-­‐21	   Fitting	   of	   RNA	   density	   into	   icosahedrally	   averaged	   and	   asymmetric	  
reconstructions	  of	  Qβ.	  A)	  Crystal	  structure	  of	  MS2	  capsid	  in	  complex	  with	  RNA	  (1AQ3)	  (pink)	   superimposed	   with	   crystal	   structure	   of	   Qβ	   (1QBE)(light	   blue).	   Unmasked,	  unsharpened,	  icosohedrally	  averaged	  (B,C,D)	  and	  asymmetric	  structure	  (E,F)	  Qβ	  structure	  with	   crystal	   structure	   of	   MS2	   capsid	   in	   complex	   with	   RNA	   (1AQ3)	   fitted	   but	   only	   RNA	  visualised.	  View	  at	  five	  fold	  axis	  (C,D,E,F)	  show	  RNA	  stem	  loop	  density	  fitted	  into	  density	  corresponding	  to	  outer	  RNA	  shell.	  Dashed	  white	  circles	  denote	  density	  beneath	  C/C	  dimer,	  black	  dashed	  circles	  A/B	  dimer.	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5.3 Discussion	  Here,	   optimisation	   of	   sample	   preparation	   and	   advances	   in	   EM	   hardware	   and	   data	  processing	  techniques,	  have	  allowed	  the	  generation	  a	  high-­‐resolution	  structure	  of	  wt	  Qβ.	  The	  global	  resolution	  of	  the	  map	  is	  4.2	  Å,	  but	  analysis	  of	  local	  resolution	  reveals	  that	  much	  of	  the	  capsid	  shell	  is	  at	  3	  Å	  (Figure	  5-­‐13,	  Figure	  5-­‐16).	  Therefore	  much	  of	  the	  density	  map	  is	  at	  a	  resolution	  very	  close	  to	  the	  Nyquist	  limit	  (2	  x	  sampling	  =	  2.7	  Å).	  At	  this	  resolution,	  secondary	  structure	  elements	  such	  as	  α-­‐helices	  and	  β	  strands	  are	  beautifully	  resolved,	  and	  tools	  such	  as	  Rosetta	  can	  be	  used	  to	  refine	  X-­‐ray	  derived	  atomic	  models.	  Here,	  Rosetta	  was	  used	   to	   refine	   the	   existing	   crystal	   structure	   of	   the	   Qβ	   capsid	   to	   significantly	   improve	  measures	  of	  atomic	  model	  quality	  (Clashscore,	  MolProbity	  score),	  and	  provide	  positioning	  for	  side	  chains	  that	  were	  previously	  only	  modelled	  to	  their	  Cβ	  atoms.	  If	  future	  work	  sought	  to	  improve	  the	  resolution	  of	  the	  electron	  density	  map	  further,	  imaging	  could	  be	  performed	  at	   a	   higher	   Å/pixel	   sampling,	   and	   a	   larger	   dataset	   might	   be	   beneficial.	   However,	  asymmetric	  aspects	  of	  Qβ	  including	  the	  genome,	  MP	  and	  extended	  coat	  protein	  may	  limit	  achievable	  resolution.	  The	  presence	  of	  an	  electron	  dense	  genome	  that	  does	  not	  conform	  to	  the	   icosahedral	   symmetry	  of	   the	   capsid	  also	  may	   reduce	   the	  overall	   accuracy	  of	   angular	  assignments	   and	   slightly	   skew	   refinement	   of	   the	   capsid	   protein,	   reducing	   global	  resolution.	  An	  interesting	  way	  to	  test	  this	  would	  be	  to	  generate	  a	  structure	  of	  an	  empty	  Qβ	  capsid,	  although	  it	  is	  possible	  that	  such	  a	  capsid	  would	  be	  less	  stable,	  or	  ordered.	  	  	  Viruses	  have	  evolved	  a	  broad	  range	  of	  ways	   to	  overcome	   the	  challenge	  of	  encapsidating	  their	  genomic	  material.	  Many	  RNA	  viruses	  assemble	  their	  virions	  spontaneously,	  including	  
Leviviridae.	  Data	  presented	  here	  provides	  insight	  into	  how	  quasi-­‐icosahedral	  symmetry	  is	  propagated	  as	  the	  capsid	  forms	  around	  the	  genome.	  Cryo-­‐EM	  has	  previously	  been	  used	  to	  study	   MS2	   (Toropova	   et	   al.,	   2008).	   An	   icosohedrally	   averaged,	   ~	   9	   Å	   structure	   was	  obtained,	  which	  suggests	  different	  density	  beneath	  quasi-­‐equivalent	  A/B	  and	  C/C	  dimers,	  providing	  evidence	  that	  allosteric	  dimer	  switching	  plays	  a	  role	  in	  mediating	  formation	  of	  the	  T=3	  capsid.	  Here,	  a	  structure	  of	  Qβ	  is	  presented	  at	  a	  significantly	  improved	  resolution	  compared	   to	   previous	   cryo-­‐EM	   studies.	   For	   the	   first	   time	   in	   Alloleviviruses,	   subtly	  different	   density	   was	   observed	   beneath	   different	   quasi-­‐equivalent	   dimer	   structures,	  providing	  evidence	  for	  the	  role	  in	  allosteric	  dimer	  switching	  in	  mediating	  formation	  of	  the	  
T=3	  capsid,	  and	  providing	  evidence	  that	  this	  mechanism	  is	  a	  generic	  feature	  of	  Leviviridae	  capsid	  assembly.	  
	  Another	   interesting	   feature	   of	   the	   outer	   ring	   of	   genomic	   RNA	   is	   the	   suggestion	   of	  connectivity	   between	   density	   beneath	   some	   dimers	   (Figure	   5-­‐20).	   This	   has	   not	   been	  observed	  previously	   in	  Leviviridae.	  It	  has	  been	  previously	  suggested	   that	  all	   the	  possible	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paths	   of	   the	   genomic	   RNA	   through	   a	   protein	   capsid	   can	   be	   modelled	   using	   the	  mathematical	  principle	  of	  Hamiltonian	  paths	  (Rudnick	  &	  Bruinsma,	  2005).	  The	  concept	  of	  Hamiltonian	  paths	  is	  derived	  from	  graph	  theory,	  and	  asks	  how	  can	  each	  vertex	  of	  a	  graph	  be	   visited	   only	   once	   by	   walking	   from	   one	   vertex	   to	   the	   next	   along	   the	   edges	   of	   a	  polyhedron.	   When	   applied	   to	   packaging	   of	   a	   genome	   in	   members	   of	   Levivirus	   it	   is	  assumed	   the	   genome	   must	   visit	   each	   of	   the	   60	   A/B	   coat	   protein	   dimers	   only	   once	   (to	  induce	  conformational	  switching	  from	  C/C	  dimer),	  and	  any	  path	  of	  the	  RNA	  from	  the	  outer	  to	  the	  inner	  shell	  of	  RNA	  returns	  to	  the	  same	  5-­‐fold	  axis	   in	  the	  outer	  shell.	  Mathematical	  modelling	   using	   this	   principle,	   combined	   with	   low-­‐resolution	   cryo-­‐EM	   density	   maps,	  determined	  that	  for	  MS2	  there	  are	  40,678	  possible	  Hamiltonian	  paths	  the	  RNA	  could	  take	  (Dykeman	   et	   al.,	   2011).	   Further	   computational	   work	   combined	   with	   an	   asymmetric	  structure	   of	   MS2	   obtained	   using	   subtomogram	   averaing	   (Dent	   et	   al.,	  2013)	   has	   further	  narrowed	  the	  number	  of	  Hamiltonian	  paths	  that	  is	  compatible	  with	  experimental	  evidence	  to	  5	  (Geraets	  et	  al.,	  2015).	  Revisiting	  the	  use	  of	  Hamiltonian	  paths	  with	  an	  improved	  cryo-­‐EM	  density	  for	  the	  outer	  shell	  of	  RNA	  may	  help	  to	  further	  constrain	  the	  number	  of	  possible	  Hamiltonian	   paths	   the	   genome	  may	   take.	   This	   raises	   the	   tantilising	   possibility	   that	   the	  asymmetric	   reconstruction	   of	  Qβ	  will	   demonstrate	   that	   a	   single	   conformation	   of	  RNA	   is	  present	  in	  every	  virion.	  	  Fundamentally,	   spherical	   viruses	   such	   as	   Qβ	   are	   asymmetric,	   both	   in	   their	   genome	  organisation	   and	   protein	   composition	   (MP	   and	   extended	   coat	   protein).	   The	   EM	   maps	  presented	   here	   are	   all	   biased	   by	   the	   icosahedral	   symmetry	   of	   the	   capsid,	   and	   do	   not	  provide	   strong	   clues	   to	   the	   location	   of	   the	  maturation	   protein	   or	   C-­‐terminally	   extended	  coat	   protein.	   These	   features	   are	   present	   in	   one	   (MP)	   or	   low	   and	   variable	   (C-­‐terminally	  extended	  coat	  protein)	  copy	  numbers	   in	  each	  virion,	  and	  contribute	   little	   to	  the	  electron	  density	  of	  each	  particle	  compared	  with	   the	  mass	  of	   the	  whole	  capsid.	  The	  SPA	  approach	  used	   here	   is	   likely,	   at	   least	   in	   part,	   to	   have	   aligned	   particles	   based	   on	   the	   overarching	  icosahedral	   symmetry	   of	   the	   particles,	   even	   when	   that	   symmetry	   is	   not	   imposed.	   Thus	  features	  with	   low	  mass	   are	   likely	   somewhat	  misaligned	   and	   lost	   in	   the	   reconstructions.	  Alternative	   approaches	   are	   needed	   to	   locate	   such	   asymmetric	   components.	   For	   the	  MP,	  this	  has	  been	  tackled	  by	  utilising	   its	  role	   in	  binding	  virions	  to	  pili.	   In	  work	  by	  Dent	  et	  al,	  subtomogram	  averaging	  was	  used	  to	  show	  that	  the	  MP	  replaces	  one	  of	  the	  dimer	  subunits	  (Dent	  et	  al.,	  2013).	  An	  alternative	  approach	  could	   involve	  the	  use	  of	  adherons.	  Adherons	  could	   be	   raised	   against	   Qβ,	   with	   a	   negative	   selection	   against	   recombinantly	   produced	  capsids,	   which	   do	   not	   contain	   the	   MP.	   This	   could	   yield	   binders	   that	   are	   specific	   to	   the	  maturation	   protein.	   The	   adheron	   mass	   could	   then	   be	   used	   during	   classification	   and	  alignment	  to	  locate	  the	  MP.	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  The	   asymmetric	   genomic	   RNA	   is	   packaged	   with	   pseudo-­‐icosahedral	   symmetry,	   with	  different	   sequences	   bound	  with	   different	   affinity	   at	   each	   symmetry-­‐related	   binding	   site.	  The	  RNA	  must	   therefore	  be	   improperly	   averaged,	   and/or	  disordered,	   and	   refinement	  of	  the	  structure	  is	  biased	  by	  the	  icosahedral	  structure	  of	  the	  capsid.	  An	  interesting	  approach	  to	  tackle	  such	  symmetry	  mis-­‐matches	  between	  genome	  and	  capsids,	  and	  therefore	  provide	  structural	  evidence	  about	  genome	  organisation,	  is	  to	  subtract	  density	  associated	  with	  the	  capsid	  from	  the	  raw	  images,	  and	  apply	  SPA	  to	  these	  new	  particles	  to	  generate	  a	  structure	  containing	  information	  relating	  to	  the	  genome.	  This	  has	  been	  applied	  to	  dsRNA	  cypovirus	  genomes	   and	   associated	   polymerases	   in	   work	   published	   recently	   (Liu	   &	   Cheng,	   2015).	  Applying	  this	  method	  to	  the	  Qβ	  genome	  may	  yield	  new	  insights	  into	  genome	  organisation.	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8.1 Appendix	  A	  Over	   the	   course	   of	   this	   PhD,	   imaging	   of	   several	   other	   biological	   specimens	   have	   been	  imaged	  by	  cryo-­‐EM,	  work	  forming	  part	  of	  several	  publications.	  Here,	  this	  work	  is	  detailed.	  	  
8.1.1 Cowpea	  mosaic	  virus	  Cowpea	  mosaic	   virus	   (CPMV),	   is	   a	   member	   of	   the	   Comoviridae	   subfamily	   of	   the	   plant-­‐infecting	  Secoviridae.	  It	  has	  a	  bipartite,	  positive-­‐sense,	  single-­‐stranded	  RNA	  genome.	  The	  two	   segments,	   RNA-­‐1	   (6kb)	   and	   RNA-­‐2	   (3.5kb)	   are	   encapsidated	   in	   separate	   virions.	   It	  forms	  icosahedral	  particles	  that	  have	  a	  maximum	  diameter	  of	  ~30	  nm	  and	  are	  comprised	  of	   60	   copies	   each	   of	   a	   Large	   and	   Small	   coat	   protein.	   Large	   and	   Small	   coat	   proteins	   are	  processed	   from	   a	   single	   precursor	   polyprotein,	   processed	   by	   the	   action	   of	   the	   RNA-­‐1-­‐encoded	  24K	  proteinase.	  Particles	  containing	  the	  two	  different	  genomic	  RNAs	  can	  readily	  be	   purified	   (CPMV	   bottom	   and	   CPMV	  middle),	   along	   with	   empty	   particles	   (CPMV	   top),	  named	  for	  the	  position	  they	  adopt	  .	  Additionally,	  empty	  virus	  like	  particles	  (eVLP)	  can	  be	  produced	   by	   the	   expression	   of	   the	   precursor	   of	   Large	   and	   Small	   subunits	   while	   co-­‐expressing	   the	   viral	   proteinase	   to	   allow	   correct	   processing	   of	   the	   polyprotein,	   using	   an	  Agrobacterium-­‐based,	  pEAQ	  vector	   system.	  The	   result	   is	   efficient	   release	  of	  mature	   coat	  protein	  subunits	  and	  large	  quantities	  of	  eVLPs.	  	  	  Cryo-­‐EM	   grids	   were	   prepared	   for	   CPMV	   bottom,	   middle	   and	   eVLP	   samples	   and	   data	  collected	  at	   the	  MRC	  LMB	  (CPMV	  bottom,	  eVLP)	  or	  NeCEN,	  Leiden	  (CPMV	  middle,	  CPMV	  top)	   on	   a	   Titan	   Krios	   microscope	   equipped	   with	   a	   Falcon	   II	   direct	   detector.	   Data	   was	  processed	  in	  RELION	  by	  Emma	  Hesketh.	  A	  3.0	  Å	  structure	  of	  the	  eVLP,	  3.4	  Å	  structure	  of	  CPMV	   bottom,	   and	   4.0	   Å	   structures	   of	   CPMV	  middle	   and	   top	   structures	  were	   obtained.	  These	  structures	  form	  part	  of;	  	  
• Emma	  L.	  Hesketh,	  Yulia	  Meshcheriakova,	  Kyle	  C.	  Dent,	  Pooja	  Saxena,	  Rebecca	   F.	  
Thompson,	   Joseph	   J.	   Cockburn,	   George	   P.	   Lomonossoff	   &	   Neil	   A.	   Ranson	   2015.	  Mechanisms	  of	  assembly	  and	  genome	  packaging	  in	  an	  RNA	  virus	  revealed	  by	  high-­‐resolution	  cryo-­‐EM.	  Nature	  Communications	  6	  p.10113.	  
8.1.2 BK	  Polyomavirus	  BK	  polyomavirus	  is	  the	  causative	  agent	  of	  several	  diseases	  in	  transplant	  patients	  and	  the	  immunosuppressed.	   In	   order	   to	   better	   understand	   the	   structure	   and	   lifecycle	   of	   BK,	  infectious	   virions	   and	   VP1	   only	   virus-­‐like	   particles	   were	   produced	   in	   cell	   culture,	   and	  determined	  their	  three-­‐dimensional	  structures	  using	  cryo-­‐electron	  microscopy	  and	  single-­‐particle	  image	  processing.	  The	  resulting	  7.6	  Å	  resolution	  structure	  of	  infections,	  wild	  type	  BK	  and	  8.7	  Å	  resolution	  of	   the	  VLP	  are	   the	  highest	   resolution	  cryo-­‐EM	  structures	  of	  any	  polyomavirus	   to	   date.	   These	   structures	   confirm	   that	   the	   architecture	   of	   the	   major	  structural	   protein	   components	   of	   these	   human	   polyomaviruses	   are	   similar	   to	   previous	  structures	   from	   other	   hosts,	   but	   give	   new	   insight	   into	   the	   location	   and	   role	   of	   the	  enigmatic	  minor	  structural	  proteins,	  VP2	  and	  VP3.	  	  These	  structures	  form	  part	  of	  the	  following	  publications;	  
• Daniel	   L.	   Hurdiss,	   Rebecca	   F.	   Thompson,	   Ethan	   L.	   Morgan,	   Emma	   L.	   Prescott,	  Margarita	  M.	   Panou,	   Andrew	  Macdonald	  &	  Neil	   A.	   Ranson.	   2015.	  New	   structural	  insights	   into	   the	   genome	   and	   minor	   capsid	   proteins	   of	   BK	   polyomavirus	   using	  cryo-­‐electron	  microscopy.	  Under	  review,	  Structure.	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8.1.3 Magnetopolymersomes	  There	  is	  growing	  interest	  in	  functionalising	  vesicles	  with	  magnetic	  nanoparticles	  (MNPs),	  in	   order	   to	   help	   target	   therapeutics	   by	   localising	   them	   using	   magnetic	   fields.	   There	   is	  considerable	  interest	  in	  MNP	  embedded	  vehicles	  for	  nanomedicine,	  but	  their	  development	  is	  currently	  hindered	  by	  difficulties	  producing	  consistently	  monodisperse	  MNPs,	  and	  their	  reliable	   loading	   into	   vesicles.	   In	   this	   work,	   a	   tuneable,	   switchable	   magnetic	   delivery	  vehicle	   for	   nanomedical	   application	   was	   developed.	   These	   are	   comprised	   of	   tailored	  polymer	   vesicles	   (polymersomes)	   embedded	   with	   superparamagnetic	   magnetite	   MNPs	  (magnetopolymersomes).	   Cryo-­‐ET	   was	   used	   to	   characterise	   the	   vesicles	   and	   their	  associated	  MNPs.	  Tomogram	  reconstruction	  enabled	  both	  the	  polymersome	  membrane	  ad	  the	  MNP,	  and	  showed	  there	  was	  no	  MNPs	  in	  the	  core	  of	  the	  vesicle.	  	  This	  work	  forms	  part	  of	  the	  following	  publication;	  
• In	   situ	   formation	   of	   magnetopolymersomes	   via	   electroporation	   for	   MRI.	   2015.	  Jennifer	   Bain,	   Lorena	   Ruiz-­‐Pérez,	   Aneurin	   J.	   Kennerley,	   Stephen	   P.	   Muench,	  
Rebecca	  Thompson,	  Giuseppe	  Battaglia	  &	  Sarah	  S.	  Staniland.	  Scientific	  Reports	  5,	  Article	  number:	  14311	  	  
8.2 Appendix	  B	  	  On	  the	  accompanying	  CD;	  
This	  thesis;	  Thesis.pdf	  
Chapter	  4	  Tilt	  series	  and	  tomograms	  from	  Percoll	  gradient,	  fraction	  9;	  Percoll-­‐tilt1.mov	  Percoll-­‐tomo1.mov	  Percoll-­‐tilt2.mov	  Percoll-­‐tomo2.mov	  Segmentation	  of	  tomogram	  containing	  membranes	  and	  amyloid	  fibrils;	  Amira.mpg	  Tomogram	  of	  Sh-­‐SY5Y	  neuroblastoma	  cell;	  Cell.mov	  	  Soft-­‐X	  ray	  microscope	  of	  RAW	  264.7	  cells	  exposed	  to	  Ls-­‐f;	  X-­‐ray.mov	  	  
Appendix	  	  Tomogram	  of	  Magnetopolymersomes;	  Magnetosome.mov	  
